BIOTECHNOLOGICAL SYNTHESIS PROCESS OF ORGANIC COMPOUNDS WITH THE AID OF AN ALKL GENE PRODUCT

Abstract

Subject matter of the invention is a biotechnological process for the production of organic compounds with the aid of at least one alkL gene product.

Description

FIELD OF THE INVENTION

Subject matter of the invention is a biotechnological process for the production of organic compounds with the aid of at least one alkL gene product.

PRIOR ART

Fatty acids and their derivatives are currently obtained exclusively from vegetable and animal oils or fats. This has a number of disadvantages:

As a consequence of the BSE crisis, animal fats in particular are virtually no longer accepted by the customer as raw materials. Vegetable oils which contain short- and medium-chain fatty acids are either not readily available or are produced in tropical regions. Here, the sustainability of the production is open to question in many cases because it may be the case that rainforest is destroyed so as to make the cropping areas available.

Furthermore, vegetable and animal oils and fats have fatty acid spectra which are specific for the raw material in question, but fixed. The consequence is a coupled production, which may determine the price of a particular fatty acid species. Finally, many of the vegetable oils are simultaneously also foodstuffs so that, under certain circumstances, competition may emerge between the use as a feed stock substance and the use as a foodstuff.

This is why there is a search for alternative sources and production pathways for fatty acids, and, as a result, a great deal of research effort is currently being invested into the production of fatty acids in, for example, algae, but also in particular in recombinant microorganisms such as, for example, yeasts and bacteria.

Although a series of technologies are being developed for the production of fatty-acid-based fuels and chemicals from renewable raw materials, in particular carbohydrates, the yields achieved are too low for a meaningful commercial utilization.

The problem of the invention was to provide a more productive biological process for the production of organic compounds.

DESCRIPTION OF THE INVENTION

Surprisingly, it has been found that the coexpression of an alkL gene product in the producing microorganism, which coexpression is described hereinbelow, is capable of solving the problem of the invention.

Subject matter of the present invention, therefore, are microorganisms which synthesize organic substances and which express alkL at a higher level.

A further subject matter of the invention is the use of the abovementioned microorganisms for the production of organic substances, and a process for producing organic substances using the microorganisms.

An advantage of the present invention is that the product inhibition in the production process can be reduced greatly.

A further advantage is that the space-time yield and the carbon yield of the process are increased in comparison with microorganisms which express no, or less, alkL.

Yet another advantage of the present invention is that the product concentration in the culture supernatant is increased so as to facilitate efficient work-up.

Unless otherwise specified, all percentages stated (%) are percent by mass.

The invention comprises methods for generating recombinant microbial cells which are capable of producing organic substances, such as carboxylic acids and carboxylic acid derivatives, such as, for example, carboxylic acid esters, alkanes, alkan-1-ols, alkan-1-als, alkan-1-amines and 1-alkenes, from unrelated carbon sources.

The present invention therefore comprises a microorganism which includes a first genetic modification so that it is capable of forming more organic substance from at least one simple carbon source in comparison with its wild type, characterized in that the microorganism includes a second genetic modification so that it forms more alkL gene product in comparison with its wild type.

In the context of the present invention, the expression “first genetic modification” is understood as meaning at least one genetic modification of the microorganism in which one or more genes have been modified, i.e. increased or reduced, in their expression in comparison with the wild-type strain.

In the context of the present invention, the expression “simple carbon source” is understood as meaning carbon sources in which, in the carbon skeleton, at least one C—C bond must be broken and/or at least one carbon atom of the simple carbon source must form at least one new bond with at least one carbon atom of another molecule so as to arrive at the carbon skeleton of the “organic substance of which more is formed”.

In the context of the present invention, the expression “alkL gene product” is understood as meaning proteins which meet at least one of the following two conditions:

1.) the protein is identified as a member of the superfamily of the OmpW proteins (Protein family 3922 in the Conserved Domain Database (CDD) of the National Centre for Biotechnology Information (NCBI)), this assignment being made by an alignment of the amino acid sequence of the protein with the database entries present in the NCBI CDD that had been deposited by 22.03.2010, using the standard search parameters, an E value less than 0.01 and using the algorithm “blastp 2.2.23+”,2.) in a search for conserved protein domains contained in the amino acid sequence of interest in the NCBI CDD (Version 2.20) by means of RPS-BLAST, the presence of the conserved domain “OmpW, Outer membrane protein W” (COG3047) with an E value less than 1×10⁻⁵ is obtained (a domain hit).

Preferred organic substances of the present invention are those which have more than one, in particular 3 to 36, preferably 6 to 24, in particular 10 to 18 carbon atoms. The organic substances may be linear, branched, saturated or unsaturated and optionally substituted by other groups.

It is preferred in accordance with the invention that the organic substance is selected from the group comprising, preferably consisting of,

carboxylic acids, in particular having 3 to 34, preferably having 6 to 22, especially preferably having 6 to 18, carbon atoms,carboxylic acid esters, in particular having 3 to 34, preferably having 6 to 22, especially preferably having 6 to 18, carbon atoms in the carboxylic acid moiety, in which the alcohol component is derived from methanol, ethanol or other primary alcohols having 3-18 carbon atoms, in particular from methanol and ethanol,alkanes having 3 to 34, preferably having 6 to 22, especially preferably having 6 to 18, carbon atoms,alkenes having 3 to 34, preferably having 6 to 22, especially preferably having 6 to 18, carbon atoms,monohydric alcohols having 3 to 34, preferably having 6 to 22, especially preferably having 6 to 18, carbon atoms,aldehydes having 3 to 34, preferably having 6 to 22, especially preferably having 6 to 18, carbon atoms,monovalent amines having 3 to 34, preferably having 6 to 22, especially preferably having 6 to 18, carbon atoms,and substituted compounds of the above group members, in particular those which carry, as further substituents, one or more hydroxyl, amine, keto, carboxyl, methyl, ethyl, cyclopropyl or epoxy functions, with unsubstituted ones being preferred.

Especially preferred are the organic substances fatty acids, fatty acid esters, alkan-1-als, alkan-1-ols and alkan-1-amines, alkanes and alkenes, in particular 1-alkenes, where the esters in the abovementioned compounds are preferably those in which the alcohol component is derived from methanol, ethanol or other primary alcohols having 3-18 carbon atoms, in particular from methanol and ethanol.

The organic substances are especially preferably selected from among fatty acids and fatty acid esters in which the fatty acid component is selected from the group consisting of formic acid, acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, oenanthic acid, caprylic acid, pelargonic acid, capric acid, lauric acid, myristic acid, pentadecanoic acid, palmitic acid, margaric acid, stearic acid, nonadecanoic acid, arachidic acid, behenic acid, lignoceric acid, cerotic acid, montanic acid, melissic acid, undecylenic acid, myristoleic acid, palmitoleic acid, petroselic acid, oleic acid, elaidic acid, vaccenic acid, gadoleic acid, eicosenoic acid, cetoleic acid, erucic acid, nervonic acid, pelargonic acid, linoleic acid, α-linolenic acid, γ-linolenic acid, calendulic acid, punicic acid, α-elaeostearic acid, β-elaeostearic acid, arachidonic acid, timnodonic acid, clupanodonic acid, cervonic acid, vernolic acid, ricinoleic acid

andtheir derivatives in the form of corresponding alkan-1-als, alkan-1-ols, alkan-1-amines and, in the case of unsaturated fatty acids, such as, for example, palmitoleic acid, oleic acid, linoleic acid, α-linolenic acid, γ-linolenic acid, also alken-1-als, alken-1-ols, alken-1-amines, and alkanes and alkenes prepared from the abovementioned fatty acids by enzymatic reduction and decarbonylation, and alkenes, in particular 1-alkenes, prepared from the abovementioned fatty acids by enzymatic decarboxylation, if appropriate having further, nonterminal double bonds.

In this context, the expression “corresponding alkane/alkene-1 compounds” is understood as meaning that the carboxyl group of the fatty acid in question is replaced by a —COH, a —CH₂OH or a —CH₂NH₂.

If, in the context of the present invention, the following text will describe enzymatic activities which catalyse reactions in which alkanoic acids, alkan-1-als, alkan-1-ols or alkan-1-amines are involved either directly or indirectly, it shall be assumed that alkanoic acids, alkan-1-als, alkan-1-ols or alkan-1-amines which additionally have one or more nonterminal double bonds are, as a rule, included in the abovementioned enzymatic activity.

Carbohydrates such as, for example, glucose, sucrose, arabinose, xylose, lactose, fructose, maltose, molasses, starch, cellulose and hemicellulose, but also glycerol or very simple organic molecules such as CO₂, CO or synthesis gas may be employed as the carbon source.

It is preferred in accordance with the invention that, owing to the good genetic accessibility, microorganisms are employed which are selected from the group of the bacteria, especially from the group containing, preferably consisting of, Magnetococcus, Mariprofundus, Acetobacter, Acidiphilium, Afipia, Ahrensia, Asticcacaulis, Aurantimonas, Azorhizobium, Azospirillum, Bartonella, tribocorum, Beijerinckia, Bradyrhizobium, Brevundimonas, subvibrioides, Brucella, Caulobacter, Chelativorans, Citreicella, Citromicrobium, Dinoroseobacter, Erythrobacter, Fulvimarina, Gluconacetobacter, Granulibacter, Hirschia, Hoeflea, Hyphomicrobium, Hyphomonas, Ketogulonicigenium, Labrenzia, Loktanella, Magnetospirillum, Maricaulis, Maritimibacter, Mesorhizobium, Methylobacterium, Methylocystis, Methylosinus, Nitrobacter, Novosphingobium, Oceanibulbus, Oceanicaulis, Oceanicola, Ochrobactrum, Octadecabacter, Oligotropha, Paracoccus, Parvibaculum, Parvularcula, Pelagibaca, Phaeobacter, Phenylobacterium, Polymorphum, Pseudovibrio, Rhodobacter, Rhodomicrobium, Rhodopseudomonas, Rhodospirillum, Roseibium, Roseobacter, Roseomonas, Roseovarius, Ruegeria, Sagittula, Silicibacter, Sphingobium, Sphingomonas, Sphingopyxis, Starkeya, Sulfitobacter, Thalassiobium, Xanthobacter, Zymomonas, Agrobacterium, Rhizobium, Sinorhizobium, Anaplasma, Ehrlichia, Neorickettsia, Orientia, Rickettsia, Wolbachia, Bordetella, Burkholderia, Cupriavidus, taiwanensis, Lautropia, Limnobacter, Polynucleobacter, Raistonia, Chromobacterium, Eikenella, corrodens, Basfia, Kingella, Laribacter, Lutiella, Neisseria, Simonsiella, Achromobacter, Acidovorax, Alicycliphilus, Aromatoleum, Azoarcus, Comamonas, Dechloromonas, Delftia, Gallionella, Herbaspirillum, Herminiimonas, Hylemonella, Janthinobacterium, Leptothrix, Methylibium, Methylobacillus, Methylophilales, Methyloversatilis, Methylovorus, Nitrosomonas, Nitrosospira, Oxalobacter, Parasutterella, Polaromonas, Polaromonas, Pusillimonas, Rhodoferax, Rubrivivax, Sideroxydans, Sutterella, wadsworthensis, Taylorella, Thauera, Thiobacillus, Thiomonas, Variovorax, Verminephrobacter, Anaeromyxobacter, Bdellovibrio, bacteriovorus, Bilophila, Desulfarculus, Desulfatibacillum, Desulfobacca, Desulfobacterium, Desulfobulbus, Desulfococcus, Desulfohalobium, Des ulfitobacterium, Desulfomicrobium, Desulfonatronospira, Desulfotalea, Desulfovibrio, Desulfuromonas, Geobacter, Haliangium, Hippea, Lawsonia, Myxococcus, Pelobacter, Plesiocystis, Sorangium, Stigmatella, Syntrophobacter, Syntrophus, Arcobacter, Caminibacter, Campylobacter, Helicobacter, Nitratifractor, Nitratiruptor, Sulfuricurvum, Sulfurimonas, Sulfurospirillum, Sulfurovum, Wolinella, Buchnera, Blochmannia, Hamiltonella, Regiella, Riesia, Citrobacter, Cronobacter, Dickeya, Edwardsiella, Enterobacter, Erwinia, Escherichia, Klebsiella, Pantoea, Pectobacterium, Proteus, Providencia, Rahnella, Salmonella, Serratia, Shigella, Sodalis, Wigglesworthia, Glossina, Xenorhabdus, Yersinia, Acidithiobacillus, Acinetobacter, Aeromonas, Alcanivorax, Alkalilimnicola, Allochromatium, Alteromonadales, Alteromonas, Baumannia, Beggiatoa, Bermanella, Carsonella, Ruthia, Vesicomyosocius, Cardiobacterium, Chromohalobacter, Colwellia, Congregibacter, Coxiella, Dichelobacter, Endoriftia, Enhydrobacter, Ferrimonas, Francisella, Glaciecola, Hahella, Halomonas, Halorhodospira, Halothiobacillus, Idiomarina, Kangiella, Legionella, Marinobacter, Marinomonas, Methylobacter, Methylococcus, Methylomicrobium, Methylophaga, Moraxella, Moritella, Neptuniibacter, Nitrococcus, Pseudoalteromonas, Psychrobacter, Psychromonas, Reinekea, Rickettsiella, Saccharophagus, Shewanella, Succinatimonas, Teredinibacter, Thioalkalimicrobium, Thioalkalivibrio, Thiomicrospira, Tolumonas, Vibrionales, Actinobacillus, Aggregatibacter, Gallibacterium, Haemophilus, Histophilus, Mannheimia, Pasteurella, Azotobacter, Cellvibrio, Pseudomonas, Aliivibrio, Grimontia, Photobacterium, Photobacterium, Vibrio, Pseudoxanthomonas, Stenotrophomonas, Xanthomonas, Xylella, Borrelia, Brachyspira, Leptospira, Spirochaeta, Treponema, Hodgkinia, Puniceispirillum, Liberibacter, Pelagibacter, Odyssella, Accumulibacter, in particular E. coli, Pseudomonas sp., Pseudomonas fluorescens, Pseudomonas putida, Pseudomonas stutzeri, Acinetobacter sp., Burkholderia sp., Burkholderia thailandensis, cyanobacteria, Klebsiella sp., Klebsiella oxytoca, Salmonella sp., Rhizobium sp. and Rhizobium meliloti, with E. coli being especially preferred.

Preferred alkL gene products which are present in the microorganisms according to the invention are characterized in that the production of the alkL gene product in the native host is induced by dicyclopropyl ketone; in this context, it is additionally preferred that the alkL gene is expressed as part of a group of genes, for example in a regulon, such as, for example, in an operon.

alkL gene products which are present in the microorganisms according to the invention are preferably encoded by alkL genes of organisms selected from the group of the Gram-negative bacteria, in particular the group containing, preferably consisting of, Pseudomonas sp., Azotobacter sp., Desulfitobacterium sp., Burkholderia sp., preferably Burkholderia cepacia, Xanthomonas sp., Rhodobacter sp., Ralstonia sp., Delftia sp. and Rickettsia sp., Oceanicaulis sp., Caulobacter sp., Marinobacter sp. and Rhodopseudomonas sp., preferably Pseudomonas putida, Oceanicaulis alexandrii, Marinobacter aquaeolei, in particular Pseudomonas putida GPo1 and P1, Oceanicaulis alexandrii HTCC2633, Caulobacter sp. K31 and Marinobacter aquaeolei VT8.

In this context, very especially preferred alkL gene products are encoded by the alkL genes from Pseudomonas putida GPo1 and P1, which are shown by SEQ ID No. 1 and SEQ ID No. 29, and proteins with the polypeptide sequence SEQ ID No. 2, SEQ ID No. 30, SEQ ID No. 31, SEQ ID No. 32 or SEQ ID No. 33 or with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, particularly up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with SEQ ID No. 2, SEQ ID No. 30, SEQ ID No. 31, SEQ ID No. 32 or SEQ ID No. 33 by deletion, insertion, substitution or a combination thereof and which products still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90% of the activity of the protein with the respective reference sequence SEQ ID No. 2, SEQ ID No. 30, SEQ ID No. 31, SEQ ID No. 32 or SEQ ID No. 33, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, more precisely in a system as described in the exemplary embodiments, in which system glucose is reacted in an E. coli cell to give palmitoleic acid. A method of choice for determining the synthesis rate can be found in the exemplary embodiments.

The definition of the units here is the definition customary in enzyme kinetics: 1 unit of biocatalyst reacts 1 μmol of substrate in one minute to form the product.

1 U=1 μmol/min

Modifications of amino acid residues of a given polypeptide sequence that do not lead to any substantial changes of the properties and function of the given polypeptide are known to the skilled worker. For instance, some amino acids, for example, can frequently be exchanged for one another without problem; examples of such suitable amino acid substitutions are: Ala for Ser; Arg for Lys; Asn for Gln or His; Asp for Glu; Cys for Ser; Gln for Asn; Glu for Asp; Gly for Pro; His for Asn or Gln; Ile for Leu or Val; Leu for Met or Val; Lys for Arg or Gln or Glu; Met for Leu or Ile; Phe for Met or Leu or Tyr; Ser for Thr; Thr for Ser; Trp for Tyr; Tyr for Trp or Phe; Val for Ile or Leu. Likewise, it is known that modifications, especially at the N- or C-terminus of a polypeptide in the form of, for example, amino acid insertions or deletions, will frequently have no substantial effect on the function of the polypeptide.

First genetic modification for the synthesis of carboxylic acids, carboxylic acid esters and other carboxylic acid derivatives from a simple carbon source

According to the invention, the microorganisms include a first genetic modification so that they are capable of forming more organic substance, in particular carboxylic acids and carboxylic acid derivatives, from at least one simple carbon source in comparison with their wild type.

In this context, it is preferred in accordance with the invention that the first genetic modification is an activity of at least one of the enzymes selected from the group

E_i acyl-ACP (Acyl Carrier Protein) thioesterase, preferably from EC 3.1.2.14 or EC 3.1.2.22, which catalyses the hydrolysis of an acyl-acyl carrier protein thioester,E_ii acyl-CoA (Coenzyme A) thioesterase, preferably from EC 3.1.2.2, EC 3.1.2.18, EC 3.1.2.19, EC 3.1.2.20 or EC 3.1.2.22, which catalyses the hydrolysis of an acyl-coenzyme A thioester,E_iib acyl-CoA (Coenzyme A): ACP (Acyl Carrier Protein) transacylase, which preferably catalyses a reaction in which a CoA thioester is converted into an ACP thioester,E_iii polyketide synthase, which catalyses a reaction which participates in the synthesis of carboxylic acids and carboxylic acid esters, andE_iv hexanoic acid synthase, a specialized fatty acid synthase of the FAS-I type, which catalyses the synthesis of hexanoic acid from two molecules malonyl-coenzyme A and one molecule acetyl-coenzyme Awhich is increased in comparison with the enzymatic activity of the wild type of the microorganism.

What will now be said on increasing the enzymatic activity in cells applies not only to the increase of the activity of the enzyme E_i to E_iv, but also to all of the enzymes mentioned thereafter, whose activity may optionally be increased, and to an increased alkL gene product formation.

The expression “increased activity of an enzyme” as used hereinabove and in what will be said hereinbelow in the context of the present invention is preferably understood as meaning an increased intracellular activity; this statement also applies to an increased alkl gene product formation.

In principle, an increase of the enzymatic activity can be achieved by increasing the number of copies of the gene sequence or of the gene sequences which encode the enzyme, using a strong promoter, modifying the codon usage of the gene, increasing in various ways the half-life of the mRNA or of the enzyme, modifying the regulation of expression of the gene or using a gene or allele which encodes a corresponding enzyme with an increased activity, and optionally combining these measures. Microorganisms which are genetically modified in accordance with the invention are generated for example by transformation, transduction, conjugation or a combination of these methods using a vector which contains the desired gene, an allele of this gene or parts thereof, and a promoter which makes possible the expression of the gene. Heterologous expression is made possible, in particular, by integrating the gene or the alleles into the chromosome of the cell or a vector which replicates extrachromosomally.

An overview over the possibilities of increasing the enzymatic activity in cells with pyruvate carboxylase as example can be found in DE-A-100 31 999, which is herewith incorporated by reference and whose disclosure regarding the possibilities of increasing the enzymatic activity in cells forms part of the disclosure of the present invention.

The expression of the abovementioned, and all hereinafter mentioned, enzymes and/or genes can be detected in the gel with the aid of one- and two-dimensional protein gel separation followed by optical identification of the protein concentration using suitable evaluation software. If the increase of an enzymatic activity is based exclusively on an increase of the expression of the gene in question, the quantification of the increase of the enzymatic activity can be determined in a simple manner by a comparison of the one- or two-dimensional protein separations between the wild type and the genetically modified cell. A customary method for preparing the protein gels in the case of bacteria and for identifying the proteins is the procedure described by Hermann et al. (Electrophoresis, 22: 1712-23 (2001). The protein concentration can likewise be analysed by Western blot hybridization with an antibody which is specific for the protein to be detected (Sambrook et al., Molecular Cloning: a laboratory manual, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. USA, 1989) followed by optical evaluation with suitable software for determining the concentration (Lohaus and Meyer (1989) Biospektrum, 5: 32-39; Lottspeich (1999), Angewandte Chemie 111: 2630-2647). This is also always the method of choice when potential products of the reaction catalysed by the enzymatic activity to be determined can be metabolized rapidly in the microorganism or else when the activity in the wild type itself is too low to be able to sufficiently determine the enzymatic activity to be determined with the aid of the product formation.

Using the above-described methods, it can also be determined whether an observed microorganism forms more alkL gene product in comparison with its wild type.

The accession numbers mentioned in the context of the present invention correspond to the ProteinBank database entries of the NCBI dated 26.07.2011; as a rule, the version number of the entry is identified here by “.number”, such as, for example, “0.1”.

Specific Enzymes E_i

The reaction catalysed by E_i differs from the reaction catalysed by E_ii only in that an acyl-coenzyme A thioester is hydrolyse in place of an acyl-acyl carrier protein thioester. It is obvious that many of the enzymes E_i mentioned can, due to the significant secondary activity, also be employed as E_ii, and vice versa.

In cells which are preferred in accordance with the invention, the enzyme E_i is an enzyme which comprises sequences selected from among:

AAC72881.1, ABB71579.1, CAC19934.1, AAC49180.1 (encoded by SEQ ID No.: 10), AAC49783.1, AAC49179.1, CAB60830.1, ABB71581.1, AAC49269.1, CAC 19933.1, CAA54060.1, AAC72882.1, Q39513.1, AAC49784.1, ABO38558.1, ABO38555.1, ABO38556.1, ABO38554.1, ADB79568.1, ADB79569.1, ACQ57188.1, ACQ57189.1, ABK96561.1, ACQ63293.1, ACQ57190.1, Q9SQI3.1, ABU96744.1, ABC47311.1, XP_—002324962.1, AAD01982.1, AAB51525.1, ACV40757.1, XP_—002309244.1, CBI28125.3, ABD91726.1, XP_—002284850.1, XP_—002309243.1, XP_—002515564.1, ACR56792.1, ACR56793.1, XP_—002892461.1, ABI18986.1, NP_—172327.1, CAA85387.1, CAA85388.1, ADA79524.1, ACR56795.1, ACR56794.1, CAN81819.1, ACF17654.1, AAB71729.1, ABH11710.1, ACQ57187.1, AAX51637.1, AAB88824.1, AAQ08202.1, AAB71731.1, AAX51636.1, CAC80370.1, CAC80371.1, AAG43858.1, ABD83939.1, AAD42220.2, AAG43860.1, AAG43861.1, AAG43857.1, AAL15645.1, AAB71730.1, NP_—001068400.1, EAY86877.1, NP_—001056776.1, XP_—002436457.1, NP_—001149963.1, ACN27901.1, EAY99617.1, ABL85052.1, XP_—002437226.1, NP_—001151366.1, ACF88154.1, NP_—001147887.1, XP_—002453522.1, BAJ99650.1, EAZ37535.1, EAZ01545.1, AAN 17328.1, EAY86884.1, EEE57469.1, Q41635.1, AAM09524.1, Q39473.1, NP_—001057985.1, AAC49001.1, XP_—001752161.1, XP_—001770108.1, XP_—001784994.1, XP_—002318751.1, NP_—001047567.1, XP_—002322277.1, XP_—002299627.1, XP_—002511148.1, CBI 15695.3, XP_—002299629.1, XP_—002280321.1, CAN60643.1, XP_—002459731.1, XP_—002975500.1, XP_—002962077.1, XP_—001773771.1, NP_—001151014.1, XP_—002317894.1, XP_—002971008.1, XP_—001774723.1, XP_—002280147.1, XP_—002526311.1, XP_—002517525.1, XP_—001764527.1, AB120759.1, BAD73184.1, XP_—002987091.1, XP_—002985480.1, CBI26947.3, ABI20760.1, XP_—002303055.1, XP_—002885681.1, ADH03021.1, XP_—002532744.1, EAY74210.1, EEC84846.1, EEE54649.1, AAG35064.1, AAC49002.1, CAD32683.1, ACF78226.1, BAJ96402.1, XP_—002462626.1, NP_—001130099.1, XP_—002462625.1, ABX82799.3, Q42712.1, NP_—193041.1, AAB51524.1, NP_—189147.1, ABR18461.1, XP_—002863277.1, AAC72883.1, AAA33019.1, CBI40881.3, XP_—002262721.1, AAB51523.1, NP_—001063601.1, ADB79567.1, AAL77443.1, AAL77445.1, AAQ08223.1, AAL79361.1, CAA52070.1, AAA33020.1, CAA52069.1, XP_—001785304.1, CAC39106.1, XP_—002992591.1, XP_—002968049.1, XP_—001770737.1, XP_—001752563.1, AAG43859.1, XP_—002978911.1, XP_—002977790.1, ACB29661.1, XP_—002314829.1, XP_—002991471.1, EAZ45287.1, XP_—002986974.1, EEC73687.1, XP_—002312421.1, ACJ84621.1, NP_—001150707.1, AAD28187.1, XP_—001759159.1, XP_—001757193.1, XP_—002322077.1, ABE01139.1, XP_—002447294.1, AAX54515.1, AAD33870.1, AEM72521.1in particularAAC72881.1, ABB71579.1, CAC19934.1, AAC49180.1 (encoded by SEQ ID No.: 10), AAC49783.1, AAC49179.1, CAB60830.1, ABB71581.1, AAC49269.1 (encoded by SEQ ID No.: 8), CAC19933.1, CAA54060.1, AAC72882.1, Q39513.1 (encoded by SEQ ID No.: 9), AAC49784.1, AAC72883.1, Q41635.1, AAC49001.1 (encoded by SEQ ID No.: 37), AEM72521.1 (encoded by SEQ ID No.: 35)andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_i is generally understood in particular as meaning the hydrolysis of the dodecanoyl-ACP thioester.

Microorganisms which are preferred according to the invention are those which are obtained when the microorganisms listed hereinbelow, which include a first genetic modification within the meaning of the invention, are employed as the starting point by being provided with the second genetic modification and, if appropriate, with at least one further genetic modification within the meaning of the invention.

WO2010063031 A2 describes microorganisms which include a first genetic modification so that they are capable of forming more microbial oil from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0007] to [0008], [0092] to [0100], [0135] to [0136], [0181] to [0186] and [0204] to [0213] and in the exemplary embodiments 4 to 8. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in sections [0012] to [0013], [0155], [0160] to [0163], [0185] to [0190] and [0197] to [0199], FIG. 12, the exemplary embodiments 4 to 8 and Table 3.

WO2010063032 A2 describes microorganisms which include a first genetic modification so that they are capable of forming more microbial oil from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0007] to [0008], [0092] to [0100], [0135] to [0136], [0181] to [0186] and [0204] to [0213] and in the exemplary embodiments 4 to 8. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in sections [0012] to [0013], [0155], [0160] to [0163], [0185] to [0190] and [0197] to [0199], FIG. 12, the exemplary embodiments 4 to 8 and Table 3.

WO2011003034 A2 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular adipic acid, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular on page 3, second section, to page 7, first section, page 20, second section, to page 22, second section, and on page 156 to page 166, fifth section, and in Claims 1 to 100. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular on page 35, third section, and page 36, first section.

WO2011008565 A1 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acids, alkan-1-als, alkan-1-ols, alkanes and fatty acid esters, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0018] to [0024] and [0086] to [0102] and in the exemplary embodiments 2, 4, 7, 9 and 10. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in sections [0009] to [0018] and [0073] to [0082], FIGS. 1 to 3 and 7, Table 4, the exemplary embodiments 1 to 10 and Claims 1 to 5 and 11 to 13.

WO2009076559 A1 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acids, alkan-1-ols, alkanes or alkenes, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0013] to [0051] and [0064] to [00111] and in Claims 1 to 10. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in Table 1, sections [0021], [0024] to [0030] and [0064] to [00111] and FIG. 6.

WO2010017245 A1 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0011] to [0015] and [00114] to [00134], in the exemplary embodiment 3 and in Claims 1 to 2 and 9 to 11. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in Tables 1, 2 and 3, sections [0080] to [00112] and Claims 3 to 8.

WO2010127318 A2 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular biodiesel equivalents and other fatty acid derivatives, mainly fatty acid ethyl esters, fatty acid esters, wax esters, alkan-1-ols and alkan-1-als, from at least one simple carbon source in comparison with their wild type and which are preferably employed in accordance with the invention, in particular on pages 1 to 9 and 11 to 16, exemplary embodiments 1, 2 and 4, FIGS. 1A to 1E and Claims 23 to 43, 62 to 79 and 101 to 120. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular on pages 17, 19 to 23.

WO2008100251 A1 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acid esters, wax esters and alkan-1-ols, from at least one simple carbon source in comparison with their wild type and which are preferably employed in accordance with the invention, in particular on pages 4 to 7 and 45 to 46, FIGS. 1A to 1E and Claims 9 to 13. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular on pages 4 to 5 and 45 to 46.

WO2007136762 A2 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acid esters, wax esters, hydrocarbons and alkan-1-ols, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular on pages 2 to 4 and 17 to 18, Table 7, FIGS. 2 to 4, exemplary embodiments 2 to 8 and Claims 13 and 35. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular on pages 17 to 18, in Tables 1, 7, 8 and 10 and in FIG. 10.

WO2008113041 A2 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acid esters, wax esters, hydrocarbons, aliphatic ketones and alkan-1-ols, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular on pages 35 to 41 and 64 to 67, FIG. 2, exemplary embodiments 6 and 10 and Claims 7 and 36. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in FIG. 7 and exemplary embodiments 6 and 10.

WO2010126891 A1 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acid esters, wax esters and alkan-1-ols, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0034] to [0091], [0195] to [0222] and [0245] to [0250], FIGS. 3 to 5 and the exemplary embodiments 1 to 5. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in sections [0245] to [0250], Table 1 and exemplary embodiments 1 to 5.

WO2010118410 A1 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acid esters and wax esters, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0022] to [0043], [0158] to [0197], FIGS. 1 to 4, exemplary embodiments 3 and 5 to 8 and Claims 1 to 53 and 82 to 100. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in sections [0158] to [0197], Table 1, FIGS. 3 and 4 and exemplary embodiments 3 and 5 to 8.

WO2010118409 A1 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acid esters and wax esters, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0134] to [0154], FIGS. 1 to 3 and 6 and exemplary embodiment 3. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in sections [0134] to [0154], FIGS. 3 and 6 and the exemplary embodiment 3.

WO2010075483 A2 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acids, fatty acid methyl esters, fatty acid ethyl esters, alkan-1-ols, fatty alkyl acetates, alkan-1-als, fatty amines, fatty amides, fatty sulphates, fatty ethers, ketones, alkanes, internal and terminal olefins, dicarboxylic acids, α,ω-dicarboxylic acids and α,ω-diols, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0061] to [0090] and [0287] to [0367], FIGS. 1, 4 and 5, exemplary embodiments 1 to 38 and Claims 18 to 26. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in sections [0012] to [0060], Tables 7, 17, 26 and 27, FIGS. 1, 44 to 47 and 55 to 59, exemplary embodiments 1 to 38 and Claims 1 to 17.

WO2010062480 A2 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular alkan-1-ols, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0022] to [0174] and [0296] to [0330], exemplary embodiments 3 and 5 to 8 and Claims 17 and 24. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in sections [0022] to [0174], Table 1 and exemplary embodiments 3 and 5 to 8.

WO2010042664 A2 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular alkan-1-als, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0022] to [0143] and [0241] to [0275], exemplary embodiment 2 and Claims 3 and 9. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in Table 1, FIG. 5 and exemplary embodiment 2.

WO2011008535 A1 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular carboxylic acids, hydroxycarboxylic acids and their lactones, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0024] to [0032] and [0138] to [0158] and FIG. 13.

WO2010022090 A1 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acid esters and wax esters, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0022] to [0143] and [0238] to [0275], FIGS. 3 to 5, the exemplary embodiment 2 and Claims 5, 15, 16 and 36. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in Table 1, FIG. 6 and exemplary embodiment 2.

WO2009140695 A1 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular hydrocarbons, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0214] to [0248] and exemplary embodiments 22 to 24. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in Table 1, FIG. 40 and exemplary embodiments 22 to 24.

WO2010021711 A1 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acid esters and wax esters, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0009] to [0020] and [0257] to [0317], FIGS. 3 to 5 and 19, exemplary embodiments 2 to 24 and Claims 4, 5 and 30. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in Table 3, FIG. 6 and exemplary embodiments 2 to 24.

WO2009085278 A1 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular olefins, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0188] to [0192] and FIG. 10. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in Table 1 and FIG. 10.

WO2011019858 A1 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular alkan-1-ols, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0023], [0064] to [0074] and [0091] to [0099], exemplary embodiments 1 to 13, FIG. 1 and Claim 8. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in sections [0085] to [0090], exemplary embodiments 1 to 13 and Table 1.

WO2009009391 A2 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acid esters, wax esters and alkan-1-ols, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0010] to [0019] and [0191] to [0299], FIGS. 3 to 5, exemplary embodiments 2, 4 to 6, 9 to 14, 17 and 19 and Claims 16, 39, 44 and 55 to 59. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in sections [0010] to [0019] and [0191] to [0299], FIG. 9 and exemplary embodiments 2, 4 to 6, 9 to 14, 17 and 19.

WO2008151149 A2 describes microorganisms which include a first genetic modification so that they are capable of forming more microbial oil from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0009], [0015] to [0033], [0053], [0071], [0174] to [0191], [0274] and [0396], Claims 53 to 114, 188 to 206 and 344 to 355 and Tables 1 to 3. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in Table 5.

WO2008147781 A2 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular hydrocarbons, olefins and aliphatic ketones, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0147] to [0156], exemplary embodiments 1 to 3, 8, 9 and 14 and Claims 65 to 71. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in exemplary embodiments 1 to 3, 8, 9 and 14.

WO2008119082 A2 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acid esters, wax esters, triglycerides, biodiesel, gasoline, jet fuel and alkan-1-ols, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular on pages 3 to 5, 8 to 10 and 40 to 77, in FIGS. 4 and 5, exemplary embodiments 2 to 5 and 8 to 18 and Claims 3 to 39 and 152 to 153. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in Table 1, FIG. 1, exemplary embodiments 2 to 5 and 8 to 18 and Claims 124 to 134 and 138 to 141.

WO2010135624 A2 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular alkan-1-ols, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0067] to [0083] and [0095] to [0098]. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in sections [0067] to [0083] and [0095] to [0098]. Zheng Z, Gong Q, Liu T, Deng Y, Chen J C and Chen G Q. (Thioesterase II of Escherichia coli plays an important role in 3-hydroxydecanoic acid production. Appl Environ Microbiol. 2004. 70(7):3807-13) describe microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acid esters, wax esters and alkan-1-ols, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular on pages 3808 to 3810 and 3012 and Table 1, 3 and 4. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular on pages 3807 and in Table 2.

Steen E J, Kang Y, Bokinsky G, Hu Z, Schirmer A, McClure A, Del Cardayre S B and Keasling J D (Microbial production of fatty-acid-derived fuels and chemicals from plant biomass. Nature. 2010. 463(7280):559-62) describe microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acids and fatty acid esters, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular on page 559, third section, to page 559, first section. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in supplementary Table 1.

Lennen R M, Braden D J, West R A, Dumesic J A and Pfleger B F (A process for microbial hydrocarbon synthesis: Overproduction of fatty acids in Escherichia coli and catalytic conversion to alkanes. Biotechnol Bioeng. 2010. 106(2):193-202) describe microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acids and fatty acid esters, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular on page 193, first section, page 194, first and second section, page 195, second section to page 197, second section, page 198, second section to page 199, third section. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular on page 193, first section, page 194, first and second section, page 196, second section, and in supplementary material.

Liu T, Vora H and Khosla C. (Quantitative analysis and engineering of fatty acid biosynthesis in E. coli. Metab Eng. 2010 July; 12(4):378-86.) describe microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acids and fatty acid esters, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections 2.2 and 3.1 and in Table 1 and 2. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in Table 1.

Yuan L, Voelker T A and Hawkins D J. (Modification of the substrate specificity of an acyl-acyl carrier protein thioesterase by protein engineering. Proc Natl Acad Sci USA. 1995 Nov. 7; 92(23):10639-43) describe microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acids and fatty acid esters, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular on page 10641, fourth section, and in FIG. 2 and Table 1. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular on page 10639, first section, page 10640, second, third and last section, page 10641, second and third section, and in FIG. 1 and Table 1 and 2.

Lu X, Vora H and Khosla C. (Overproduction of free fatty acids in E. coli: implications for biodiesel production. Metab Eng. 2008. 10(6):333-9.) describe microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acids and fatty acid esters, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention in particular on page 334, second section, sections 2.2, 2.3 and 3 (first to fourth section) and in Table 1. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular in section 2.2.

Liu X, Sheng J and Curtiss IIII R. (Fatty acid production in genetically modified cyanobacteria. Proc Natl Acad Sci USA. 2011. 108(17):6899-904) describe microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acids and fatty acid esters, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular on page 6899, fourth and last section, page 6900, first to penultimate section, and in Table S1 of the “Supporting Information”. The document also describes enzymes E_i which are preferred according to the invention and their sequences, in particular on page 6899, sixth and last section.

Specific Enzymes E_ii

Microorganisms which are preferred according to the invention are those which are obtained when the microorganisms listed hereinbelow, which include a first genetic modification within the meaning of the invention, are employed as the starting point by being provided with the second genetic modification and, if appropriate, with at least one further genetic modification within the meaning of the invention.

Steen E J, Kang Y, Bokinsky G, Hu Z, Schirmer A, McClure A, Del Cardayre S B and Keasling J D (Microbial production of fatty-acid-derived fuels and chemicals from plant biomass. Nature. 2010. 463(7280):559-62) describe microorganisms which include a first genetic modification so that they are capable of forming more carboxylic acids and carboxylic acid esters, in particular fatty acids and fatty acid esters, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular on page 559, third section, to page 559, first section. The document also describes enzymes E_ii which are preferred according to the invention and their sequences, in particular in supplementary Table 1.

Lennen R M, Braden D J, West R A, Dumesic J A and Pfleger B F (A process for microbial hydrocarbon synthesis: Overproduction of fatty acids in Escherichia coli and catalytic conversion to alkanes. Biotechnol Bioeng. 2010. 106(2):193-202) describe microorganisms which include a first genetic modification so that they are capable of forming more carboxylic acids and carboxylic acid esters, in particular fatty acids and fatty acid esters, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular on page 193, first section, page 194, first and second section, page 195, second section to page 197, second section, page 198, second section to page 199, third section. The document also describes enzymes E_ii which are preferred according to the invention and their sequences, in particular on page 193, first section, page 194, first and second section, page 196, second section, and in supplementary material. Liu T, Vora H and Khosla C. (Quantitative analysis and engineering of fatty acid biosynthesis in E. coli. Metab Eng. 2010 July; 12(4):378-86.) describe microorganisms which include a first genetic modification so that they are capable of forming more carboxylic acids and carboxylic acid esters, in particular fatty acids and fatty acid esters, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections 2.2 and 3.1 and in Table 1 and 2. The document also describes enzymes E_ii which are preferred according to the invention and their sequences, in particular in Table 1.

Yuan L, Voelker T A and Hawkins D J. (Modification of the substrate specificity of an acyl-acyl carrier protein thioesterase by protein engineering. Proc Natl Acad Sci USA. 1995 Nov. 7; 92(23):10639-43) describe microorganisms which include a first genetic modification so that they are capable of forming more carboxylic acids and carboxylic acid esters, in particular fatty acids and fatty acid esters, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular on page 10641, fourth section, and in FIG. 2 and Table 1. The document also describes enzymes E_ii which are preferred according to the invention and their sequences, in particular on page 10639, first section, page 10640, second, third and last section, page 10641, second and third section, and in FIG. 1 and Table 1 and 2.

Lu X, Vora H and Khosla C. (Overproduction of free fatty acids in E. coli: implications for biodiesel production. Metab Eng. 2008. 10(6):333-9.) describe microorganisms which include a first genetic modification so that they are capable of forming more carboxylic acids and carboxylic acid esters, in particular fatty acids and fatty acid esters, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention in particular on page 334, second section, sections 2.2, 2.3 and 3 (first to fourth section) and in Table 1. The document also describes enzymes E_ii which are preferred according to the invention and their sequences, in particular in section 2.2.

Liu X, Sheng J and Curtiss IIII R. (Fatty acid production in genetically modified cyanobacteria. Proc Natl Acad Sci USA. 2011. 108(17):6899-904) describe microorganisms which include a first genetic modification so that they are capable of forming more carboxylic acids and carboxylic acid esters, in particular fatty acids and fatty acid esters, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular on page 6899, fourth and last section, page 6900, first to penultimate section, and in Table S1 of the “Supporting Information”. The document also describes enzymes E_ii which are preferred according to the invention and their sequences, in particular on page 6899, sixth and last section.

Specific Enzymes E_iii

Microorganisms which are preferred according to the invention are those which are obtained when the microorganisms listed hereinbelow, which include a first genetic modification within the meaning of the invention, are employed as the starting point by being provided with the second genetic modification and, if appropriate, with at least one further genetic modification within the meaning of the invention.

WO2009121066 A1 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular dicarboxylic acids, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in Claims 8 to 14. The document also describes enzymes E_iii which are preferred according to the invention and their sequences, in particular in sections [00026] to [0054], in exemplary embodiments 1 to 6, FIGS. 4 to 10 and Claims 1 to 7.

WO2009134899 A1 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular carboxylic acids, hydroxycarboxylic acids and their lactones, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0079] to [0082], exemplary embodiment 1 and Claim 20. The document also describes enzymes E_iii which are preferred according to the invention and their sequences, in particular in sections [0009] to [0010] and [0044] to [0078], exemplary embodiment 1, FIGS. 1 and 5 to 8 and Claims 15 to 17 and 19.

Specific Enzymes E_iv

In cells which are preferred according to the invention, the enzyme E_iv is one which comprises sequences selected from among:

AAS90071.1, XP_—002379948.1, AAS90024.1, XP_—001821514.2, BAE59512.1, AAL99898.1, AAS90001.1, AAS90049.1, XP_—001911518.1, ACH72901.1, XP_—681084.1, AAC49198.1, EFW18013.1, XP_—003070494.1, XP_—001241401.1, XP_—002384449.1, XP_—001827206.1, XP_—002836001.1, XP_—001393196.1, XP_—660984.1, XP_—001395284.1, XP_—002148677.1, XP_—001827151.2, BAE66018.1, XP_—001217254.1, CAK40139.1, XP_—001393516.2, XP_—002477829.1, XP_—002146311.1, XP_—002340042.1, XP_—002544942.1, CBF87553.1, XP_—002149766.1, 2UV8_A, XP_—682676.1, CBX98966.1, XP_—002560069.1, XP_—001273102.1, P15368.1, XP_—001273530.1, CBX99714.1, AAB41493.1, XP_—001823764.1, XP_—001388458.1, XP_—748738.1, EDP53207.1, XP_—001259179.1, XP_—001825741.2, BAE64608.1, XP_—001213437.1, XP_—002377327.1, XP_—002152724.1, EFZ04065.1, XP_—001792784.1, EGP89632.1, XP_—001407660.1, EFQ31023.1, XP_—003040066.1, 2UV9_A, XP_—002486436.1, XP_—001585982.1, EFY87204.1, XP_—002620504.1, XP_—003295647.1, EEQ86108.1, XP_—001938586.1, XP_—001547465.1, XP_—001906653.1, XP_—001402457.2, CAK40502.1, XP_—002568116.1, XP_—003230922.1, XP_—001647236.1, XP_—385497.1, EGD94294.1, EGE05134.1, XP_—002849847.1, XP_—003015737.1, EFX06093.1, XP_—003019052.1, EEH03423.1, XP_—001942351.1, EGC45478.1, XP_—002556020.1, XP_—003011025.1, CAY86729.1, EDN60916.1, EGA84463.1, EGA56454.1, EEU05652.1, NP_—015093.1, XP_—003231214.1, XP_—445956.1, EGA60201.1, XP_—003349949.1, XP_—003070417.1, XP_—001241314.1, EGR48038.1, XP_—002615278.1, EFW 15042.1, EGO59647.1, XP_—452914.1, XP_—962466.1, XP_—001537327.1, XP_—002796517.1, XP_—003305240.1, XP_—002543037.1, XP_—002499262.1, NP_—985412.2, XP_—003019770.1, EFW96269.1, XP_—002843350.1, EEH43965.1, XP_—457388.1, XP_—001799391.1, EEH21370.1, BAD08376.1, XP_—001486434.1, BAF79876.1, EFY90998.1, XP_—001939431.1, EER44845.1, EFZ02060.1, XP_—001386834.2, XP_—501096.1, XP_—003299758.1, XP_—002419391.1, XP_—002490414.1, ACZ66251.1, XP_—002548204.1, P43098.1, XP_—002176039.1, XP_—002479407.1, EEQ44526.1, AAA34601.1, XP_—001791764.1, XP_—003009337.1, BAA11913.1, NP_—593823.1, BAB62031.1, BAB62032.1, BAB62030.1, 2 PFF_A, XP_—380212.1, ADN94478.1, EGF83443.1, XP_—681149.1, EGG00662.1, ADN94479.1, ABC94883.1, XP_—571099.1, EFY94095.1, EFW39589.1, XP_—003194430.1, XP_—003031600.1, XP_—001836417.1, XP_—001880844.1, XP_—762607.1, EGN98830.1, EGO24420.1, ACD87451.1, XP_—003328630.1, XP_—002997955.1, CCA25392.1, XP_—002901724.1, EFY86381.1, XP_—002901728.1, ADN97213.1, XP_—759118.1, XP_—003325251.1, XP_—003169619.1, XP_—002555446.1, ABJ98780.1, XP_—723161.1, EDZ68993.1, XP_—001526334.1, XP_—001223165.1, YP_—889015.1, AAO43178.1, YP_—001702252.1, XP_—003026305.1, YP_—003659808.1, ZP_—08155637.1, ZP_—04749666.1, ZP_—08022190.1, YP_—004007770.1, YP_—954908.1, YP_—004522637.1, YP_—640811.1, ZP_—04448562.1, NP_—301868.1, ZP_—06851996.1, YP_—003273140.1, YP_—001071929.1, YP_—001133797.1, YP_—004076455.1, YP_—701403.1, ZP_—03324816.1, YP_—002778327.1, ZP_—02028077.1, YP_—909119.1, YP_—880884.1, YP_—002767320.1, NP_—961266.1, ZP_—07457010.1, ZP_—08206945.1, ZP_—02917151.1, ZP_—04387794.1, YP_—003359863.1, EGO39886.1, ABE96385.1, ZP_—05228143.1, ZP_—06522069.1, EGL13180.1, ZP_—06976698.1, YP_—001852225.1, ZP_—06596502.1, YP_—907384.1, ZP_—06518033.1, AEF27803.1, YP_—003374392.1, ZP_—07485570.1, NP_—217040.1, ZP_—03742148.1, NP_—856198.1, YP_—004724192.1, NP_—337093.1, AEJ51135.1, ZP_—05765008.1, YP_—004745991.1, AEJ47516.1, ZP_—06927266.1, ZP_—03646962.1, AEF31807.1, YP_—003939358.1, YP_—003971698.1, YP_—003986333.1, ZP_—05750911.1, ADD61451.1, ZP_—07942485.1, YP_—004209716.1, YP_—004221489.1, AEI96705.1, NP_—696693.1, AEG82252.1, YP_—004001156.1, ZP_—03976473.1, ZP_—04663991.1, ZP_—00121397.1, YP_—003662064.1, YP_—003646283.1, YP_—004630447.1, YP_—002323720.1, YP_—002835610.1, YP_—117466.1, ZP_—02963252.1, ADC85342.1, NP_—940183.1, NP_—739002.1, ZP_—06755645.1, ADL21513.1, YP_—003784047.1, ADL11108.1, ZP_—06608499.1, ZP_—07967121.1, ZP_—05966223.1, ZP_—08682531.1, ZP_—03918327.1, ZP_—07879655.1, ZP_—03972703.1, ZP_—06162645.1, ZP_—06837277.1, ZP_—07990916.1, ZP_—03394081.1, CAA46024.1, YP_—004760934.1, ZP_—06751771.1, ZP_—03934033.1, NP_—601696.1, BAB99888.1, YP_—001139316.1, ZP_—03926457.1, NP_—737523.1, ZP_—02044858.1, ZP_—07404023.1, ZP_—03709883.1, XP_—002388648.1, ZP_—07402466.1, ZP_—03710807.1, ZP_—08294093.1, ZP_—08232611.1, XP_—682514.1, ZP_—06837028.1, YP_—001137826.1, CAA61087.1, ZP_—06043461.1, YP_—002833817.1, YP_—225128.1, NP_—600065.1, ABU23831.1, ZP_—07716892.1, ZP_—03935133.1, ZP_—02549600.1, ZP_—05215994.1, YP_—004494858.1, XP_—001526333.1, AAS90085.1, XP_—002379947.1, AAS90025.1, XP_—001821515.1, AAL99899.1, AAS90002.1, AAS90050.1, XP_—001911517.1, ACH72900.1, XP_—681083.1, AAC49199.1, XP_—003070495.1, XP_—001241402.1, EFW18012.1, CBX98970.1, EEH03422.1, EEQ86107.1, EGC45479.1, XP_—002620503.1, XP_—001537328.1, XP_—002796516.1, 2UVA_G, EEH43966.1, DAA05950.1, EGR47893.1, XP_—003070418.1, XP_—001241316.1, XP_—001827193.1, XP_—002384436.1, XP_—682677.1, XP_—002486435.1, EGP88608.1, EDP53206.1, XP_—001259180.1, EEH21369.1, XP_—002543038.1, XP_—748739.1, XP_—003015735.1, EGE05135.1, XP_—002152723.1, XP_—002560068.1, XP_—001273529.1, XP_—003230923.1, EFX05327.1, XP_—003019051.1, XP_—001585981.1, XP_—361644.2, XP_—001223166.1, XP_—003349948.1, XP_—002380737.1, AAB41494.1, XP_—001823765.1, XP_—962465.1, EGO59648.1, XP_—001906652.1, XP_—003039864.1, XP_—001213436.1, XP_—385498.1, XP_—003295646.1, EFQ31022.1, XP_—002849848.1, XP_—002148679.1, CBX99715.1, XP_—002149767.1, EFY87205.1, EFZ04064.1, XP_—002340041.1, EGD94295.1, XP_—001938587.1, CAK45758.1, XP_—001792785.1, XP_—001393189.2, XP_—003169620.1, XP_—001547461.1, XP_—001217253.1, XP_—001939430.1, BAA92930.1, Q92215.1, EDK38075.2, EFW97345.1, XP_—002495511.1, XP_—451653.1, XP_—500912.1, CAA42211.1, XP_—001486502.1, XP_—002477835.1, XP_—445436.1, NP_—594370.1, XP_—001827152.2, BAE66019.1, BAA36384.1, BAB62141.1, XP_—003299759.1, XP_—002553365.1, XP_—002489642.1, 2UV8_G, XP_—457311.1, CAY80909.1, XP_—001395285.1, EGA61562.1, EDN60099.1, EDV12927.1, NP_—012739.1, XP_—002616181.1, XP_—002420328.1, XP_—001524822.1, XP_—002550943.1, XP_—001386364.2, NP_—984945.2, 227846, AAB59310.1, XP_—001646561.1, XP_—716877.1, XP_—001836417.1, XP_—002146312.1, P34731.1, EGO24420.1, XP_—002544941.1, EFZ02054.1, XP_—002175228.1, XP_—001393490.2, XP_—003031600.1, XP_—002479408.1, XP_—002568119.1, XP_—001825735.2, XP_—002377320.1, EGN98830.1, ACD87451.1, XP_—001880844.1, XP_—571100.1, ABC94882.1, XP_—775164.1, BAE64602.1, EFY90992.1, XP_—003194424.1, XP_—001273103.1, XP_—681142.1, XP_—003011020.1, AAA34602.1, XP_—003231209.1, XP_—003019765.1, ADN94478.1, EEQ46070.1, XP_—001799393.1, CAK40504.1, AAM75418.1, ADN94479.1, XP_—002843356.1, CAA27616.1, XP_—380213.1, ADN97213.1, XP_—759118.1, XP_—762607.1, CAK49094.1, EER44843.1, XP_—003009335.1, XP_—002997955.1, XP_—002901724.1, CCA25392.1, CAK36856.1, XP_—001388457.2, ABO37974.1, ABJ98780.1, XP_—660985.1, EDZ71063.1, XP_—001402459.2, XP_—001791765.1, XP_—003324647.1, EGG 10429.1, EFW 15039.1, XP_—002384390.1, XP_—003031976.1, EDZ71062.1, EFW39589.1, ACZ80683.1, XP_—002901728.1, XP_—003328630.1, XP_—681125.1, XP_—003325251.1,andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_iv is generally understood in particular as meaning the conversion into hexanoic acid of two molecules malonyl-coenzyme A and one molecule acetyl-coenzyme A.

Microorganisms which are preferred according to the invention are those which are obtained when the microorganisms listed hereinbelow, which include a first genetic modification within the meaning of the invention, are employed as the starting point by being provided with the second genetic modification and, if appropriate, with at least one further genetic modification within the meaning of the invention.

WO2011003034 A2 describes microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular hexanoic acid, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular on page 2 to 3, page 5, third section, in exemplary embodiments 1 to 4, 7 to 9 and 12 to 14 and Claims 1 to 100. The document also describes enzymes E_iv which are preferred according to the invention and their sequences, in particular on page 5 and in exemplary embodiment 3.

Hitchman T S, Schmidt E W, Trail F, Rarick M D, Linz J E and Townsend C A. (Hexanoate synthase, a specialized type I fatty acid synthase in aflatoxin B1 biosynthesis. Bioorg Chem.

2001. 29(5):293-307) describe microorganisms which include a first genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular hexanoic acid, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular on page 296, penultimate section to page 298, second section. The document also describes enzymes E_iv which are preferred according to the invention and their sequences, in particular on page 299, fourth section, to page 302, first section.

In the context of the first genetic modification, it may be beneficial to employ, in place of the enzyme E_i, a combination of the activity increase in comparison with that of the wild type of an enzyme E_ii paired with that of an enzyme E_iib, which catalyses a reaction in which a CoA thioester is converted into an ACP thioester.

Such enzymes E_iib are known as acyl-CoA (Coenzyme A):ACP (Acyl Carrier Protein) transacylases. Preferred enzymes E_iib are selected from among

XP_—003402554.1, YP_—002908243.1, YP_—001778804.1, YP_—001670627.1, YP_—004703658.1, YP_—001747923.1, YP_—004348703.1, YP_—004352505.1, YP_—004379169.1, ADR61731.1, YP_—001269622.1, YP_—001186851.1, YP_—004659609.1, YP_—003519049.1, YP_—001811696.1, YP_—004616040.1, NP_—252697.1, NP_—252169.1, NP_—249421.1, ZP_—06456665.1, ZP_—01167071.1, ZP_—08557569.1, ZP_—08554397.1, YP_—001157914.1, YP_—004475334.1, EGM20156.1, BAK10182.1, YP_—347066.1, Q9KJH8.1, YP_—002987902.1, ZP_—03794633.1, ZP_—03627777.1, YP_—004434330.1, NP_—743567.1, ZP_—03456835.1, ZP_—07911512.1, ZP_—07264431.1, ZP_—02265387.2, ZP_—03456013.1, ZP_—07577798.1, ZP_—08429367.1, YP_—004055319.1, YP_—004053883.1, YP_—275219.1, YP_—276116.1, YP_—003882762.1, EGH97259.1, EGH95622.1, EGH90852.1, EGH85976.1, EGH81248.1, EGH79586.1, EGH79549.1, EGH73565.1, EGH66549.1, EGH64812.1, EGH58099.1, EGH54896.1, EGH50352.1, EGH43364.1, EGH41593.1, EGH29888.1, EGH29417.1, EGH22392.1, EGH22129.1, EGH11618.1, EGH10011.1, ZP_—04589662.1, CCA60711.1, YP_—003004716.1, BAK16630.1, YP_—003264146.1, YP_—371314.1, YP_—439272.1, NP_—762892.1, ADW02533.1, YP_—003291774.1, EGC99875.1, ZP_—08139631.1, YP_—003333890.1, EGC08366.1, YP_—080427.1, YP_—258557.1, YP_—001985016.1, YP_—002875182.1, YP_—002871082.1, YP_—237050.1, YP_—236199.1, NP_—794008.1, NP_—793082.1, YP_—609790.1, EFW81598.1, EFW79804.1, ZP_—07261632.1, ZP_—07229875.1, ZP_—06458504.1, ZP_—05640568.1, ZP_—03399268.1, ZP_—03398232.1, ZP_—08004496.1, ZP_—06876938.1, ZP_—03227482.1, ZP_—02511781.1, ZP_—02503964.1, ZP_—02477255.1, ZP_—02466678.1, ZP_—02465791.1, ZP_—02461688.1, ZP_—02417235.1, ZP_—02414413.1, ZP_—02408727.1, ZP_—02376540.1, ZP_—02358949.1, ZP_—07778021.1, ZP_—07774051.1, ZP_—07795409.1, ZP_—07089008.1, YP_—776393.1, ZP_—07684652.1, ZP_—06640022.1, ZP_—03054335.1, ZP_—02907621.1, ZP_—02891475.1, ZP_—01862226.1, ZP_—01769192.1, ZP_—01367441.1, ZP_—01366930.1, ZP_—01364106.1, ZP_—01312991.1, ZP_—01173135.1, ZP_—07005523.1, ZP_—04955702.1, ZP_—04943305.1, ZP_—04936014.1, ZP_—04932415.1, ZP_—04930223.1, ZP_—04905334.1, ZP_—04893870.1, ZP_—04893165.1, ZP_—04892059.1, ZP_—04884056.1, YP_—002438575.1, YP_—002234939.1, YP_—001488024.1, YP_—001346487.1, YP_—001350135.1, YP_—001347031.1, YP_—990329.1, YP_—860279.1, YP_—789111.1, YP_—792557.1, YP_—623139.1, YP_—175644.1, YP_—111362.1, YP_—110557.1, YP_—105231.1, NP_—937516.1, AAU44816.1, AAA25978.1, XP_—002721010.1, AAK81868.1, AAK71350.1, AAK71349.1, ZP_—06499968.1, ZP_—06498781.1, YP_—003472045.1, ACA03779.1, ABL84756.1, AAQ16175.1, AAT51302.1, AAT51199.1, ZP_—05639386.1, ACH70299.1, ACA60824.1, BAB32432.1, in particular AAK81868.1, NP_—743567.1, AAK71349.1, YP_—001269622.1, ADR61731.1, AAU44816.1, AAQ16175.1, YP_—001670627.1, ACH70299.1, Q9KJH8.1, YP_—004703658.1, ZP_—08139631.1, YP_—609790.1, YP_—001747923.1, YP_—258557.1, YP_—347066.1, YP_—002871082.1, YP_—004352505.1, ACA60824.1, ZP_—07774051.1, BAB32432.1, ZP_—05640568.1, EGH58099.1, EGH64812.1, EGH11618.1, ZP_—06456665.1, YP_—276116.1, EFW81598.1, EGH95622.1, EGH22129.1, NP_—794008.1, ZP_—03399268.1, ZP_—07264431.1, EGH73565.1, YP_—237050.1, ZP_—06498781.1, EGH29888.1, EGH79586.1, EGH35052.1, YP_—792557.1, YP_—001350135.1, ZP_—01364106.1, ZP_—04932415.1, NP_—249421.1, YP_—004379169.1, ACA03779.1, YP_—001186851.1, YP_—004475334.1, ZP_—04589662.1, ZP_—03398232.1, EGH10011.1, ZP_—07229875.1, ZP_—05639386.1, EGH66549.1, YP_—275219.1, ZP_—07005523.1, EFW79804.1, ZP_—06458504.1, EGH85976.1, YP_—236199.1, EGH43364.1, ZP_—07261632.1, ZP_—06499968.1, EGH29417.1, EGH54896.1, EGH22392.1, EGH97259.1, NP_—793082.1, EGH90852.1, EGH41593.1, NP_—252169.1, ZP_—01366930.1, YP_—001347031.1, ZP_—07778021.1, YP_—002875182.1, AAA25978.1, ABL84756.1, EGH81248.1, ZP_—07795409.1 and especially preferably AAU44816.1, NP_—743567.1, YP_—001269622.1, ADR61731.1, AAK71349.1, YP_—001670627.1, AAK81868.1, AAQ16175.1, Q9KJH8.1, ACH70299.1, YP_—004703658.1, ZP_—08139631.1, YP_—609790.1, YP_—001747923.1, AAK71350.1,andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_iib is generally understood in particular as meaning the conversion of dodecanoyl-CoA thioester into dodecanoyl-ACP thioester.Third Genetic Modification for the Production of Carboxylic Acid Esters from a Simple Carbon Source

It is advantageous in particular for the production of carboxylic acid esters when the microorganism additionally includes a third genetic modification which comprises an activity of at least one of the enzymes E_iib, E_v, E_vi, or E_vii which is increased in comparison with the enzymatic activity of the wild type of the microorganism.

In this context, it is preferred according to the invention that this genetic modification is an activity of at least one of the enzymes selected from the group

E_iib acyl-CoA (Coenzyme A):ACP (Acyl Carrier Protein) transacylase, which converts an ACP thioester into a CoA thioester or a CoA thioester into an ACP thioester,E_v wax ester synthase or alcohol O-acyltransferase, preferably of EC 2.3.1.75 or EC 2.3.1.84, which catalyses the synthesis of an ester from an acyl-coenzyme A thioester or an ACP thioester and an alcohol,E_va fatty acid O-methyl transferase, preferably of EC 2.1.1.15, which catalyses the synthesis of a fatty acid methyl ester from a fatty acid and S-adenosylmethionine,E_vi acyl-CoA (Coenzyme A) synthetase, preferably of EC 6.2.1.3, which catalyses the synthesis of an acyl-coenzyme A thioester, andE_vii acyl thioesterase, preferably of EC 3.1.2.2, EC 3.1.2.4, EC 3.1.2.18, EC 3.1.2.19, EC 3.1.2.20 or EC 3.1.2.22, which catalyses the conversion of an acyl thioester with an alcohol to give a carboxylic acid ester,which is increased in comparison with the enzymatic activity of the wild type of the microorganism.

In this context, it is especially preferred that the third genetic modification comprises combinations of the increased activities of the enzymes selected from among E_v, E_va, E_vii, E_vaE_vii, E_vE_vi, E_viE_vii, E_viE_viiE_iib.

Preferred enzymes E_iib in connection with the third genetic modification correspond to the enzymes E_iib which have been emphasized above as being preferred in connection with the first genetic modification.

Specific Enzymes E_v

In cells which are preferred according to the invention, the enzyme E_v is one which comprises sequences selected from among:

NP_—808414.2, NP_—001178653.1, XP_—003272721.1, XP_—002720111.1, NP_—001002254.1, XP_—529027.1, XP_—002831804.1, BAC28882.1, XP_—549056.2, XP_—002918053.1, XP_—001085075.1, XP_—002763005.1, XP_—002700092.1, XP_—599558.4, EDL95940.1, XP_—001496780.1, CAD89267.1, EFB28125.1,YP_—004747160.1, YP_—004746900.1, YP_—004746665.1, YP_—004746558.1, YP_—004746531.1, YP_—004746530.1, YP_—004745948.1, YP_—004745222.1, YP_—004744358.1, YP_—004743710.1, YP_—002492297.1, AEK40846.1, YP_—001847685.1, YP_—001712672.1, YP_—001706290.1, YP_—004724737.1, YP_—004723134.1, AEJ51098.1, AEJ48174.1, AEJ47480.1, YP_—004392630.1, YP_—004099725.1, YP_—003912033.1, YP_—003652731.1, YP_—003301387.1, YP_—003298139.1, YP_—001509672.1, YP_—001505948.1, YP_—001432486.1, YP_—001432432.1, YP_—924893.1, YP_—923981.1, YP_—922869.1, YP_—922597.1, YP_—922419.1, ZP_—08629145.1, ZP_—08628906.1, YP_—001380027.1, YP_—001280731.1, YP_—001280730.1, YP_—888966.1, YP_—890540.1, YP_—888236.1, YP_—888223.1, YP_—888574.1, YP_—884705.1, YP_—889488.1, YP_—886248.1, YP_—882534.1, YP_—881069.1, YP_—881444.1, YP_—883472.1, YP_—879642.1, YP_—884073.1, YP_—880917.1, YP_—882201.1, YP_—879422.1, YP_—707862.1, YP_—707847.1, YP_—707633.1, YP_—707572.1, YP_—707571.1, YP_—706785.1, YP_—706267.1, YP_—705586.1, YP_—705294.1, YP_—702929.1, YP_—701572.1, YP_—700576.1, YP_—700081.1, YP_—700033.1, YP_—700018.1, YP_—700017.1, YP_—699999.1, CCB78299.1, CCB78283.1, CCB72233.1, YP_—004663601.1, YP_—004525283.1, YP_—004524901.1, YP_—004524237.1, YP_—004524223.1, YP_—004523752.1, YP_—004522677.1, YP_—004521797.1, YP_—004521441.1, YP_—004020500.1, YP_—004014348.1, EGO40684.1, EGO38684.1, EGO38655.1, EGO37244.1, EGO36970.1, EGO36701.1, YP_—003951335.1, YP_—003812176.1, YP_—003811992.1, YP_—003810691.1, YP_—003810418.1, YP_—003809501.1, ZP_—08574204.1, CCA19760.1, XP_—002900672.1, ZP_—06414567.1, ZP_—06413635.1, ZP_—06411773.1, ZP_—06411772.1, ZP_—06271823.1, ZP_—05620754.1, ZP_—05360001.1, ZP_—04752019.1, ZP_—04751943.1, ZP_—04750965.1, ZP_—04750465.1, ZP_—04750453.1, ZP_—04750228.1, ZP_—04750091.1, ZP_—04749363.1, ZP_—04749348.1, ZP_—04749293.1, ZP_—04749287.1, ZP_—04749022.1, ZP_—04748677.1, ZP_—04747379.1, ZP_—04747377.1, ZP_—04747348.1, ZP_—04747282.1, ZP_—04747159.1, ZP_—04747093.1, ZP_—04746958.1, ZP_—04717323.1, ZP_—04684258.1, ZP_—04386203.1, ZP_—04385082.1, ZP_—04384030.1, ZP_—04384029.1, ZP_—03534755.1, ZP_—01115502.1, ZP_—01102322.1, YP_—004583872.1, YP_—004583323.1, YP_—004573656.1, YP_—004571392.1, YP_—003513699.1, ZP_—08553011.1, ZP_—08552672.1, YP_—003467054.1, YP_—003572597.1, YP_—579515.1, YP_—001136465.1, YP_—001136231.1, YP_—001135959.1, YP_—001135349.1, YP_—001133828.1, YP_—001133806.1, YP_—001133693.1, YP_—001133270.1, YP_—001132329.1, YP_—001131721.1, YP_—001131631.1, YP_—001073715.1, YP_—001073143.1, YP_—001072388.1, YP_—001072036.1, YP_—001071893.1, YP_—001071814.1, YP_—001071689.1, YP_—001070856.1, YP_—001069682.1, YP_—001069164.1, YP_—001068496.1, YP_—939377.1, YP_—642242.1, YP_—641664.1, YP_—641419.1, YP_—640919.1, YP_—640783.1, YP_—640704.1, YP_—640572.1, YP_—640571.1, YP_—640494.1, YP_—639709.1, YP_—639198.1, YP_—638523.1, YP_—638030.1, YP_—637968.1, YP_—637380.1, YP_—446603.1, NP_—001185377.1, NP_—200151.2, NP_—568547.1, NP_—197641.1, NP_—200150.1, NP_—197139.1, NP_—190490.1, NP_—190488.1, NP_—177356.1, YP_—004495408.1, YP_—004495023.1, YP_—004494197.1, YP_—004494168.1, YP_—004493973.1, YP_—004493936.1, YP_—004493628.1, YP_—004493589.1, YP_—004493509.1, YP_—004493477.1, YP_—004493462.1, YP_—004492352.1, YP_—004492155.1, YP_—004492039.1, YP_—004491716.1, YP_—004491715.1, YP_—004491501.1, YP_—003375642.1, YP_—003411203.1, YP_—003410436.1, YP_—003395271.1, YP_—003395089.1, YP_—003393635.1, YP_—003384208.1, YP_—003379551.1, ZP_—04388235.1, YP_—002134168.1, ZP_—01900421.1, ZP_—01900085.1, ZP_—01899829.1, ZP_—01898741.1, BAK05274.1, BAJ93623.1, BAJ97841.1, BAK08349.1, BAJ93204.1, BAJ92722.1, BAK06983.1, BAJ86545.1, BAK02325.1, BAJ85619.1, BAJ84892.1, ZP_—05218281.1, ZP_—05218149.1, ZP_—05217310.1, ZP_—05216978.1, ZP_—05216447.1, ZP_—05216446.1, ZP_—05216025.1, ZP_—05214687.1, ZP_—08476543.1, ZP_—04749239.1, YP_—823060.1, ADP99639.1, ADP98951.1, ADP98855.1, ADP98710.1, ADP96265.1, ZP_—08461736.1, ZP_—08461735.1, ZP_—07608690.1, YP_—045555.1 (encoded by SEQ ID No.: 19), YP_—872243.1, YP_—004009106.1, YP_—004008736.1, YP_—004008003.1, YP_—004007600.1, YP_—004006799.1, YP_—004006436.1, YP_—004006072.1, YP_—004005008.1, YP_—003486913.1, NP_—301898.1, ZP_—08434757.1, YP_—004079491.1, YP_—004078785.1, YP_—004077880.1, YP_—004076486.1, YP_—004076464.1, YP_—004076350.1, YP_—004075391.1, YP_—004074864.1, ZP_—01103855.1, YP_—465274.1, ZP_—08403393.1, ZP_—08402717.1, ZP_—08402716.1, YP_—004427559.1, YP_—001277083.1, YP_—001276783.1, YP_—524767.1, YP_—522739.1, YP_—521788.1, YP_—004335162.1, YP_—004333708.1, YP_—004332973.1, YP_—004332349.1, YP_—004157731.1, YP_—004224204.1, YP_—003275673.1, YP_—003275371.1, YP_—003274979.1, YP_—003274924.1, YP_—003274705.1, YP_—956544.1, YP_—955502.1, YP_—955007.1, YP_—954887.1, YP_—954886.1, YP_—954859.1, YP_—954399.1, YP_—953715.1, YP_—953073.1, YP_—952592.1, YP_—951909.1, YP_—951298.1, YP_—951083.1, ZP_—08287899.1, ZP_—08272356.1, ZP_—08270967.1, CCA60099.1, CCA56737.1, YP_—983728.1, YP_—550833.1, YP_—549124.1, YP_—121795.1, YP_—120815.1, YP_—118589.1, YP_—117783.1, YP_—117375.1, YP_—003646883.1, YP_—003646055.1, YP_—003645661.1, EGE49469.1, ZP_—08234310.1, CBZ53121.1, YP_—004010866.1, EGE24961.1, EGE18726.1, EGE15701.1, EGE12950.1, EGE10026.1, EGB03968.1, ZP_—08206563.1, ZP_—08205089.1, ZP_—08204958.1, ZP_—08204416.1, ZP_—08203326.1, YP_—714381.1, YP_—713817.1, YP_—694462.1 (encoded by SEQ ID No.: 67), YP_—693524.1, YP_—003341775.1, YP_—003339587.1, ZP_—08197177.1, ADW01905.1, YP_—004242683.1, ZP_—07484742.2, ZP_—07441979.2, ZP_—07441978.2, ZP_—07437333.2, ZP_—06960424.1, ZP_—06801236.1, ZP_—06799517.1, ZP_—05769718.1, ZP_—05768326.1, ZP_—05767970.1, ZP_—05766272.1, ZP_—05763839.1, YP_—003204265.1, YP_—003203570.1, YP_—003200768.1, YP_—003134884.1, YP_—003134608.1, ZP_—05140320.1, NP_—001140997.1, EEE64643.1, EEE55448.1, EEE32548.1, ZP_—03534756.1, ZP_—03533653.1, ZP_—03531929.1, EEC71274.1, EAY98969.1, EAY75974.1, EAY75973.1, ADZ24988.1, ZP_—08157247.1, ZP_—08156660.1, ZP_—08156249.1, ZP_—08153292.1, ZP_—08152876.1, ZP_—08152662.1, YP_—002946672.1, YP_—960669.1, YP_—960629.1, YP_—960328.1, YP_—958134.1, YP_—957462.1, YP_—001022272.1, ZP_—08123690.1, ZP_—08120547.1, ZP_—08119498.1, EGB29195.1, EGB27143.1, YP_—003770089.1, YP_—003769971.1, YP_—003764703.1, YP_—003764513.1, YP_—003103950.1, YP_—003168536.1, YP_—003168331.1, YP_—003166844.1, CAJ88696.1, NP_—769520.1, YP_—001141853.1, YP_—001108534.1, YP_—001106516.1, YP_—907824.1, YP_—907344.1, YP_—906945.1, YP_—906856.1, YP_—906855.1, YP_—906831.1, YP_—906494.1, YP_—906243.1, YP_—905962.1, YP_—905765.1, YP_—905343.1, YP_—905239.1, YP_—325796.1, YP_—130413.1, NP_—625255.1, NP_—624462.1, NP_—338129.1, NP_—338004.1, NP_—337859.1, NP_—337740.1, NP_—337694.1, NP_—336266.1, NP_—335919.1, NP_—335351.1, NP_—334638.1, NP_—218257.1, NP_—218251.1, NP_—217997.1, NP_—217888.1, NP_—217751.1, NP_—217750.1, NP_—217646.1, NP_—217604.1, NP_—217603.1, NP_—217000.1, NP_—216801.1, NP_—216276.1, NP_—215941.1, NP_—215410.1, NP_—214735.1, ZP_—04661667.1, EFW44815.1, EFW44455.1, ZP_—08024634.1, ZP_—08024620.1, ZP_—08023777.1, ZP_—08023597.1, YP_—002784032.1, YP_—002783585.1, YP_—002782904.1, YP_—002782647.1, YP_—002780099.1, YP_—002779887.1, YP_—002778497.1, YP_—002777657.1, YP_—002777402.1, ZP_—07966321.1, ZP_—07944768.1, CBI21867.3, CBI40547.3, CBI40544.3, CBI40540.3, CBI40536.3, CBI40534.3, CBI40533.3, CBI32385.3, ZP_—05765756.1, ZP_—05765643.1, ZP_—05765597.1, ZP_—05765596.1, YP_—001705267.1, YP_—001704692.1, YP_—001704281.1, YP_—001702654.1, YP_—001701260.1, ZP_—05770434.1, ZP_—05766274.1, ZP_—05762133.1, ZP_—05762130.1, ZP_—01101223.1, YP_—481580.1, YP_—979623.1, YP_—979196.1, ZP_—07414300.2, ZP_—03537340.1, ZP_—03537339.1, ZP_—03536772.1, ZP_—03536404.1, ZP_—03433478.1, ZP_—03430367.1, ZP_—03430260.1, ZP_—03429345.1, ZP_—03428583.1, ZP_—03426905.1, ZP_—03426458.1, ZP_—03426456.1, ZP_—03426455.1, ZP_—03425014.1, ZP_—03424082.1, ZP_—03421649.1, ZP_—03419291.1, ZP_—03418394.1, ZP_—03417976.1, ZP_—03414875.1, ZP_—06952098.1, ZP_—05528769.1, ZP_—05527907.1, ZP_—05227984.1, ZP_—05227897.1, ZP_—05227653.1, ZP_—05227585.1, ZP_—05227420.1, ZP_—05227202.1, ZP_—05226387.1, ZP_—05226386.1, ZP_—05225355.1, ZP_—05225200.1, ZP_—05223431.1, ZP_—05223402.1, ZP_—04697793.1, ZP_—02550609.1, ZP_—02548969.1, EEE25493.1, ABO13188.2, ZP_—07205208.1, YP_—589436.1, BAJ33896.1, ZP_—07718107.1, ZP_—07717513.1, ZP_—07717390.1, ZP_—07716424.1, ZP_—04384387.1, ZP_—07376578.1, ZP_—06871097.1, ZP_—06852444.1, ZP_—06852442.1, ZP_—06852283.1, ZP_—06852150.1, ZP_—06852032.1, ZP_—06850980.1, ZP_—06850766.1, ZP_—06850644.1, ZP_—06849846.1, ZP_—06849446.1, ZP_—06849265.1, ZP_—06848894.1, ZP_—06848550.1, ZP_—06847321.1, ZP_—06847245.1, ZP_—06728640.1, ZP_—06155537.1, ZP_—03822106.1, ZP_—03822105.1, ZP_—03264909.1, ZP_—01915979.1, ZP_—01914209.1, ZP_—01909198.1, ZP_—01895985.1, ZP_—01893763.1, ZP_—01893601.1, ZP_—01893547.1, ZP_—01864269.1, ZP_—01736818.1, ZP_—01693481.1, ZP_—01626518.1, ZP_—01616172.1, ZP_—01461648.1, ZP_—01439861.1, ZP_—01311414.1, ZP_—01222733.1, ZP_—01038993.1, ZP_—00997001.1, ZP_—06533596.1, ZP_—07308012.1, ZP_—07282351.1, ZP_—07282257.1, ZP_—07278697.1, ZP_—07277986.1, ZP_—07277799.1, ZP_—07011797.1, ZP_—06913634.1, ZP_—06711075.1, ZP_—06575037.1, ZP_—06523715.1, ZP_—06522644.1, ZP_—06520408.1, ZP_—06518751.1, ZP_—06514733.1, ZP_—06511304.1, ZP_—06510466.1, ZP_—06509700.1, ZP_—06504004.1, ZP_—06452618.1, ZP_—06451687.1, ZP_—06450049.1, ZP_—06444722.1, ZP_—06443996.1, ZP_—06443677.1, ZP_—06438510.1, ZP_—06435077.1, ZP_—06434554.1, ZP_—06432969.1, ZP_—06431341.1, ZP_—06430915.1, ZP_—05129423.1, ZP_—05127637.1, ZP_—05126217.1, ZP_—05096686.1, ZP_—05095013.1, ZP_—05094400.1, ZP_—05093434.1, ZP_—05043539.1, ZP_—05041631.1, ZP_—04959394.1, ZP_—04956551.1, ZP_—01052702.1, YP_—437020.1, YP_—436128.1, YP_—432512.1, YP_—432391.1, ZP_—06072118.1, ZP_—06069021.1, ZP_—06065092.1, ZP_—06062254.1, YP_—003032200.1, YP_—003030813.1, YP_—002766854.1, YP_—002766842.1, YP_—002766292.1, YP_—002765623.1, YP_—002765076.1, YP_—002764977.1, YP_—002764976.1, YP_—002764693.1, YP_—002764633.1, YP_—002646305.1, YP_—002646304.1, YP_—001853537.1, YP_—001853530.1, YP_—001853214.1, YP_—001852100.1, YP_—001851711.1, YP_—001851686.1, YP_—001851684.1, YP_—001851611.1, YP_—001851610.1, YP_—001851579.1, YP_—001850950.1, YP_—001850935.1, YP_—001850900.1, YP_—001850899.1, YP_—001850378.1, YP_—001849911.1, YP_—001849825.1, YP_—001849624.1, YP_—001849470.1, YP_—001848848.1, YP_—001848784.1, YP_—001822237.1, YP_—001289190.1, YP_—001289078.1, YP_—001288434.1, YP_—001287727.1, YP_—001286168.1, YP_—001085790.1, YP_—856793.1, YP_—629387.1, YP_—615587.1, YP_—615252.1, YP_—457389.1, YP_—263530.1, NP_—962591.1, NP_—962411.1, NP_—962281.1, NP_—961234.1, NP_—960903.1, NP_—960387.1, NP_—960090.1, NP_—959281.1, NP_—959065.1, NP_—857403.1, NP_—857149.1, NP_—857148.1, NP_—857047.1, NP_—856907.1, NP_—856759.1, NP_—856156.1, NP_—855443.1, NP_—855112.1, NP_—853892.1, NP_—828432.1, NP_—603766.1, XP_—003081224.1, YP_—003778608.1, YP_—003730939.1, XP_—003059244.1, ADI13131.1, XP_—002992800.1, XP_—002963877.1, XP_—001419779.1, XP_—002988280.1, XP_—002987493.1, CBH32551.1, CBH32550.1, CBH19575.1, CBH19574.1, YP_—003627553.1, XP_—002879777.1, XP_—002877657.1, XP_—002877655.1, XP_—002873570.1, XP_—002871716.1, XP_—002870738.1, XP_—002868506.1, XP_—002865972.1, XP_—002864239.1, XP_—002862308.1, ZP_—05823139.1, NP_—001043877.1, ZP_—06693274.1, ZP_—06058985.1, NP_—001044374.1, XP_—002835451.1, XP_—002787542.1, XP_—002785958.1, XP_—002785645.1, XP_—002783220.1, XP_—002774061.1, XP_—002767852.1, XP_—002766051.1, XP_—002765456.1, XP_—002765455.1, XP_—002677788.1, XP_—002671612.1, XP_—002736281.1, CBA31373.1, XP_—002184474.1, XP_—002325936.1, XP_—002323705.1, XP_—002325937.1, XP_—002323911.1, XP_—002323706.1, XP_—002328965.1, XP_—002318416.1, XP_—002310400.1, ACY38597.1, ACY38596.1, ACY38595.1, ACY38594.1, ACY38593.1, ACY38592.1, ACY38591.1, ACY38590.1, ACX81315.1, ACX81314.1, XP_—001868729.1, XP_—001847517.1, XP_—001847515.1, XP_—002502575.1, ACU20370.1, ACU18073.1, XP_—002523348.1, XP_—002516707.1, XP_—002429016.1, BAH89673.1, XP_—002440221.1, XP_—002459294.1, XP_—002458560.1, XP_—320167.4, XP_—001780431.1, XP_—002364905.1, XP_—002263196.1, XP_—002263137.1, XP_—002263409.1, XP_—002263252.1, XP_—002268615.1, XP_—002278404.1, XP_—002274522.1, XP_—002282418.1, XP_—001633379.1, XP_—001632267.1, XP_—001632004.1, XP_—001622638.1, XP_—002155609.1, XP_—759225.1, XP_—002152406.1, XP_—001914129.1, XP_—001738032.1, XP_—001731626.1, XP_—001209859.1, CAN79451.1, CAN78449.1, CAN72806.1, CAN71951.1, CAN71950.1, CAN76656.1, CAN62907.1, AAZ08051.1, ABO21022.1, ABO21021.1, ABO21020.1, ABJ96321.1, BAF01088.1, XP_—758106.1, BAC42871.1, BAB09801.1, BAB09102.1, in particular YP_—045555.1 (encoded by SEQ ID No.: 19), YP_—694462.1 (encoded by SEQ ID No.: 67) and NP_—808414.2.andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_v is generally understood in particular as meaning the conversion of dodecanoyl-CoA thioester and/or dodecanoyl-ACP thioester with methanol into dodecanoyl methyl ester.

If the enzyme E_v is an alcohol O-acyltransferase of EC 2.3.1.84, it is preferred that they are selected from among:

EGA72844.1, NP_—015022.1, S69991, AAP72991.1, EDN63695.1, BAA05552.1, AAP72992.1, S69992, AAP72995.1, XP_—002552712.1, XP_—001646876.1, XP_—002551954.1, EGA82692.1, EDN61766.1, EGA86689.1, EGA74966.1, AAU09735.1, NP_—011693.1, XP_—445666.1, BAA13067.1, AAP72993.1, EGA62172.1, XP_—455762.1, EGA58658.1,andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_v is generally understood in particular as meaning the conversion of dodecanoyl-CoA thioester with methanol into dodecanoyl methyl ester.

Microorganisms which are preferred according to the invention are those which are obtained when the microorganisms listed hereinbelow featuring a third genetic modification within the meaning of the invention are employed as starting point by being equipped with a first and second genetic modification and, if appropriate, at least one further genetic modification within the meaning of the invention.

WO2007136762 A2 describes microorganisms which include a third genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acid esters, wax esters, hydrocarbons and alkan-1-ols, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular on pages 2 to 4 and 21 to 24, FIGS. 2 to 4, exemplary embodiments 1, 2 and 5 to 7 and Claims 1, 2, 5, 6, 9 to 27 and 33. The document also describes enzymes E_v which are preferred according to the invention and their sequences, in particular on pages 21 to 24, in Table 10 and FIG. 10.

Specific Enzymes E_va

In cells which are preferred according to the invention, the enzyme E_va is one which comprises sequences selected from among YP_—001851637.1 (encoded by SEQ ID No.: 114) and proteins having a polypeptide sequence in which up to 60%, preferably up to 25%, particularly preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequence by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, particularly preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_va is generally understood in particular as meaning the conversion of lauric acid and S-adenosylmethionine to lauric acid methyl ester and S-adenosylhomocysteine.

Specific Enzymes E_vi

In cells which are preferred according to the invention, the enzyme E_vi is one which comprises sequences selected from among YP_—001724804.1 (encoded by SEQ ID No.: 18)

andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequence by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_vi is generally understood in particular as meaning the synthesis of dodecanoyl-CoA thioester.

Specific Enzymes E_vii

Microorganisms which are preferred according to the invention are those which are obtained when the microorganisms listed hereinbelow featuring a third genetic modification within the meaning of the invention are employed as starting point by being equipped with a first and second genetic modification and, if appropriate, at least one further genetic modification within the meaning of the invention.

WO2010075483 A2 describes microorganisms which include a third genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acids, fatty acid methyl esters, fatty acid ethyl esters, fatty alcohols, fatty alkyl acetates, fatty aldehydes, fatty amines, fatty amides, fatty sulphates, fatty ethers, ketones, alkanes, internal and terminal olefins, dicarboxylic acids, α,ω-dicarboxylic acids and α,ω-diols, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0061] to [0090] and [0287] to [0367], FIGS. 1, 4 and 5, exemplary embodiments 1 to 38 and Claims 18 to 26. The document also describes enzymes E_vii which are preferred according to the invention and their sequences, in particular in sections [0012] to [0060], Tables 7, 17, 26 and 27, FIGS. 1, 44 to 47 and 55 to 59, exemplary embodiments 1 to 38 and Claims 1 to 17.

Fourth Genetic Modification for the Production of Alkan-1-ols, Alkan-1-als, Alkan-1-Amines, Alkanes, Olefins, Alken-1-als, Alken-1-ols and Alken-1-Amines from a Simple Carbon Source

In the event that the production of alkan-1-ols, alkan-1-als, alkan-1-amines and olefins is desired, it may be advantageous to suitably enzymatically reduce, aminate, decarboxylate or decarbonylate the corresponding carboxylic acids or carboxylic acid esters.

To this end, microorganisms which are preferred according to the invention include a fourth genetic modification which comprises an activity of at least one of the following, selected from the group

E_iib acyl-CoA (Coenzyme A):ACP (Acyl Carrier Protein) transacylase, which converts an ACP thioester into a CoA thioester or a CoA thioester into an ACP thioester,E_vi acyl-CoA (Coenzyme A) synthetase, preferably of EC 6.2.1.3, which catalyses the synthesis of an acyl-coenzyme A thioester,E_viii acyl-CoA (Coenzyme A) reductase, preferably of EC 1.2.1.42 or EC 1.2.1.50, which preferably catalyses the reduction of an acyl-coenzyme A thioester to give the corresponding alkan-1-al or alkan-1-ol,E_ix fatty acid reductase (also fatty aldehyde dehydrogenase or arylaldehyde oxidoreductase), preferably of EC 1.2.1.3, EC 1.2.1.20 or EC 1.2.1.48, which preferably catalyses the reduction of an alkanoic acid to give the corresponding alkan-1-al,E_x acyl-ACP (Acyl Carrier Protein) reductase, preferably of EC 1.2.1.80, which catalyses the reduction of an acyl-ACP thioester to give the corresponding alkan-1-al or alkan-1-ol,E_xi cytochrome P450 fatty acid decarboxylase, which catalyses the conversion of an alkanoic acid with n carbon atoms into a corresponding terminal olefin with n−1 carbon atoms, in particular of dodecanoic acid to undec-10-enoic acid,E_xii alkan-1-al decarbonylase, which catalyses the conversion of an alkan-1-al (n carbon atoms) into a corresponding alkane (n−1 carbon atoms), andE_xiii alkan-1-al transaminase, which catalyses the conversion of an alkan-1-al into a corresponding alkan-1-amine,which is increased in comparison with the enzymatic activity of the wild type of the microorganism.

In this context, it is especially preferred that the fourth genetic modification comprises combinations of increased activities of the enzymes selected from among

E_ix, E_x, E_xi, E_viE_viii, E_viE_xE_iib, E_viiiE_xii, E_viiiE_xiii, E_ixE_xii, E_ixE_xiii, E_xE_xii, E_xE_xiii, E_viE_viiiE_xii, E_viE_viiiE_xiii, E_xE_xiiE_viE_iib and E_xE_xiiiE_viE_iib.

Preferred enzymes E_iib in connection with the fourth genetic modification correspond to the enzymes E_iib emphasized above as being preferred in the context of the first and third genetic modification.

Preferred enzymes E_vi in connection with the fourth genetic modification correspond to the enzymes E_vi emphasized above as being preferred in the context of the third genetic modification.

Specific Enzymes E_viii

Microorganisms which are preferred according to the invention are those which are obtained when the microorganisms including a fourth genetic modification within the meaning of the invention listed hereinbelow are employed as starting point by being equipped with a first and second genetic modification and, if appropriate, at least one further genetic modification within the meaning of the invention.

WO2011008565 A1 describes microorganisms which include a fourth genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acids, fatty aldehydes, fatty alcohols, alkanes and fatty acid esters, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0021], [0103] to [0106], [0108] and [0129]. The document also describes enzymes E_viii which are preferred according to the invention and their sequences, in particular in sections [0104] to [0106] and [0108] and [0129] and exemplary embodiment 11.

WO2008151149 A2 describes microorganisms which include a fourth genetic modification so that they are capable of forming more microbial oil in comparison with their wild type from at least one simple carbon source and which are preferably employed according to the invention, in particular in sections [0009], [0015] to [0037], [0053], [0071], [0171], [0174] to [0191], [0274] and [0396], Claims 53 to 114, 188 to 206 and 344 to 355 and Tables 1 to 3. The document also describes enzymes E_viii which are preferred according to the invention and their sequences, in particular in sections [0255] to [0261] and [0269] and Tables 6 and 7.

WO2007136762 A2 describes microorganisms which include a fourth genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acid esters, wax esters, hydrocarbons and fatty alcohols, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular on pages 2 to 4 and 19 to 20, FIGS. 2 to 4, exemplary embodiments 2 to 7 and Claims 4, 8 to 27 and 33. The document also describes enzymes E_viii which are preferred according to the invention and their sequences, in particular on pages 19 to 20, in Table 10 and FIG. 10.

WO2011019858 A1 describes microorganisms which include a fourth genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty alcohols, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0015] to [0020], [0064] to [0074], [0085] to [0086] and [0092] to [0099], exemplary embodiments 1 to 13, FIG. 1 and Claims 1 to 14. The document also describes enzymes E_viii which are preferred according to the invention and their sequences, in particular in sections [0004] to [0007] and [0075] to [0080] and exemplary embodiments 1 to 13.

WO2009140695 A1 describes microorganisms which include a fourth genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular hydrocarbons, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention in particular in sections [0031] to [0040], [0051] and [0214] to [0233], exemplary embodiments 5 to 24 and 28 to 30, Table 1, FIG. 40, and Claims 29 to 30. The document also describes enzymes E_viii which are preferred according to the invention and their sequences, in particular in sections [0023] to [0030], [0056], [0066] to [0069] and [0193] to [0208], Table 1, FIG. 39, exemplary embodiments 5 to 24 and 28 to 30 and Claims 69 to 74.

WO2011008535 A1 describes microorganisms which include a fourth genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular carboxylic acids, hydroxycarboxylic acids and their lactones from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0023] to [0024] and [0133] to [0158], FIG. 13, Claims 39 and 45 to 47 and exemplary embodiments 1 to 5. The document also describes enzymes E_viii which are preferred according to the invention and their sequences, in particular in sections [0017] to [0022], [0084] to [0132], FIGS. 2 to 12, Claims 31 to 37 and 40 to 44 and exemplary embodiments 1 to 5.

WO2010063031 A2 describes microorganisms which include a fourth genetic modification so that they are capable of forming more microbial oil from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0007], [0092] to [0100], [0181] to [0183] and [0199] to [0213]. The document also describes enzymes E_viii which are preferred according to the invention and their sequences, in particular in sections [0191] to [0194] and Tables 4 and 5.

WO2010063032 A2 describes microorganisms which include a fourth genetic modification so that they are capable of forming more microbial oil from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0007], [0092] to [0100], [0181] to [0183] and [0199] to [0213]. The document also describes enzymes E_viii which are preferred according to the invention and their sequences, in particular in sections [0191] to [0194] and Tables 4 and 5.

Specific Enzymes E_ix

In cells which are preferred according to the invention, the enzyme E_ix is one which comprises sequences selected from among YP_—887275.1 (encoded by SEQ ID No. 117), ABI83656.1 (encoded by SEQ ID No.: 122), and

proteins with a polypeptide sequence in which up to 60%, preferably up to 25%, particularly preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequence by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, particularly preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight) [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_ix is generally understood in particular as meaning the synthesis of lauryl aldehyde, NADP, AMP and 2 P_i from lauric acid, ATP, NADPH and H⁺.

Microorganisms which are preferred according to the invention are those which are obtained when the microorganisms including a fourth genetic modification within the meaning of the invention listed hereinbelow are employed as starting point by being equipped with a first and second genetic modification and, if appropriate, at least one further genetic modification within the meaning of the invention.

WO2011019858 A1 describes microorganisms which include a fourth genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty alcohols, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0004] to [0008], [0064] to [0074], [0085] to [0086], [0095] to [0099]. The document also describes enzymes E_ix which are preferred according to the invention and their sequences, in particular in sections [0008] to [0009], [0074] and [0081] to [0082] and exemplary embodiments 1 to 13.

WO2010135624 A2 describes microorganisms which include a fourth genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular carboxylic acids, hydroxycarboxylic acids and their lactones, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0005], [0067] to [0085] and [0092] to [0102], Claims 13 to 17 and exemplary embodiments 1 to 4. The document also describes enzymes E_ix which are preferred according to the invention and their sequences, in particular in sections [0005] to [0006] and [0086] to [0090], FIGS. 3 to 7, Claim 28 and exemplary embodiments 1 to 4.

WO2010062480 A2 describes microorganisms which include a fourth genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty alcohols, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0022] to [0174] and [0292] to [0316], exemplary embodiments 1 and 3 to 8, FIG. 9 and Claims 17 and 24. The document also describes enzymes E_ix which are preferred according to the invention and their sequences, in particular in sections [0019] to [0032] and [0263] to [0286], Table 1, FIGS. 6 to 8 and exemplary embodiments 1 and 3 to 8.

WO201042664 A2 describes microorganisms which include a fourth genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty alcohols, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0236] to [0261], exemplary embodiment 2, FIGS. 1 and 5 and Claim 25. The document also describes enzymes E_ix which are preferred according to the invention and their sequences, in particular in sections [0211] to [0233], FIGS. 2 to 4 and exemplary embodiments 1 to 2.

Specific Enzymes E_x

In cells which are preferred according to the invention, the enzyme E_x is one which comprises sequences selected from among BAB85476.1 (encoded by SEQ ID No. 77), YP_—047869.1 (encoded by SEQ ID No. 79 or 81), YP_—959486.1 (encoded by SEQ ID No. 83), YP_—959769.1 (encoded by SEQ ID No. 139), B9TSP7.1 (encoded by SEQ ID No. 141), and proteins with a polypeptide sequence in which up to 60%, preferably up to 25%, particularly preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, particularly preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_x is generally understood in particular as meaning the synthesis of lauryl alcohol and NAD(P)⁺ from lauryl-ACP, NAD(P)H and H⁺.

Microorganisms which are preferred according to the invention are those which are obtained when the microorganisms including a fourth genetic modification within the meaning of the invention listed hereinbelow are employed as starting point by being equipped with a first and second genetic modification and, if appropriate, at least one further genetic modification within the meaning of the invention.

WO2007136762 A2 describes microorganisms which include a fourth genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty acid esters, wax esters, hydrocarbons and fatty alcohols, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular on pages 2 to 4 and 19 to 20, FIGS. 2 to 4, exemplary embodiments 2 to 7 and Claims 4, 8 to 27 and 33. The document also describes enzymes E_x which are preferred according to the invention and their sequences, in particular on pages 19 to 20, in Table 10 and FIG. 10.

WO2011019858 A1 describes microorganisms which include a fourth genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular fatty alcohols, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0015] to [0020], [0064] to [0074], [0085] to [0086] and [0092] to [0099], exemplary embodiments 1 to 13, FIG. 1 and Claims 1 to 14. The document also describes enzymes E_x which are preferred according to the invention and their sequences, in particular in sections [0004] to [0007] and [0075] to [0080] and exemplary embodiments 1 to 13.

WO2009140695 A1 describes microorganisms which include a fourth genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular hydrocarbons, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0031] to [0040], [0051] and [0214] to [0233], exemplary embodiments 5 to 24 and 28 to 30, Table 1, FIG. 40, and Claims 29 to 30. The document also describes enzymes E_x which are preferred according to the invention and their sequences, in particular in sections [0023] to [0030], [0056], [0066] to [0069] and [0193] to [0208], Table 1, FIG. 39, exemplary embodiments 5 to 24 and 28 to 30 and Claims 69 to 74.

WO2011008535 A1 describes microorganisms which include a fourth genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular carboxylic acids, hydroxycarboxylic acids and their lactones, from at least one simple carbon source in comparison with their wild type and which are preferably employed according to the invention, in particular in sections [0023] to [0024] and [0133] to [0158], FIG. 13, Claims 39 and 45 to 47 and exemplary embodiments 1 to 5. The document also describes enzymes E_x which are preferred according to the invention and their sequences, in particular in sections [0017] to [0022], [0084] to [0132], FIGS. 2 to 12, Claims 31 to 37 and 40 to 44 and exemplary embodiments 1 to 5.

Specific Enzymes E_xi

In cells which are preferred according to the invention, the enzyme E_xi is one which comprises sequences selected from among ADW41779.1 (encoded by SEQ ID No. 168) and proteins with a polypeptide sequence in which up to 60%, preferably up to 25%, particularly preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequence by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, particularly preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context the determination of the activity of the enzyme E_xiii is generally understood in particular as meaning the reaction of sodium palmitate with hydrogen peroxide to form pentadecene, CO₂ and water.

Microorganisms which are preferred according to the invention are those which are obtained when the microorganisms including a fourth genetic modification within the meaning of the invention listed hereinbelow are employed as starting point by being equipped with a first and second genetic modification and, if appropriate, at least one further genetic modification within the meaning of the invention.

WO2009085278 A1 describes microorganisms which include a fourth genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular olefins, from at least one simple carbon source in comparison with their wild type and which are preferred according to the invention, in particular in sections [0033] to [0048], [0056] to [0063] and [0188] to [0202], FIG. 10, Table 8, exemplary embodiments 5 to 18 and Claims 28 to 51 and 188 to 195. The document also describes enzymes E_xi which are preferred according to the invention and their sequences, in particular in sections [0021] to [0032], [0051] to [0055], [0081] to [0084] and [0160] to [0183], Table 8, exemplary embodiments 5 to 18, Claims 1 to 25 and FIGS. 3, 7 and 9.

Specific Enzymes E_xii

Microorganisms which are preferred according to the invention are those which are obtained when the microorganisms including a fourth genetic modification within the meaning of the invention listed hereinbelow are employed as starting point by being equipped with a first and second genetic modification and, if appropriate, at least one further genetic modification within the meaning of the invention.

WO2009140695 A1 describes microorganisms which include a fourth genetic modification so that they are capable of forming more fatty acids and fatty acid derivatives, in particular hydrocarbons, from at least one simple carbon source in comparison with their wild type and which are preferred according to the invention, in particular in sections [0031] to [0040], [0051] and [0214] to [0233], exemplary embodiments 5 to 24 and 28 to 30, Table 1, FIG. 40, and Claims 29 to 30. The document also describes enzymes E_xii which are preferred according to the invention and their sequences, in particular in sections [0023] to [0030], [0056], [0066] to [0069] and [0193] to [0208], Table 1, FIG. 38, exemplary embodiments 5 to 24 and 28 to 30 and Claims 69 to 74.

WO2008151149 A2 describes microorganisms which include a fourth genetic modification so that they are capable of forming more microbial oil, from at least one simple carbon source in comparison with their wild type and which are preferred according to the invention, in particular in sections [0009], [0015] to [0037], [0053], [0071], [0171], [0174] to [0191], [0274] and [0396], Claims 53 to 114, 188 to 206 and 344 to 355 and Tables 1 to 3. The document also describes enzymes E_xii which are preferred according to the invention and their sequences, in particular in Table 8.

Specific Enzymes E_xiii

The enzyme E_xiii is preferably according to the invention an ω-transaminase of EC 2.6.1.-. Preferred enzymes E_xiii are selected from the group:

3HMU_A, AAD41041.1, AAK15486.1, ABE03917.1, ADR60699.1, ADR61066.1, ADR62525.1, AEL07495.1, CAZ86955.1, EFW82310.1, EFW87681.1, EGC99983.1, EGD03176.1, EGE58369.1, EGH06681.1, EGH08331.1, EGH24301.1, EGH32343.1, EGH46412.1, EGH55033.1, EGH62152.1, EGH67339.1, EGH70821.1, EGH71404.1, EGH78772.1, EGH85312.1, EGH97105.1, EGP57596.1, NP_—102850.1, NP_—106560.1, NP_—248912.1, NP_—248990.1, NP_—354026.2, NP 421926.1, NP_—637699.1, NP_—642792.1, NP_—744329.1, NP_—744732.1, NP_—747283.1, NP_—795039.1, NP_—901695.1 (encoded by SEQ ID No. 132), XP_—002943905.1, YP_—001021095.1, YP_—001059677.1, YP_—001061726.1, YP_—001066961.1, YP_—001074671.1, YP_—001120907.1, YP_—001140117.1, YP_—001170616.1, YP_—001185848.1, YP_—001188121.1, YP_—001233688.1, YP_—001268866.1, YP_—001270391.1, YP_—001345703.1, YP_—001412573.1, YP_—001417624.1, YP_—001526058.1, YP_—001579295.1, YP_—001581170.1, YP_—001668026.1, YP_—001669478.1, YP_—001671460.1, YP_—001685569.1, YP_—001747156.1, YP_—001749732.1, YP_—001765463.1, YP_—001766294.1, YP_—001790770.1, YP_—001808775.1, YP_—001809596.1, YP_—001859758.1, YP_—001888405.1, YP_—001903233.1, YP_—001977571.1, YP_—002229759.1, YP_—002231363.1, YP_—002280472.1, YP_—002297678.1, YP_—002543874.1, YP_—002549011.1, YP_—002796201.1, YP_—002801960.1, YP_—002875335.1, YP_—002897523.1, YP_—002912290.1, YP_—002974935.1, YP_—003060891.1, YP_—003264235.1, YP_—003552364.1, YP_—003578319.1, YP_—003591946.1, YP_—003607814.1, YP_—003641922.1, YP_—003674025.1, YP_—003692877.1, YP_—003755112.1, YP_—003896973.1, YP_—003907026.1, YP_—003912421.1, YP_—004086766.1, YP_—004142571.1, YP_—004147141.1, YP_—004228105.1, YP_—004278247.1, YP_—004305252.1, YP_—004356916.1, YP_—004361407.1, YP_—004378186.1, YP_—004379856.1, YP_—004390782.1, YP_—004472442.1, YP_—004590892.1, YP_—004612414.1, YP_—004676537.1, YP_—004693233.1, YP_—004701580.1, YP_—004701637.1, YP_—004704442.1, YP_—108931.1, YP_—110490.1, YP_—168667.1, YP_—237931.1, YP_—260624.1, YP_—262985.1, YP_—271307.1, YP_—276987.1, YP_—334171.1, YP_—337172.1, YP_—350660.1, YP_—351134.1, YP_—364386.1, YP_—366340.1, YP_—369710.1, YP_—370582.1, YP_—426342.1, YP_—440141.1, YP_—442361.1, YP_—468848.1, YP_—521636.1, YP_—554363.1, YP_—608454.1, YP_—610700.1, YP_—614980.1, YP_—622254.1, YP_—625753.1, YP_—680590.1, YP_—751687.1, YP_—767071.1, YP_—774090.1, YP_—774932.1, YP_—788372.1, YP_—858562.1, YP_—928515.1, YP_—983084.1, YP_—995622.1, ZP_—00948889.1, ZP_—00954344.1, ZP_—00959736.1, ZP_—00998881.1, ZP_—01011725.1, ZP_—01037109.1, ZP_—01058030.1, ZP_—01076707.1, ZP_—01103959.1, ZP_—01167926.1, ZP_—01224713.1, ZP_—01442907.1, ZP_—01446892.1, ZP_—01550953.1, ZP_—01625518.1, ZP_—01745731.1, ZP_—01750280.1, ZP_—01754305.1, ZP_—01763880.1, ZP_—01769626.1, ZP_—01865961.1, ZP_—01881393.1, ZP_—01901558.1, ZP_—02145337.1, ZP_—02151268.1, ZP_—02152332.1, ZP_—02167267.1, ZP_—02190082.1, ZP_—02242934.1, ZP_—02360937.1, ZP_—02367056.1, ZP_—02385477.1, ZP_—02456487.1, ZP_—02883670.1, ZP_—03263915.1, ZP_—03263990.1, ZP_—03400081.1, ZP_—03452573.1, ZP_—03456092.1, ZP_—03517291.1, ZP_—03529055.1, ZP_—03571515.1, ZP_—03572809.1, ZP_—03587785.1, ZP_—03588560.1, ZP_—03697266.1, ZP_—03697962.1, ZP_—04521092.1, ZP_—04590693.1, ZP_—04890914.1, ZP_—04891982.1, ZP_—04893793.1, ZP_—04902131.1, ZP_—04905327.1, ZP_—04941068.1, ZP_—04944536.1, ZP_—04945255.1, ZP_—04959332.1, ZP_—04964181.1, ZP_—05053721.1, ZP_—05063588.1, ZP_—05073059.1, ZP_—05077806.1, ZP_—05082750.1, ZP_—05091128.1, ZP_—05095488.1, ZP_—05101701.1, ZP_—05116783.1, ZP_—05121836.1, ZP_—05127756.1, ZP_—05637806.1, ZP_—05742087.1, ZP_—05783548.1, ZP_—05786246.1, ZP_—05843149.1, ZP_—05945960.1, ZP_—06459045.1, ZP_—06487195.1, ZP_—06492453.1, ZP_—06493162.1, ZP_—06703644.1, ZP_—06731146.1, ZP_—06839371.1, ZP_—07007312.1, ZP_—07266194.1, ZP_—07374050.1, ZP_—07662787.1, ZP_—07778196.1, ZP_—07797983.1, ZP_—08099459.1, ZP_—08138203.1, ZP_—08141719.1, ZP_—08142973.1, ZP_—08177102.1, ZP_—08185821.1, ZP_—08186468.1, ZP_—08208888.1, ZP_—08266590.1, ZP_—08402041.1, ZP_—08406891.1, ZP_—08522175.1, ZP_—08527488.1, ZP_—08631252.1, ZP_—08636687.1,in particular NP_—901695.1 (encoded by SEQ ID No. 132), ZP_—03697266.1, AAD41041.1, YP_—002796201.1, ZP_—03697962.1, YP_—001859758.1, YP_—002229759.1, YP_—001120907.1, YP_—110490.1, ZP_—04964181.1, YP_—774932.1, YP_—001766294.1, YP_—001581170.1, YP_—622254.1, ZP_—03588560.1, YP_—001809596.1, YP_—370582.1, ZP_—03572809.1, NP_—248990.1, YP_—001888405.1, ZP_—04905327.1, YP_—001061726.1, YP_—001668026.1, ZP_—01750280.1, ZP_—07778196.1, EGH71404.1, NP_—744329.1, YP_—004147141.1, ADR61066.1, ZP_—05783548.1, YP_—004701637.1, YP_—366340.1, YP_—003264235.1, EGD03176.1, YP_—001268866.1, ZP_—01901558.1, ZP_—05121836.1, YP_—003692877.1, ZP_—03517291.1, YP_—002974935.1, YP_—001668026.1, ADR61066.1, NP_—744329.1, YP_—001268866.1, YP_—004701637.1, ZP_—08142973.1, ADR62525.1, YP_—610700.1, NP_—747283.1, ADR62525.1, YP_—001270391.1, YP_—004704442.1, YP_—610700.1, YP_—001747156.1, ZP_—08138203.1, ZP_—07266194.1, EGH70821.1, YP_—351134.1, EGH32343.1, EGH08331.1, EGH67339.1, YP_—001668026.1, YP_—004701637.1, YP_—237931.1, ZP_—03400081.1, ZP_—05116783.1, ZP_—01550953.1, ZP_—07662787.1, YP_—928515.1, YP_—788372.1, YP_—001021095.1, ZP_—07797983.1, YP_—003578319.1, YP_—004305252.1, NP_—248912.1, ZP_—08636687.1, YP_—003912421.1, YP_—751687.1, ZP_—08142973.1, YP_—271307.1, ZP_—05082750.1, YP_—001417624.1, YP_—353455.1,and especially preferably NP_—901695.1 (encoded by SEQ ID No. 132), YP_—353455.1,andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_xiii is generally understood in particular as meaning the conversion of ω-oxo lauric acid and/or its methyl ester to give ω-amino lauric acid and/or its methyl ester.

E_xiv, Auxiliary Enzyme for E_xiii

For an increased activity of the enzyme E_xiii, it may be beneficial to employ, in place of the enzyme E_xiii alone, the combination of an enzyme E_xiii paired with an enzyme E_xiv, which catalyses the conversion of an α-keto carboxylic acid to an amino acid, the enzyme E_xiv is preferably an amino acid dehydrogenase, such as, for example, serine dehydrogenases, aspartate dehydrogenases, phenylalanine dehydrogenases and glutamate dehydrogenases, especially preferably an alanine dehydrogenase of EC 1.4.1.1.

Such preferred alanine dehydrogenases are selected from among

EGR93259.1, YP_—004743277.1, YP_—004741620.1, YP_—004737294.1, YP_—002509853.1, YP_—002492255.1, YP_—002489845.1, YP_—002481919.1, YP_—001819330.1, YP_—004728333.1, ZP_—08670930.1, YP_—004672392.1, YP_—004467026.1, YP_—004326214.1, YP_—002349951.1, YP_—001674437.1, YP_—003921585.1, YP_—001699731.1, YP_—004720756.1, YP_—004719515.1, EGQ22316.1, EGQ21760.1, YP_—004689232.1, YP_—004698526.1, YP_—004694875.1, EGP67576.1, YP_—001832691.1, YP_—001760857.1, AEJ53875.1, AEJ42949.1, YP_—004392931.1, YP_—004404798.1, YP_—004374160.1, YP_—004303162.1, YP_—004196134.1, YP_—004178581.1, YP_—004163857.1, YP_—004161555.1, YP_—004099081.1, YP_—004101986.1, YP_—004042336.1, YP_—003994181.1, YP_—003966543.1, YP_—003913256.1, YP_—003825828.1, YP_—003806106.1, YP_—003686355.1, YP_—003678575.1, YP_—003654745.1, YP_—003651439.1, YP_—003637111.1, YP_—003631815.1, YP_—003300711.1, YP_—002886396.1, ZP_—03493991.1, YP_—001890813.1, YP_—001888849.1, YP_—001554753.1, YP_—001529018.1, YP_—001528954.1, YP_—001502090.1, YP_—001412833.1, YP_—001363812.1, YP_—923679.1, NP_—440110.1, ZP_—08640273.1, ZP_—08639751.1, ZP_—08637916.1, YP_—004171395.1, YP_—001366419.1, YP_—001327051.1, YP_—001262560.1, YP_—886996.1, YP_—882850.1, YP_—704410.1, YP_—703508.1, ZP_—08624689.1, YP_—001230376.1, P17557.1, P17556.1, CCB94892.1, CCB73698.1, YP_—001168635.1, YP_—004668736.1, YP_—911378.1, YP_—003686997.1, YP_—002263235.1, NP_—820115.1, YP_—004653761.1, YP_—004651159.1, YP_—003869397.1, YP_—004641708.1, YP_—004641134.1, YP_—001996597.1, YP_—001998297.1, YP_—001943676.1, YP_—001810799.1, YP_—004630087.1, YP_—004621893.1, YP_—004613083.1, ZP_—08621144.1, YP_—003954200.1, YP_—001372688.1, YP_—001233686.1, ZP_—08594848.1, ZP_—08586665.1, ZP_—08578896.1, ZP_—08575937.1, YP_—004604438.1, YP_—004600931.1, ZP_—08569139.1, ZP_—08566255.1, AEB25326.1, YP_—374584.1, YP_—004216732.1, ZP_—06806151.1, ZP_—06440291.1, ZP_—06369993.1, ZP_—06254238.1, ZP_—05844252.1, ZP_—05472927.1, ZP_—05365401.1, ZP_—04747945.1, ZP_—04678933.1, ZP_—03779761.1, ZP_—03728859.1, ZP_—03711891.1, ZP_—03697269.1, ZP_—01628294.1, ZP_—01546224.1, ZP_—01444021.1, ZP_—01308570.1, ZP_—01228194.1, ZP_—01164841.1, ZP_—01114638.1, YP_—004566582.1, YP_—004572166.1, YP_—004571401.1, YP_—004569425.1, YP_—003513168.1, YP_—004561169.1, ZP_—08554945.1, YP_—400777.1, ZP_—08533479.1, ZP_—08533412.1, ZP_—08525779.1, ZP_—08523693.1, YP_—004471329.1, YP_—004368103.1, YP_—001536790.1, YP_—001158763.1, YP_—662032.1, YP_—967824.1, YP_—004542206.1, YP_—002958019.1, YP_—645630.1, ZP_—08520595.1, AEG81976.1, YP_—002560779.1, YP_—496956.1, YP_—411850.1, YP_—300065.1, NP_—840123.1, ZP_—08514775.1, YP_—002250769.1, YP_—002155665.1, YP_—002137991.1, YP_—001135275.1, YP_—001070365.1, YP_—639268.1, NP_—864377.1, YP_—004554709.1, YP_—004546384.1, YP_—004544159.1, ZP_—01448725.1, ZP_—01255407.1, EGL88594.1, EGL87587.1, YP_—004536059.1, ZP_—08512666.1, ZP_—08501410.1, ZP_—08493566.1, ZP_—08486369.1, YP_—004497891.1, YP_—004494473.1, YP_—003945301.1, YP_—003835539.1, YP_—003634898.1, YP_—003503876.1, ZP_—06503131.1, YP_—003376450.1, YP_—003409976.1, YP_—003409004.1, YP_—003395275.1, YP_—003393138.1, YP_—003387714.1, YP_—003382934.1, ZP_—05760008.1, ZP_—05300490.1, ZP_—04387987.1, ZP_—03725713.1, YP_—002134125.1, YP_—001618802.1, ZP_—01899015.1, ZP_—01881250.1, ZP_—01731833.1, YP_—004529602.1, YP_—004512974.1, YP_—004479110.1, YP_—004434722.1, YP_—004430602.1, CBX28458.1, ZP_—05217624.1, ZP_—01074124.1, ZP_—01062209.1, ZP_—01011939.1, ZP_—00956754.1, YP_—388045.1, ZP_—07910902.1, ZP_—07835291.1, ZP_—07831081.1, ZP_—07704117.1, ZP_—07112933.1, ZP_—06860168.1, ZP_—05915689.1, YP_—002352943.1, YP_—826544.1, YP_—004087624.1, ADP99134.1, YP_—003590847.1, YP_—003589189.1, YP_—001192379.1, ZP_—08473868.1, ZP_—08469833.1, ZP_—08462614.1, ZP_—07709417.1, ZP_—07672507.1, ZP_—07608107.1, ZP_—07404685.1, ZP_—07334010.1, ZP_—07333254.1, ZP_—06888732.1, ZP_—06837313.1, YP_—873046.1, YP_—004060177.1, YP_—004007860.1, YP_—003492711.1, ZP_—08456143.1, YP_—003675989.1, YP_—003159562.1, NP_—302068.1, YP_—004461013.1, ZP_—08426378.1, ZP_—08422563.1, YP_—004122643.1, YP_—004077807.1, YP_—004058618.1, YP_—004055696.1, YP_—003898888.1, YP_—003575339.1, ZP_—06186049.1, YP_—003314861.1, YP_—003148148.1, YP_—002786543.1, YP_—001661762.1, YP_—001666058.1, YP_—001549204.1, YP_—001518627.1, YP_—004453289.1, YP_—004450492.1, YP_—004301609.1, YP_—465316.1, ZP_—08411512.1, YP_—001394062.1, YP_—001035553.1, YP_—417038.1, YP_—301147.1, YP_—014199.1, EGJ45059.1, EGJ36821.1, EGJ36552.1, EGJ19019.1, ZP_—08388916.1, YP_—004427278.1, YP_—003909234.1, YP_—002536659.1, YP_—001940410.1, YP_—001329977.1, YP_—001323343.1, YP_—001114195.1, YP_—001096594.1, YP_—949547.1, YP_—756289.1, YP_—722774.1, YP_—525283.1, YP_—461225.1, YP_—320697.1, YP_—289022.1, YP_—075651.1, NP_—988633.1, YP_—004399762.1, YP_—004335185.1, ADX76365.1, YP_—004203407.1, YP_—001917832.1, YP_—001642542.1, ZP_—08332142.1, YP_—041174.1, ZP_—08328264.1, YP_—004225082.1, EGG96712.1, ZP_—08311476.1, ZP_—08310170.1, ZP_—08267322.1, ZP_—08263846.1, ZP_—07898723.1, YP_—003273311.1, ZP_—05909597.1, YP_—003073095.1, YP_—003022905.1, YP_—003013384.1, YP_—003011072.1, ZP_—04777180.1, ZP_—04432601.1, YP_—001016505.1, YP_—953175.1, YP_—731492.1, ZP_—08302086.1, ZP_—08296718.1, ZP_—08285373.1, ZP_—08280138.1, ZP_—08270040.1, ZP_—08261780.1, ZP_—08258406.1, ZP_—08246570.1, YP_—003113209.1, YP_—002436565.1, ZP_—04409790.1, YP_—428767.1, EGG40837.1, CCA54694.1, YP_—004147180.1, YP_—550034.1, YP_—173042.1, EGF75662.1, YP_—004205024.1, YP_—003670363.1, YP_—003476027.1, YP_—003241464.1, YP_—863990.1, YP_—004149630.1, YP_—003646700.1, EGF24326.1, BAK15593.1, YP_—003991014.1, YP_—003988127.1, YP_—003722297.1, YP_—003254539.1, YP_—003251916.1, NP_—901692.1, EGF16043.1, EGF07290.1, YP_—003048854.1, YP_—149301.1, YP_—148605.1, YP_—004340432.1, EFT09946.1, EFS80513.1, EFS51332.1, EFS42459.1, YP_—003060895.1, YP_—003059033.1, ZP_—03305373.1, YP_—002379520.1, YP_—372555.1, NP_—085655.1, YP_—004321492.1, ZP_—08239446.1, YP_—003817108.1, YP_—002951286.1, YP_—002950656.1, YP_—002522266.1, YP_—001982538.1, YP_—001127463.1, YP_—001126767.1, NP_—764939.1, NP_—761756.1, NP_—244046.1, NP_—243195.1, YP_—003194671.1, YP_—003161559.1, YP_—002797803.1, YP_—002634404.1, YP_—439119.1, YP_—314402.1, YP_—143482.1, NP_—295618.1, ZP_—08215173.1, YP_—004282846.1, YP_—004267961.1, YP_—001867313.1, YP_—001301882.1, YP_—847214.1, YP_—004095847.1, YP_—003338282.1, YP_—003337256.1, YP_—355846.1, YP_—253131.1, ZP_—08197563.1, ZP_—08196283.1, ADW06447.1, YP_—003370508.1, YP_—003317645.1, YP_—003184411.1, YP_—003198349.1, YP_—003084639.1, YP_—004294565.1, YP_—004243057.1, CBZ55377.1, EGC26795.1, EGC25718.1, EGC23378.1, ZP_—07887872.1, YP_—003269716.1, YP_—003203632.1, YP_—003199972.1, YP_—003153148.1, YP_—003146304.1, YP_—002893498.1, ZP_—03230841.1, ZP_—03229411.1, YP_—001050520.1, YP_—963387.1, YP_—927645.1, YP_—869684.1, YP_—734091.1, NP_—372233.1, NP_—102173.1, ZP_—08170259.1, EGD36706.1, EGD32748.1, ZP_—08155540.1, YP_—004142849.1, YP_—002417649.1, YP_—001301040.1, YP_—001211208.1, YP_—266230.1, ZP_—08145165.1, YP_—001801454.1, YP_—001736003.1, YP_—833487.1, YP_—831236.1, YP_—384064.1, YP_—094958.1, YP_—009793.1, NP_—975075.1, NP_—847074.1, EGC82166.1, YP_—004261609.1, YP_—004255502.1, YP_—678603.1, YP_—004181700.1, ZP_—08122013.1, ADT87541.1, YP_—003524764.1, YP_—002992990.1, YP_—002992892.1, YP_—081348.1, YP_—080482.1, YP_—002476349.1, ZP_—08115025.1, ZP_—08114403.1, YP_—003552869.1, YP_—002358112.1, ZP_—08111138.1, YP_—003770046.1, YP_—003103898.1, ZP_—08101069.1, ZP_—08097706.1, ZP_—08094005.1, YP_—003167240.1, YP_—002371817.1, YP_—004231854.1, EGA98455.1, YP_—002430239.1, ZP_—01049900.1, NP_—769819.1, NP_—768378.1, YP_—001143837.1, YP_—001108475.1, YP_—906040.1, YP_—726477.1, YP_—575010.1, YP_—477594.1, YP_—474564.1, YP_—130399.1, YP_—129373.1, YP_—123314.1, NP_—810467.1, NP_—646469.1, NP_—626044.1, NP_—391071.1, ZP_—08086822.1, ZP_—08084776.1, ZP_—08083119.1, NP_—465104.1, NP_—374819.1, NP_—337355.1, NP_—217296.1, ZP_—08072064.1, YP_—004197762.1, ZP_—08065558.1, ZP_—08063535.1, ZP_—08061612.1, ZP_—08059482.1, ZP_—08057644.1, ZP_—08055701.1, ZP_—08049025.1, ZP_—08047015.1, ZP_—04062925.1, YP_—269473.1, ZP_—08033402.1, ZP_—07829339.1, ZP_—06603053.1, ZP_—08020768.1, ZP_—08013590.1, ZP_—08011832.1, YP_—003783744.1, YP_—002781576.1, YP_—002780533.1, ZP_—02195873.1, NP_—797482.1, ZP_—08006697.1, ZP_—08006365.1, ZP_—08005962.1, ZP_—08004522.1, EFV89241.1, ZP_—07980135.1, ZP_—07974222.1, ZP_—07970379.1, ZP_—07962751.1, ZP_—07953732.1, ZP_—07945354.1, ZP_—06273519.1, YP_—003428808.1, YP_—003426902.1, YP_—001711555.1, YP_—001703831.1, YP_—001621081.1, YP_—001223643.1, YP_—001228127.1, YP_—849789.1, YP_—759696.1, NP_—969291.1, NP_—896596.1, NP 470950.1, YP_—359521.1, ZP_—01946735.1, ZP_—03631968.1, ZP_—01101833.1, YP_—002826017.1, YP_—003796926.1, ZP_—07873974.1, ZP_—07870908.1, ZP_—07645051.1, ZP_—07643260.1, ZP_—06611917.1, AAT40119.1, ZP_—07864946.1, YP_—004068409.1, YP_—002796203.1, YP_—002774420.1, YP_—003600348.1, YP_—003599946.1, YP_—003565624.1, YP_—003565223.1, YP_—335198.1, YP_—423850.1, YP_—155059.1, ZP_—07843538.1, ZP_—07841226.1, ZP_—03566837.1, EFS39373.1, EFS35044.1, ZP_—05287373.1, ZP_—05280407.1, ZP_—05224249.1, ZP_—04701236.1, ZP_—04692180.1, ZP_—03561728.1, ZP_—03227314.1, ZP_—02931419.1, ZP_—02731551.1, ZP_—02465413.1, ZP_—02451335.1, ZP_—02384332.1, ZP_—02381808.1, ZP_—02330643.1, YP_—004047600.1, EFR99988.1, EFR93766.1, EFR90643.1, EFR84459.1, ZP_—04059923.1, ZP_—03613601.1, ZP_—07743242.1, ZP_—07740118.1, ZP_—07728760.1, ZP_—07728640.1, YP_—003557047.1, ZP_—07204792.1, ZP_—07033145.1, ZP_—06949396.1, ZP_—06928932.1, ZP_—05692073.1, ZP_—05687006.1, ZP_—04867480.1, YP_—775531.1, CBE70214.1, ZP_—07721182.1, CBW22027.1, BAJ31519.1, ZP_—07694389.1, ZP_—07653390.1, ZP_—07548028.1, ZP_—07547185.1, ZP_—07462497.1, ZP_—07458778.1, ZP_—07399459.1, ZP_—07397253.1, ZP_—07397250.1, ZP_—07390390.1, ZP_—07390003.1, ZP_—07388675.1, ZP_—07367724.1, ZP_—07206561.1, ZP_—07053170.1, ZP_—07048770.1, ZP_—06873224.1, ZP_—06852862.1, ZP_—06427630.1, ZP_—06307332.1, ZP_—06252577.1, ZP_—06175164.1, ZP_—06080808.1, ZP_—06052314.1, ZP_—06033748.1, ZP_—05945907.1, ZP_—05924840.1, ZP_—05885109.1, ZP_—05882095.1, ZP_—05877865.1, ZP_—05855512.1, ZP_—05745159.1, ZP_—05716384.1, ZP_—04866524.1, ZP_—04819572.1, ZP_—04797418.1, ZP_—04319784.1, ZP_—04302850.1, ZP_—04298961.1, ZP_—04287684.1, ZP_—04277177.1, ZP_—04248389.1, ZP_—04235899.1, ZP_—04230016.1, ZP_—04226233.1, ZP_—04219330.1, ZP_—04216141.1, ZP_—04209092.1, ZP_—04188247.1, ZP_—04184510.1, ZP_—04176651.1, ZP_—04172877.1, ZP_—04170954.1, ZP_—04166021.1, ZP_—04160852.1, ZP_—04158983.1, ZP_—04154769.1, ZP_—04153266.1, ZP_—04149717.1, ZP_—04122524.1, ZP_—04110635.1, ZP_—04109769.1, ZP_—04109049.1, ZP_—04108444.1, ZP_—04104350.1, ZP_—04100460.1, ZP_—04075249.1, ZP_—04074263.1, ZP_—04009917.1, ZP_—03916440.1, ZP_—03703407.1, ZP_—03675960.1, ZP_—03588177.1, ZP_—03569636.1, ZP_—03497916.1, ZP_—03459468.1, ZP_—03299979.1, ZP_—03127493.1, ZP_—03054334.1, ZP_—03015779.1, ZP_—02478038.1, ZP_—02434435.1, ZP_—01891777.1, ZP_—01134782.1, ZP_—01084087.1, ZP_—00959435.1, ZP_—06021901.1, ZP_—02908521.1, ZP_—02892318.1, ZP_—02883918.1, ZP_—02433787.1, ZP_—02428013.1, ZP_—02424229.1, ZP_—02420399.1, ZP_—02190089.1, ZP_—02184200.1, ZP_—02166566.1, ZP_—02159718.1, ZP_—02152178.1, ZP_—02147727.1, ZP_—02144676.1, ZP_—02078507.1, ZP_—02072824.1, ZP_—02067293.1, ZP_—02061844.1, ZP_—01996280.1, ZP_—01991915.1, ZP_—01958087.1, ZP_—01908911.1, ZP_—01901606.1, ZP_—01895406.1, ZP_—01872936.1, ZP_—01870578.1, ZP_—01863314.1, ZP_—01859623.1, ZP_—01852574.1, ZP_—01834861.1, ZP_—01816459.1, ZP_—01770050.1, ZP_—01754550.1, ZP_—01750331.1, ZP_—01746097.1, ZP_—01736276.1, ZP_—01723571.1, ZP_—01688551.1, ZP_—01666824.1, ZP_—01627178.1, ZP_—01623088.1, ZP_—01612926.1, ZP_—01470938.1, ZP_—01460341.1, ZP_—01452344.1, ZP_—01439206.1, ZP_—01386817.1, ZP_—01313561.1, ZP_—01304248.1, ZP_—01264036.1, ZP_—01261877.1, ZP_—01235013.1, ZP_—01233072.1, ZP_—01224625.1, ZP_—01223017.1, ZP_—01221216.1, ZP_—01215557.1, ZP_—01202668.1, ZP_—01159834.1, ZP_—01158968.1, ZP_—01157579.1, ZP_—01130649.1, ZP_—01126987.1, ZP_—01122900.1, ZP_—01118752.1, ZP_—01090470.1, ZP_—01067027.1, ZP_—01058751.1, ZP_—01043459.1, ZP_—01041526.1, ZP_—01036767.1, ZP_—01001935.1, ZP_—00995212.1, ZP_—00992904.1, ZP_—00962062.1, ZP_—00952239.1, ZP_—00741173.1, ZP_—00740055.1, ZP_—00738801.1, ZP_—00517716.1, ZP_—00231205.1, ZP_—00208007.1, YP_—003974610.1, YP_—003546595.1, YP_—002317127.1, ZP_—07313778.1, ZP_—07302778.1, ZP_—07298850.1, ZP_—07285992.1, ZP_—07282306.1, ZP_—07279420.1, ZP_—07270582.1, ZP_—07001670.1, YP_—003706150.1, ZP_—06916083.1, ZP_—06912607.1, ZP_—06707160.1, ZP_—06324727.1, ZP_—06199155.1, ZP_—06197322.1, ZP_—05788488.1, ZP_—05785587.1, ZP_—05779471.1, ZP_—05739072.1, ZP_—05649780.1, ZP_—05647025.1, ZP_—05546023.1, ZP_—05341228.1, ZP_—05256588.1, ZP_—05127284.1, ZP_—05121710.1, ZP_—05119732.1, ZP_—05105668.1, ZP_—05101668.1, ZP_—05095370.1, ZP_—05090860.1, ZP_—05080646.1, ZP_—05076859.1, ZP_—05069222.1, ZP_—05065142.1, ZP_—05056378.1, ZP_—05052029.1, ZP_—05046506.1, ZP_—05037402.1, ZP_—05033610.1, ZP_—05026858.1, ZP_—05001187.1, ZP_—04959306.1, ZP_—04947229.1, ZP_—04941878.1, ZP_—04896669.1, ZP_—04890139.1, ZP_—04852481.1, ZP_—04849996.1, ZP_—04608704.1, ZP_—04581931.1, ZP_—04555275.1, ZP_—04553607.1, ZP_—04545440.1, ZP_—04538537.1, YP_—002311919.1, ZP_—01052096.1, YP_—432286.1, ZP_—07039851.1, ZP_—07036831.1, ZP_—07035634.1, ZP_—06826623.1, ZP_—06202690.1, ZP_—06091438.1, ZP_—06060476.1, YP_—002955941.1, YP_—002764322.1, YP_—002761274.1, YP_—002754767.1, YP_—002605829.1, YP_—002544281.1, YP_—002453687.1, YP_—002444060.1, YP_—002369417.1, YP_—002365390.1, YP_—002297006.1, YP_—002233968.1, YP_—001861152.1, YP_—001850232.1, YP_—001827236.1, YP_—001815332.1, YP_—001661116.1, YP_—001647239.1, YP_—001643400.1, YP_—001625970.1, YP_—001584357.1, YP_—001488077.1, YP_—001473862.1, YP_—001450010.1, YP_—001444991.1, YP_—001424576.1, YP_—001422460.1, YP_—001376512.1, YP_—001373857.1, YP_—001217438.1, YP_—001155448.1, YP_—001117213.1, YP_—001094151.1, YP_—950353.1, YP_—949946.1, YP_—944887.1, YP_—854776.1, YP_—837848.1, YP_—795217.1, YP_—750481.1, YP_—746463.1, YP_—681383.1, YP_—673989.1, YP_—632321.1, YP_—624008.1, YP_—615612.1, YP_—611857.1, YP_—604242.1, YP_—562748.1, YP_—536656.1, YP_—517218.1, YP_—459264.1, YP_—382475.1, YP_—340233.1, YP_—295387.1, YP_—285355.1, YP_—204286.1, YP_—174267.1, YP_—165491.1, YP_—126314.1, YP_—111103.1, YP_—098760.1, YP_—082111.1, YP_—064280.1, YP_—064276.1, YP_—062161.1, YP_—056928.1, YP_—008485.1, YP_—005739.1, NP_—961822.1, NP_—953341.1, NP_—926915.1, NP_—875991.1, NP_—834329.1, NP_—830409.1, NP_—827683.1, NP_—694147.1, NP_—693109.1, NP_—682897.1, NP_—661601.1, NP_—621858.1, NP_—486395.1, NP_—385730.1, NP_—231539.1, ADL65712.1, XP_—003087064.1, YP_—003886520.1, YP_—003699559.1, YP_—003516134.1, ADI98200.1, BAI86717.1, YP_—003794343.1, YP_—003790454.1, ADI11356.1, YP_—003845821.1, ADK69870.1, YP_—003784546.1, CBW36497.1, CBW26165.1, YP_—003709979.1, CAQ50186.1, ZP_—06770463.1, CBK69442.1, YP_—003413835.1, YP_—003595089.1, ZP_—06807811.1, YP_—003582455.1, YP_—003464731.1, YP_—003496397.1, YP_—003421918.1, CBL07274.1, CBK64956.1, YP_—003508515.1, AAL87460.1, AAC23579.1, AAC23578.1, AAC23577.1, ACU78652.1, YP_—003471439.1, YP_—003452777.1, ZP_—06384971.1, ACY25368.1, ABC26869.1, AAP44334.1, EEZ80018.1, ZP_—05110458.1, 1PJB_A, ZP_—04717201.1, ZP_—04689103.1, ZP_—04658071.1, XP_—002364705.1, ACN89388.1, 2VHW_A, 2VHV_A, XP_—001324625.1, ABZ06259.1, ABR57171.1, CAO90307.1, CAM75354.1, CAA44791.1, BAA77513.1, EGR96638.1, EGR94699.1, ZP_—08693646.1, YP_—004740306.1, YP_—004738947.1, AEE73472.1, YP_—002478771.1, YP_—002018970.1, YP_—001953230.1, ZP_—08683223.1, YP_—004073823.1, EGQ99856.1, ZP_—08664912.1, EGQ79321.1, YP_—001681700.1, AEJ51356.1, YP_—004378292.1, YP_—004237802.1, YP_—004166920.1, YP_—004043011.1, YP_—003997728.1, YP_—002975437.1, YP_—002514072.1, YP_—001433829.1, YP_—001185975.1, YP_—004676549.1, YP_—004016358.1, YP_—911347.1, YP_—004658403.1, YP_—002015455.1, YP_—001996171.1, YP_—001998271.1, YP_—001960099.1, YP_—001942826.1, YP_—001130666.1, YP_—004608353.1, YP_—508400.1, YP_—374553.1, ZP_—06298411.1, ZP_—06044299.1, ZP_—04390473.1, ZP_—04055222.1, ZP_—03779980.1, ZP_—03729400.1, ZP_—03390832.1, YP_—004580682.1, YP_—001988281.1, YP_—644219.1, YP_—665459.1, NP_—895289.1, YP_—004275231.1, NP_—208189.1, BAJ60529.1, BAJ59008.1, BAJ57509.1, BAJ56032.1, ZP_—01254396.1, YP_—445036.1, EGL90046.1, YP_—004510847.1, ZP_—08450330.1, YP_—003387804.1, YP_—003058152.1, ZP_—03438664.1, ZP_—01884341.1, AEG33860.1, YP_—004429375.1, ZP_—08459444.1, ZP_—07909193.1, ZP_—07908670.1, EFT26139.1, EFT23947.1, EFT12708.1, EFT03750.1, EFS82814.1, EFS74272.1, EFS67128.1, ZP_—06844564.1, YP_—826658.1, YP_—001195249.1, YP_—003095978.1, YP_—469292.1, YP_—004442054.1, YP_—004461174.1, YP_—004055616.1, YP_—003576656.1, YP_—003094537.1, YP_—001295973.1, AEE71143.1, YP_—004447480.1, YP_—001978005.1, ZP_—08413507.1, ZP_—07820264.1, YP_—416780.1, EGI86036.1, YP_—003109321.1, YP_—001275268.1, YP_—380171.1, YP_—159073.1, YP_—004203456.1, YP_—003761844.1, YP_—040853.1, ZP_—08328557.1, CBL87253.1, CBL87167.1, YP_—004316768.1, EFS92548.1, YP_—001016505.1, EGG67688.1, YP_—003528837.1, YP_—002434942.1, YP_—117835.1, YP_—004150583.1, YP_—003755105.1, YP_—002526442.1, YP_—003120958.1, EGE94241.1, YP_—004345416.1, EFS79952.1, ZP_—06964253.1, EGE60050.1, CBZ52359.1, ADU40304.1, ADQ77229.1, YP_—003196038.1, YP_—144713.1, YP_—001304143.1, YP_—113082.1, ADO76516.1, YP_—003326349.1, YP_—003289755.1, YP_—003089327.1, ZP_—07911965.1, ZP_—05773583.1, ZP_—05765271.1, YP_—003154888.1, YP_—003142045.1, YP_—002280953.1, NP_—371963.1, NP_—422368.1, EGC98966.1, EGC76398.1, YP_—004263661.1, YP_—004252039.1, YP_—679036.1, YP_—499973.1, ZP_—08090745.1, ZP_—08108339.1, YP_—001531594.1, ZP_—01051588.1, NP_—646145.1, NP_—224146.1, ZP_—08054972.1, ZP_—08053009.1, YP_—003584878.1, ZP_—07939405.1, ZP_—03439290.1, ADU82392.1, ADU83943.1, ADU85424.1, ADU80668.1, YP_—001225733.1, YP_—003863039.1, ZP_—01061682.1, YP_—767568.1, ZP_—07865749.1, ZP_—06858058.1, YP_—628213.1, EFT81350.1, EFT66610.1, EFT51424.1, ZP_—04839161.1, ZP_—05633406.1, ZP_—05288381.1, AAR37813.1, EFS03282.1, EFS03278.1, YP_—004046539.1, ZP_—07749550.1, ZP_—07729731.1, ADN80650.1, ZP_—07088856.1, ZP_—07080219.1, ZP_—06949721.1, ZP_—05685436.1, YP_—002550450.1, YP_—803715.1, ZP_—07720023.1, ZP_—07469700.1, ZP_—07365619.1, ZP_—06924335.1, ZP_—06715776.1, ZP_—06303722.1, ZP_—06303721.1, ZP_—06264319.1, ZP_—06155528.1, ZP_—05745707.1, ZP_—04866244.1, ZP_—04199629.1, ZP_—04195783.1, ZP_—04067276.1, ZP_—03968868.1, ZP_—03963857.1, ZP_—03933079.1, ZP_—03497046.1, ZP_—03475134.1, ZP_—01890152.1, ZP_—01086712.1, ZP_—06021845.1, ZP_—02183427.1, ZP_—02162695.1, ZP_—02032824.1, ZP_—01993906.1, ZP_—01993127.1, ZP_—01983694.1, ZP_—01972527.1, ZP_—01819838.1, ZP_—01817962.1, ZP_—01740947.1, ZP_—01734991.1, ZP_—01694775.1, ZP_—01678972.1, ZP_—01468566.1, ZP_—01408749.1, ZP_—01386800.1, ZP_—01202184.1, ZP_—01174108.1, ZP_—01174047.1, ZP_—01118729.1, ZP_—01081268.1, ZP_—00998573.1, ZP_—00739793.1, YP_—002302140.1, ZP_—07358151.1, ZP_—06668925.1, ZP_—06668924.1, ZP_—06667106.1, ZP_—06324464.1, ZP_—06196777.1, ZP_—05114159.1, ZP_—05083968.1, ZP_—05070370.1, ZP_—05030022.1, ZP_—04673064.1, ZP_—04581752.1, ZP_—01052079.1, ZP_—07661104.1, ZP_—06077819.1, YP_—002835579.1, YP_—002267069.1, YP_—002129114.1, YP_—001929236.1, YP_—001910999.1, YP_—001854051.1, YP_—001094152.1, YP_—001044252.1, YP_—861818.1, YP_—915522.1, YP_—807371.1, YP_—353800.1, YP_—342402.1, YP_—065168.1, YP_—015797.1, YP_—005051.1, NP_—856449.1, NP_—661547.1, NP_—358448.1, YP_—003929442.1, YP_—003927769.1, ADO06185.1, ADO04689.1, ADL23243.1, YP_—003789202.1, ADJ79786.1, YP_—003516488.1, ADI97953.1, ADI35485.1, YP_—003716800.1, ZP_—00241359.1, YP_—003718040.1, CAQ49862.1, YP_—003282331.1, AAP97897.1, ACX99978.1, ACX98578.1, YP_—003472544.1, ZP_—06382734.1, EEZ79852.1, ZP_—05299989.1, ZP_—05299895.1, XP_—002367632.1, ZP_—03529835.1, ZP_—03517011.1, ZP_—03505783.1, XP_—001310698.1, ABK27691.1, CAB59281.2,in particular NP_—391071.1, BAI86717.1, YP_—004205024.1, ZP_—06873224.1, YP_—003974610.1, YP_—001422460.1, AEB25326.1, YP_—003921585.1, YP_—080482.1, ZP_—03054334.1, YP_—001488077.1, YP_—081348.1, YP_—003426902.1, NP_—243195.1, ZP_—08004522.1, YP_—003565624.1, YP_—004095847.1, YP_—003600348.1, ZP_—08006697.1, ZP_—04248389.1, YP_—174267.1, YP_—001376512.1, ZP_—04226233.1, ZP_—04100460.1, YP_—002369417.1, ZP_—03229411.1, ZP_—04110635.1, ZP_—04287684.1, ZP_—04172877.1, ZP_—04158983.1, ZP_—04219330.1, NP_—830409.1, YP_—003790454.1, ZP_—04184510.1, YP_—001642542.1, ZP_—04074263.1, ZP_—04319784.1, NP_—847074.1, YP_—001373857.1, ZP_—04122524.1, ZP_—03230841.1, YP_—082111.1, NP_—834329.1, YP_—002444060.1, ZP_—04170954.1, YP_—002453687.1, ZP_—04153266.1, ZP_—04302850.1, YP_—002365390.1, ZP_—04216141.1, ZP_—04298961.1, ZP_—00740055.1, ZP_—04277177.1, ZP_—04104350.1, ZP_—04176651.1, YP_—001647239.1, ZP_—04188247.1, ZP_—04149717.1, YP_—003794343.1, ZP_—04230016.1, YP_—001643400.1, ZP_—04209092.1, ZP_—04235899.1, YP_—003428808.1, ZP_—08005962.1, YP_—003599946.1, YP_—003565223.1, ZP_—01859623.1, YP_—004569425.1, ZP_—04432601.1, ZP_—03227314.1, YP_—003699559.1, ZP_—07709417.1, ZP_—01723571.1, NP_—244046.1, ZP_—08006365.1, ZP_—00738801.1, ZP_—04160852.1, ZP_—04166021.1, ZP_—04154769.1, ZP_—04109769.1, ZP_—04109049.1, ZP_—04108444.1, ZP_—04075249.1, ZP_—00741173.1, ZP_—00739793.1, ZP_—01174108.1, ZP_—01174047.1, ZP_—00241359.1, ZP_—04195783.1, ZP_—04199629.1, ZP_—04067276.1and especially preferably NP_—391071.1.andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, to be more precise in a system in which pyruvate is converted into alanine.

Fifth Genetic Modification for Suppressing the Degradation of Carboxylic Acids and Carboxylic Acid Derivatives

Furthermore preferred according to the invention are microorganisms which include a fifth genetic modification which comprises an activity of at least one of the enzymes selected from the group

E_a acyl-CoA synthetase, preferably of EC 6.2.1.3, which catalyses the synthesis of an acyl-coenzyme A thioester,E_b acyl-CoA dehydrogenase, preferably of EC 1.3.99.-, EC 1.3.99.3 or EC 1.3.99.13, which catalyses the oxidation of an acyl-coenzyme A thioester to give the corresponding enoyl-coenzyme A thioester,E_c acyl-CoA oxidase, preferably of EC 1.3.3.6, which catalyses the oxidation of an acyl-coenzyme A thioester to give the corresponding enoyl-coenzyme A thioester,E_d enoyl-CoA hydratase, preferably of EC 4.2.1.17 or EC 4.2.1.74, which catalyses the hydratization of an enoyl-coenzyme A thioester to give the corresponding 3-hydroxyacyl-coenzyme A thioester,E_e 3-hydroxyacyl-CoA dehydrogenase, preferably of EC 1.1.1.35 or EC 1.1.1.211, which catalyses the oxidation of a 3-hydroxyacyl-coenzyme A thioester to give the corresponding 3-oxoacyl-coenzyme A thioester, andE_f acetyl-CoA acyltransferase, preferably of EC 2.3.1.16, which catalyses the transfer of an acetyl residue from a 3-oxoacyl-coenzyme A thioester to coenzyme A and thus generates an acyl-coenzyme A thioester which is shortened by two carbon atoms,which is reduced in comparison with the enzymatic activity of the wild type of the microorganism.

The technical effect of this is that the drain of the carboxylic acids and carboxylic acid derivatives formed in larger amounts due to the first genetic modification, but also of those formed in larger amounts due to the second, third and fourth genetic modification, is prevented.

The wording “activity which is reduced in comparison with its wild type” is preferably understood as meaning an activity which is reduced by at least 50%, especially preferably by at least 90%, more preferably by at least 99.9%, even more preferably by at least 99.99% and most preferably by at least 99.999%, based on the wild type activity. The wording “reduced activity” also comprises no detectable activity (“zero activity”). The reduction of the activity of a specific enzyme can be effected for example by the targeted mutation or by other means known to a person skilled in the art for reducing the activity of a specific enzyme. Other methods of reducing enzymatic activities in microorganisms are known to a person skilled in the art.

Methods of choice here are, in particular, molecular-biological techniques. Information on the modification and reduction of protein expressions and reduced enzymatic activity which these entail specifically for Candida, in particular for interrupting specific genes, can be found by the skilled worker in WO91/006660 and WO03/100013.

Microorganisms which are preferred according to the invention are characterized in that the reduction of the enzymatic activity is achieved by modifying a gene comprising a nucleic acid sequence encoding the abovementioned enzymes, the modification being selected from the group comprising, preferably composed of, insertion of foreign DNA into the gene, deletion of at least parts of the gene, point mutations in the gene sequence, RNA interference (siRNA), antisense RNA or modification (insertion, deletion or point mutations) of regulatory sequences which flank the gene. In this context, foreign DNA is understood as meaning any DNA sequence which is “foreign” to the gene (but not the organism). In this context it is especially preferred that the gene is interrupted by inserting a selection marker gene, the foreign DNA thus being a selection marker gene, where the insertion has preferably been effected by homologous recombination into the gene locus. In this context, it may be advantageous to extend the selection marker gene by further functionalities which, in turn, make possible a subsequent removal from the gene. This may be achieved for example by recombination systems which are foreign to the organism, such as a Cre/loxP system or FRT (Flippase Recognition Target) system or by the homologous recombination system which belongs to the organism. The reduction of the activity of the microorganism according to the invention in comparison with its wild type is determined by abovementioned methods for determining the activity using cell numbers/concentrations which are as equal as possible, the cells having been grown under identical conditions such as, for example, medium, gas supply, agitation.

Specific Enzymes E_a

In cells which are preferred according to the invention, the enzyme E_a is one which comprises the sequence NP_—416319.1 (SEQ ID No.: 18)

proteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_a is generally understood in particular as meaning the synthesis of dodecanoyl-CoA thioester.

Specific Enzymes E_b

Furthermore, it is preferred according to the invention that the enzyme E_b in the cells according to the invention is one which comprises sequences selected from among:

YP_—488518.1 (encoded by SEQ ID No. 14, formerly AP_—000876.1), ZP_—08341828.1, YP_—002291517.1, ZP_—08393771.1, EFW53921.1, YP_—003227327.1, YP_—001461409.1, AEG35025.1, YP_—002385739.1, EGJ00024.1, ZP_—08352177.1, ZP_—03070250.1, ZP_—08367389.1, EGM63466.1, CBI99746.1, ZP_—06660773.1, ZP_—08372569.1, YP_—309282.2, YP_—001879017.1, YP_—003497883.1, ACI71032.1, YP_—002406464.1, EGB79412.1, EFZ76765.1, ZP_—07145000.1, ZP_—07151031.1, AAZ87047.1, EFZ56676.1, ZP_—06656148.1, EGB35012.1, EGB71054.1, EFW49392.1, ZP_—07183316.1, YP_—002396328.1, YP_—002327805.1, ZP_—03027602.1, AAG54546.1, YP_—001742341.1, ZP_—04538240.1, EFX12717.1, ACI71029.1, NP_—285938.2, ZP_—03064986.1, ZP_—07120505.1, YP_—539295.2, ZP_—03049609.1, ZP_—06652178.1, AAP15817.1, NP_—706224.3, ABI99723.1, EGB60663.1, EFW71911.1, EGH38574.1, YP_—668186.1, EGK29152.1, EGC05203.1, ZP_—02801146.2, YP_—687886.1, ZP_—08346491.1, EGJ94671.1, EGC94003.1, ZP_—08362542.1, YP_—002381459.1, AAN78852.1, NP_—752308.2, ZP_—07173894.1, ZP_—08357265.1, ZP_—08382276.1, ZP_—02902298.1, ZP_—04560694.1, ZP_—06354226.1, CBY94356.1, NP_—459307.1, EGE28353.1, ZP_—04657138.1, YP_—002225434.1, YP_—002635948.1, YP_—151638.1, ZP_—02663643.1, NP_—454921.1, YP_—004729161.1, YP_—215297.1, YP_—001454506.1, YP_—001571699.1, YP_—003363866.1, EGK30199.1, EGJ91900.1, EGK28208.1, ZP_—08497358.1, CBK85993.1, YP_—003611563.1, YP_—004592567.1, YP_—003441061.1, YP_—002240296.1, YP_—002917946.1, ZP_—06549304.1, ZP_—06017126.1, YP_—001333918.1, AAM28523.1, ZP_—08305363.1, YP_—001439185.1, EGL74026.1, YP_—001175495.1, ZP_—05968792.1, YP_—003209204.1, YP_—003943022.1, YP_—004499335.1, ZP_—06191708.1, YP_—001477183.1, ZP_—07951567.1, YP_—003740265.1, NP_—668276.1, ZP_—04637564.1, ZP_—04631714.1, CBY26031.1, YP_—004297237.1, YP_—001007400.1, ZP_—04625511.1, YP_—069424.1, ZP_—04616432.1, ZP_—04639135.1, YP_—001871363.1, ZP_—04620883.1, ZP_—06636999.1, ZP_—07377275.1, YP_—003929932.1, YP_—001722031.1, ZP_—04614013.1, ZP_—04628476.1, YP_—003713213.1, YP_—003530236.1, CBX79727.1, YP_—004114694.1, YP_—001908526.1, ADP 11689.1, YP_—002649711.1, YP_—003469212.1, YP_—003519171.1, YP_—051564.1, ZP_—03833764.1, ZP_—03827249.1, NP_—928504.1, YP_—004211704.1, ZP_—07681706.1, YP_—003018849.1, YP_—003260788.1, YP_—003042091.1, ZP_—05973896.1, ZP_—03317495.1, ZP_—02958330.2, EFW60358.1, EGI98786.1, ZP_—06127315.2, YP_—002150121.1, ZP_—03842196.1, YP_—003884303.1, YP_—003003248.1, YP_—003334792.1, ZP_—03379559.1, CBA73629.1, YP_—002986552.1, ZP_—06538530.1, ZP_—01258771.1, ZP_—04921840.1, ZP_—06180371.1, ZP_—08308836.1, ZP_—06174994.1, YP_—001446380.1, ZP_—01237449.1, ZP_—01161468.1, ZP_—01222040.1, ZP_—06038476.1, ZP_—05925639.1, ZP_—06154677.1, ZP_—02195704.1, ZP_—01989646.1, ZP_—01868523.1, YP_—131060.1, ZP_—05722161.1, ZP_—05716057.1, NP_—798668.1, EGF45205.1, ZP_—05120764.1, EGR07881.1, ZP_—08100412.1, ZP_—04919383.1, ZP_—06054287.1, YP_—002156761.1, YP_—205315.2, ZP_—04961417.1, ZP_—06050299.1, ZP_—08103013.1, ZP_—01949008.1, NP_—231862.1, AEA79156.1, ZP_—06081122.1, ZP_—04418155.1, YP_—001217747.1, ZP_—04413631.1, NP_—935312.1, ZP_—01977990.1, NP_—760770.1, YP_—004188005.1, YP_—002810906.1, ZP_—05884155.1, ZP_—05946273.1, ZP_—01065180.1, ZP_—01815735.1, YP_—002417909.1, YP_—002263750.1, YP_—856109.1, ZP_—07744057.1, ZP_—08520214.1, ZP_—06034047.1, YP_—004565576.1, ZP_—05881167.1, ZP_—00991316.1, YP_—734276.1, ADT86286.1, YP_—001142550.1, YP_—869958.1, ZP_—08566610.1, ZP_—05876732.1, YP_—001366225.1, YP_—001094233.1, ADV54653.1, YP_—963612.1, YP_—738268.1, YP_—001502248.1, YP_—004391846.1, YP_—002311644.1, YP_—002358241.1, YP_—001050670.1, ZP_—07390237.1, YP_—001674114.1, YP_—001554497.1, NP_—718122.1, YP_—001760976.1, YP_—927745.1, YP_—562771.1, YP_—003557130.1, ZP_—02159449.1, YP_—003913548.1, YP_—001473736.1, YP_—750554.1, ZP_—01897495.1, YP_—268985.1, ZP_—01042474.1, ZP_—08570996.1, YP_—004427315.1, ZP_—07010199.1, YP_—156047.1, ZP_—07097521.1, YP_—004467113.1, ZP_—01614110.1, YP_—340459.1, YP_—004434754.1, YP_—662062.1, YP_—004068195.1, ZP_—08409704.1, ZP_—08622396.1, ZP_—01135962.1, ZP_—03560927.1, ZP_—04716612.1, EGB41427.1, EGP48304.1, EFV84045.1, ZP_—08505249.1, ZP_—06688896.1, YP_—003980530.1, YP_—003168652.1, YP_—003146346.1, YP_—001250478.1, YP_—095752.1, YP_—124009.1, CBW99992.1, YP_—284763.1, YP_—127029.1, YP_—746940.1, ZP_—07663653.1, ZP_—03349444.1, YP_—002354470.1, YP_—004145615.1, YP_—003524477.1, ZP_—03698069.1, YP_—003376672.1, ZP_—06188282.1, EFW81359.1, EGH83675.1, EGH67821.1, EFW83732.1, YP_—273865.1, NP_—902393.1, ZP_—06457469.1, EGH99235.1, ZP_—03397893.1, ZP_—07004262.1, ZP_—06732661.1, ZP_—07263971.1, EGH75297.1, NP_—888341.1, EGH31566.1, EGH45251.1, NP_—643363.1, EGH24154.1, EGH92666.1, EGH73945.1, EGH12424.1, NP_—793629.1, ZP_—06705890.1, YP_—234714.1, EGH62932.1, EGH52925.1, ZP_—01126966.1, NP_—841588.1, ZP_—05109483.1, YP_—003847638.1, YP_—004294524.1, ZP_—02244088.1, NP_—884586.1, ZP_—08176463.1, ZP_—04588788.1, YP_—450732.1, ZP_—08185386.1, YP_—001914265.1, YP_—003527565.1, YP_—004696148.1, NP_—638218.1, ZP_—05046817.1, YP_—343737.1, ZP_—07652844.1, YP_—004227922.1, YP_—364921.1, YP_—001632020.1, NP_—744048.1, YP_—001898007.1, YP_—003145987.1, YP_—558241.1, YP_—410795.1, YP_—001895310.1, YP_—002980410.1, ZP_—06841648.1, YP_—258889.1, YP_—931967.1, YP_—003760619.1, YP_—002029446.1, YP_—004474743.1, YP_—158312.1, YP_—004380764.1, YP_—001973352.1, CBJ39115.1, YP_—349912.1, YP_—003753442.1, ZP_—05135288.1, YP_—004700980.1, YP_—927690.1, YP_—001269130.1, YP_—742956.1, ADR61321.1, YP_—001347709.1, YP_—004355482.1, YP_—003907207.1, NP_—251505.1, ZP_—04929120.1, NP_—518658.1, YP_—002871500.1, ZP_—01451059.1, EGM21899.1, YP_—001187411.1, ZP_—08570514.1, ZP_—07794119.1, YP_—004391835.1, YP_—002256385.1, ZP_—07774414.1, YP_—855885.1, YP_—563120.1, YP_—001172167.1, YP_—004713921.1, ZP_—08138366.1, AEA83572.1, YP_—003746704.1, ZP_—08521441.1, ZP_—05061205.1, YP_—001667709.1, YP_—750573.1, YP_—607261.1, ZP_—05118288.1, YP_—002311716.1, NP_—718079.1, YP_—003777020.1, ZP_—06052248.1, ZP_—00943163.1, ZP_—08309312.1, AEG70141.1, YP_—001748377.1, YP_—001857928.1, YP_—001094176.1, YP_—003604813.1, ZP_—01947893.1,in particularEFW81359.1, EGH83675.1, EGH67821.1, EFW83732.1, YP_—273865.1, ZP_—06457469.1, EGH99235.1, ZP_—03397893.1, ZP_—07004262.1, ZP_—07263971.1, EGH75297.1, EGH31566.1, EGH45251.1, EGH24154.1, EGH92666.1, EGH73945.1, EGH12424.1, NP_—793629.1, YP_—234714.1, EGH62932.1, EGH52925.1, ZP_—04588788.1, NP_—744048.1, YP_—258889.1, YP_—004474743.1, YP_—004380764.1, YP_—349912.1, YP_—004700980.1, YP_—001269130.1, ADR61321.1, YP_—001347709.1, YP_—004355482.1, NP_—251505.1, ZP_—04929120.1, YP_—002871500.1, EGM21899.1, YP_—001187411.1, ZP_—07794119.1, ZP_—07774414.1, YP_—001172167.1, YP_—004713921.1, ZP_—08138366.1, AEA83572.1, YP_—001667709.1, YP_—607261.1, YP_—001748377.1, YP_—260045.1, YP_—002873091.1, ZP_—07775826.1, CAC34855.1, EGH11916.1, ZP_—05641615.1, ZP_—06480669.1, ZP_—06480668.1, ZP_—05641616.1, ZP_—06492823.1, ZP_—06492821.1, EGH11920.1, EGH25319.1, ZP_—06492824.1, ADX52254.1, YP_—488518.1 (encoded by SEQ ID No. 14, formerly AP_—000876.1), ZP_—08341828.1, YP_—002291517.1, YP_—003227327.1, YP_—001461409.1, AEG35025.1, YP_—002385739.1, ZP_—08352177.1, ZP_—03070250.1, ZP_—08367389.1, CBI99746.1, ZP_—06660773.1, ZP_—08372569.1, YP_—003497883.1, ACI71032.1, YP_—002406464.1, EGB79412.1, EFZ76765.1, ZP_—07145000.1, ZP_—07151031.1, EFZ56676.1, ZP_—06656148.1, EGB35012.1, EGB71054.1, ZP_—07183316.1, YP_—002396328.1, YP_—002327805.1, ZP_—03027602.1, AAG54546.1, YP_—001742341.1, ABE05764.1, EFX12717.1, ACI71029.1, NP_—285938.2, ZP_—07120505.1, YP_—539295.2, ZP_—03049609.1, ZP_—06652178.1, ABI99723.1, EGB60663.1, EFW71911.1, EGH38574.1, YP_—668186.1, ZP_—02801146.2, ZP_—08346491.1, ZP_—08362542.1, AAN78852.1, NP_—752308.2, ZP_—07173894.1, ZP_—08357265.1, ZP_—08382276.1, AAM28523.1, ZP_—07097521.1, EGB41427.1, EGB41426.1, BAA07583.1, ZP_—07100038.1, CAX20347.1and especially preferablyNP_—744048.1, YP_—004700980.1, YP_—001269130.1, ADR61321.1, YP_—001667709.1, YP_—001748377.1, YP_—258889.1, YP_—349912.1, YP_—002871500.1, ZP_—07774414.1, YP_—260045.1, YP_—002873091.1, ZP_—07775826.1, CAC34855.1, YP_—001172167.1, YP_—004713921.1, AEA83572.1, YP_—488518.1 (encoded by SEQ ID No. 14, formerly AP_—000876.1), BAA07583.1, ZP_—07594808.1,andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_b is generally understood in particular as meaning the oxidation of dodecanoyl-CoA thioester to give 2-dodecenoyl-CoA thioester.

Specific Enzymes E_c

Furthermore, it is preferred according to the invention that the enzyme E_c in the cells according to the invention is one which comprises sequences selected from among:

YP_—003571780.1, YP_—445820.1, YP_—634556.1, YP_—004665862.1, ZP_—01461690.1, YP_—921666.1, YP_—002778910.1, ZP_—08550394.1, YP_—003384289.1, YP_—001195727.1, YP_—702012.1, ZP_—04384437.1, YP_—002765110.1, ZP_—04996322.1, ZP_—08195144.1, ZP_—04700546.1, YP_—954595.1, YP_—004736804.1, ADW07059.1, YP_—001827916.1, ZP_—04691466.1, YP_—001109453.1, ZP_—08240125.1, YP_—003272226.1, YP_—004053469.1, ZP_—06272176.1, YP_—004491616.1, YP_—001133991.1, YP_—001071715.1, YP_—290295.1, YP_—003193744.1, YP_—001704317.1, YP_—004008413.1, YP_—004655806.1, YP_—640598.1, ZP_—08153802.1, ZP_—00995173.1, ZP_—05225674.1, YP_—888747.1, YP_—003114111.1, YP_—004522832.1, ZP_—06848773.1, ZP_—08203814.1, YP_—001851901.1, EGO40578.1, YP_—003134974.1, ZP_—07282448.1, YP_—003770185.1, YP_—881295.1, YP_—004336131.1, NP_—961035.1, YP_—004164861.1, YP_—003681133.1, ZP_—04749633.1, ZP_—07718288.1, ZP_—01201898.1, YP_—004223976.1, YP_—118690.1, YP_—905275.1, BAE47462.1, YP_—831622.1, YP_—003407476.1, ZP_—01129477.1, YP_—003645654.1, YP_—004454693.1, YP_—002487953.1, YP_—004084231.1, YP_—003836912.1, YP_—004241154.1, ZP_—07706098.1, YP_—001855531.1, ZP_—08124588.1, YP_—947882.1, BAE47461.1, YP_—003327670.1, YP_—001363757.1, YP_—004601796.1, YP_—001625220.1, YP_—003638017.1, ZP_—06501585.1, YP_—004404736.1, YP_—062974.1, YP_—002957230.1, YP_—003316209.1, YP_—003149881.1, YP_—001221553.1, YP_—003162313.1, ZP_—03978917.1, YP_—001708860.1, ZP_—05912043.1, ZP_—06806059.1, YP_—003155732.1, YP_—002835700.1, YP_—003916799.1, ZP_—03936415.1, ZP_—07090640.1, ZP_—08516453.1, AAB97825.1, YP_—004541029.1, YP_—004606508.1, YP_—001801238.1, ZP_—07989876.1, YP_—004761186.1, YP_—002883572.1, ZP_—08023616.1, ZP_—05847263.1, YP_—251740.1, ZP_—03394212.1, YP_—001107648.1, YP_—002872770.1, YP_—001821654.1, ZP_—08233739.1, AAD12170.1, ZP_—08215859.1, AAD40800.1, ZP_—05005905.1, ADW07311.1, YP_—348592.1, NP_—824883.1, NP_—627459.1, YP_—001828149.1, ZP_—05525554.1, ZP_—08240364.1, ZP_—07299658.1, ZP_—06582153.1, ZP_—06921827.1, ZP_—04703961.1, BAJ27090.1, ZP_—06592678.1, ZP_—04691265.1, YP_—001751500.1, BAJ31579.1, preferably YP_—003571780.1, YP_—445820.1, YP_—634556.1, YP_—004665862.1, ZP_—01461690.1, YP_—921666.1, YP_—002778910.1, ZP_—08550394.1, YP_—003384289.1, YP_—001195727.1, YP_—702012.1, ZP_—04384437.1, YP_—002765110.1, ZP_—04996322.1, ZP_—08195144.1, ZP_—04700546.1, YP_—954595.1, YP_—004736804.1, ADW07059.1, YP_—001827916.1, ZP_—04691466.1, YP_—001109453.1, ZP_—08240125.1, YP_—003272226.1, YP_—004053469.1, ZP_—06272176.1, YP_—004491616.1, YP_—001133991.1, YP_—001071715.1, YP_—290295.1, YP_—003193744.1, YP_—001704317.1, YP_—004008413.1, YP_—004655806.1, YP_—640598.1, ZP_—08153802.1, ZP_—00995173.1, ZP_—05225674.1, YP_—888747.1, YP_—003114111.1, YP_—004522832.1, ZP_—06848773.1, ZP_—08203814.1, YP_—001851901.1, EGO40578.1, YP_—003134974.1, ZP_—07282448.1, YP_—003770185.1, YP_—881295.1, YP_—004336131.1, NP_—961035.1, YP_—004164861.1, YP_—003681133.1, ZP_—04749633.1, ZP_—07718288.1, ZP_—01201898.1, YP_—004223976.1, YP_—118690.1, YP_—905275.1, BAE47462.1, YP_—831622.1, YP_—003407476.1, ZP_—01129477.1, YP_—003645654.1, YP_—004454693.1, YP_—002487953.1, YP_—004084231.1, YP_—003836912.1, YP_—004241154.1, ZP_—07706098.1, YP_—001855531.1, ZP_—08124588.1, YP_—947882.1, BAE47461.1, YP_—003327670.1, YP_—001363757.1, YP_—004601796.1, YP_—001625220.1, YP_—003638017.1, ZP_—06501585.1, YP_—004404736.1, YP_—062974.1, YP_—002957230.1, YP_—003316209.1, YP_—003149881.1, YP_—001221553.1, YP_—003162313.1, ZP_—03978917.1, YP_—001708860.1, ZP_—05912043.1, ZP_—06806059.1, YP_—003155732.1, YP_—002835700.1, YP_—003916799.1, ZP_—03936415.1, ZP_—07090640.1, ZP_—08516453.1, AAB97825.1, YP_—004541029.1, YP_—004606508.1, YP_—001801238.1, ZP_—07989876.1, YP_—004761186.1, YP_—002883572.1, ZP_—08023616.1, ZP_—05847263.1, YP_—251740.1,and especially preferably YP_—002835700.1, ZP_—03936415.1, BAE47461.1, YP_—001801238.1, ZP_—03978917.1, ZP_—03394212.1, ZP_—05847263.1, ZP_—08516453.1, YP_—004606508.1, YP_—251740.1, ZP_—07090640.1, ZP_—07989876.1, YP_—004761186.1,proteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_c is generally understood in particular as meaning oxidation of dodecanoyl-CoA thioester to give 2-dodecenoyl-CoA thioester.

Specific Enzymes E_d and E_e

Furthermore, it is preferred according to the invention that the enzyme E_d or E_e in the cells according to the invention is one which comprises sequences selected from among:

ZP_—07164313.1, NP_—418288.1, YP_—003231641.1, EGM59778.1, EFZ53307.1, AAA23750.1, ZP_—07192215.1, YP_—001460638.1, YP_—001727088.1, EGK16564.1, ZP_—08380619.1, ZP_—07136310.1, CAB40809.1, NP_—839030.1, ZP_—07690617.1, EGC97039.1, ZP_—07103516.1, ZP_—03027888.1, ZP_—07121980.1, YP_—002414996.1, EGP22873.1, EGJ82677.1, EGB59499.1, ZP_—07118761.1, YP_—002409078.1, YP_—002295407.1, EGE62412.1, EGB69560.1, ZP_—06655948.1, ZP_—06664574.1, ZP_—03070699.1, ZP_—07145404.1, ZP_—08376058.1, EGB85466.1, ZP_—07189176.1, ZP_—02999920.1, ZP_—08356523.1, ZP_—06659936.1, ZP_—07139396.1, YP_—001746178.1, YP_—002384700.1, ZP_—07098889.1, CBG37051.1, ZP_—04873109.1, CBJ03626.1, ZP_—08366395.1, ZP_—03066301.1, BAI57243.1, YP_—001465330.1, YP_—405325.1, NP_—312801.1, EGI89589.1, EGC09628.1, EFW73050.1, ZP_—07221474.1, EGB39932.1, EFW72281.1, ZP_—07154547.1, YP_—002331616.1, EGB76756.1, EFZ75005.1, ZP_—07449248.1, NP_—756652.2, ZP_—04006347.1, NP_—290476.1, EGH36687.1, YP_—671920.1, ZP_—08350773.1, EGC05062.1, ZP_—07174622.1, CAP78309.1, ZP_—08361145.1, YP_—002400350.1, ZP_—08386169.1, EFU60028.1, ZP_—02904283.1, YP_—859447.1, YP_—543379.2, NP_—462868.1, ZP_—02663494.1, ACY91152.1, ZP_—03221347.1, YP_—001591071.1, YP_—002639596.1, EFY10009.1, ZP_—04656823.1, ZP_—03213459.1, ZP_—02701437.1, ZP_—02347126.1, YP_—002217909.1, ZP_—02658976.1, YP_—002245833.1, YP_—002228260.1, YP_—001451793.1, EGE35935.1, YP_—002047992.1, ZP_—02834645.1, ZP_—02669606.1, YP_—001572623.1, ZP_—03075319.1, YP_—002148908.1, YP_—004591813.1, ZP_—03163685.1, YP_—002043211.1, NP_—457769.1, YP_—003367347.1, YP_—004732313.1, ZP_—06546517.1, ZP_—08495782.1, ZP_—04558441.1, YP_—002241091.1, ZP_—06354348.2, ZP_—06552493.1, YP_—001337975.1, YP_—001178655.1, CBK87780.1, ZP_—05970964.1, ZP_—06014071.1, YP_—002917176.1, YP_—152910.1, Q9F0Y7.1, ZP_—08302760.1, YP_—003615422.1, YP_—003943709.1, EGI93642.1, YP_—001439747.1, YP_—003208640.1, YP_—001476499.1, ZP_—06638309.1, YP_—004498688.1, YP_—004296470.1, ZP_—06192594.1, YP_—001004653.1, ZP_—04634366.1, CBY29055.1, ZP_—04641538.1, ZP_—04628383.1, ZP_—04620754.1, ZP_—04624649.1, YP_—003739635.1, ZP_—07953302.1, YP_—001399280.1, NP_—667802.1, YP_—068813.1, ADV97208.1, ZP_—04637125.1, YP_—003019595.1, YP_—048335.1, ZP_—04612255.1, ZP_—03831342.1, ZP_—03827989.1, YP_—003261565.1, ZP_—04616540.1, EFW54755.1, YP_—004214864.1, BAK13441.1, YP_—003518496.1, YP_—003933023.1, ZP_—07380063.1, YP_—003042702.1, YP_—003713991.1, YP_—003466462.1, YP_—004114076.1, YP_—001906200.1, NP_—931575.1, EGK17810.1, CBX79037.1, YP_—003529581.1, ZP_—06937250.1, YP_—002647270.1, ADP11112.1, ZP_—05974166.1, ZP_—03318464.1, ZP_—02958886.1, YP_—003331802.1, ZP_—06125606.1, YP_—003006180.1, YP_—003885045.1, YP_—128321.1, ZP_—01236908.1, ZP_—01161145.1, YP_—002989323.1, YP_—002154796.1, YP_—203408.1, ZP_—08310903.1, YP_—002264299.1, ZP_—01221704.1, ZP_—06050960.1, ZP_—03841335.1, ZP_—05883431.1, YP_—002153226.1, ADT85583.1, ZP_—05879947.1, ZP_—04923724.1, ZP_—01262258.1, ZP_—06179383.1, ZP_—05883853.1, EGF42158.1, ZP_—01957954.1, ZP_—08101926.1, ZP_—06177050.1, NP_—759944.1, NP_—796409.1, ZP_—04419618.1, ZP_—01987794.1, ZP_—05121182.1, YP_—001443702.1, ZP_—01948571.1, ZP_—01682057.1, ZP_—04405432.1, NP_—232384.1, ZP_—04409574.1, ZP_—01870127.1, NP_—932822.1, ZP_—06943917.1, EGR05147.1, ZP_—04961951.1, EGR10674.1, ZP_—04414292.1, ZP_—05718020.1, ZP_—08098153.1, ZP_—05719938.1, ZP_—03356468.1, ZP_—07742015.1, YP_—004564872.1, ZP_—01979859.1, ZP_—00992843.1, ZP_—05927571.1, ZP_—01065523.1, YP_—002415749.1, ZP_—01815881.1, ZP_—02196043.1, YP_—001143922.1, ZP_—08518445.1, ZP_—06156529.1, YP_—004394586.1, ZP_—01900693.1, YP_—854676.1, ZP_—05943242.1, CBA71812.1, ZP_—01991723.1, YP_—001092151.1, YP_—001672251.1, YP_—961420.1, YP_—003554801.1, YP_—003911300.1, ADV52504.1, YP_—001364252.1, YP_—001552462.1, ZP_—07394327.1, YP_—001048426.1, YP_—002355987.1, ZP_—02158912.1, ABE53312.1, YP_—561035.2, YP_—748714.1, ZP_—01135242.1, NP_—715663.1, YP_—732157.1, YP_—867675.1, YP_—736079.1, YP_—001758417.1, YP_—001499882.1, YP_—004436299.1, YP_—659787.1, ZP_—08620874.1, YP_—002309470.1, CBW44433.1, ZP_—08568624.1, YP_—958423.1, YP_—925914.1, YP_—001471764.1, ZP_—01165107.1, ZP_—04717156.1, ZP_—01042072.1, ZP_—08568929.1, YP_—004468425.1, ZP_—01614054.1, EGH60623.1, NP_—744285.1, ZP_—04587907.1, EGH84450.1, YP_—609235.1, Q93Q12.1, ZP_—07263341.1, YP_—004425808.1, EGH10831.1, ZP_—08142928.1, YP_—435877.1, YP_—004701152.1, ADR61111.1, EGH72107.1, ZP_—07255969.1, EGH76237.1, YP_—154404.1, EGH66371.1, ZP_—07005687.1, YP_—001268914.1, ZP_—03397164.1, YP_—267151.1, EGH45982.1, NP_—793297.1, YP_—236360.1, YP_—001667915.1, EGH29726.1, ZP_—03561781.1, YP_—275370.1, ABP88736.1, ZP_—06458302.1, YP_—001748526.1, YP_—002871195.1, ZP_—06478839.1, EGH95845.1, YP_—004067126.1, EGH21541.1, ZP_—05638744.1, Q9AHY3.2, YP_—338568.1, ZP_—06078672.1, YP_—004352961.1, ZP_—01892768.1, ZP_—06040413.1, YP_—349607.1, YP_—259059.1, ZP_—08409548.1, ADP97276.1, YP_—004713990.1, YP_—003626258.1, P28793.1, YP_—001172246.1, YP_—003810247.1, YP_—004313957.1, EGE21928.1, EGE19309.1, EGE13641.1, ZP_—08462037.1, EGE13529.1, ZP_—06034789.1, EGE12165.1, AEA83639.1, YP_—002798635.1, ZP_—01306165.1, YP_—004474976.1, ZP_—01739261.1, NP_—251704.1, ACP17923.1, YP_—004379416.1, YP_—001280990.1, YP_—003145204.1, YP_—001347517.1, ZP_—06877966.1, YP_—001187076.1, ZP_—08638729.1, YP_—001340441.1, ZP_—05128804.1, YP_—003896827.1, YP_—003073151.1, ZP_—05096745.1, ZP_—01103278.1, YP_—693372.1, ZP_—01366482.1, ZP_—05619303.1, ZP_—08328596.1, ZP_—05042935.1, YP_—574439.1, ZP_—01074264.1, YP_—004482149.1, YP_—045111.1, YP_—265216.1, ZP_—05362445.1, YP_—001715228.1, YP_—001844981.1, YP_—001708314.1, YP_—581488.1, ADY83798.1, ZP_—06692406.1, YP_—003733838.1, ZP_—05824704.1, ZP_—06058514.1, ZP_—08554004.1, ZP_—06068411.1, ZP_—06067277.1, ZP_—06726497.1, ADX01983.1, ZP_—03822268.1, ZP_—03347927.1, ZP_—01116792.1, YP_—527079.1, ZP_—06063435.1, ZP_—06534677.1, ZP_—01219812.1, ZP_—03347768.1, YP_—002798829.1, ZP_—07774142.1, YP_—003557881.1, ZP_—06157092.1, ZP_—01223872.1, ZP_—05946076.1, ZP_—06499586.1, YP_—003451185.1, YP_—002361722.1, YP_—003266103.1, YP_—285556.2, AAZ47086.1, NP_—968701.1, ZP_—06936670.1, ZP_—03805048.1, YP_—943922.1, ZP_—01217009.1, ADT87675.1, ZP_—05877956.1, ZP_—03355309.1, ZP_—05885304.1, EGK17811.1, ZP_—05944972.1, ZP_—05119053.1, ZP_—06039619.1, ZP_—05716842.1, ZP_—05721090.1, ZP_—06079171.1, ZP_—06033023.1, ZP_—08098475.1, ZP_—08104504.1, ZP_—06048048.1, ZP_—01677170.1, ZP_—01681193.1, NP_—230692.2, ZP_—05926205.1, ZP_—05881372.1, ZP_—01975051.1, ZP_—04412573.1, ZP_—01977591.1, ZP_—04415061.1, ZP_—06048243.1, YP_—742943.1, ZP_—04962518.1, ZP_—01955504.1, ZP_—07741831.1, EGK33112.1, ZP_—01980800.1, CBW26643.1, EGQ99075.1, ZP_—03561616.1, ZP_—06155835.1, ZP_—01613403.1, YP_—003147156.1, ZP_—01866421.1, ZP_—08569601.1, YP_—004068133.1, ZP_—01992793.1, YP_—003760621.1, NP_—760849.1, NP_—935233.1, YP_—661240.1, CBA76402.1, YP_—003527567.1, ZP_—05071916.1, YP_—155382.1, ZP_—08567109.1, ZP_—08410490.1, YP_—002357526.1, YP_—001473368.1, ZP_—05061211.1, ZP_—08309062.1, ZP_—00990722.1, ZP_—01813160.1, YP_—343735.1, YP_—001366977.1, ZP_—07393465.1, YP_—002312436.1, ZP_—03805047.1, ZP_—04716066.1, ZP_—01043968.1, YP_—562538.1, ZP_—01064421.1, YP_—928042.1, YP_—002416486.1, YP_—962941.1, YP_—001051116.1, YP_—004467793.1, YP_—004434876.1, YP_—001183979.1, ZP_—01125518.1, YP_—001555281.1, ZP_—01900341.1, YP_—001459147.1, ADV54930.1, ZP_—06054161.1, YP_—001674882.1, YP_—001381324.1, ZP_—02158374.1, NP_—718651.1, YP_—737529.1, YP_—869101.1, ZP_—01258852.1, ZP_—05978956.1, ZP_—06179776.1, YP_—733543.1, ZP_—01989664.1, NP_—798587.1, EGF45285.1, ZP_—05908370.1, YP_—001502453.1, ZP_—06639387.1, YP_—003557654.1, ZP_—04921889.1, YP_—001436988.1, YP_—003468880.1, YP_—001761392.1, YP_—003267851.1, YP_—004730996.1, EGL72460.1, YP_—003742516.1, YP_—003258850.1, ZP_—01132697.1, ZP_—01987078.1, YP_—004392689.1, ZP_—06191156.1, YP_—002381996.1, ZP_—06176023.1, EGC06853.1, ZP_—07196084.1, NP_—754768.1, ZP_—02901855.1, ZP_—08620438.1, EGE30558.1, YP_—003211325.1, ZP_—03220131.1, YP_—217377.1, YP_—003940937.1, YP_—004669896.1, YP_—633521.1, YP_—002041652.1, NP_—456929.1, YP_—001446296.1, ZP_—02699767.1, YP_—001586838.1, YP_—751355.1, ZP_—08384609.1, YP_—002216460.1, A8 GH86.2, ZP_—02667448.1, YP_—004595105.1, YP_—002408448.1, YP_—001479604.1, YP_—149790.1, NP_—461330.1, YP_—002227302.1, ZP_—07187886.1, ZP_—08374604.1, ZP_—02343362.1, ZP_—02683558.1, YP_—001141958.1, ZP_—02662473.1, ZP_—07151809.1, YP_—004211957.1, YP_—003366276.1, YP_—003713364.1, ZP_—03035287.1, ZP_—08364768.1, YP_—002413389.1, ZP_—07448710.1, ZP_—04656170.1, ZP_—02654823.1, ZP_—01222785.1, EGB63194.1, ZP_—08359459.1, YP_—002636921.1, YP_—002329984.1, YP_—001744544.1, CAP76837.1, EFZ73229.1, EFU57443.1, YP_—002398712.1, YP_—003018387.1, ZP_—08520753.1, YP_—541623.1, ZP_—02574174.1, ZP_—07144040.1, ZP_—08349090.1, CBG35413.1, ZP_—04562847.1, ZP_—02195785.1, ZP_—02773221.1, EGB40918.1, ZP_—03050715.1, ZP_—07787570.1, ZP_—03831301.1, YP_—003003682.1, ZP_—08354786.1, YP_—051168.1, YP_—002403607.1, AEE57458.1, YP_—856678.1, YP_—001177597.1, ZP_—06658276.1, NP_—288914.1, YP_—002392166.1, ZP_—06654274.1, ZP_—07102361.1, EGB72544.1, YP_—004501987.1, ZP_—03027319.1, YP_—670274.1, YP_—003913906.1, ZP_—07097669.1, YP_—001463687.1, BAI55757.1, ZP_—08553509.1, YP_—003500399.1, ZP_—07121648.1, ZP_—01235780.1, CBK87125.1, YP_—002293925.1, ZP_—05431367.1, YP_—129175.1, ZP_—03003629.1, YP_—002387809.1, ZP_—03043524.1, YP_—001569579.1, ZP_—05435840.1, ZP_—01464666.1, YP_—001724305.1, ZP_—03068335.1, CBJ01980.1, AEJ57562.1, NP_—416843.1, YP_—002920590.1, ZP_—03828462.1, EGM60943.1, ZP_—06351976.1, ZP_—05968584.1, EGK21055.1, YP_—003040254.1, NP_—708223.1, YP_—689824.1, ZP_—04625886.1, AEJ99232.1, ZP_—07135079.1, YP_—339488.1, ZP_—07247352.1, ZP_—07590743.1, ZP_—08303100.1, EFU96242.1, EFZ69715.1, YP_—001336370.1, YP_—001094550.1, ZP_—07679578.1, ZP_—06547779.1, EGI93593.1, YP_—003438264.1, YP_—003614165.1, YP_—408769.1, YP_—001881164.1, YP_—003655512.1, YP_—002237269.1, YP_—004116642.1, ZP_—03065203.1, ZP_—07951118.1, CAQ79951.1, AAZ26206.1, BAK12062.1, YP_—269853.2, NP_—930429.2, YP_—404102.1, ZP_—04620204.1, ZP_—08498986.1, YP_—001452041.1, ZP_—01159981.1, CAE15574.1, A1JK30.2, ZP_—04635573.1, ZP_—02904987.1, ZP_—02961182.1, YP_—001005598.1, ZP_—01301762.1, ZP_—06016509.1, CBY28037.1, ZP_—05060968.1, ZP_—04632512.1, YP_—002156637.1, YP_—002132807.1, Q5E3U1.2, YP_—205193.1, ZP_—04613435.1, ZP_—07380136.1, YP_—004299028.1, YP_—003334344.1, YP_—001610684.1, YP_—001720255.1, YP_—001400379.1, YP_—652007.1, NP_—668898.1, ZP_—04640314.1, ADV98116.1, ZP_—03840558.1, ZP_—07047543.1, ZP_—03320348.1, YP_—001681761.1, ZP_—04615169.1, ZP_—08182604.1, YP_—003520988.1, YP_—002151536.1, NP_—641653.1, ZP_—08188276.1, Q668V1.2, YP_—463621.1, ZP_—05032523.1, YP_—363100.1, YP_—002490860.1, YP_—071146.1, YP_—003527951.1, YP_—004615064.1, ZP_—06702935.1, YP_—003277339.1, ZP_—06729873.1, YP_—004552309.1, ZP_—08178119.1, YP_—558747.1, YP_—003059322.1, ZP_—04628689.1, ZP_—05043496.1, YP_—755774.1, NP_—106254.1, NP_—774461.1, YP_—004145058.1, NP_—636640.1, YP_—001411745.1, YP_—244043.1, YP_—003906899.1, ZP_—02151779.1, EFW54754.1, YP_—004147062.1, YP_—434583.1, ZP_—06862658.1, YP_—003559491.1, ZP_—07474361.1, ZP_—07478578.1, ZP_—03787298.1, ZP_—06840682.1, ZP_—05161835.1, ZP_—06794105.1, ZP_—05181908.1, ZP_—05174379.1, YP_—003883888.1, NP_—541475.1, NP_—949054.1, YP_—003931777.1, YP_—001993209.1, ZP_—06124668.1, YP_—001594738.1, ZP_—06070710.1, ZP_—06484372.1, YP_—002515449.1, YP_—001895558.1, YP_—002029364.1, ZP_—02891585.1, ZP_—04682672.1, YP_—003761433.1, YP_—004107983.1, YP_—223224.1, YP_—003812264.1, YP_—001622574.1, ZP_—05452320.1, YP_—002734532.1, YP_—001257739.1, YP_—001372564.1, ZP_—05137372.1, YP_—001973266.1, YP_—342869.1, NP_—699967.1, ZP_—05086267.1, ZP_—01736760.1, YP_—001914218.1, ZP_—05157647.1, YP_—485365.1, YP_—001926123.1, ZP_—05116437.1, ZP_—03544469.1, ZP_—08330383.1, ZP_—06491403.1, ZP_—01896167.1, ADP99705.1, ZP_—02883593.1, YP_—004228182.1, YP_—570677.1, ZP_—01225298.1, YP_—200487.1, YP_—002988196.1, ZP_—08269313.1, NP_—767800.1, YP_—001094989.1, ZP_—06065014.1, YP_—002981447.1, YP_—001260831.1, YP_—003817548.1, YP_—532099.1, ZP_—07676723.1, YP_—001242863.1, ZP_—02244047.1, YP_—982073.1, YP_—001899020.1, NP_—519880.1, ZP_—02379339.1, NP_—946171.1, ZP_—01615132.1, YP_—456953.1, ZP_—02168372.1, ZP_—08552434.1, CBJ37969.1, YP_—004418392.1, ZP_—02362492.1, YP_—004107339.1, YP_—001203133.1, ZP_—01546752.1, YP_—002974094.1, ZP_—02186892.1, YP_—001989920.1, YP_—002964466.1, ZP_—03265887.1, YP_—555553.1, CBA26305.1, ZP_—06728723.1, ZP_—07656835.1, ZP_—05620865.1, YP_—575713.1, YP_—001907090.1, YP_—002911224.1, YP_—047520.1, YP_—004688052.1,in particularEGH60623.1, NP_—744285.1, ZP_—04587907.1, EGH84450.1, YP_—609235.1, Q93Q12.1, ZP_—07263341.1, EGH10831.1, ZP_—08142928.1, YP_—004701152.1, ADR61111.1, EGH72107.1, ZP_—07255969.1, EGH76237.1, EGH66371.1, ZP_—07005687.1, YP_—001268914.1, ZP_—03397164.1, EGH45982.1, NP_—793297.1, YP_—236360.1, YP_—001667915.1, EGH29726.1, YP_—275370.1, ABP88736.1, ZP_—06458302.1, YP_—001748526.1, YP_—002871195.1, ZP_—06478839.1, EGH95845.1, EGH21541.1, ZP_—05638744.1, Q9AHY3.2, YP_—004352961.1, YP_—349607.1, YP_—259059.1, YP_—004713990.1, P28793.1, YP_—001172246.1, AEA83639.1, YP_—004474976.1, NP_—251704.1, ACP17923.1, YP_—004379416.1, YP_—001347517.1, ZP_—06877966.1, YP_—001187076.1, ZP_—01366482.1, ZP_—07774142.1, ZP_—06499586.1, YP_—791508.1, ZP_—07796310.1, NP_—250428.1, YP_—002441177.1, YP_—001348922.1, ZP_—06879352.1, AEA82038.1, YP_—001170648.1, YP_—004473370.1, YP_—004712521.1, YP_—004353314.1, ZP_—07164313.1, NP_—418288.1, YP_—003231641.1, AAA23750.1, ZP_—07192215.1, YP_—001460638.1, YP_—001727088.1, ZP_—08380619.1, ZP_—07136310.1, CAB40809.1, ZP_—07690617.1, ZP_—07103516.1, ZP_—03027888.1, ZP_—07121980.1, YP_—002414996.1, EGP22873.1, EGB59499.1, ZP_—07118761.1, YP_—002409078.1, YP_—002295407.1, EGE62412.1, EGB69560.1, ZP_—06655948.1, ZP_—06664574.1, ZP_—03070699.1, ZP_—07145404.1, ZP_—08376058.1, EGB85466.1, ZP_—07189176.1, ZP_—02999920.1, ZP_—08356523.1, ZP_—06659936.1, ZP_—07139396.1, YP_—001746178.1, ZP_—07098889.1, CBG37051.1, CBJ03626.1, ZP_—08366395.1, BAI57243.1, YP_—001465330.1, NP_—312801.1, EGC09628.1, EFW73050.1, ZP_—07221474.1, EGB39932.1, EFW72281.1, ZP_—07154547.1, YP_—002331616.1, EGB76756.1, EFZ75005.1, ZP_—07449248.1, NP_—756652.2, ZP_—04006347.1, NP_—290476.1, EGH36687.1, YP_—671920.1, ZP_—08350773.1, ZP_—07174622.1, CAP78309.1, ZP_—08361145.1, YP_—002400350.1, ZP_—08386169.1, EFU60028.1, YP_—859447.1, YP_—543379.2, ZP_—06937250.1, ZP_—06936670.1, YP_—001459147.1, ZP_—07196084.1, NP_—754768.1, ZP_—08384609.1, YP_—002408448.1, ZP_—07187886.1, ZP_—08374604.1, ZP_—07151809.1, ZP_—03035287.1, ZP_—08364768.1, YP_—002413389.1, ZP_—07448710.1, EGB63194.1, ZP_—08359459.1, YP_—002329984.1, YP_—001744544.1, CAP76837.1, EFZ73229.1, EFU57443.1, YP_—002398712.1, YP_—541623.1, ZP_—07144040.1, ZP_—08349090.1, CBG35413.1, ZP_—02773221.1, EGB40918.1, ZP_—03050715.1, ZP_—07787570.1, ZP_—08354786.1, YP_—002403607.1, AEE57458.1, ZP_—06658276.1, NP_—288914.1, YP_—002392166.1, ZP_—06654274.1, ZP_—07102361.1, EGB72544.1, ZP_—03027319.1, YP_—670274.1, ZP_—07097669.1, YP_—001463687.1, BAI55757.1, YP_—003500399.1, ZP_—07121648.1, YP_—002293925.1, ZP_—03003629.1, YP_—002387809.1, ZP_—03043524.1, YP_—001724305.1, ZP_—03068335.1, CBJ01980.1, AEJ57562.1, NP_—416843.1, ZP_—07135079.1, ZP_—07247352.1, ZP_—07590743.1, EFU96242.1, EFZ69715.1,and especially preferablyNP_—744285.1, YP_—004701152.1, ADR61111.1, YP_—001268914.1, YP_—001667915.1, ABP88736.1, YP_—001748526.1, Q9AHY3.2, YP_—004713990.1, YP_—001172246.1, AEA83639.1, AEA82038.1, YP_—001170648.1, YP_—004712521.1, YP_—002871195.1, YP_—349607.1, YP_—259059.1, ZP_—07774142.1, NP_—418288.1, NP_—416843.1, ZP_—07593201.1, ZP_—07590743.1,andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_d and E_e is generally understood in particular as meaning conversion of 2-dodecenoyl-CoA thioester into 3-oxododecanoyl-CoA thioester.

Specific Enzymes E_f

Furthermore, it is preferred according to the invention that the enzyme E_f in the cells according to the invention is one which comprises sequences selected from among:

YP_—026272.1, YP_—002389323.1, EGB30581.1, YP_—001460637.1, YP_—001727089.1, CAB40810.1, EGK16565.1, NP_—709649.1, YP_—001882545.1, ZP_—08356522.1, ZP_—06664573.1, AAA67642.1, ADA76222.1, EGK17812.1, YP_—405326.1, YP_—003236969.1, ZP_—06659935.1, YP_—410143.1, NP_—290475.1, ZP_—03027945.1, EFZ59092.1, YP_—002295406.1, CBG37050.1, EGP22872.1, EGE62411.1, EGC97040.1, ZP_—05435276.1, YP_—002400349.1, EGB59498.1, EFW54756.1, ZP_—08361144.1, YP_—001465329.1, YP_—002384701.1, YP_—002409079.1, ZP_—06655947.1, YP_—002414995.1, EGB69559.1, YP_—859446.1, EGC05061.1, ZP_—02904263.1, ZP_—08386168.1, YP_—543378.1, ZP_—08366394.1, ZP_—03066325.1, YP_—001746177.1, ZP_—07154548.1, ZP_—03070708.1, NP_—756651.1, YP_—312775.1, YP_—671919.1, YP_—002331615.1, YP_—003367348.1, ZP_—07449249.1, ZP_—04558440.1, ZP_—06354347.1, YP_—001451792.1, YP_—004732312.1, ZP_—06938722.1, NP_—457770.1, ZP_—02834646.1, ZP_—02658975.1, ZP_—03221210.1, EFY10008.1, YP_—001591070.1, YP_—218866.1, YP_—003943710.1, ZP_—03086141.1, ZP_—03163187.1, ZP_—08495783.1, EGE35936.1, YP_—003615423.1, YP_—002228261.1, YP_—002148907.1, ZP_—05970963.1, YP_—002241092.1, YP_—004591812.1, YP_—001178656.1, ZP_—08302761.1, YP_—002917175.1, YP_—001337974.1, Q9F0Y6.1, ZP_—06014072.1, YP_—001439748.1, YP_—003208639.1, 3GOA_A, YP_—003739634.1, ZP_—06192593.1, YP_—001906199.1, YP_—001476498.1, YP_—003019596.1, YP_—003261566.1, ZP_—03831341.1, ZP_—07380062.1, YP_—048334.1, YP_—003933022.1, ZP_—07953301.1, YP_—004114075.1, YP_—002647269.1, ADP 11111.1, ZP_—03827988.1, ZP_—06638308.1, YP_—004214865.1, YP_—003518495.1, ZP_—04616541.1, BAK13440.1, CBX79036.1, YP_—003529580.1, ZP_—04628384.1, ZP_—04634365.1, ZP_—04641537.1, ZP_—04612254.1, ZP_—04637126.1, YP_—003331801.1, YP_—001004652.1, YP_—004296469.1, YP_—003006181.1, ZP_—04620755.1, YP_—003885046.1, ZP_—04624648.1, NP_—667801.1, EGI89588.1, YP_—128320.1, ZP_—01221705.1, YP_—002989324.1, ZP_—01236909.1, ZP_—01161146.1, ZP_—08310904.1, YP_—003713992.1, YP_—003466461.1, NP_—931576.1, YP_—003042703.1, ZP_—06050959.1, EGF42157.1, ZP_—00992844.1, YP_—002415748.1, ZP_—01065522.1, ZP_—05883432.1, ZP_—05879948.1, ZP_—06156528.1, ZP_—05927570.1, ZP_—07189177.1, YP_—004564871.1, ZP_—01870126.1, ZP_—02196042.1, YP_—003911299.1, ZP_—01815882.1, NP_—796408.1, YP_—004394587.1, ZP_—08518444.1, YP_—854675.1, ZP_—07742014.1, ZP_—01135243.1, YP_—002154795.1, NP_—759945.1, YP_—001143923.1, NP_—932821.1, Q5E8X7.2, ZP_—08568928.1, ZP_—06078671.1, ZP_—05718021.1, ZP_—01948567.1, YP_—203407.3, ZP_—04923725.1, ZP_—05719937.1, YP_—002309469.1, ZP_—06179384.1, ZP_—06048881.1, ZP_—01979851.1, ZP_—01262259.1, ZP_—01957951.1, ZP_—04405431.1, ZP_—08098152.1, ZP_—06034494.1, YP_—001758416.1, ZP_—04414293.1, ZP_—06040414.1, ZP_—01682043.1, NP_—232385.1, ZP_—05883854.1, YP_—002264298.1, ZP_—01987792.1, YP_—338567.1, ZP_—01900694.1, YP_—001672250.1, YP_—925913.1, YP_—001499881.1, ZP_—02158913.1, YP_—001471763.1, NP_—715662.1, YP_—748713.1, YP_—736078.1, ZP_—08568623.1, ZP_—02958885.2, YP_—004067125.1, ZP_—08409549.1, YP_—001181547.1, ADV52503.1, YP_—732156.1, YP_—001092150.1, YP_—003554800.1, YP_—001048425.1, YP_—961419.1, YP_—561034.1, ZP_—06125607.2, YP_—867674.1, YP_—001443701.1, ZP_—05943241.1, ZP_—05121169.1, ZP_—05974167.1, ZP_—03318463.1, ZP_—08620875.1, ZP_—01042073.1, YP_—154403.1, ZP_—04717155.1, ZP_—03805050.1, YP_—004468426.1, ZP_—03841336.1, YP_—002153225.1, YP_—004425807.1, ZP_—03351120.1, YP_—659788.1, YP_—004436298.1, YP_—267150.1, ZP_—06034790.1, YP_—003145205.1, ZP_—03561780.1, YP_—003810248.1, ZP_—05043383.1, YP_—693373.1, ZP_—01306166.1, YP_—004313956.1, YP_—790159.1, ZP_—06877967.1, NP_—251703.1, YP_—004482148.1, EGH66370.1, EGH10832.1, YP_—349606.1, YP_—236359.1, ZP_—07263340.1, EGH95844.1, ZP_—03368595.1, NP_—793296.1, ZP_—01165108.1, 1WDK_C, P28790.2, YP_—259060.1, ZP_—01074263.1, ZP_—04587908.1, EGH45981.1, ZP_—07774144.1, EGH84449.1, YP_—958424.1, YP_—275369.1, ZP_—07005686.1, YP_—001172247.1, YP_—004352962.1, ACP17922.1, YP_—002871196.1, YP_—435876.1, ZP_—01739262.1, YP_—003557880.1, ZP_—01892767.1, ZP_—08142929.1, ZP_—08462036.1, YP_—004701153.1, YP_—001667916.1, YP_—001280989.1, YP_—001268913.1, Q93Q11.1, ZP_—05619304.1, AEA79634.1, Q9R9W0.1, NP_—744286.1, YP_—001187077.1, YP_—609234.1, ADP97277.1, YP_—045110.1, YP_—004379417.1, YP_—003626259.1, ZP_—06692405.1, ZP_—06063436.1, YP_—003733839.1, EGE12166.1, ZP_—05824703.1, EGE26385.1, EGE13530.1, YP_—004474975.1, YP_—001708315.1, EGE 16076.1, ZP_—06726496.1, ZP_—06067276.1, ZP_—06058513.1, ZP_—06068412.1, ZP_—06157093.1, ZP_—03822267.1, A3M1H9.2, YP_—001340442.1, ZP_—05362446.1, ABP88737.1, ZP_—01219813.1, ZP_—08638730.1, YP_—265215.1, YP_—581487.1, YP_—003896828.1, YP_—002798636.1, ZP_—01678475.1, ZP_—05946075.1, YP_—527080.1, ZP_—08554005.1, ZP_—03360083.1, YP_—574438.1, YP_—003073152.1, YP_—001083375.1, ZP_—08648989.1, YP_—001982171.1, ZP_—05096741.1, ZP_—03336985.1, ZP_—01103277.1, ZP_—07136312.1, ZP_—08328590.1, ZP_—05128805.1, EGH76239.1, ZP_—03377529.1, CBA71811.1, EFZ47010.1, ZP_—03377530.1, ZP_—07136311.1, EFZ47009.1, EGH29725.1, YP_—003022611.1, YP_—002138248.1, ZP_—01462439.1, ZP_—06499584.1, YP_—004669687.1, YP_—633289.1, ZP_—01907074.1, YP_—001611010.1, ADI22030.1, ZP_—03026937.1, YP_—580525.1, YP_—003265025.1, YP_—001525888.1, YP_—002298157.1, YP_—002945338.1, YP_—003271056.1, YP_—004198848.1, ZP_—01895445.1, ZP_—08636846.1, ADP95813.1, ZP_—03357270.1, YP_—002535575.1, YP_—160280.1, YP_—385012.1, YP_—004154467.1, YP_—742957.1, YP_—984918.1, ZP_—07949467.1, YP_—002552054.1, YP_—003439807.1, YP_—002919224.1, YP_—001475439.1, ZP_—07652842.1, YP_—001335140.1, YP_—972400.1, ZP_—08308052.1, YP_—001749490.1, YP_—004594280.1, ZP_—05360584.1, YP_—002490812.1, ZP_—03336986.1, YP_—004236457.1, ZP_—08387650.1, YP_—046370.1, ZP_—03823670.1, AEJ97944.1, ZP_—06188204.1, ABF82237.1, ZP_—06016043.1, YP_—046135.1, YP_—942111.1, ZP_—01614052.1, YP_—001341942.1, YP_—004713534.1, ZP_—01460231.1, YP_—001630800.1, YP_—001264278.1, CAD76924.1, ZP_—07200324.1, YP_—550745.1, YP_—001413963.1, YP_—002132758.1, ZP_—05972210.1, ZP_—06065848.1, ZP_—08209169.1, ZP_—06061642.1, ZP_—05109438.1, YP_—001419321.1, YP_—463572.1, YP_—608369.1, YP_—001683323.1, AEA83130.1, YP_—001230361.1, YP_—001832875.1, YP_—002237684.1, AAN39378.1, YP_—001019613.1, YP_—426398.1, ZP_—03543802.1, YP_—001171793.1, YP_—002138936.1, YP_—001562369.1, ZP_—01786296.1, YP_—001528043.1, NP_—881363.1, ZP_—04625099.1, ZP_—02187462.1, YP_—002355162.1, YP_—248479.1, ZP_—07043392.1, YP_—002028041.1, YP_—001900023.1, ZP_—01792340.1, ZP_—03541158.1, NP_—438930.1, ZP_—04464778.1, YP_—003278968.1, YP_—004490499.1, ZP_—07662038.1, AAM48101.1, YP_—422117.1, YP_—524752.1, YP_—918568.1, YP_—001264814.1, YP_—003807823.1, YP_—001260276.1, ZP_—07046088.1, ZP_—01784141.1, ZP_—05135853.1, YP_—002982015.1, EEZ80724.1, YP_—001292714.1, YP_—001971860.1, YP_—788379.1, ZP_—05783989.1, YP_—004415862.1, CAE45106.1, YP_—004618019.1, ZP_—01126529.1, ZP_—06062289.1, YP_—004538662.1, NP_—248919.1, YP_—001098905.1, YP_—003847633.1, YP_—002432816.1, YP_—003280245.1, A64092, ZP_—08404839.1, YP_—003466069.1, YP_—001348923.1, YP_—158582.1, YP_—004229600.1, ZP_—07797976.1, YP_—001416028.1, YP_—001747677.1, YP_—002362051.1, YP_—931973.1, ZP_—08505255.1, EGP53986.1, NP_—250427.1, YP_—366806.1, ZP_—04638299.1, ZP_—08485306.1, YP_—001675166.1, AAA23322.1, NP_—927515.1, AAR83740.1, YP_—433439.1, YP_—001668851.1, YP_—001713606.1, YP_—002354475.1, ZP_—06548530.1, ZP_—04764695.1, ZP_—01910282.1, YP_—004146469.1, YP_—095382.1, ZP_—06495825.1, YP_—003777379.1, ZP_—01914912.1, ZP_—06895226.1, YP_—004379898.1, YP_—003365234.1, YP_—001784146.1, YP_—003021900.1, YP_—004555586.1, YP_—001101071.1, CBW99592.1, YP_—003254723.1, AAG30258.1, YP_—004536011.1, NP_—884797.1, NP_—635761.1, YP_—002429235.1, YP_—001901798.1, ZP_—06485970.1, YP_—123631.1, YP_—001352245.1, ZP_—03697428.1, ZP_—05824476.1, ZP_—01014491.1, EGH60624.1, YP_—004028852.1, ZP_—04633718.1, YP_—001846659.1, ZP_—04933402.1, YP_—003731942.1, YP_—001345710.1, YP_—003979747.1, ZP_—00053266.1, YP_—126656.1, YP_—003442067.1, YP_—585810.1, ZP_—01614053.1, ZP_—06690229.1, YP_—001858908.1, ZP_—01128624.1, NP_—888558.1, ZP_—05827098.1, Q8VPF1.1, YP_—004473788.1, EGH77345.1, P45363.1, EGH44350.1, YP_—001676522.1, ZP_—05824514.1, ZP_—06487592.1, ZP_—02887415.1, ZP_—04761513.1, YP_—003377502.1, YP_—001188713.1, ZP_—01167911.1, ZP_—06690267.1, YP_—004680403.1, YP_—003731982.1, YP_—002800937.1, YP_—001758618.1, YP_—004380648.1, YP_—001188079.1, YP_—001707349.1, YP_—004687867.1, CAZ89607.1, ZP_—05827058.1, ZP_—08142248.1, YP_—195739.1, YP_—004703691.1, YP_—001354779.1, ZP_—08627639.1, ZP_—04936650.1, NP_—642338.1, ZP_—03451105.1, YP_—001713567.1, EFV87627.1, YP_—728366.1, YP_—002912837.1, YP_—001707333.1, YP_—363794.1, YP_—003524466.1, YP_—959751.1, YP_—606872.1, YP_—102034.1, YP_—002942733.1, YP_—002238110.1, ZP_—05032457.1, YP_—001846620.1, YP_—004153168.1, ZP_—02462362.1, YP_—003777513.1, YP_—199120.1, ZP_—08179077.1, ZP_—08188845.1, YP_—107279.1, ADP98459.1, YP_—004157409.1, YP_—610092.1, EGP55478.1, CBJ37328.1, ZP_—08181461.1, ZP_—06842278.1, ZP_—06703672.1, ADR61907.1, ZP_—06688595.1, ZP_—04934614.1, ZP_—07262554.1, YP_—786611.1, YP_—003439146.1, YP_—003592852.1, YP_—001747891.1, YP_—004386570.1, Q51956.1, YP_—004593695.1, YP_—560516.1, ZP_—06731844.1, YP_—001897101.1, ZP_—08388430.1, YP_—001166210.1, YP_—557015.1, ZP_—06843809.1, EGP42659.1, YP_—002005592.1, YP_—002871766.1, YP_—555845.1, ZP_—05921114.1, NP_—746745.1, NP_—637343.1, ZP_—02243308.1, YP_—001267798.1, ZP_—02354510.1, NP_—841567.1, ZP_—08177693.1, YP_—004703877.1, YP_—001166143.1, EGH73771.1, ZP_—06489206.1, ZP_—01892079.1, YP_—934562.1, ADY81955.1, EGB73439.1, NP_—520373.1, YP_—003905682.1, EGH61062.1, YP_—001894311.1, ZP_—02245330.1, YP_—918778.1, YP_—001120651.1, YP_—003612896.1, YP_—004125334.1, ZP_—07952596.1, YP_—001479268.1, ZP_—07043083.1, YP_—003644271.1, NP_—421210.1, ZP_—02882590.1, EGP25245.1, YP_—233920.1, EGD00226.1, YP_—004418315.1, ADY81914.1, ZP_—04944762.1, YP_—003603999.1, YP_—001060552.1, ZP_—03026966.1, YP_—441123.1, YP_—201177.1, ZP_—05117283.1, YP_—004232360.1, YP_—002802211.1, YP_—106085.1, YP_—258448.1, YP_—001989549.1, NP_—945866.1, ZP_—03573123.1, YP_—283604.1, YP_—004702122.1, ZP_—03398400.1, YP_—105310.1, YP_—001479310.1, CAC41637.1, ZP_—02372747.1, YP_—001578772.1, ZP_—08181762.1, ZP_—00439074.2, ADX92638.1, ZP_—03790444.1, YP_—110295.1, YP_—002439726.1, YP_—004361986.1, ZP_—04946665.1, YP_—003751825.1, YP_—001061488.1, ZP_—03545148.1, ZP_—01767462.1, ZP_—01769818.1, YP_—990241.1, YP_—002382777.1, YP_—002898389.1, YP_—003452421.1, EGH66881.1, CBW26817.1, YP_—004352451.1, EGC07165.1, YP_—003982691.1, ZP_—02906520.1, YP_—410799.1, YP_—001189077.1, YP_—004226900.1, ADP96997.1, YP_—237079.1, YP_—002946310.1, YP_—004029037.1, NP_—745423.1, ZP_—08139209.1, YP_—004294989.1, NP_—251630.1, EGH73592.1, ZP_—04934925.1, ZP_—03583227.1, ZP_—03584241.1, YP_—004684330.1, YP_—004501533.1, YP_—001186637.1, YP_—003980170.1, AEJ98540.1, YP_—004688333.1, YP_—003276725.1, EGH11975.1, YP_—276147.1, YP_—790233.1, ZP_—01736635.1, YP_—002440908.1, YP_—002230040.1, YP_—724980.1, YP_—004231717.1, ZP_—01226775.1, ZP_—03454556.1, ZP_—05586076.1, ZP_—02890239.1, YP_—001172996.1, ZP_—02377875.1, ZP_—07202399.1, YP_—774661.1, YP_—440314.2, YP_—443408.1, ZP_—06878044.1, ZP_—08274339.1, YP_—001618203.1, ZP_—08631485.1, ZP_—01545529.1, ZP_—03267843.1, ZP_—07797009.1, YP_—003376084.1, EGH21143.1, YP_—003753513.1, YP_—004282234.1, YP_—726356.1, ZP_—06014951.1, YP_—109637.1, ZP_—06461447.1, YP_—001795795.1, YP_—621981.1, ZP_—07794257.1, ZP_—05060451.1, YP_—002919830.1, YP_—001796645.1, NP_—794063.1, ZP_—01365347.1, YP_—003610065.1, YP_—001462757.1, YP_—001807185.1, ZP_—04928407.1, YP_—002229986.1, ZP_—02883901.1, YP_—370284.1, ZP_—05053491.1, AAC24332.1, ZP_—04929241.1, ZP_—00943679.1, YP_—001766064.1, YP_—001670661.1, YP_—003296167.1, YP_—003773673.1, NP_—250691.1, ZP_—05823066.1, YP_—004381309.1, YP_—004714773.1, YP_—746962.1, YP_—002513585.1, YP_—294674.1, YP_—004593822.1, YP_—622032.1, YP_—001897940.1, YP_—001335713.1, YP_—001856626.1, YP_—791238.1, YP_—004140309.1, YP_—001269802.1, ZP_—06879064.1, ZP_—01736318.1, ZP_—02886139.1, ZP_—04941413.1, YP_—001670851.1, YP_—371023.1, YP_—002980343.1, YP_—002795605.1, ZP_—06069679.1, ZP_—02463309.1, ZP_—05785212.1, YP_—001793049.1, YP_—003965283.1, YP_—001233153.1, YP_—299776.1, ZP_—06498740.1, AEJ99148.1, YP_—004685690.1, YP_—003746771.1, YP_—004381943.1, YP_—004378973.1, YP_—004314684.1, EGH79619.1, ZP_—04882546.1, YP_—347001.1, YP_—347471.1, YP_—001757758.1, YP_—002911324.1, NP_—518596.1, ZP_—00948908.1, YP_—442777.1, YP_—002874183.1, YP_—002230989.1, YP_—004360850.1, ABC36127.1, YP_—004696127.1, YP_—002799527.1, YP_—001631275.1, YP_—626125.1, ZP_—05090649.1, ZP_—07774002.1, ZP_—04940525.1, AEK60371.1, ADR60119.1, YP_—102981.1, YP_—003451423.1, NP_—743536.1, CAA45255.1,in particularYP_—790159.1, ZP_—06877967.1, NP_—251703.1, EGH66370.1, EGH10832.1, YP_—349606.1, YP_—236359.1, ZP_—07263340.1, EGH95844.1, NP_—793296.1, 1WDK_C, P28790.2, YP_—259060.1, ZP_—04587908.1, EGH45981.1, ZP_—07774144.1, EGH84449.1, YP_—275369.1, ZP_—07005686.1, YP_—001172247.1, YP_—004352962.1, ACP17922.1, YP_—002871196.1, ZP_—08142929.1, YP_—004701153.1, YP_—001667916.1, YP_—001268913.1, Q93Q11.1, Q9R9W0.1, NP_—744286.1, YP_—001187077.1, YP_—609234.1, YP_—004379417.1, YP_—004474975.1, ABP88737.1, EGH76239.1, EGH29725.1, ZP_—06499584.1, YP_—001749490.1, ABF82237.1, YP_—004713534.1, CAD76924.1, YP_—608369.1, AEA83130.1, YP_—001171793.1, YP_—788379.1, CAE45106.1, NP_—248919.1, YP_—001348923.1, ZP_—07797976.1, YP_—001747677.1, NP_—250427.1, AAR83740.1, YP_—001668851.1, ZP_—06495825.1, YP_—004379898.1, EGH60624.1, ZP_—04933402.1, YP_—001345710.1, Q8VPF1.1, YP_—004473788.1, EGH77345.1, EGH44350.1, YP_—001188713.1, YP_—004380648.1, YP_—001188079.1, ZP_—08142248.1, YP_—004703691.1, ZP_—04936650.1, YP_—606872.1, YP_—610092.1, ADR61907.1, ZP_—04934614.1, ZP_—07262554.1, YP_—001747891.1, Q51956.1, YP_—002871766.1, NP_—746745.1, YP_—001267798.1, YP_—004703877.1, EGH73771.1, EGH61062.1, YP_—233920.1, YP_—258448.1, YP_—004702122.1, ZP_—03398400.1, YP_—002439726.1, EGH66881.1, YP_—004352451.1, YP_—001189077.1, YP_—237079.1, NP_—745423.1, ZP_—08139209.1, NP_—251630.1, EGH73592.1, ZP_—04934925.1, YP_—001186637.1, EGH11975.1, YP_—276147.1, YP_—790233.1, YP_—002440908.1, YP_—001172996.1, ZP_—06878044.1, ZP_—07797009.1, EGH21143.1, ZP_—06461447.1, ZP_—07794257.1, NP_—794063.1, ZP_—01365347.1, ZP_—04928407.1, AAC24332.1, ZP_—04929241.1, YP_—001670661.1, NP_—250691.1, YP_—004381309.1, YP_—004714773.1, YP_—791238.1, YP_—001269802.1, ZP_—06879064.1, YP_—001670851.1, ZP_—06498740.1, YP_—004381943.1, YP_—004378973.1, EGH79619.1, YP_—347001.1, YP_—347471.1, YP_—002874183.1, ZP_—07774002.1, ADR60119.1, NP_—743536.1, YP_—001269653.1, ZP_—06482365.1, ADI95330.1, ZP_—07003619.1, BAB96553.1, ZP_—07777009.1, ABA10831.1, YP_—273131.1, YP_—259428.1, EFW86233.1, EGH85840.1, ZP_—07774597.1, EGH54613.1, YP_—004353129.1, YP_—002871014.1, YP_—001171232.1, EGH67454.1, EFW82139.1, ZP_—04590526.1, EGH58132.1, EGH06629.1, EGH99157.1, ZP_—05638078.1, NP_—790796.1, AEE59172.1, YP_—026272.1, YP_—002389323.1, EGB30581.1, YP_—001460637.1, YP_—001727089.1, CAB40810.1, ZP_—03049054.1, ZP_—08356522.1, ZP_—06664573.1, AAA67642.1, YP_—003236969.1, ZP_—06659935.1, NP_—290475.1, ZP_—03027945.1, EFZ59092.1, YP_—002295406.1, CBG37050.1, EGP22872.1, EGE62411.1, YP_—002400349.1, EGB59498.1, ZP_—08361144.1, YP_—001465329.1, YP_—002409079.1, ZP_—06655947.1, YP_—002414995.1, EGB69559.1, YP_—859446.1, ZP_—08386168.1, YP_—543378.1, ZP_—08366394.1, YP_—001746177.1, ZP_—07154548.1, ZP_—03070708.1, NP_—756651.1, YP_—671919.1, YP_—002331615.1, ZP_—07449249.1, ZP_—06938722.1, ZP_—03086141.1, ZP_—07189177.1, ZP_—07136312.1, EFZ47010.1, ZP_—07136311.1, EFZ47009.1, ZP_—03026937.1, EGB73439.1, EGP25245.1, ZP_—03026966.1, YP_—001462757.1, CAP76727.1, YP_—670163.1,and especially preferablyYP_—026272.1, AAA67642.1, ZP_—07593202.1, YP_—004701153.1, YP_—001667916.1, YP_—001268913.1, Q9R9W0.1, NP_—744286.1, ABP88737.1, YP_—001749490.1, YP_—001747677.1, YP_—001668851.1, YP_—004703691.1, ADR61907.1, YP_—001747891.1, Q51956.1, NP_—746745.1, YP_—001267798.1, YP_—004703877.1, YP_—004702122.1, NP_—745423.1, AAC24332.1, YP_—001670661.1, YP_—001269802.1, YP_—001670851.1, ADR60119.1, NP_—743536.1, YP_—001269653.1, ADI95330.1, BAB96553.1, YP_—001172247.1, YP_—004713534.1, AEA83130.1, YP_—001171793.1, YP_—001172996.1, YP_—004714773.1, YP_—001171232.1, YP_—349606.1, YP_—259060.1, ZP_—07774144.1, YP_—002871196.1, ABF82237.1, YP_—002871766.1, YP_—258448.1, YP_—347001.1, YP_—347471.1, YP_—002874183.1, ZP_—07774002.1, ZP_—07777009.1, YP_—259428.1, ZP_—07774597.1, YP_—002871014.1,AAC72881.1, ABB71579.1, CAC19934.1, AAC49180.1 (encoded by SEQ ID No.: 10), AAC49783.1, AAC49179.1, CAB60830.1, ABB71581.1, AAC49269.1, CAC 19933.1, CAA54060.1, AAC72882.1, 039513.1, AAC49784.1, ABO38558.1, ABO38555.1, ABO38556.1, ABO38554.1, ADB79568.1, ADB79569.1, ACQ57188.1, ACQ57189.1, ABK96561.1, ACQ63293.1, ACQ57190.1, Q9SQI3.1, ABU96744.1, ABC47311.1, XP_—002324962.1, AAD01982.1, AAB51525.1, ACV40757.1, XP_—002309244.1, CBI28125.3, ABD91726.1, XP_—002284850.1, XP_—002309243.1, XP_—002515564.1, ACR56792.1, ACR56793.1, XP_—002892461.1, ABI18986.1, NP_—172327.1, CAA85387.1, CAA85388.1, ADA79524.1, ACR56795.1, ACR56794.1, CAN81819.1, ACF17654.1, AAB71729.1, ABH11710.1, ACQ57187.1, AAX51637.1, AAB88824.1, AAQ08202.1, AAB71731.1, AAX51636.1, CAC80370.1, CAC80371.1, AAG43858.1, ABD83939.1, AAD42220.2, AAG43860.1, AAG43861.1, AAG43857.1, AAL15645.1, AAB71730.1, NP_—001068400.1, EAY86877.1, NP_—001056776.1, XP_—002436457.1, NP_—001149963.1, ACN27901.1, EAY99617.1, ABL85052.1, XP_—002437226.1, NP_—001151366.1, ACF88154.1, NP_—001147887.1, XP_—002453522.1, BAJ99650.1, EAZ37535.1, EAZ01545.1, AAN17328.1, EAY86884.1, EEE57469.1, Q41635.1, AAM09524.1, Q39473.1, NP_—001057985.1, AAC49001.1, XP_—001752161.1, XP_—001770108.1, XP_—001784994.1, XP_—002318751.1, NP_—001047567.1, XP_—002322277.1, XP_—002299627.1, XP_—002511148.1, CBI15695.3, XP_—002299629.1, XP_—002280321.1, CAN60643.1, XP_—002459731.1, XP_—002975500.1, XP_—002962077.1, XP_—001773771.1, NP_—001151014.1, XP_—002317894.1, XP_—002971008.1, XP_—001774723.1, XP_—002280147.1, XP_—002526311.1, XP_—002517525.1, XP_—001764527.1, ABI20759.1, BAD73184.1, XP_—002987091.1, XP_—002985480.1, CBI26947.3, ABI20760.1, XP_—002303055.1, XP_—002885681.1, ADH03021.1, XP_—002532744.1, EAY74210.1, EEC84846.1, EEE54649.1, AAG35064.1, AAC49002.1, CAD32683.1, ACF78226.1, BAJ96402.1, XP_—002462626.1, NP_—001130099.1, XP_—002462625.1, ABX82799.3, Q42712.1, NP_—193041.1, AAB51524.1, NP_—189147.1, ABR18461.1, XP_—002863277.1, AAC72883.1, AAA33019.1, CBI40881.3, XP_—002262721.1, AAB51523.1, NP_—001063601.1, ADB79567.1, AAL77443.1, AAL77445.1, AAQ08223.1, AAL79361.1, CAA52070.1, AAA33020.1, CAA52069.1, XP_—001785304.1, CAC39106.1, XP_—002992591.1, XP_—002968049.1, XP_—001770737.1, XP_—001752563.1, AAG43859.1, XP_—002978911.1, XP_—002977790.1, ACB29661.1, XP_—002314829.1, XP_—002991471.1, EAZ45287.1, XP_—002986974.1, EEC73687.1, XP_—002312421.1, ACJ84621.1, NP_—001150707.1, AAD28187.1, XP_—001759159.1, XP_—001757193.1, XP_—002322077.1, ABE01139.1, XP_—002447294.1, AAX54515.1, AAD33870.1, AAX54514.1, CBI15694.3, XP_—002270653.1, AAZ83073.1, CAC14164.1, XP_—001753224.1, CBI35766.3, ACU22895.1, BAC43222.1, XP_—002965875.1, AAX54516.1, XP_—002983123.1, XP_—002447046.1, ACL52706.1, CAA06001.1, XP_—001772711.1,andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_f is generally understood in particular as meaning the reaction of 3-oxododecanoyl-CoA thioester and CoA to give decanoyl-CoA thioester and acetyl-CoA.

Sixth Genetic Modification for Enhancing the Acyl-ACP Thioester Synthesis

According to the invention, the microorganisms include a sixth genetic modification so that they are capable of forming more acyl-ACP thioester from at least one simple carbon source in comparison with their wild type. An overview over correspondingly desirable genetic modifications can be found in FIG. 1 of WO2008119082, section 1 (fatty acid production increase/product production increase).

The technical effect of this is that the formation of carboxylic acids and carboxylic acid derivatives which is increased by the first genetic modification, but also of carboxylic acids and carboxylic acid derivatives which are formed in larger amounts due to the second, third, fourth or fifth genetic modification, is increased even further.

Preferred Microorganisms for the Production of Alkan-1-ols, Alkan-1-als, Alkan-1-Amines, Alkanes, Olefins, Alken-1-als, Alken-1-ols and Alken-1-Amines

If the microorganisms according to the invention are intended to be used in a process for the production of alkan-1-ols, alkan-1-als, alkan-1-amines, alkanes, alken-1-als, alken-1-ols and alken-1-amines and terminal olefins which optionally contain further double bonds, it may be advantageous that the microorganisms according to the invention include a seventh genetic modification comprising an activity of at least one enzyme E₁ that is reduced in comparison with its wild type, selected from the group:

E_1a P450 alkane hydroxylases, which preferably catalyse the following reactions:reduced haem+alkanoic acid (ester)=oxidized haem+ω-hydroxyalkanoic acid (ester)+H₂O,2 reduced haem+alkanoic acid (ester)=2 oxidized haem+ω-oxoalkanoic acid (ester)+2H₂Oor3 reduced haem+alkanoic acid (ester)=alkane monoxygenase+3 oxidized haem+ω-carboxyalkanoic acid (ester)+3H₂O and preferablycomponent of a reaction system composed of the two enzyme components “cytochrome P450 alkane hydroxylase and NADPH-cytochrome P450 oxidoreductase of EC 1.6.2.4” or component of a reaction system composed of the three enzyme components “cytochrome P450 alkane hydroxylase of the type CYP_—153, ferredoxin-NAD(P)⁺ reductases of EC 1.18.1.2 or EC 1.18.1.3 and ferredoxin” andE_1b AlkB alkane hydroxylases of EC 1.14.15.3, which preferably catalyse the following reactions: reduced rubredoxin+alkanoic acid (ester)=oxidized rubredoxin+ω-hydroxyalkanoic acid (ester)+H₂O,2 reduced rubredoxins+alkanoic acid (ester)=2 oxidized rubredoxins+ω-oxoalkanoic acid (ester)+2H₂O or3 reduced rubredoxins+alkanoic acid (ester)=alkane monoxygenase+3 oxidized rubredoxins+ω-carboxyalkanoic acid (ester)+3H₂O and preferablycomponent of a reaction system composed of the three enzyme components “AlkB alkane hydroxylase of EC 1.14.15.3, AlkT rubredoxin-NAD(P)⁺ reductase of EC 1.18.1.1 or EC 1.18.1.4 and rubredoxin AlkG”,E_1c fatty alcohol oxidases of EC 1.1.3.20, which preferably catalyse at least one of the following irreversible reactions:alkan-1-ol+O₂=alkan-1-al+H₂O₂ oralkan-1-al+O₂=alkanoic acid+H₂O₂,E_1d AlkJ alcohol dehydrogenases of EC 1.1.99.-, which preferably catalyse at least one of the following reversible reactions:alkan-1-ol+oxidized acceptor=alkan-1-al+reduced acceptor or alkan-1-al+oxidized acceptor=alkanoic acid+reduced acceptor,E_1e alcohol dehydrogenases of EC 1.1.1.1 or EC 1.1.1.2, which preferably catalyse at least one of the following reversible reactions:alkan-1-ol+NAD(P)⁺=alkan-1-al+NAD(P)H+H⁺ oralkan-1-al+NAD(P)⁺=alkanoic acid+NAD(P)H+H⁺ andE_1f aldehyde dehydrogenases of EC 1.2.1.3, EC 1.2.1.4 or EC 1.2.1.5, which preferably catalyse the following reversible reaction:alkan-1-al+NAD(P)⁺=alkanoic acid+NAD(P)H+H⁺

It may be advantageous in particular for the production of alkan-1-ols that the microorganisms according to the invention have an activity of at least one enzyme E_1e and E_1f in comparison with their wild type.

WO2010062480 A2 describes microorganisms which are capable of forming more fatty acids and fatty acid derivatives, in particular fatty alcohols, from at least one simple carbon source in comparison with their wild type, in particular in exemplary embodiments 3, 4, 6 and 7. The document also describes enzymes E_1e which are preferred according to the invention and their sequences, in particular in FIG. 10 and in exemplary embodiments 2 to 7.

If the microorganisms according to the invention are to be used in a process for the production of alkan-1-ols, alkan-1-als, alkan-1-amines and alkanes, it is especially preferred according to the invention that the activity of such enzymes E_1a to E_1f, which catalyse the above-described reactions of an alkan-1-al to give the corresponding alkanoic acid, is reduced.

If the microorganisms according to the invention are to be used in a process for the production of alkan-1-als, alkan-1-amines, alkanes and 1-alkenes, it is especially preferred according to the invention that the activity of such enzymes E_1a to E_1e, which catalyse the above-described conversion of an alkan-1-al to give the corresponding alkan-1-ol, is reduced.

If the microorganisms according to the invention are to be used in a process for the production of alkan-1-ols, it is especially preferred according to the invention that the activity of such enzymes E_1a to E_1e, which catalyse the above-described conversion of an alkan-1-ol to give the corresponding alkan-1-al, is reduced.

Specific Enzymes E_1a

P450 alkane hydroxylases E_1a which are preferred in this context are selected from among the list

AAO73954.1, AAO73953.1, XP_—002546279.1, AAA34353.2, P30607.1, XP_—002421627.1, XP_—718670.1, CAA39366.1, XP_—001527524.1, AAO73955.1, AAO73956.1, XP_—002546278.1, EEQ43157.1, XP_—718669.1, AAA34354.1, P10615.3, XP_—002421628.1, 226487, P16141.3, CAA39367.1, Q9Y757.2, XP_—001485567.1, AAO73958.1, XP_—001383506.2, XP_—460111.2, AAO73959.1, Q12586.1, XP_—460112.2, AAO73960.1, Q12589.1, AAO73961.1, XP_—460110.2, EEQ43763.1, XP_—710174.1, EDK41572.2, XP_—001482650.1, CAA75058.1, XP_—002548818.1, Q12588.1, XP_—002422222.1, XP_—001383636.2, XP_—001525381.1, XP_—002548823.1, P30610.1, AAO73952.1, XP_—002548428.1, CAA36197.1, XP_—002421126.1, AAA34320.1, P16496.3, P30608.1, P24458.1, XP_—717999.1, XP_—001383817.1, Q9Y758.1, XP_—001482092.1, XP_—001383710.2, P30609.1, AAB24479.1, XP_—457792.1, XP_—001524144.1, XP_—457727.2, XP_—001525578.1, XP_—002616743.1, XP_—002614836.1, XP_—001525577.1, AAO73957.1, Q12585.1, XP_—001386440.2, XP_—002616857.1, XP_—001483276.1, XP_—500402.1, EDK39907.2, XP_—500560.1, XP_—001211376.1, XP_—002560027.1, XP_—504857.1, XP_—500855.1, XP_—504406.1, BAA31433.1, XP_—500856.1, XP_—501148.1, XP_—746567.1, XP_—001262425.1, XP_—001274843.1, XP_—002840588.1, XP_—002377641.1, XP_—001825995.1, XP_—001400739.1, XP_—718066.1, CAA35593.1, XP_—664735.1, XP_—002150795.1, XP_—500097.1, XP_—002483325.1, XP_—504311.1, XP_—500273.1, XP_—002548817.1, EDP54484.1, XP_—755288.1, XP_—001260447.1, EFY97851.1, ACD75398.1, ADK36660.1, XP_—001213081.1, XP_—002377989.1, XP_—001826299.1, XP_—001554811.1, XP_—501667.1, XP_—002148942.1, ADK36662.1, XP_—002565827.1, P30611.1, XP_—001267871.1, XP_—002372373.1, EFY84686.1, P43083.1, XP_—001263094.1, XP_—002148355.1, XP_—002568429.1, XP_—001817314.1, Q12587.1, XP_—001396435.1, XP_—001938589.1, XP_—001388497.2, XP_—663661.1, XP_—003295335.1, XP_—002152088.1, XP_—001212071.1, Q12573.1, XP_—002379858.1, XP_—001821592.1, XP_—002844341.1, XP_—001394678.1, ACD75400.1, BAK03594.1, XP_—003170343.1, XP_—001265480.1, XP_—002550661.1, EDP55514.1, XP_—001528842.1, XP_—749919.1, XP_—001593058.1, P30612.1, EGC48494.1, EEH04429.1, XP_—001585586.1, XP_—003236182.1, XP_—001400199.1, EEQ46951.1, XP_—721410.1, EGP87864.1, XP_—002380808.1, XP_—001792771.1, XP_—001208515.1, XP_—001216161.1, XP_—003071804.1, EFW16963.1, XP_—002542118.1, XP_—001936677.1, EGD95268.1, XP_—003015678.1, XP_—501748.1, XP_—003169562.1, EFY96492.1, XP_—682653.1, XP_—002421356.1, CAK43439.1, EFY93677.1, XP_—747767.1, XP_—001244958.1, XP_—003019635.1, XP_—002847463.1, EGP83273.1, EGR52487.1, XP_—002622526.1, XP_—002563618.1, CBX99718.1, XP_—001552081.1, XP_—003066638.1, XP_—003176049.1, ACD75402.1, BAA05145.1, XP_—002482834.1, XP_—001257501.1, XP_—001934574.1, XP_—001269972.1, XP_—001587438.1, XP_—001215856.1, XP_—002149824.1, XP_—001550556.1, XP_—003011982.1, XP_—001827121.1, XP_—003233566.1, XP_—003022481.1, EGR47044.1, EFQ34695.1, XP_—003170005.1, BAG09241.1, XP_—002796370.1, XP_—003019300.1, XP_—002563873.1, CAK40654.1, EEH19741.1, XP_—003012518.1, EGD95716.1, XP_—003239409.1, BAJ04363.1, XP_—001537012.1, BAE66393.1, EGP85214.1, XP_—002487227.1, AAV66104.1, EGE07669.1, XP_—362943.2, XP_—003016806.1, EFQ27388.1, XP_—002384360.1, XP_—002836323.1, XP_—001274959.1, EFZ03093.1, XP_—661521.1, XP_—002849803.1, XP_—001589398.1, AAR99474.1, XP_—003189427.1, XP_—001823699.1, XP_—364111.1, XP_—001262753.1, EFY86805.1, XP_—001390153.2, XP_—002384738.1, XP_—001941811.1, XP_—001220831.1, XP_—003296981.1, XP_—002480829.1, BAD83681.1, XP_—001827526.2, XP_—369556.1, CAK38224.1, EFQ26532.1, XP_—002562328.1, XP_—001904540.1, EGO52476.1, XP_—002382002.1, XP_—001225874.1, XP_—958030.2, XP_—002540883.1, XP_—001908957.1, XP_—001559255.1, XP_—364102.1, EDP48064.1, XP_—365075.1, XP_—381460.1, CBX95930.1, XP_—003054099.1, XP_—361347.2, XP_—002846867.1, XP_—001214985.1, EFQ35175.1, XP_—002479062.1, XP_—001908613.1, XP_—003345380.1, EGR50567.1, XP_—002479350.1, XP_—001394417.2, XP_—001394159.2, XP_—002146776.1, EGP86783.1, EFX02953.1, CAK45889.1, XP_—003006887.1, XP_—002541427.1, XP_—750735.1, XP_—001257962.1, EGO51720.1, XP_—003005336.1, EGP83197.1, XP_—002149832.1, XP_—003052680.1, XP_—365851.1, XP_—001799910.1, XP_—003347175.1, XP_—002565258.1, EGR48918.1, EGR52524.1, XP_—964653.2, XP_—002147083.1, XP_—002843935.1, EEH19393.1, CAC 10088.1, EEH47609.1, EEQ92528.1, XP_—001246560.1, XP_—002626168.1, XP_—003024880.1, XP_—003169255.1, XP_—003013780.1, XP_—003235691.1, XP_—746816.1, EGD98483.1, XP_—001389925.2, XP_—002842817.1, XP_—002797278.1, ADK36666.1, XP_—003305469.1, XP_—001548471.1, XP_—001806478.1, EFQ34989.1, XP_—001552987.1, CAC24473.1, XP_—002541530.1, EEQ89262.1, XP_—001247332.1, XP_—003066043.1, EDP47672.1, XP_—002628451.1, XP_—001910644.1, EGR44510.1, EFQ36733.1, XP_—003052472.1, XP_—001393445.2, XP_—001522438.1, EGO04179.1, XP_—001397944.2, CAK49049.1, EFQ30109.1, XP_—001585052.1, EGO30123.1, XP_—388496.1, XP_—003173913.1, CBF76609.1, XP_—003028593.1, EGO04180.1, CAK46976.1, XP_—370476.1, XP_—002145942.1, XP_—003004457.1, ADK36663.1, XP_—003040708.1, XP_—003351473.1, EFY84692.1, XP_—748328.2, XP_—003190325.1, XP_—002378813.1, EGR46513.1, XP_—003033448.1, XP_—002145326.1, XP_—662462.1, XP_—747469.1, XP_—001935085.1, EGR45892.1, E0001601.1, EGP89995.1, XP_—001222615.1, XP_—001224356.1, EGN93507.1, XP_—001934479.1, BAK09464.1, EGO30124.1, XP_—001267956.1, ADK36661.1, EFY97845.1, XP_—001834501.1, EGO03790.1, XP_—001884320.1, XP_—003028899.1, AAP79879.1, EFY84206.1, BAK09467.1, XP_—003030469.1, XP_—001412594.1, XP_—001834508.1, XP_—001839436.2, XP_—002583529.1, XP_—001886288.1, XP_—002843371.1, XP_—001587730.1, BAK09418.1, BAK09442.1, EGO28830.1, EGE03365.1, EFZ01428.1, EGO03065.1, XP_—001558890.1, XP_—002487181.1, EGO29652.1, AAX49400.1, EFY92529.1, XP_—002380252.1, XP_—001884460.1, BAK09387.1, XP_—001839366.2, XP_—003031835.1, EFY99978.1, AAL67906.1, BAG09240.1, XP_—002381768.1, XP_—001800031.1, XP_—001825073.2, BAE63940.1, XP_—003028894.1, AAL67905.1, XP_—002910303.1, EGO22856.1, XP_—003028896.1, XP_—681680.1, XP_—002486603.1, XP_—001838945.2, EGR50064.1, XP_—001884349.1, XP_—001883816.1, CAK37996.1, CAO91865.1, XP_—003031227.1, XP_—001258702.1, XP_—001586739.1, XP_—001560806.1, CBF69707.1, ADN43682.1, XP_—001593179.1, XP_—001886909.1, XP_—001934479.1, XP_—001587730.1, XP_—001886909.1, XP_—001831709.2, XP_—001392650.1, XP_—366716.2, CAL69594.1, XP_—001269140.1, XP_—002566307.1, XP_—001555473.1, XP_—663925.1, XP_—001598033.1, XP_—001835239.2, EGN97256.1, XP_—001554305.1, NP_—182075.1, XP_—001560475.1, EFQ32286.1, XP_—001216788.1, XP_—002483975.1, AAC31835.1, NP_—850427.1, XP_—002143660.1, XP_—003327130.1, BAJ78287.1, XP_—002880182.1, ACB59278.1, EFQ36688.1, BAJ78285.1, BAJ78286.1, XP_—001798699.1, EEH44101.1, BAJ78288.1, BAJ78284.1, EGG02425.1, EGG03011.1, AAA34334.1, NP_—001189747.1, EGG02601.1, XP_—002978645.1, EGG 11203.1, XP_—762610.1, XP_—762620.1, XP_—001545581.1, CAB44684.1, CAN80536.1, AAN05337.1, NP_—001049423.1, XP_—001791898.1, NP_—001031814.1, XP_—002279531.1, ABK94777.1, AAZ39646.1, XP_—002880183.1, ABC68403.1, XP_—002839066.1, EGG03014.1, XP_—002320074.1, NP_—001182854.1, CBI38795.3, XP_—002310605.1, NP_—196442.2, XP_—002270594.1, ABZ80830.1, XP_—002275905.1, CBI38796.3, XP_—002476978.1, CAB93726.1, EGG03624.1, EGG06527.1, NP_—197710.1, XP_—001768338.1, XP_—002270673.1, BAJ86572.1, XP_—002275806.1, CBI38797.3, XP_—002320072.1, CAN60189.1, XP_—002986290.1, XP_—002465888.1, CAN80040.1, XP_—002336104.1, XP_—002988354.1, XP_—002264277.1, EGD72898.1, XP_—002866853.1, EAY95236.1, XP_—002979701.1, XP_—002988762.1, XP_—002304502.1, XP_—002873349.1, XP_—003192947.1, CAN63571.1, NP_—001053615.1, NP_—176558.1, EGC49561.1, EGG09027.1, XP_—002314581.1, XP_—002446966.1, XP_—002320802.1, ABC59095.1, XP_—003323121.1, XP_—002974639.1, XP_—002395587.1, XP_—002866852.1, XP_—002319770.1, NP_—001146262.1, NP_—001169224.1, AAM65207.1, XP_—002529058.1, XP_—002886391.1, XP_—002320071.1, XP_—002446967.1, XP_—757870.1, EAY95147.1, XP_—002899664.1, EEH05830.1, XP_—002874114.1, ADO24345.1, BAJ88802.1, BAA05146.1, XP_—002963351.1, EAY88475.1, NP_—195658.3, XP_—002976944.1, ABC59093.1, XP_—002275114.1, XP_—003328407.1, CAN75428.1, BAJ86471.1, XP_—002981144.1, XP_—002277006.1, EAZ26110.1, ACN41008.1, XP_—002899542.1, XP_—001781614.1, EAY76187.1, BAK06758.1, XP_—002511745.1, XP_—002982626.1, XP_—002963763.1, NP_—001065111.1, ABF93892.1, XP_—002314117.1, BAK06287.1, XP_—001745327.1, NP_—001047674.1, XP_—002878665.1, XP_—002974847.1, NP_—179899.1, CAN80156.1, NP_—001053543.1, ABC59094.1, XP_—002328165.1, XP_—002270628.1, XP_—002275115.1, XP_—002980688.1, XP_—002465039.1, AAL91155.1, NP_—195910.1, XP_—002509820.1, NP_—200694.1, CAA62082.1, AAL75903.1, XP_—002468241.1, XP_—002883546.1, XP_—002862636.1, XP_—002312905.1, EAY79269.1, AAM12494.1, XP_—002875027.1, XP_—758010.1, XP_—002509524.1, AAP54707.2, XP_—002869292.1, NP_—001143079.1, ACF82946.1, XP_—002270497.1, XP_—002979685.1, XP_—002465041.1, XP_—002533544.1, AAG17470.1, XP_—002985393.1, NP_—191946.1, XP_—002525608.1, AAZ39642.1, XP_—002270428.1, XP_—002529227.1, CBI24485.3, XP_—001763206.1, EGG02922.1, XP_—002974848.1, NP_—001141467.1, CBI27149.3, NP_—001130907.1, XP_—002982474.1, NP_—001048917.1, XP_—002465889.1, ABZ80831.1, XP_—002464461.1, EAY88476.1, BAJ90714.1, XP_—002893825.1, ACN28568.1, XP_—002452782.1, XP_—002280004.1, XP_—001764611.1, NP_—001183394.1, BAJ89570.1, CBI24484.3, BAJ88840.1, ACG38359.1, CAN77648.1, BAJ91452.1, NP_—001141345.1, XP_—002282185.1, XP_—002980994.1, XP_—002299820.1, BAJ87982.1, BAJ91842.1, XP_—003325270.1, XP_—001760399.1, CBI34058.3, ADG34845.1, XP_—002523775.1, EEH21852.1, Q50EK3.1, BAK06748.1, XP_—002963764.1, ACN34158.1, XP_—001764503.1, XP_—002311750.1, XP_—001782495.1, XP_—002988642.1, XP_—002465625.1, XP_—002892051.1, XP_—002279649.1, NP_—171666.1, ABK28430.1, BAC42067.1, AED99869.1, NP_—174713.1, XP_—001781706.1, ABG66204.1, XP_—002964775.1, NP_—001064901.2, XP_—002961706.1, XP_—002519477.1, XP_—001559854.1, CBH32594.1, BAB92258.1, XP_—002264897.1, AAL59025.1, XP_—002862576.1, ACL53124.1, XP_—002521476.1, NP_—200045.1, BAJ89814.1, CBI38794.3, XP_—776769.1, NP_—001141372.1, EEC74485.1, EAY76557.1, XP_—002318861.1, NP_—001172660.1, XP_—002880978.1, AAO00706.1, BAK07606.1, XP_—002979336.1, BAC42841.1, BAF46296.1, XP_—002306380.1, XP_—002865907.1, ACG34921.1, XP_—002876375.1, NP_—001056685.1, XP_—002264292.1, XP_—002893443.1, NP_—001066096.1, EEE53477.1, CBH32607.1, EAY94753.1, NP_—001130939.1, NP_—182121.1, XP_—002437749.1, NP_—191222.1, XP_—002865881.1, XP_—569708.1, XP_—002279670.1, BAJ94774.1, ABF93894.1, BAD94304.1, ACG33785.1, NP_—194944.1, NP_—180337.1, AAB63277.1, BAJ85246.1, XP_—002456654.1, ACN27732.1, XP_—002445325.1, EER40289.1, XP_—001838184.2, BAJ85532.1, XP_—002866555.1, EAY88477.1, ACG47870.1, XP_—002310074.1, XP_—002457224.1, EAZ25521.1, BAJ87689.1, NP_—001044838.1, XP_—002521004.1, XP_—002882043.1, XP_—002527038.1, XP_—002318721.1, XP_—002979339.1, NP_—176086.1, XP_—001560028.1, ABC59092.1, ABF93891.1, ACR38435.1, EAY78983.1, NP_—179782.1, CCA21696.1, XP_—002334340.1, EFX88387.1, NP_—001044554.1, XP_—002321857.1, NP_—173862.1, NP_—195660.1, XP_—001554079.1, EAZ13864.1, EEC67630.1, EAY76183.1, AAP54710.2, NP_—001065112.2, ACD10924.1, XP_—001559275.1, EEC67338.1, XP_—002273811.1, ADJ68242.1, NP_—001065698.1, CAN66874.1, CAB41474.1, XP_—002868908.1, XP_—002904660.1, CAR47816.1, NP_—189243.1, EAY98229.1, XP_—002448320.1, 081117.2, XP_—002458797.1, XP_—002277129.1, BAJ88829.1, CAN67559.1, BAK08034.1, XP_—002894062.1, XP_—002894891.1, XP_—002279981.1, ABR16451.1, NP_—201150.1, AAM60854.1, XP_—002521002.1, XP_—002521474.1, XP_—002875311.1, NP_—195661.1, AAP79889.1, NP_—175193.1, P98188.1, BAK08270.1, CBI21357.3, XP_—002870817.1, XP_—002904451.1, ABA95812.1, XP_—002998647.1, NP_—001066166.2, XP_—002894690.1, EFY92064.1, XP_—002278009.1, XP_—002336002.1, CCA16508.1, XP_—002868909.1, EAZ31703.1, C96517, EAY86526.1, XP_—002307954.1, XP_—002904638.1, XP_—002266883.1, XP_—002439880.1, XP_—002892730.1, ADI52567.1, EGI61791.1, XP_—002511196.1, EGG04372.1, XP_—002511875.1, ACE75189.1, NP_—001055681.1, XP_—001589816.1, NP_—001170655.1, XP_—002300789.1, XP_—001934479.1, XP_—001587730.1, XP_—001554079.1, XP_—001559275.1, XP_—002868908.1, XP_—002998647.1, EFY92064.1, XP_—002605799.1, BAC43393.1, ABK28457.1, AAL54887.1, BAC43161.1, XP_—002333384.1, ZP_—03631129.1, AAL84318.1, BAJ99856.1, XP_—002593704.1, YP_—001965159.1, XP_—002454121.1, EFX88390.1, ABR16969.1, NP_—177109.3, XP_—002441724.1, NP_—001166017.1, BAB92256.1, ACE75340.1, AAZ39645.1, XP_—002312417.1, XP_—002887239.1, NP_—001172609.1, NP_—001065766.1, XP_—002515053.1, AAL54885.1, ABR16897.1, XP_—002878579.1, NP_—001140775.1, XP_—003275955.1, ZP_—08045694.1, BAJ94069.1, XP_—001654558.1, XP_—002436562.1, EAY88702.1, BAK03685.1, XP_—003327629.1, XP_—002322606.1, EEH42702.1, XP_—002037976.1, NP_—172774.1, XP_—002282477.1, EFX88388.1, XP_—002522465.1, EFZ21470.1, AAO41955.1, AAL54886.1, XP_—002450277.1, XP_—002862559.1, XP_—002335046.1, XP_—003328408.1, ACE75187.1, XP_—001849294.1, XP_—002444132.1, XP_—002894061.1, EFN77015.1, EGI69992.1, CBI17962.3, AAL54884.1, XP_—002998650.1, XP_—002105150.1, XP_—002877615.1, EFZ22412.1, XP_—002439815.1, XP_—002300790.1, CBI40391.3, AEI59774.1, XP_—002801151.1, XP_—003325267.1, XP_—001554577.1, EAY79865.1, XP_—002465796.1, XP_—002931035.1, ABA91371.1, ACE75338.1, XP_—001592850.1, XP_—001362981.1, XP_—002271246.1, EGB11905.1, NP_—176713.1, CBJ27248.1, NP_—566155.1, EFX87732.1, EEC71661.1, ACG29046.1, NP_—001130576.1, XP_—001843663.1, ABK25134.1, EGI65081.1, XP_—002722841.1, AAL67908.2, AAO15579.1, YP_—122047.1, EFA04617.1, YP_—001522424.1, ACB87383.1, NP_—001027517.1, EEE52725.1, XP_—002078257.1, XP_—002722842.1, ZP_—05128707.1, XP_—003208874.1, AAK31592.1, ABA95747.2, NP_—001181472.1, NP_—001075572.1, XP_—001108915.1, XP_—001520882.1, XP_—002063219.1, EFZ22408.1, AAL57721.1, EFW47740.1, AAQ20834.1, CAN74644.1, XP_—002722849.1, BAC30028.1, CAN75729.1, XP_—002115603.1, AAN72309.1, EEC68823.1, CAM18519.1, EAZ13863.1, XP_—002906159.1, NP_—001003947.1, ZP_—01858832.1, XP_—002882162.1, XP_—002089195.1, XP_—002892729.1, CAN68037.1, NP_—001130648.1, NP_—001166016.1, NP_—172773.4, ADJ68241.1, EGI62551.1, EFN63658.1, XP_—002300103.1, XP_—001658673.1, XP_—001367719.1, NP_—775146.1, XP_—001375048.1, AAH21377.1, NP_—727589.1, XP_—002271847.1, XP_—001809620.1, XP_—002897528.1, NP_—190421.1, XP_—002282468.1, XP_—536868.2, EEE58297.1, XP_—001992105.1, EAY82190.1, ADD20161.1, XP_—001363065.1, EAU77129.3, EAY72807.1, EGG03077.1, NP_—001181489.1, NP_—001177869.1, XP_—001966135.1, BAA99522.1, BAK07250.1, XP_—002133118.1, NP_—001042228.1, AAL57720.1, XP_—002897529.1, AAA35712.1, YP_—002275016.1, NP_—000770.2, XP_—002721578.1, XP_—321208.4, AAM09532.1, EFN61085.1, BAK06179.1, EFX88389.1, YP_—001602608.1, XP_—513140.3, NP_—001182438.1, AAD31068.1, NP_—001093242.1, XP_—001367758.2, EFZ18984.1, YP_—691921.1, CAH59968.1, AAS80270.1, CAH59967.1, ACQ99381.2, YP_—003810988.1, YP_—957888.1, CBW44755.1, ZP_—05042596.1, ZP_—01913735.1, ZP_—05043097.1, ADO00145.1, YP_—004494060.1, ZP_—08206912.1, BAE78452.1, NP_—114222.1, ACZ56357.1, YP_—640381.1, ZP_—04384919.1, ZP_—08025219.1, ZP_—07715822.1, ZP_—06847816.1, YP_—001702784.1, AEK27137.1, ZP_—07716433.1, ZP_—08199554.1, YP_—004495520.1, YP_—345718.1, ZP_—08022914.1, YP_—001851443.1, BAG50428.1, YP_—001135848.1, BAF95905.1, YP_—345695.1, ACP39691.1, ACP39664.1, ACP39635.1, ACP39633.1, ACP39710.1, ACP39698.1, ACP39711.1, BAE47475.1, BAE47474.1, ABW76858.1, ACO50699.1, ACP39643.1, ACP39639.1, ACP39708.1, ACM68663.1, ACP39642.1, ACP39684.1, ACP39636.1, ZP_—05095005.1, ACP39652.1, BAE47473.1, ACM68664.1, ACP39646.1, ACP39680.1, ACP39692.1, ACP39675.1, ACP39632.1, ZP_—05129284.1, ACP39706.1, ACP39695.1, ACM68665.1, ACP39654.1, ACP39665.1, ACP39649.1, BAE47472.1, ACM68668.1, ACP39676.1, ACP39648.1, ACP39647.1, ZP_—01102434.1, ACM68666.1, ACP39641.1, ACM68669.1, ZP_—01625037.1, ACP39690.1, ACP39696.1, ACP39697.1, ACP39707.1, ACP39682.1, ACP39650.1, ACP39638.1, ZP_—05126641.1, CAH04396.1, ACP39658.1, ZP_—01102687.1, ACJ06772.1, YP_—001413041.1, YP_—552058.1, ADE05601.1, ADI19685.1, BAE47479.1, ZP_—01626700.1, ZP_—01618279.1, CAH61448.1, YP_—001411305.1, YP_—003591161.1, ZP_—01615522.1, ACM68667.1, ACP39651.1, ZP_—05095535.1, ZP_—01618489.1, NP_—418882.1, ADI19983.1, ACP39677.1, BAE47476.1, ACP39655.1, ACP39656.1, ADI19696.1, BAE47477.1, YP_—001413399.1, YP_—459878.1, BAE47480.1, BAE47481.1, ACP39653.1, BAE47478.1, YP_—001681656.1, ZP_—01618281.1, ZP_—01627262.1, YP_—001413057.1, YP_—760740.1, YP_—001242466.1, YP_—001203574.1, CAH61454.1, YP_—002129656.1, YP_—001672075.1, ACP39709.1, YP_—001990805.1, NP_—946959.1, YP_—001203575.1, YP_—783213.1, YP_—003059227.1, YP_—004110202.1, ACP39645.1, YP_—487538.1, CAH61451.1, YP_—570816.1, YP_—534107.1, YP_—001413223.1, YP_—001242465.1, YP_—557448.1, ZP_—08631162.1, NP_—773883.1, ZP_—00997728.1, ACP39683.1, NP_—768493.1, NP_—773882.1, ZP_—08271781.1, CAH61449.1, YP_—003883668.1, YP_—003332953.1, YP_—004535688.1, YP_—495502.1, YP_—459378.1, ZP_—08700267.1, ZP_—01863452.1, ZP_—06860085.1, BAE47487.1, YP_—617903.1, ZP_—08207422.1, BAE47486.1, ZP_—01041003.1, BAE47484.1, ACR78197.1, CAH61456.1, ZP_—01858113.1, ACP39681.1, BAE47485.1, ACP39673.1, BAE47483.1, ACP39669.1, BAE47482.1, ACP39674.1, ACP39704.1, ACP39703.1, YP_—497095.1, ACP39672.1, ACP39702.1, ACP39670.1, ACP39666.1, YP_—458852.1, ACP39687.1, ACP39688.1, ACP39634.1, ACP39686.1, ACP39660.1, ACP39700.1, YP_—001411309.1, ZP_—01465241.1, ACP39701.1, ACP39679.1, ACP39657.1, ACP39694.1, ACP39659.1, ACP39671.1, ACP39693.1 and YP_—003342921.1,in particularAAO73954.1, AAO73953.1, XP_—002546279.1, AAA34353.2, P30607.1, XP_—002421627.1, XP_—718670.1, CAA39366.1, XP_—001527524.1, AAO73955.1, AAO73956.1, XP_—002546278.1, EEQ43157.1, XP_—718669.1, AAA34354.1, P10615.3, XP_—002421628.1, 226487, P16141.3, CAA39367.1, Q9Y757.2, XP_—001485567.1, AAO73958.1, XP_—001383506.2, XP_—460111.2, AAO73959.1, Q12586.1, XP_—460112.2, AAO73960.1, Q12589.1, AAO73961.1, XP_—460110.2, EEQ43763.1, XP_—710174.1, EDK41572.2, XP_—001482650.1, CAA75058.1, XP_—002548818.1, Q12588.1, XP_—002422222.1, XP_—001383636.2, XP_—001525381.1, XP_—002548823.1, P30610.1, AAO73952.1, XP_—002548428.1, CAA36197.1, XP_—002421126.1, AAA34320.1, P16496.3, P30608.1, P24458.1, XP_—717999.1, XP_—001383817.1, Q9Y758.1, XP_—001482092.1, XP_—001383710.2, P30609.1, AAB24479.1, XP_—457792.1, XP_—001524144.1, XP_—457727.2, XP_—001525578.1, XP_—002616743.1, XP_—002614836.1, XP_—001525577.1, AAO73957.1, Q12585.1, XP_—001386440.2, XP_—002616857.1, XP_—001483276.1, XP_—500402.1, EDK39907.2, XP_—500560.1, XP_—001211376.1, XP_—002560027.1, XP_—504857.1, XP_—500855.1, XP_—504406.1, BAA31433.1, XP_—500856.1, XP_—501148.1, XP_—746567.1, XP_—001262425.1, XP_—001274843.1, XP_—002840588.1, XP_—002377641.1, XP_—001825995.1, XP_—001400739.1, XP_—718066.1, CAA35593.1, XP_—664735.1, XP_—002150795.1, XP_—500097.1, XP_—002483325.1, XP_—504311.1, XP_—500273.1, XP_—002548817.1, EDP54484.1, XP_—755288.1, XP_—001260447.1, EFY97851.1, ACD75398.1, ADK36660.1, XP_—001213081.1, XP_—002377989.1, XP_—001826299.1, XP_—001554811.1, XP_—501667.1, XP_—002148942.1, ADK36662.1, XP_—002565827.1, P30611.1, XP_—001267871.1, XP_—002372373.1, EFY84686.1, P43083.1, XP_—001263094.1, XP_—002148355.1, XP_—002568429.1, XP_—001817314.1, Q12587.1, XP_—001396435.1, XP_—001938589.1, XP_—001388497.2, XP_—663661.1, XP_—003295335.1, XP_—002152088.1, XP_—001212071.1, Q12573.1, XP_—002379858.1, XP_—001821592.1, XP_—002844341.1, XP_—001394678.1, ACD75400.1, XP_—003170343.1, XP_—001265480.1, XP_—002550661.1, EDP55514.1, XP_—001528842.1, XP_—749919.1, XP_—001593058.1, P30612.1, EGC48494.1, EEH04429.1, XP_—001585586.1, XP_—003236182.1, XP_—001400199.1, EEQ46951.1, XP_—721410.1, EGP87864.1, XP_—002380808.1, XP_—001792771.1, XP_—001208515.1, XP_—001216161.1, XP_—003071804.1, EFW16963.1, XP_—002542118.1, XP_—001936677.1, EGD95268.1, XP_—003015678.1, XP_—501748.1, XP_—003169562.1, EFY96492.1, XP_—682653.1, XP_—002421356.1, CAK43439.1, EFY93677.1, XP_—747767.1, XP_—001244958.1, XP_—003019635.1, XP_—002847463.1, EGP83273.1, EGR52487.1, XP_—002622526.1, XP_—002563618.1, CBX99718.1, XP_—001552081.1, XP_—003066638.1, XP_—003176049.1, ACD75402.1, BAA05145.1, XP_—002482834.1, XP_—001257501.1, XP_—001934574.1, XP_—001269972.1, XP_—001587438.1, XP_—001215856.1, XP_—002149824.1, XP_—001550556.1, XP_—003011982.1, XP_—001827121.1, XP_—003233566.1, XP_—003022481.1, EGR47044.1, EFQ34695.1, XP_—003170005.1, BAG09241.1, XP_—002796370.1, XP_—003019300.1, XP_—002563873.1, CAK40654.1, EEH19741.1, XP_—003012518.1, EGD95716.1, XP_—003239409.1, BAJ04363.1, XP_—001537012.1, BAE66393.1, EGP85214.1, XP_—002487227.1, AAV66104.1, EGE07669.1, XP_—362943.2, XP_—003016806.1, EFQ27388.1, XP_—002384360.1, XP_—002836323.1, XP_—001274959.1, EFZ03093.1, XP_—661521.1, XP_—002849803.1, XP_—001589398.1, AAR99474.1, XP_—003189427.1, XP_—001823699.1, XP_—364111.1, XP_—001262753.1, EFY86805.1, XP_—001390153.2, XP_—002384738.1, XP_—001941811.1, XP_—001220831.1, XP_—003296981.1, XP_—002480829.1, BAD83681.1, XP_—001827526.2, XP_—369556.1, CAK38224.1, EFQ26532.1, XP_—002562328.1, XP_—001904540.1, EGO52476.1, XP_—002382002.1, XP_—001225874.1, XP_—958030.2, XP_—002540883.1, XP_—001908957.1, XP_—001559255.1, XP_—364102.1, EDP48064.1, XP_—365075.1, XP_—381460.1, CBX95930.1, XP_—003054099.1, XP_—361347.2, XP_—002846867.1, XP_—001214985.1, EFQ35175.1, XP_—002479062.1, XP_—001908613.1, XP_—003345380.1, EGR50567.1, XP_—002479350.1, XP_—001394417.2, XP_—001394159.2, XP_—002146776.1, EGP86783.1, EFX02953.1, CAK45889.1, XP_—003006887.1, XP_—002541427.1, XP_—750735.1, XP_—001257962.1, EGO51720.1, XP_—003005336.1, EGP83197.1, XP_—002149832.1, XP_—003052680.1, XP_—365851.1, XP_—001799910.1, XP_—003347175.1, XP_—002565258.1, EGR48918.1, EGR52524.1, XP_—964653.2, XP_—002147083.1, XP_—002843935.1, EEH19393.1, CAC10088.1, EEH47609.1, EEQ92528.1, XP_—001246560.1, XP_—002626168.1, XP_—003024880.1, XP_—003169255.1, XP_—003013780.1, XP_—003235691.1, XP_—746816.1, EGD98483.1, XP_—001389925.2, XP_—002842817.1, XP_—002797278.1, ADK36666.1, XP_—003305469.1, XP_—001548471.1, XP_—001806478.1, EFQ34989.1, XP_—001552987.1, CAC24473.1, XP_—002541530.1, EEQ89262.1, XP_—001247332.1, XP_—003066043.1, EDP47672.1, XP_—002628451.1, XP_—001910644.1, EGR44510.1, EFQ36733.1, XP_—003052472.1, XP_—001393445.2, XP_—001522438.1, XP_—001397944.2, CAK49049.1, EFQ30109.1, XP_—001585052.1, XP_—388496.1, XP_—003173913.1, CBF76609.1, CAK46976.1, XP_—370476.1, XP_—002145942.1, XP_—003004457.1, ADK36663.1, XP_—003040708.1, XP_—003351473.1, EFY84692.1, XP_—748328.2, XP_—003190325.1, XP_—002378813.1, EGR46513.1, XP_—002145326.1, XP_—662462.1, XP_—747469.1, XP_—001935085.1, EGR45892.1, EGP89995.1, XP_—001222615.1, XP_—001224356.1, XP_—001934479.1, XP_—001267956.1, ADK36661.1, EFY97845.1, EFY84206.1, XP_—001412594.1, XP_—002583529.1, XP_—002843371.1, XP_—001587730.1, EGE03365.1, EFZ01428.1, XP_—001558890.1, XP_—002487181.1, EFY92529.1, XP_—002380252.1, EFY99978.1, BAG09240.1, XP_—002381768.1, XP_—001800031.1, XP_—001825073.2, BAE63940.1, XP_—681680.1, XP_—002486603.1, EGR50064.1, CAK37996.1, CAO91865.1, XP_—001258702.1, XP_—001586739.1, XP_—001560806.1, CBF69707.1, ADN43682.1, XP_—001593179.1, XP_—001392650.1, XP_—366716.2, CAL69594.1, XP_—001269140.1, XP_—002566307.1, XP_—001555473.1, XP_—663925.1, XP_—001598033.1, XP_—001554305.1, XP_—001560475.1, EFQ32286.1, XP_—001216788.1, XP_—002483975.1, XP_—002143660.1, EFQ36688.1, XP_—001798699.1, EEH44101.1, AAA34334.1, XP_—001545581.1, XP_—001791898.1, XP_—002839066.1, EGC49561.1, EEH05830.1, BAA05146.1, EEH21852.1, XP_—001559854.1, EER40289.1, XP_—001560028.1, XP_—001554079.1, XP_—001559275.1, EFY92064.1, XP_—001589816.1, EEH42702.1, XP_—001554577.1, XP_—001592850.1, YP_—691921.1, CAH59968.1, AAS80270.1, CAH59967.1, ACQ99381.2, YP_—003810988.1, YP_—957888.1, CBW44755.1, ZP_—05042596.1, ZP_—01913735.1, ZP_—05043097.1, ADO00145.1, YP_—004494060.1, ZP_—08206912.1, BAE78452.1, NP_—114222.1, ACZ56357.1, YP_—640381.1, ZP_—04384919.1, ZP_—08025219.1, ZP_—07715822.1, ZP_—06847816.1, YP_—001702784.1, AEK27137.1, ZP_—07716433.1, ZP_—08199554.1, YP_—004495520.1, YP_—345718.1, ZP_—08022914.1, YP_—001851443.1, BAG50428.1, YP_—001135848.1, BAF95905.1, YP_—345695.1, ACP39691.1, ACP39664.1, ACP39635.1, ACP39633.1, ACP39710.1, ACP39698.1, ACP39711.1, BAE47475.1, BAE47474.1, ABW76858.1, ACO50699.1, ACP39643.1, ACP39639.1, ACP39708.1, ACM68663.1, ACP39642.1, ACP39684.1, ACP39636.1, ZP_—05095005.1, ACP39652.1, BAE47473.1, ACM68664.1, ACP39646.1, ACP39680.1, ACP39692.1, ACP39675.1, ACP39632.1, ZP_—05129284.1, ACP39706.1, ACP39695.1, ACM68665.1, ACP39654.1, ACP39665.1, ACP39649.1, BAE47472.1, ACM68668.1, ACP39676.1, ACP39648.1, ACP39647.1, ZP_—01102434.1, ACM68666.1, ACP39641.1, ACM68669.1, ZP_—01625037.1, ACP39690.1, ACP39696.1, ACP39697.1, ACP39707.1, ACP39682.1, ACP39650.1, ACP39638.1, ZP_—05126641.1, CAH04396.1, ACP39658.1, ZP_—01102687.1, ACJ06772.1, YP_—001413041.1, YP_—552058.1, ADE05601.1, ADI19685.1, BAE47479.1, ZP_—01626700.1, ZP_—01618279.1, CAH61448.1, YP_—001411305.1, YP_—003591161.1, ZP_—01615522.1, ACM68667.1, ACP39651.1, ZP_—05095535.1, ZP_—01618489.1, NP_—418882.1, ADI19983.1, ACP39677.1, BAE47476.1, ACP39655.1, ACP39656.1, ADI19696.1, BAE47477.1, YP_—001413399.1, YP_—459878.1, BAE47480.1, BAE47481.1, ACP39653.1, BAE47478.1, YP_—001681656.1, ZP_—01618281.1, ZP_—01627262.1, YP_—001413057.1, YP_—760740.1, YP_—001242466.1, YP_—001203574.1, CAH61454.1, YP_—002129656.1, YP_—001672075.1, ACP39709.1, YP_—001990805.1, NP_—946959.1, YP_—001203575.1, YP_—783213.1, YP_—003059227.1, YP_—004110202.1, ACP39645.1, YP_—487538.1, CAH61451.1, YP_—570816.1, YP_—534107.1, YP_—001413223.1, YP_—001242465.1, YP_—557448.1, ZP_—08631162.1, NP_—773883.1, ZP_—00997728.1and especially preferablyAAO73954.1, AAO73953.1, XP_—002546279.1, AAA34353.2, P30607.1, XP_—002421627.1, XP_—718670.1, CAA39366.1, AAO73955.1, AAO73956.1, XP_—002546278.1, EEQ43157.1, XP_—718669.1, AAA34354.1, P10615.3, XP_—002421628.1, 226487, P16141.3, CAA39367.1, AAO73958.1, AAO73959.1, Q12586.1, AAO73960.1, Q12589.1, AAO73961.1, EEQ43763.1, XP_—710174.1, CAA75058.1, XP_—002548818.1, Q12588.1, XP_—002422222.1, XP_—002548823.1, P30610.1, AAO73952.1, XP_—002548428.1, CAA36197.1, XP_—002421126.1, AAA34320.1, P16496.3, P30608.1, P24458.1, XP_—717999.1, P30609.1, AAB24479.1, AAO73957.1, Q12585.1, XP_—718066.1, CAA35593.1, XP_—002548817.1, P30611.1, P43083.1, Q12587.1, Q12573.1, XP_—002550661.1, P30612.1, EEQ46951.1, XP_—721410.1, XP_—002421356.1, BAA05145.1, BAG09241.1, CAC24473.1, BAG09240.1, AAA34334.1, BAA05146.1, XP_—500402.1, XP_—500560.1, XP_—504857.1, XP_—500855.1, XP_—504406.1, BAA31433.1, XP_—500856.1, XP_—501148.1, XP_—500097.1, XP_—504311.1, XP_—500273.1, XP_—501667.1, XP_—501748.1, YP_—691921.1, CAH59968.1, AAS80270.1, CAH59967.1, ACQ99381.2, YP_—003810988.1, YP_—957888.1, CBW44755.1, ZP_—05042596.1, ZP_—01913735.1, ZP_—05043097.1, ADQ00145.1, YP_—004494060.1, ZP_—08206912.1, BAE78452.1, NP_—114222.1, ACZ56357.1, YP_—640381.1, ZP_—04384919.1, ZP_—08025219.1, ZP_—07715822.1, ZP_—06847816.1, YP_—001702784.1, AEK27137.1, ZP_—07716433.1, ZP_—08199554.1, YP_—004495520.1, YP_—345718.1, ZP_—08022914.1, YP_—001851443.1, BAG50428.1, YP_—001135848.1, BAF95905.1, YP_—345695.1, ACP39691.1, ACP39664.1, ACP39635.1, ACP39633.1, ACP39710.1, ACP39698.1, ACP39711.1, BAE47475.1, BAE47474.1, ABW76858.1, ACO50699.1, ACP39643.1, ACP39639.1, ACP39708.1, ACM68663.1, ACP39642.1, ACP39684.1, ACP39636.1, ZP_—05095005.1, ACP39652.1, BAE47473.1, ACM68664.1, ACP39646.1, ACP39680.1, ACP39692.1, ACP39675.1, ACP39632.1, ZP_—05129284.1, ACP39706.1, ACP39695.1, ACM68665.1, ACP39654.1, ACP39665.1, ACP39649.1, BAE47472.1, ACM68668.1, ACP39676.1, ACP39648.1, ACP39647.1, ZP_—01102434.1, ACM68666.1, ACP39641.1, ACM68669.1, ZP_—01625037.1, ACP39690.1, ACP39696.1, ACP39697.1, ACP39707.1, ACP39682.1, ACP39650.1 and ACP39638.1andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_1a is generally understood in particular as meaning the conversion of lauric acid and/or its methyl ester into ω-hydroxylauric acid and/or its methyl ester.

Specific Enzymes E_1b

AlkB alkane hydroxylases E_1b which are preferred according to the invention are selected from among the list

YP_—001185946.1, Q9WWW6.1, YP_—957898.1, YP_—957728.1, YP_—694427.1, BAC98365.1, ZP_—00957064.1, CAC86944.1, YP_—001672212.1, CAB59525.1, ACH99213.1, ACH99215.1, ACH99216.1, AAK56792.1, ACH99229.1, ACS91348.1, AAP41820.1, ZP_—05128075.1, CAM58121.1, CAM58085.1, ACQ44675.1, ACZ62808.1, ZP_—01738706.1, ZP_—01916228.1, ZP_—01225325.1, YP_—001023605.1, ACJ22747.1, ACT91140.1, AAT91722.2, CBA27418.1, YP_—001889129.1, EGC97932.1, ACT91201.1, ZP_—05083049.1, YP_—554098.1, ZP_—01900149.1, ADG26619.1, ADG26657.1, ADG26640.1, ZP_—06838771.1, ADG26649.1, ADG26651.1, ZP_—02374120.1, YP_—368326.1, ZP_—02380481.1, ADG26643.1, ADG26628.1, YP_—442346.1, ADG26620.1, ADG26647.1, ZP_—07673680.1, ADG26638.1, YP_—002232139.1, YP_—001118743.1, ZP_—01764629.1, YP_—108945.1, YP_—334185.1, ZP_—04897834.1, ZP_—02889567.1, YP_—620386.1, YP_—002897546.1, ZP_—02166109.1, ZP_—02904755.1, ADG26639.1, YP_—001892637.1, ADG26642.1, ZP_—04939380.1, ZP_—02464124.1, YP_—102417.1, CAC36356.1, ACJ22727.1, YP_—001764240.1, YP_—002765609.1, YP_—001945311.1, ZP_—03586616.1, ACJ22665.1, ZP_—03574223.1, CAC37038.1, ZP_—02456517.1, YP_—001807560.1, YP_—002779449.1, AAK97454.1, YP_—002912304.1, ACR55689.1, YP_—003397515.1, YP_—004361423.1, YP_—772734.1, ACJ65014.1, ACT31523.1, ACJ22750.1, ZP_—07375042.1, YP_—002776786.1, ACB11552.1, ZP_—02363472.1, ADG26653.1, ZP_—04383196.1, ZP_—02356342.1, ACJ22751.1, YP_—952571.1, ACU43494.1, YP_—001135977.1, YP_—002764193.1, YP_—003855036.1, YP_—004078475.1, AAK97448.1, ZP_—04388098.1, ACX30747.1, ADG26632.1, ACJ22719.1, ADO21492.1, ZP_—05061580.1, ADR72654.1, ACZ65961.1, ACX30755.1, YP_—001849604.1, AAV64895.1, YP_—004495037.1, YP_—702497.1, YP_—001069662.1, ZP_—06850622.1, BAF34299.1, CAB51024.2, YP_—004008018.1, YP_—003768535.1, ACJ65013.1, ZP_—07282765.1, YP_—886209.1, ACJ22725.1, ZP_—08155372.1, YP_—004493362.1, ZP_—05228000.1, ZP_—07717360.1, BAD67020.1, YP_—004524245.1, ZP_—07715778.1, NP_—217769.1, ACS91349.1, YP_—960105.1, ZP_—07014137.1, YP_—004746682.1, ZP_—08022271.1, ACN62569.1, ADQ37951.1, YP_—003647687.1, YP_—003837040.1, ADG26600.1, YP_—002768905.1, ZP_—08553310.1, ADG26597.1, ACJ22749.1, ADG26598.1, YP_—001704327.1, ZP_—04385381.1, ZP_—04751264.1, ADG26609.1, ADG26610.1, ZP_—06417258.1, ADG26607.1, ADP98338.1, YP_—003275257.1, YP_—004084103.1, ADG26630.1, ADG26625.1, ADG26605.1, ADG26599.1, ZP_—05218167.1, ADQ37950.1, YP_—921354.1, ADG26645.1, ADG26612.1, YP_—004493370.1, YP_—638501.1, YP_—003809668.1, NP_—962298.1, ZP_—04750514.1, ADG26608.1, ADT82701.1, ACJ06773.1, YP_—120833.1, ADG26618.1, ADG26602.1, ADG26623.1, ZP_—04383566.1, ZP_—08122407.1, YP_—004077166.1, ZP_—05041651.1, ZP_—04608296.1, ABU93351.2, YP_—003658078.1, ADQ37949.1, ADG26652.1, YP_—002765850.1, AAK97447.1, CAD24434.1, CAC40954.1, ACT91203.1, YP_—120829.1, ZP_—07282558.1, YP_—003298195.1, YP_—001851790.1, ZP_—05827357.1, ADG26633.1, CAB51020.1, YP_—953908.1, ZP_—07990416.1, YP_—119532.1, ZP_—08442348.1, ZP_—08276444.1, ZP_—04661203.1, ABO12068.2, YP_—001846325.1, ADQ37952.1, ZP_—08198697.1, ZP_—00996652.1, YP_—001707231.1, ZP_—08433663.1, ZP_—08205256.1, YP_—003732372.1, YP_—906529.1, ACT91204.1, YP_—001506534.1, YP_—001713880.1, YP_—883357.1, YP_—004525252.1, ADG26604.1, YP_—001134633.1, ZP_—08195602.1, ZP_—06690500.1, ZP_—05826167.1, ADY81595.1, ZP_—06056754.1, AAK31348.1, YP_—251715.1, ZP_—08461977.1, ZP_—05847237.1, YP_—712218.1, YP_—001084670.1, ZP_—04387164.1, YP_—260041.1, YP_—002873097.1, ADG26614.1, AAK97446.1, YP_—001280943.1, ZP_—04386125.1, AAC36353.2, CCA29159.1, CAD10804.1, CCA29151.1, CAC40953.1, CCA29161.1, ABA55770.1, AAS93604.4, CCA29173.1, CCA29155.1, CCA29156.1, ABA55772.1, CCA29154.1, ABA55793.1, CCA29162.1, CCA29170.1, ZP_—03824539.1, CCA29166.1, CCA29136.1, ZP_—06065934.1, ABB54493.1, CCA29169.1, YP_—003112137.1, CCA29127.1, CCA29148.1, CCA29160.1, ZP_—06057458.1, ABA55773.1, YP_—004016090.1, CCA29139.1, YP_—480358.1, ABA55787.1, CCA29150.1, CCA29130.1, ZP_—07775830.1, ABA55779.1, CCA29132.1, YP_—003732938.1, BAB33284.1, CCA29149.1, CCA29145.1, ABA55783.1, CCA29137.1, CCA29129.1, CCA29158.1, CCA29176.1, CCA29142.1, CCA29144.1, BAB33287.1, CCA29133.1, CCA29140.1, CCA29135.1, ZP_—06066074.1, ZP_—03823182.1, CCA29171.1, CCA29152.1, CCA29131.1, ABA55780.1, CCA29163.1, CCA29143.1, CCA29153.1, YP_—001580600.1, CCA29134.1, CCA29138.1, YP_—046098.1, ZP_—06072466.1, ZP_—05361594.1, ACU43504.1, CCA29147.1, CCA29146.1, ZP_—06061712.1, ACT91185.1, ACT91147.1, ACT91178.1, ACT91167.1, ACT91181.1, ACT91188.1, ZP_—06069784.1, ACT91205.1, ZP_—06725872.1, ACT91171.1, CCA29128.1, ABY56787.1, ADE05602.1, ACU43474.1, ACJ22718.1, ABB90688.1, ACU43519.1, ABB96093.1, ACU43485.1, ACU43493.1, ABW76857.1, ACT91163.1, ACJ22673.1, ZP_—06188150.1, ACT91242.1, ACT91225.1, ACT91211.1, ACU43479.1, ACU43491.1, ACU43522.1, ACU43486.1, ACT91221.1, ACJ22662.1, ACU43506.1, ACU43487.1, ACT91259.1, AAA97866.1, ACU43502.1, YP_—001252544.1, ABB96084.1, ACU43520.1, ACJ22668.1, ACU43503.1, ACT91230.1, ABA55777.1, ACT91231.1, ZP_—01748311.1, ACJ22724.1, ACU43475.1, ACU43511.1, ACU43490.1, ZP_—08330953.1, ACU43484.1, CBX01596.1, ACT91168.1, YP_—096989.1, ACT91215.1, YP_—125370.1, ACT91233.1, ACU43478.1, ADE05603.1, ACJ22715.1, ACU43512.1, ACT91196.1, ACJ22692.1, ACU43510.1, ACU43521.1, ACT91174.1, ACT91213.1, ACT91142.1, ACT91206.1, ACT91216.1, ACT91182.1, ACT91255.1, ACT91246.1, ACT91217.1, ACT91155.1, ACT91240.1, ACT91207.1, ACU43495.1, YP_—128249.1, ACT91160.1, YP_—004052990.1, ACT91226.1, ACU43507.1, ABO61855.1, ACT91214.1, ACT91220.1, YP_—001188237.1, ACJ22689.1, ZP_—01689499.1, YP_—004379711.1, ACJ22748.1, ABB90683.1, ACT91223.1, ACT91235.1, ABO61786.1, ACU43508.1, ACU43492.1, ACT91219.1, ACT91244.1, ABO61856.1, ACT91239.1, ACU43473.1, ABO61850.1, ACT91262.1, ACT91261.1, ACT91224.1, ACU43499.1, ACU43488.1, ADO21767.1, YP_—004654946.1, ADO21777.1, ABB96089.1, ABO61852.1, ABO61847.1, ACT91222.1, ADO21764.1, ACU43477.1, ADO21773.1, ABO61787.1, ABB96080.1, ABO61857.1, ACT91228.1, ABB96070.1, ADO21744.1, ACT91245.1, CAG17608.1, ADO21747.1, YP_—001349162.1, ABK63807.1, ZP_—06879583.1, NP_—250216.1, ACT91234.1, ZP_—01364874.1, ABO61789.1, ADO21772.1, ACU43516.1, ACU43505.1, ACU43501.1, ACT91236.1, ZP_—07792758.1, ACZ64723.1, ADO21743.1, ADO21759.1, ACZ64752.1, ADO21755.1, ACD75517.1, YP_—790621.1, ACB11551.1, ADO21748.1, NP_—251264.1, ZP_—01365940.1, ADO21762.1, ADO21739.1, ACU43496.1, ABO61854.1, ZP_—06878434.1, ACU43489.1, ACU43483.1, ADO21746.1, ACT91237.1, ZP_—01895378.1, ACT91164.1, ADO21736.1, ACJ22711.1, ACZ64754.1, ZP_—05042146.1, ADO21688.1, ADO21648.1, YP_—001348003.1, ADP98656.1, ADO21737.1, ADO21760.1, ADO21754.1, ADO21740.1, ACZ64758.1, ACU43497.1, ZP_—01912185.1, ABB96111.1, ACU43482.1, ACB11549.1, ADO21775.1, CCA29157.1, ADO21681.1, ADO21668.1, ADO21656.1, ACU43517.1, ACT91165.1, ACJ22695.1, ACJ22688.1, ABB96071.1, ADO21763.1, ACT91241.1, ADO21735.1, ACB11550.1, ADO21778.1, ACT91172.1, ADO21765.1, ABB96087.1, CBJ30233.1, ACJ22752.1, ABB96105.1, ACB15251.1, ACJ22694.1, ACZ64741.1, ACZ64706.1, ABB96108.1, ACT91191.1, ABB96101.1, ABB90691.1, ACZ64745.1, YP_—691842.1, ABB96075.1, ABB90682.1, ABB90690.1, ADO21676.1, ADO21679.1, ABO61768.1, YP_—435857.1, ACJ22722.1, ACT91238.1, ACZ64725.1, CAC14062.1, ADO21682.1, ACZ64771.1, ACZ64718.1, ACZ64724.1, ADO21670.1, ADO21667.1, CAC37048.1, ACZ64708.1, ABB96092.1, ACJ22687.1, ACZ64703.1, ADO21690.1, ABB92364.1, ACB11547.1, ACZ64720.1, ADO21655.1, ACZ64717.1, ADO21680.1, ACZ64757.1, ACZ64733.1, ACT91144.1, ACU43481.1, ACT91179.1, ZP_—02181409.1, ACZ64704.1, ABB96073.1, ACJ22675.1, ACZ64721.1, ABB96090.1, ACJ22729.1, ACU43515.1, ZP_—01307000.1, ABB90685.1, YP_—003862088.1, ACZ64715.1, ACZ64710.1, ACJ22735.1, ABB90687.1, ADO21661.1, ADO21674.1, ACT91177.1, ABB54492.1, ABB96076.1, ABB92365.1, ACT91194.1, ADO21689.1, ACJ22691.1, ABB90681.1, ADO21649.1, ADO21671.1, ACZ64728.1, ABB96095.1, CAC40945.1, ADO21652.1, ADO21665.1, ADE08461.1, ADO21678.1, ACZ64705.1, ACJ22690.1, ADO21675.1, ADO21685.1, ABB96072.1, ACJ22736.1, ACB11540.1, ABB96091.1, AC 104540.1, ACT91251.1, ACT91146.1, ACT91166.1, ACT91156.1, ADO21752.1, ADO21673.1, ADO21725.1, ABB96104.1, ABB90694.1, ABB90696.1, ACT91173.1, ADO21647.1, ZP_—03700804.1, ACT91232.1, ADO21694.1, CAC40949.1, ABB92361.1, ACT91195.1, ACI04538.1, ADO21691.1, ACJ22685.1, ADO21653.1, ABS12461.1, ACZ64736.1, ACZ64772.1, ABB90680.1, ADO21659.1, ACZ64774.1, ADO21684.1, ADO21729.1, ADO21650.1, ADO21733.1, ACZ64755.1, ACZ64751.1, ABA55775.1, ADO21738.1, CCA29174.1, ADO21669.1, ACZ64744.1, ADO21654.1, ADO21768.1, ABB96106.1, CCA29168.1, ACT91176.1, ACB11555.1, ABB90695.1, ADO21660.1, ACJ22666.1, ACZ64778.1, ADO21766.1, ADO21677.1, ZP_—02161687.1, CCA29165.1, ADO21745.1, ACB11548.1, ABB90689.1, ABB96107.1, AAT46052.1, ADO21718.1, ADO21722.1, ABB96088.1, EFW40271.1, ADO21686.1, ABB96103.1, ACU43500.1, ACB11536.1, ABB92360.1, CCA29167.1, ACT91199.1, ACZ64770.1, ACJ22716.1, ABA55786.1, ACZ64737.1, ABB96083.1, ACJ22676.1, ACZ64735.1, ACT91212.1, ACJ22765.1, CAJ01371.1, CAC 17734.1, ABD36389.1, ACB11537.1, CAC08515.1, ACZ64714.1, ACU43513.1, ABB96082.1, ADN21387.1, ADO21711.1, ABD36392.1, ABR10770.1, CAC37049.1, ABB96098.1, ABB90692.1, ACB11535.1, ACZ64768.1, ACJ22756.1, ABB96094.1, ABA55791.1, ABB96078.1, ACT91141.1, ACZ64779.1, ACZ64750.1, CAJ01370.1, ACZ64753.1, ACU43480.1, ABA55794.1, ABB96085.1, ABB96110.1, YP_—004448035.1, ACZ64709.1, ABB96102.1, ACZ64773.1, CCA29175.1, ACZ64749.1, ACZ64756.1, ACZ64781.1, ABO61777.1, ACZ64759.1, ACZ64764.1, ACZ64740.1, ACT91249.1, ZP_—03702922.1, ACB11545.1, ACZ64775.1, ACZ64769.1, ACT91145.1, ACZ64742.1, ACT91254.1, ACZ64762.1, ACZ64716.1, ACZ64777.1, ADM26559.1, ABB96096.1, ACZ64780.1, ZP_—01201250.1, CAH55829.1, ZP_—01052921.1, ABB96077.1, ADO21658.1, ACT91161.1, ABB90684.1, ACR56750.1, ABB90697.1, ACZ64746.1, ABB92367.1, ACT91139.1, ACZ64763.1, ACT91200.1, ABO61773.1, ABB96081.1, ACZ64748.1, ACZ64782.1, ACU43498.1, ADO21651.1, ABB90679.1, BAG06233.1, ACZ64747.1, ABB96086.1, ACZ64761.1, ABB92370.1, ABO61774.1, ACT91175.1, ABB90686.1, ACB11546.1, ZP_—01740604.1, ABO61785.1, YP_—001531377.1, XP_—001434539.1, ABA55767.1, ABO21865.1, ABF55636.1, ABA55751.1, ABB90698.1, ADD12311.1, ACZ64765.1, ABB92366.1, ABB92368.1, ACI04539.1, XP_—001023288.1, ACZ64783.1, ADO21692.1, ZP_—01753800.1, ACZ64760.1, ACZ64700.1, ZP_—01055480.1, ACZ64767.1, ACZ64701.1, ABA55745.1, ABA55752.1, ACZ64766.1, YP_—614640.1, ABA55759.1, ADO21723.1, BAG06232.1, ZP_—01002389.1, ABB90693.1, ACT91264.1, ABB92358.1, BAF99026.1, ABR10769.1, ZP_—00959618.1, AEA08580.1, ADD22986.1, CAB51023.1, CAC40958.1, ADO21709.1, CAB51025.1, ACI15226.1, ACJ22680.1, ZP_—05741459.1, ACT91248.1, ABU48567.1, ABO61792.1, ACJ22754.1, EFN53276.1, AAL87644.1, ACT91209.1, ZP_—02147281.1, ACU43518.1, ACZ64776.1, ACB11543.1, ACT91151.1, ACJ22764.1, ACT91159.1, ABA18186.1, AEA08579.1, ADO21770.1, ABF55634.1, CAA27179.1, ABA55741.1, ADO21705.1, ZP_—01754375.1, ACB11541.1, ACR56751.1, ACT91250.1, ADO21769.1, ADO21753.1, ABB96097.1, ACT91208.1, ABO21867.1, ADO21757.1, ACB11554.1, ABA55749.1, CAC40951.1, ADO21719.1, ABB96074.1, ZP_—00954267.1, ZP_—05786269.1, AEH76912.1, ABA55742.1, ABA55748.1, BAG06236.1, ADO21732.1, ABA55750.1, ABA55768.1, ACT31522.1, ZP_—05090796.1, ACZ64739.1, YP_—915886.1, ADO21731.1, CAC40948.1, XP_—001032273.1, AEH76911.1, ABA55743.1, ABO61769.1, ABA55755.1, ZP_—05122263.1, ADO21756.1, ABA55744.1, ABA55746.1, ZP_—01901011.1, ZP_—02150761.1, ADO21742.1, ACR56752.1, ABA55747.1, ABF55637.1, ABA55740.1, ABA55760.1, ZP_—00948812.1, ABA55804.1, ADO21771.1, ZP_—05342453.1, ABF55638.1, YP_—508336.1, ABB92357.1, ZP_—01049702.1, ABU48546.1, ABU48555.1, ABA55764.1, ABO21866.1, ZP_—05079274.1, ZP_—01880441.1, ACZ64738.1, ZP_—05842058.1, ACT91218.1, ABA55769.1, ABA55739.1, ABA55803.1, ACT91247.1, ABA55782.1, ACZ17539.1, ABB92359.1, ACH69966.1, ZP_—01035050.1, ACZ17537.1, ABA55774.1, ACZ64729.1, ACZ17538.1, ZP_—01751972.1, ACZ64731.1, ACZ64702.1, AAR13803.1, AEJ28400.1, ZP_—05099213.1, CAB51021.1, ACZ17531.1, AEH76914.1, ZP_—05051648.1, ACZ64726.1, ACZ17540.1, ACZ64727.1, ZP_—02152773.1, ACT91253.1, ACZ17536.1, XP_—001423873.1, ACZ17534.1, YP_—168645.1, ACZ17520.1, ABY56786.1, ACB11539.1, ZP_—01157350.1, AEH76910.1, ABY56784.1, AAY85982.1, ACT91257.1, ACB11544.1, ACZ17532.1, ZP_—01746661.1, ABA55771.1, BAG06235.1, EGR32049.1, YP_—001166282.1, ABO61799.1, ABA55757.1, AEH76915.1, ACO59264.1, ABO26125.1, AEA08577.1, ACT91265.1, ABY56785.1, ACZ17528.1, ABO61798.1, ADO21749.1, ACT91263.1, ACT91252.1, ACZ64722.1, ABO61771.1, ACZ17526.1, ABO26123.1, ADO21714.1, ZP_—01000906.1, ABO61796.1, ADC29534.1, ACB15250.1, ACD47155.1, ACZ17525.1, ACB11553.1, ABD36391.1, AEH76913.1, ACZ17523.1, ABO61781.1, ACZ17524.1, ZP_—01914093.1, ACB11538.1, ZP_—01015838.1, ACJ22693.1, ACB15252.1, CAC86945.1, ACO59265.1, ABO61791.1, ACZ17521.1, ABO26124.1, ACZ64732.1, ACU43514.1, ACT91256.1, ACM63043.1, ACS75820.1, ZP_—08666479.1, CAH03133.1, BAG06234.1, AEH76916.1, ABO61790.1, ABE72965.1, ACZ64711.1, ACB11542.1, AAY26148.1, ABA55776.1, ACZ17522.1, ACZ64734.1, AEA08578.1, ACZ17530.1, ZP_—04062748.1, ACJ22755.1, NP_—969039.1, AAY26149.1, ACJ22761.1, ABU48543.1, ZP_—08414255.1, AAT91720.1, ZP_—01444283.1, ABA55796.1, ABU48542.1, YP_—001042010.1, YP_—001234392.1, YP_—351510.1, ACZ64730.1, ZP_—08634611.1, ACZ17529.1, ACJ22667.1, AAT91719.1, YP_—004283531.1, ABO61801.1, ACZ17519.1, ABO15266.1, CAB51040.1, ACZ64707.1, ACJ22766.1, ABO26121.1, ZP_—01878984.1, CAB51039.1, ABA55795.1, ABO15269.1, ABO15247.1, ACJ22763.1, ABO15251.1, ACZ17527.1, ABO15270.1, ACJ22769.1, ADE06670.1, ZP_—05780387.1, ABO61770.1, ACT91258.1, ABO15258.1, ABO15257.1, ABU48545.1, CAC86946.1, ABO15267.1, ZP_—01741446.1, ABU48544.1, YP_—002296646.1, AEH76917.1, ADC29550.1, YP_—002527219.1, ABK88246.1, ADN21388.1, ACT91210.1, ZP_—05064795.1, ABJ16487.1, XP_—002675644.1, ABJ16489.1, ADA71089.1, ADA71088.1, AAT46053.1, ZP_—01744806.1, ZP_—01037964.1, ZP_—00955262.1, ABJ 16493.1, YP_—001840157.1, ZP_—00964204.1, ABB40596.1, ACB15249.1, ADD82963.1, YP_—004499590.1, ZP_—01011524.1, ACJ22758.1, ZP_—01748906.1, ACV30052.1, ZP_—06191942.1, YP_—001188029.1, ACD63080.1, YP_—166583.1, AAV41375.1, ZP_—00998265.1, ACJ22757.1, ABB13506.2, ABI13999.1, ABI14004.1, ABB13509.1, YP_—371980.1, ZP_—01755711.1, ZP_—05065835.1, ZP_—00959368.1, XP_—001020063.1, ABJ16481.1, ABI14006.1, ZP_—05101918.1, ZP_—01913733.1, ABI14001.1, ABM92270.1, ABI14003.1, CAH03132.1, YP_—973211.1, ABA55797.1, YP_—003578527.1, ABJ16483.1, ABJ16482.1, CBY78068.1, ACT91260.1, YP_—509155.1, ABB13508.1, ABJ16485.1, ABO61779.1, ABI14005.1, ACM63042.1, ADC29543.1, ZP_—02153440.1, YP_—709335.1, ABI13998.1, ABI14002.1, AAB70825.1, ACX30751.1, ABI14000.1, YP_—003617173.1, ZP_—01155421.1, ACX30752.1, NP_—542887.1, ADC29546.1, AAC38359.1, ADC29541.1, XP_—001020064.1, ZP_—01442436.1, ZP_—05103090.1, ADC29544.1, ABO61809.1, AAY89939.1, ACH99235.1, CAH55830.1, ABO26095.1, YP_—004011670.1, ABO26084.1, ADA71083.1, ABO26087.1, ABO61806.1, ADC29531.1, ABO26109.1, ACJ22753.1, ABO26089.1, ABO26093.1, ABO26092.1, ABO61827.1, ABO26105.1, ABO26112.1, AAT91721.1, ABO26120.1, ABO26090.1, ABO26088.1, ABO61811.1, ABO61783.1, CAH55827.1, ACH99232.1, ABO61828.1, ADC29530.1, ACH99234.1, AAQ88276.1, CAH55823.1, ABO26103.1, ACH99233.1, ABO61836.1, ABO26094.1, ABO61840.1, YP_—004534277.1, ZP_—05845010.1, ABO61821.1, ACH99231.1, AAV68403.1, ABO61839.1, CAH56098.1, ABO26085.1, ABO61826.1, ABO61822.1, ABO26110.1, ABO61810.1, ABO61844.1, ABO61825.1, ABO26099.1, ACJ22767.1, ABO26102.1, YP_—004535707.1, ACJ22762.1, ABO26097.1, BAC65444.1, ABO61829.1, YP_—114083.1, CAH55828.1, ABO26106.1, YP_—552229.1, NP_—049190.1, ABO26116.1, CAH56107.1, CAM32407.1, ABO26101.1, ABO61841.1, ABM79805.1, ZP_—05075249.1, AAC27438.2, YP_—003754872.1, ADC29532.1, ADA71139.1, ADA71107.1, ADA71095.1, YP_—001268217.1, ADA71126.1, ADA71094.1, CAH56108.1, ADC29533.1, ADA71085.1, ZP_—05054453.1, ADA71097.1, ADA71086.1, ADA71114.1, ADC29548.1, ADA71101.1, ADC29547.1, ADA71138.1, ADC29542.1, ADA71098.1, ADA71128.1, ADA71105.1, ADA71093.1, ADA71135.1, ADA71100.1, YP_—557479.1, ADA71113.1, ADA71091.1, ADC29537.1, ADA71084.1, ADA71090.1, CAH56094.1, XP_—002945767.1, ADA71137.1, ADA71103.1, ADA71118.1, ADA71133.1, ADA71102.1, ADC29536.1, CAH56100.1, CAH56101.1, ACI15225.1, ACI15225.1, ABO26091.1, CAH55826.1, CAH55824.1, ZP_—08484419.1, ADA71111.1, ACJ22759.1, CAH55825.1, CAH56106.1, CAH56099.1, CAC40957.1, ZP_—05075037.1, CAH56102.1, ZP_—06846296.1, ABJ16491.1, ZP_—05067177.1, XP_—001698107.1, BAH10789.1, BAH10791.1, BAH10793.1, BAH10788.1, ABJ16490.1, BAH10800.1, BAH10790.1, BAH10792.1, ZP_—05075214.1, BAH10799.1, BAH10795.1, BAH10787.1, BAH10798.1, BAH10794.1, BAH10801.1, BAH10796.1, BAH10797.1, BAH10802.1, CAH56095.1, CAH56096.1, ADC29538.1, ABX76425.1, ZP_—06727686.1, ZP_—07774883.1, YP_—001615042.1,in particular YP_—001185946.1, Q9WWW6.1, YP_—957898.1, YP_—957728.1, YP_—694427.1, BAC98365.1, ZP_—00957064.1, CAC86944.1, YP_—001672212.1, CAB59525.1, ACH99213.1, ACH99215.1, ACH99216.1, AAK56792.1, ACH99229.1, ACS91348.1, AAP41820.1and especially preferably YP_—001185946.1,andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_1b is generally understood in particular as meaning the conversion of lauric acid and/or its methyl ester into w-hydroxylauric acid and/or its methyl ester.

Specific Enzymes E_c1

Eukaryotic fatty alcohol oxidases E_1c which are preferred in this context are selected from among the list

AAS46878.1, ACX81419.1, AAS46879.1, CAB75353.1, AAS46880.1, XP_—712350.1, XP_—002422236.1, XP_—712386.1, EEQ43775.1, XP_—001525361.1, XP_—001386087.1, XP_—459506.2, CAB75351.1, CAB75352.1, XP_—001385255.2, EDK39369.2, XP_—001484086.1, XP_—002618046.1, XP_—002548766.1, XP_—002548765.1, XP_—003041566.1, XP_—003328562.1, XP_—001214264.1, XP_—001904377.1, XP_—658227.1, XP_—001591990.1, XP_—753079.1, XP_—002569337.1, XP_—001268562.1, XP_—003348911.1, EGP90120.1, XP_—001389382.1, EER37923.1, XP_—001264046.1, EGO58212.1, XP_—001554225.1, XP_—003298648.1, XP_—959005.1, XP_—002841296.1, XP_—001940486.1, EGR52262.1, EEQ89581.1, EGD99881.1, EFQ33355.1, XP_—001821106.1, XP_—002622231.1, EGG03784.1, EGC44059.1, XP_—003018036.1, XP_—003011696.1, EFY90752.1, XP_—001227812.1, XP_—758170.1, XP_—001243546.1, XP_—002479333.1, XP_—003344707.1, EFW 14100.1, XP_—003071927.1, XP_—003171263.1, XP_—003051757.1, XP_—002147053.1, EEH19591.1, EEH50473.1, XP_—001792978.1, XP_—387094.1, EFY98644.1, XP_—002788971.1, XP_—002842592.1, EFX04185.1, XP_—003231449.1, XP_—001729067.1, CBX94189.1, XP_—001413535.1, ACF22878.1, B5WWZ9.1, XP_—002994642.1, XP_—002269629.1, XP_—002519938.1, XP_—002982582.1, NP_—001047464.1, EEC73620.1, XP_—002981110.1, XP_—002960521.1, NP_—566729.1, XP_—001541970.1, XP_—002967201.1, BAK00483.1, XP_—002182547.1, BAK02336.1, XP_—002454190.1, XP_—002328753.1, XP_—002867943.1, XP_—002285334.1, CAC87643.1, CAN71289.1, XP_—002454188.1, AAL31049.1, XP_—002464494.1, AAL31021.1, YP_—117187.1, XP_—002543430.1, CAA18625.1, XP_—002883430.1, NP_—193673.2, XP_—002529832.1, XP_—001753124.1, NP_—001142399.1, ACN27562.1, XP_—002464495.1, ACR36691.1, BAJ86655.1, B5WWZ8.1, NP_—001148058.1, ABR17814.1, EAY78905.1, NP_—194586.1, AAM63097.1, AAK64154.1, NP_—001064839.2, XP_—002869492.1, XP_—002314488.1, AAL31024.1, ZP_—06967355.1, AAP54248.2, XP_—002311685.1, ACF87929.1, YP_—907078.1, EGE07035.1, YP_—001849908.1, XP_—002464496.1, EEC67160.1, AAL31027.1, XP_—001761391.1, XP_—002961172.1, XP_—002528823.1, XP_—002966834.1, NP_—001176205.1, XP_—001763007.1, XP_—002272123.1, XP_—002889487.1, XP_—003003157.1, NP_—285451.1, EGG23219.1, NP_—171895.2, YP_—003395677.1, Q9ZWB9.1, ACF88407.1, ZP_—06413771.1, EEE51131.1, YP_—003835264.1, YP_—003397164.1, YP_—004081922.1, XP_—003294587.1, EEE51130.1, YP_—003647529.1, YP_—003647985.1, CBI29206.3, XP_—629786.1, ZP_—07964664.1, EEE57396.1, EEH09589.1, YP_—003265796.1, YP_—001840752.1, ZP_—08620775.1, ACR36076.1, ZP_—05043749.1, YP_—980677.1, ZP_—05043728.1, YP_—692894.1, NP_—710223.1, EEC67159.1, AAP03110.1, EFA85697.1, YP_—691805.1, YP_—551012.1, YP_—001174466.1, YP_—002796294.1, YP_—004716331.1, YP_—001019547.1, YP_—585737.1, AEA86007.1, YP_—960830.1, YP_—004743970.1, ZP_—03431349.1, ZP_—06448642.1, ZP_—07430351.1, NP_—215006.2, ZP_—03535393.1, ZP_—06801690.1, YP_—001849132.1, NP_—854165.1, ZP_—03427234.1, CBJ27378.1, NP_—334920.1, ZP_—08571383.1, YP_—728161.1, ZP_—01896040.1, ZP_—03530923.1, YP_—551306.1, YP_—003167456.1, YP_—606070.1, ZP_—06850167.1, ADP99095.1, YP_—907986.1, ZP_—04924166.1, ZP_—08139923.1, YP_—001270300.1, YP_—521830.1, YP_—003147410.1, YP_—002007173.1, ADR62464.1, YP_—004382294.1, NP_—747223.1, YP_—004687462.1, NP_—902159.1, ZP_—04936784.1, YP_—003914667.1, ZP_—01306356.1, ZP_—04750553.1, YP_—002875279.1, YP_—004704374.1, YP_—001671392.1, NP_—249055.1, ZP_—06876360.1, YP_—001345853.1, YP_—002437969.1, YP_—004356853.1, YP_—351075.1, CBI23676.3, YP_—001189668.1, YP_—001528881.1, YP_—001613612.1, YP_—001747218.1, YP_—003393002.1, YP_—001365074.1, ZP_—07778129.1, ZP_—07392715.1, YP_—001553329.1, YP_—262925.1, YP_—751961.1, YP_—564183.1, YP_—003811876.1, YP_—002356821.1, YP_—001051828.1, YP_—001837525.1, NP_—716513.1, ZP_—01915079.1, ZP_—02156621.1, YP_—001184631.1, YP_—001475595.1, ZP_—05042393.1, YP_—962228.1, YP_—001612275.1, ADV55625.1, YP_—001675797.1, YP_—003555260.1, ZP_—01075039.1, YP_—003812822.1, YP_—001503351.1, EFN52938.1, YP_—001759063.1, ZP_—06503577.1, YP_—871025.1, ZP_—08564919.1, YP_—002310162.1, YP_—732875.1, YP_—001092722.1, YP_—739324.1, XP_—002333995.1, NP_—085596.1, YP_—928870.1, EGD05748.1, NP_—443993.1, ZP_—08138057.1, ZP_—05041587.1, ZP_—07011380.1, YP_—001612684.1, ZP_—07669342.1, ZP_—06508361.1, ZP_—03423639.1, YP_—923293.1, ZP_—05061865.1, ZP_—08181496.1, YP_—559605.1, ZP_—06841320.1, ZP_—01620712.1, YP_—001896340.1, ZP_—03276650.1, YP_—004303194.1, ZP_—08180715.1, ZP_—06382740.1, ZP_—01034555.1, YP_—004604560.1, YP_—001020142.1, YP_—935375.1, ZP_—01546137.1, ZP_—07661079.1, YP_—001860640.1, ZP_—06052841.1, ZP_—01881170.1, ZP_—05781455.1, YP_—932732.1, ZP_—08119300.1, YP_—004715268.1, ZP_—03697402.1, YP_—004126957.1, ZP_—06703136.1, NP_—642445.1, ZP_—08273900.1, YP_—004524313.1, ZP_—01902993.1, YP_—001900094.1, AEA84888.1, YP_—004690289.1, NP_—714358.1, YP_—682471.1, YP_—003239.1, YP_—997465.1, YP_—003452130.1, ZP_—01739153.1, YP_—004219483.1, YP_—001761298.1, ZP_—01438251.1, CBI37146.3, ZP_—04748383.1, YP_—004362245.1, ZP_—05912795.1, YP_—003390234.1, YP_—003122799.1, CCB77579.1, EGB06416.1, ZP_—08389346.1, YP_—191496.1, ZP_—05224727.1, ZP_—01125614.1, YP_—466287.1, YP_—001368620.1, YP_—001380256.1, YP_—002361951.1, YP_—002756103.1, YP_—001801399.1, ZP_—06847140.1, YP_—003200069.1, YP_—001940247.1, YP_—001584322.1, ZP_—04679227.1, YP_—002493674.1, YP_—002135530.1, YP_—004290424.1, YP_—001772011.1, ZP_—08189046.1, ZP_—03423640.1, YP_—001834251.1, ZP_—01041752.1, YP_—001533410.1, YP_—269751.1, YP_—002432994.1, YP_—003694653.1, CAD47896.1, NP_—769359.1, YP_—004239460.1, YP_—004605221.1, YP_—001961214.1, YP_—001837513.1, YP_—004335962.1, YP_—004358600.1, ZP_—05050026.1, YP_—003202983.1, BAD03777.1, ZP_—02165013.1, NP_—774131.1, YP_—432169.1, ZP_—05000547.1, YP_—001261233.1, XP_—002593969.1, XP_—002603265.1, YP_—003342435.1, ZP_—01253183.1, EGO36831.1, YP_—001866737.1, YP_—001523879.1, YP_—133594.1, YP_—003768990.1, YP_—001237820.1, YP_—003133224.1, ZP_—01896771.1, ZP_—01865125.1, NP_—960319.1, YP_—826958.1, YP_—003326608.1, YP_—002219515.1, NP_—217926.1, ZP_—07441899.2, YP_—001208178.1, ADM42038.1, YP_—002433510.1, ZP_—08274313.1, EGO38668.1, ZP_—03393221.1, NP_—356358.1, ZP_—06055780.1, YP_—001684562.1, ZP_—08528157.1, BAD03162.1, YP_—001800712.1, ACL37106.1, YP_—883489.1, ZP_—01075202.1, NP_—969446.1, ZP_—01129577.1, YP_—001530285.1, ZP_—04746501.1, YP_—001341980.1, YP_—905003.1, ZP_—05218299.1, ZP_—08665577.1,preferablyAAS46878.1, ACX81419.1, AAS46879.1, CAB75353.1, AAS46880.1, XP_—712350.1, XP_—002422236.1, XP_—712386.1, EEQ43775.1, XP_—001525361.1, XP_—001386087.1, XP_—459506.2, CAB75351.1, CAB75352.1, XP_—001385255.2, EDK39369.2, XP_—001484086.1, XP_—002618046.1, XP_—002548766.1, XP_—002548765.1, XP_—003041566.1, XP_—001214264.1, XP_—001904377.1, XP_—658227.1, XP_—001591990.1, XP_—753079.1, XP_—002569337.1, XP_—001268562.1, XP_—003348911.1, EGP90120.1, XP_—001389382.1, EER37923.1, XP_—001264046.1, EGO58212.1, XP_—001554225.1, XP_—003298648.1, XP_—959005.1, XP_—002841296.1, XP_—001940486.1, EGR52262.1, EEQ89581.1, EGD99881.1, EFQ33355.1, XP_—001821106.1, XP_—002622231.1, EGC44059.1, XP_—003018036.1, XP_—003011696.1, EFY90752.1, XP_—001227812.1, XP_—001243546.1, XP_—002479333.1, XP_—003344707.1, EFW14100.1, XP_—003071927.1, XP_—003171263.1, XP_—003051757.1, XP_—002147053.1, EEH19591.1, EEH50473.1, XP_—001792978.1, XP_—387094.1, EFY98644.1, XP_—002788971.1, XP_—002842592.1, EFX04185.1, XP_—003231449.1, CBX94189.1, XP_—001413535.1, XP_—001541970.1, XP_—002543430.1, EGE07035.1, XP_—003003157.1and especially preferably

AAS46878.1, ACX81419.1, AAS46879.1, CAB75353.1, AAS46880.1, XP_—712350.1, XP_—002422236.1, XP_—712386.1, EEQ43775.1, CAB75351.1, CAB75352.1, XP_—002548766.1, XP_—002548765.1,

andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_1c is generally understood in particular as meaning the conversion of dodecan-1-ol into dodecan-1-al or dodecan-1-al into dodecanoic acid.

Specific Enzymes E_1d

Such preferred AlkJ alcohol dehydrogenases are selected from among

Q00593.1, Q9WWW2.1, ZP_—00957061.1, YP_—957894.1, CAC38030.1, YP_—694430.1, YP_—957725.1, YP_—001672216.1, YP_—552061.1, YP_—130410.1, ZP_—06155535.1, ZP_—01222730.1, YP_—691907.1, YP_—002297804.1, YP_—004283522.1, YP_—001234383.1, YP_—004435031.1, ZP_—05110316.1, ZP_—05042898.1, YP_—004466324.1, ZP_—08553549.1, YP_—004125220.1, ADI22536.1, ADI18461.1, YP_—003810975.1, YP_—662346.1, YP_—004427557.1, YP_—692606.1, ZP_—05043291.1, YP_—440752.1, ZP_—02386160.1, ZP_—04763547.1, ZP_—02361232.1, YP_—003376674.1, ZP_—02354055.1, ZP_—05085930.1, ADQ00130.1, YP_—003643016.1, ZP_—05040520.1, YP_—691922.1, AAX23098.1, BAD07371.1, NP_—104379.1, YP_—002551960.1, YP_—003908558.1, YP_—987903.1, ZP_—05785860.1, YP_—004145612.1, YP_—004140926.1, CAZ88300.1, ZP_—05041901.1, YP_—533645.1, ZP_—01754259.1, CBA31223.1, YP_—587542.1, YP_—106852.1, ZP_—08402506.1, ZP_—05055020.1, ZP_—02400829.1, YP_—104747.1, ZP_—02409412.1, YP_—001057269.1, YP_—004229837.1, YP_—294429.1, YP_—001028112.1, ZP_—02479747.1, YP_—002874799.1, ZP_—03541051.1, YP_—003606536.1, ZP_—02887167.1, YP_—001795572.1, YP_—487451.1, ACZ62814.1, YP_—560809.1, ZP_—02167462.1, YP_—004482869.1, YP_—001581248.1, ZP_—07374066.1, YP_—001203981.1, ZP_—06840259.1, ZP_—01915145.1, NP_—774525.1, ZP_—03561080.1, YP_—001208258.1, YP_—001897374.1, YP_—001413909.1, YP_—366469.1, YP_—521854.1, YP_—004490642.1, YP_—003280349.1, ZP_—03588744.1, YP_—001562229.1, YP_—001120981.1, ZP_—03574970.1, YP_—004234225.1, ZP_—02377531.1, ZP_—02149954.1, YP_—001237360.1, ZP_—03266156.1, YP_—782821.1, YP_—004754039.1, BAB61732.1, ZP_—07046388.1, ZP_—02145452.1, BAF45123.1, YP_—002129953.1, YP_—003812439.1, ZP_—01055291.1, BAF45124.1, EGH71399.1, ZP_—05060389.1, ZP_—05090872.1, BAF45126.1, BAB07804.1, ZP_—06053464.1, YP_—001238278.1, ZP_—04944469.1, YP_—001171160.1, YP_—002984373.1, YP_—002237649.1, ZP_—08276443.1, BAF98451.1, ZP_—05124197.1, YP_—568640.1, ZP_—05785341.1, NP_—769037.1, YP_—370657.1, YP_—775005.1, ZP_—02911119.1, YP_—165460.1, ZP_—02891796.1, YP_—622328.1, ZP_—07675057.1, YP_—001901188.1, YP_—003592183.1, ZP_—02361040.1, NP_—518244.1, YP_—001809673.1, NP_—947032.1, YP_—001766369.1, YP_—002255997.1, ZP_—04940241.1, YP_—004012032.1, YP_—841049.1, YP_—002983249.1, YP_—003643276.1, YP_—003855487.1, YP_—003778137.1, ZP_—02361104.1, CBA30511.1, ZP_—05781295.1, YP_—756865.1, ZP_—02461782.1, YP_—002007988.1, YP_—004110133.1, YP_—002229680.1, ZP_—02386040.1, YP_—004684069.1, YP_—373268.1, YP_—440614.1, NP 421441.1, YP_—264896.1, YP_—004362617.1, ZP_—06053847.1, YP_—366538.1, YP_—003812285.1, YP_—004154520.1, ZP_—01901081.1, ZP_—02372179.1, ZP_—02453559.1, ADP98564.1, YP_—003747084.1, ZP_—02487888.1, ZP_—01768075.1, ZP_—02400664.1, YP_—106680.1, YP_—724753.1, YP_—002907583.1, YP_—004482470.1, YP_—167582.1, YP_—270109.1, YP_—004362333.1, ZP_—02504034.1, YP_—003189363.1, YP_—973212.1, ZP_—00952746.1, YP_—459665.1, YP_—777218.1, YP_—581107.1, ZP_—01878091.1, ZP_—01057973.1, YP_—002913124.1, ZP_—01035570.1, YP_—001777560.1, YP_—552627.1, ZP_—02890876.1, YP_—587146.1, YP_—004141814.1, YP_—001685369.1, ZP_—05343380.1, NP_—886000.1, ZP_—04942359.1, ZP_—01913732.1, ZP_—08244266.1, YP_—002233254.1, ZP_—01816670.1, YP_—837233.1, ZP_—07478008.1, ZP_—01985205.1, ZP_—07473972.1, ZP_—01067090.1, ZP_—01867788.1, ZP_—01754024.1, EGM19144.1, ZP_—07741283.1, ZP_—06876839.1, YP_—002395287.1, ZP_—07795498.1, NP_—102692.1, NP_—252789.1, YP_—004451100.1, ZP_—01305514.1, YP_—002438481.1, ZP_—04930310.1, YP_—001810189.1, YP_—104187.1, ZP_—01367534.1, YP_—001346382.1, ZP_—01878466.1, YP_—789017.1, YP_—001115422.1, ZP_—05067451.1, ZP_—05842072.1, YP_—001682976.1, YP_—761348.1, YP_—004611600.1, YP_—004188241.1, NP_—419761.1, EFV85163.1, YP_—684227.1, ZP_—06177455.1, NP_—935088.1, YP_—004614491.1, ZP_—08697916.1, YP_—004689366.1, ZP_—05052326.1, YP_—267420.1, YP_—728575.1, YP_—001759584.1, YP_—557446.1, ZP_—06844897.1, ZP_—06079799.1, YP_—003771143.1, ZP_—05094472.1, YP_—511622.1, ACF98205.1, YP_—582314.1, ZP_—07660450.1, YP_—004065269.1, YP_—003979606.1, YP_—002520401.1, YP_—003579281.1, ZP_—01749397.1, ZP_—03265018.1, ZP_—07283393.1, YP_—001532150.1, YP_—298941.1, ZP_—06688181.1, ZP_—01611660.1, ZP_—02367747.1, EGP42870.1, ZP_—00993245.1, ABY65992.1, YP_—354800.1, ZP_—01747277.1, YP_—561728.1, ZP_—02190947.1, YP_—605824.1, YP_—001991873.1, ZP_—00955792.1, YP_—003594401.1, YP_—004156101.1, YP_—001472858.1, YP_—001746950.1, ZP_—08410042.1, ZP_—01116604.1, ADP99912.1, ZP_—01692203.1, YP_—001328534.1, YP_—999236.1, YP_—002278452.1, ZP_—01306234.1, YP_—002871776.1, ZP_—02369920.1, ZP_—01896942.1, YP_—002289724.1, AEG07584.1, YP_—999005.1, YP_—003552461.1, YP_—270668.1, ZP_—06862917.1, YP_—001811327.1, YP_—001166036.1, ABW06653.1, ZP_—01548976.1, ZP_—07774606.1, ZP_—05888080.1, YP_—003301477.1, YP_—341748.1, ZP_—05100248.1, YP_—918038.1, YP_—001500869.1, YP_—004305296.1, YP_—003342584.1, NP_—947961.1, ZP_—05124765.1, ZP_—01904700.1, YP_—003696207.1, YP_—004156699.1, YP_—001241858.1, NP_—104253.1, YP_—676241.1, ZP_—01736903.1, ZP_—00960121.1, NP_—436019.1, YP_—002945716.1, YP_—259594.1, EFV86615.1, AAY87334.1, NP_—900970.1, AEG07409.1, YP_—349087.1, YP_—004141055.1, YP_—001169476.1, YP_—001566960.1, YP_—260472.1, ZP_—07028078.1, YP_—004610468.1, YP_—003066461.1, YP_—961096.1, ZP_—08666573.1, ZP_—02187363.1, YP_—001631518.1, ZP_—08141293.1, YP_—001666324.1, NP_—387083.1, YP_—001526184.1, YP_—165213.1, YP_—003694923.1, YP_—004433897.1, YP_—001265431.1, ZP_—05068964.1, YP_—002313077.1, ZP_—02372305.1, YP_—004486039.1, YP_—341901.1, YP_—001862312.1, YP_—004681983.1, YP_—617373.1, EFV86570.1, YP_—001673285.1, BAK39604.1, YP_—001669327.1, YP_—004353150.1, YP_—001888124.1, ZP_—08645365.1, YP_—003410784.1, YP_—841363.1, EGP44033.1, YP_—001633470.1, EGP42855.1, ZP_—01115125.1, ADR57794.1, YP_—784649.1, YP_—373898.1, Q47944.1, YP_—001117950.1, ZP_—02380339.1, ZP_—03697092.1, YP_—003187112.1, YP_—004065439.1, NP_—742226.1, YP_—002429878.1, YP_—003556403.1, AEH81535.1, YP_—001887935.1, YP_—554605.1, ZP_—07333059.1, YP_—001991668.1, YP_—003694210.1, YP_—222680.1, YP_—002232672.1, YP_—001763402.1, YP_—001806802.1, YP_—662156.1, ZP_—05153429.1, ZP_—01893457.1, ZP_—04595387.1, ADP99389.1, ZP_—02890074.1, YP_—001313582.1, NP_—387401.1, ZP_—01863693.1, YP_—750630.1, ZP_—04939997.1, YP_—268077.1, ZP_—05169265.1, NP_—888994.1, ZP_—08408421.1, YP_—001155137.1, NP_—699017.1, YP_—002008190.1, YP_—004493716.1, YP_—266277.1, YP_—004654190.1, YP_—943422.1, ZP_—05162503.1, ZP_—02905080.1, ZP_—02905080.1, ZP_—03784461.1, YP_—001601784.1, YP_—002233786.1, YP_—622842.1, YP_—002822679.1, ZP_—04944312.1, ZP_—05179897.1, YP_—004483124.1, YP_—003390414.1, YP_—771968.1, YP_—001628465.1, YP_—004311599.1, ZP_—01037150.1, ZP_—01611812.1, ZP_—03575238.1, YP_—002278603.1, YP_—001593845.1, EGD01613.1, YP_—297574.1, YP_—367509.1, YP_—998315.1, ZP_—08664883.1, ZP_—05114787.1, ZP_—05450190.1, YP_—298028.1, ZP_—01034678.1, YP_—002827796.1, YP_—372762.1, YP_—004466723.1, ZP_—01012072.1, YP_—320380.1, ZP_—01075202.1, YP_—001312358.1, YP_—681895.1, ZP_—07718189.1, EGP55868.1, YP_—003750799.1, YP_—002984725.1, YP_—002543360.1, ZP_—01040714.1, ZP_—04717111.1, YP_—002422932.1, YP_—003506115.1, ZP_—01444019.1, ZP_—03587285.1, YP_—771439.1, YP_—001947593.1, YP_—001049712.1, YP_—003979888.1, YP_—001553786.1, YP_—003980878.1, YP_—001578274.1, YP_—472442.1, YP_—778292.1, EGE56670.1, YP_—002779312.1, YP_—432169.1, YP_—560963.1, YP_—001265285.1, YP_—002822699.1, YP_—002278091.1, ZP_—08632361.1, YP_—002229178.1, ZP_—06840392.1, ZP_—05069105.1, ZP_—00998644.1, YP_—004487901.1, YP_—680905.1, YP_—728088.1, YP_—001985833.1, YP_—002007099.1, ZP_—05066777.1, ZP_—01551182.1, YP_—002973332.1, ZP_—04681414.1, ZP_—07675148.1, AEH83964.1, YP_—004692042.1, CBJ36337.1, EGP48473.1, ZP_—03585612.1, YP_—001369428.1, YP_—001897527.1, AEG08472.1, YP_—001166065.1, NP_—437018.1, NP_—294689.1, YP_—002541437.1, YP_—004692953.1, NP_—107484.1, YP_—995681.1, YP_—765267.1, YP_—166223.1, ZP_—01740635.1, YP_—001234127.1, ZP_—02186681.1, YP_—004140839.1, YP_—001584499.1, ADI17244.1, ZP_—08698744.1, YP_—001022991.1, EFV84582.1, ZP_—01743515.1, YP_—001816113.1, YP_—004688050.1, YP_—001342912.1, ZP_—01125614.1, EGD05029.1, ZP_—03569823.1, ZP_—05089337.1, YP_—001901091.1, NP_—886663.1, ZP_—07718907.1, YP_—004687387.1, NP_—521464.1, ZP_—06688394.1, ZP_—08099738.1, ZP_—02885452.1, YP_—003744085.1, YP_—001328823.1, ZP_—02488044.1, ZP_—01015005.1, YP_—002983153.1, ZP_—06898725.1, ZP_—05886707.1, ZP_—08101209.1, ZP_—03319462.1, YP_—003134969.1, YP_—001188857.1, YP_—004557767.1, YP_—004675666.1, YP_—004358728.1, YP_—002252541.1, YP_—684009.1, ZP_—05085667.1, ZP_—02144674.1, YP_—004127560.1, ZP_—01901604.1, YP_—004280074.1, AEG67402.1, YP_—001416516.1, ZP_—01054720.1, ZP_—08197897.1, NP_—107235.1, YP_—002909966.1, ZP_—01545876.1, ZP_—02147729.1, ZP_—00946537.1, ZP_—01903844.1, ZP_—05085589.1, ACV84069.1, YP_—367172.1, ZP_—02165272.1, YP_—701696.1, ZP_—04935724.1, ZP_—02191362.1, ZP_—01740154.1, ZP_—07662819.1, NP_—103908.1, YP_—003159313.1, YP_—003197010.1, ZP_—02152342.1, YP_—001907189.1, YP_—004387414.1, YP_—001413869.1, ZP_—01916549.1, ZP_—03264661.1, AAY82840.1, YP_—003277969.1, YP_—767433.1, ZP_—01226234.1, EGE55950.1, NP_—882474.1, ZP_—04680938.1, YP_—004417965.1, ZP_—01367142.1, EGM13684.1, YP_—001262083.1, ZP_—01881606.1, ZP_—01002680.1, YP_—003606679.1, YP_—001868359.1, ZP_—01446736.1, YP_—004141411.1, YP_—002438878.1, YP_—002500414.1, EGP55675.1, ZP_—08405873.1, YP_—002975318.1, YP_—002823637.1, ZP_—02188786.1, YP_—004617386.1, ABL61001.1, YP_—004190679.1, YP_—004418710.1, YP_—001264994.1, NP_—252399.1, ACA21517.1, YP_—002541208.1, YP_—001369943.1, YP_—789454.1, YP_—004688060.1, YP_—611623.1, ZP_—07795086.1, ZP_—04929943.1, YP_—004444316.1, ZP_—01866687.1, ZP_—05973466.1, YP_—004353327.1, ZP_—05780591.1, ZP_—05784784.1, NP_—936564.1, ZP_—05739211.1, ZP_—05113045.1, ZP_—06689273.1, ZP_—06972168.1, ZP_—01616404.1, ZP_—07659253.1, ZP_—05117914.1, YP_—585662.1, YP_—004230016.1, NP_—763554.1, NP_—744101.1, ZP_—02465308.1, ACN56476.1, YP_—004689565.1, YP_—001600608.1, ZP_—06792595.1, YP_—001258553.1, ZP_—05165722.1, ZP_—03785098.1, YP_—002276744.1, YP_—002524856.1, ADP98420.1, YP_—001669248.1, ZP_—04764988.1, ZP_—08528163.1, ZP_—08529409.1, ZP_—05944625.1, YP_—676267.1, CBA26630.1, YP_—001592413.1, YP_—003486465.1, ZP_—02187562.1, ZP_—03702891.1, YP_—760283.1, ZP_—05450850.1, YP_—004533595.1, ZP_—02153313.1, YP_—001859265.1, YP_—001524099.1, ZP_—06126913.1, ZP_—07374926.1, ZP_—05050787.1, ZP_—01035411.1, Q8YFY2.2, YP_—002280903.1, EGM21512.1, YP_—004603010.1, ZP_—05088581.1, YP_—004302488.1, YP_—004141219.1, NP_—697569.1, YP_—003908705.1, YP_—915505.1, YP_—001789228.1, YP_—001042739.1, YP_—133405.1, ZP_—05180516.1, ZP_—05174702.1, ZP_—01438051.1, ZP_—04590345.1, ZP_—08411937.1, NP_—356519.2, ZP_—00964019.1, ZP_—00998343.1, ZP_—05181994.1, YP_—004107969.1, ZP_—02168070.1, ZP_—01750865.1, YP_—574504.1, YP_—004579902.1, YP_—104440.1, ZP_—05452167.1, ZP_—05342702.1, YP_—001862883.1, YP_—004538242.1, ZP_—07471513.1, ZP_—05169558.1, ZP_—00956995.1, ZP_—05096699.1, YP_—004610916.1, ZP_—01218118.1, AAU95210.1, ZP_—02405087.1, ZP_—04890639.1, YP_—352237.1, ZP_—02413594.1, ZP_—07474023.1, NP_—541317.1, YP_—001993222.1, ZP_—08199001.1, YP_—471839.1, ZP_—02492080.1, ZP_—04901176.1, ZP_—06915396.1, ZP_—07474845.1, ZP_—07477743.1, YP_—004152647.1, YP_—004755056.1, ZP_—05086419.1, YP_—004577547.1, ACD99850.1, YP_—980426.1, ZP_—05457072.1, ZP_—05936041.1, NP_—700124.1, ADT85599.1, YP_—110012.1, ZP_—05076113.1, YP_—001068288.1, ZP_—02457871.1, ZP_—01014169.1, EGE60620.1, YP_—001346810.1, YP_—003408795.1, YP_—003769675.1, YP_—001257876.1, EGH93583.1, ZP_—01442222.1, YP_—331617.1, ZP_—05636703.1, YP_—001594896.1, YP_—002822967.1, YP_—118823.1, ZP_—01878717.1, ZP_—07375284.1, YP_—001371250.1, ZP_—07658682.1, YP_—002898825.1, ZP_—01547199.1, YP_—223070.1, ZP_—05161482.1, ZP_—04679742.1, YP_—002778618.1, ZP_—01626756.1, ZP_—05101564.1, YP_—002947374.1, NP_—385053.1, YP_—001328117.1, YP_—004493948.1, YP_—003339515.1, YP_—004699488.1, ZP_—05101969.1, YP_—485352.1, ZP_—01746033.1, ZP_—06712293.1, ZP_—01158125.1, ZP_—01058616.1, ZP_—05739755.1, NP_—949067.1, ZP_—02364657.1, YP_—570690.1, YP_—001208663.1, ZP_—02357557.1, ZP_—04751682.1, YP_—001326253.1, YP_—487666.1, ZP_—05167919.1, ADI18237.1, YP_—002825245.1, ZP_—02144858.1, ZP_—02188790.1, ZP_—06794586.1, YP_—001809828.1, YP_—997974.1, YP_—001476791.1, ZP_—08635286.1, YP_—676287.1, ZP_—07308228.1, ZP_—04596242.1, YP_—001622726.1, NP_—699590.1, ZP_—01446884.1, YP_—001168504.1, ZP_—01616388.1, ZP_—05117189.1, ZP_—05876432.1, ADT64694.1, ZP_—01754911.1, ZP_—05880498.1, ZP_—02360829.1, ZP_—06052433.1, ZP_—08663540.1, YP_—003768966.1, ZP_—02165422.1, ZP_—00960985.1, ZP_—07026655.1, YP_—001753039.1, YP_—371288.1, YP_—002974725.1, YP_—776880.1, ZP_—05784963.1, ZP_—05124380.1, YP_—459030.1, ZP_—05090690.1, ZP_—05064893.1, ZP_—02367982.1, ZP_—01890564.1, NP 541848.1, ZP_—00960263.1, ZP_—02961617.1, YP_—001242097.1, ZP_—05838258.1,in particular000593.1, Q9WWW2.1, ZP_—00957061.1, YP_—957894.1, CAC38030.1, YP_—694430.1, YP_—957725.1, YP_—001672216.1, YP_—552061.1, YP_—130410.1, ZP_—06155535.1, ZP_—01222730.1, YP_—691907.1, YP_—002297804.1, YP_—004283522.1, YP_—001234383.1, YP_—004435031.1, ZP_—05110316.1, ZP_—05042898.1, YP_—004466324.1, ZP_—08553549.1, YP_—004125220.1, ADI22536.1, ADI18461.1, YP_—003810975.1, YP_—662346.1, YP_—004427557.1, YP_—692606.1, ZP_—05043291.1, YP_—440752.1, ZP_—02386160.1, ZP_—04763547.1, ZP_—02361232.1, YP_—003376674.1, ZP_—02354055.1, ZP_—05085930.1, ADQ00130.1, YP_—003643016.1, ZP_—05040520.1, YP_—691922.1, AAX23098.1, BAD07371.1, NP_—104379.1, YP_—002551960.1, YP_—003908558.1, YP_—987903.1, ZP_—05785860.1, YP_—004145612.1, YP_—004140926.1, CAZ88300.1,and especially preferably

Q00593.1, Q9WWW2.1, ZP_—00957061.1, YP_—957894.1, CAC38030.1, YP_—694430.1, YP_—957725.1, YP_—001672216.1.

andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_1d is generally understood in particular as meaning the conversion of dodecan-1-ol into dodecan-1-al or dodecan-1-al into dodecanoic acid.

Specific Enzymes E_1e

Such preferred alcohol dehydrogenases of EC 1.1.1.1 or EC 1.1.1.2 are selected from among

AdhE, AdhP, YjgB, YqhD, GIdA, EutG, YiaY, AdhE, AdhP, YhhX, YahK, HdhA, HisD, SerA, Tdh, Ugd, Udg, Gmd, YefA, YbiC, YdfG, YeaU, TtuC, YeiQ, YgbJ, YgcU, YgcT, YgcV, YggP, YgjR, YliI, YqiB, YzzH, LdhA, GapA, Epd, Dld, GatD, Gcd, GlpA, GlpB, GlpC, GlpD, GpsA and YphC from bacteria, in particular E. coli, andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_1e is generally understood in particular as meaning the conversion of dodecan-1-al into dodecanoic acid.

Specific Enzymes E_1f

Such preferred aldehyde dehydrogenases are selected from among Prr, Usg, MhpF, AstD, GdhA, FrmA, Feab, Asd, Sad, PuuE, GabT, YgaW, BetB, PutA, PuuC, FeaB, AldA, Prr, EutA, GabD, AIdB, TynA and YneI from bacteria, in particular E. coli,

andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_1f is generally understood in particular as meaning the conversion of dodecan-1-al into dodecanoic acid.

Auxiliary Enzymes for E_1a

It is preferred according to the invention that, when the activity of an enzyme E_1a, a eukaryotic P450 alkane hydroxylase, is reduced, the microorganism according to the invention also has an activity of an NADPH-cytochrome P450 oxidoreductase of EC 1.6.2.4 which is reduced in comparison with its wild type. This has the technical effect of the activity of the eukaryotic P450 alkane hydroxylases is reduced further and the product yields of alkan-1-ols, alkan-1-als, alkan-1-amines, alkanes and terminal olefins are increased.

NADPH-cytochrome P450 oxidoreductases of EC 1.6.2.4 catalyse the following reaction: oxidized cytochrome P450+NADPH⁺=reduced cytochrome P450+NADP⁺+H⁺

It is preferred according to the invention that, when the activity of an enzyme E_1a, a prokaryotic P450 alkane hydroxylase, is reduced, the microorganism according to the invention also has an activity of a ferredoxin-NAD(P)⁺ reductase of EC 1.18.1.2 or EC 1.18.1.3 and/or of a ferredoxin which is reduced in comparison with its wild type. This has the technical effect that the activity of the prokaryotic P450 alkane hydroxylase of the CYP_—153 type is reduced further and that the product yields of alkan-1-ols, alkan-1-als, alkan-1-amines, alkanes and terminal olefins are increased.

Ferredoxin-NAD(P)⁺ reductases of EC 1.18.1.2 or EC 1.18.1.3 catalyse the following reaction: oxidized ferredoxin+NAD(P)H+H⁺=reduced ferredoxin+NAD(P)⁺ and are preferably encoded by a gene which is located in the immediate vicinity of a gene of an abovementioned prokaryotic P450 alkane hydroxylase of the CYP_—153 type or of a ferredoxin described in the context of the present invention.

The expression “in the immediate vicinity” means that not more than three other structural genes are located between the genes in question.

Ferredoxins catalyse the following reactions:

alkane hydroxylase+reduced ferredoxin+alkanoic acid (ester)=alkane monoxygenase+oxidized ferredoxin+ω-hydroxyalkanoic acid (ester)+H₂O,alkane hydroxylase+2 reduced ferredoxins+alkanoic acid (ester)=alkane hydroxylase+2 oxidized ferredoxins+ω-oxoalkanoic acid (ester)+2H₂O oralkane hydroxylase+3 reduced ferredoxins+alkanoic acid (ester)=alkane hydroxylase+3 oxidized ferredoxins+ω-carboxyalkanoic acid (ester)+3H₂O andare preferably encoded by a gene which is located in the immediate vicinity of a gene of an abovementioned prokaryotic P450 alkane hydroxylase of the CYP_—153 type or of an abovementioned ferredoxin-NAD(P)⁺ reductase of EC 1.18.1.2 or EC 1.18.1.3. The expression “in the immediate vicinity” means that not more than three other structural genes are located between the genes in question.

Preferred microorganisms have an activity of the ferredoxin-NAD(P)⁺ reductase AlkT and of a ferredoxin which is increased in comparison with their wild type.

Auxiliary Enzymes for E_1b

It is preferred according to the invention that, when the activity of an enzyme E_1b, an AlkB alkane hydroxylase of EC 1.14.15.3, is reduced, the microorganism according to the invention likewise has an activity of an AlkT rubredoxin-NAD(P)⁺ reductase of EC 1.18.1.1 or of EC 1.18.1.4 and/or of a rubredoxin AlkG which is increased in comparison with its wild type. This has the technical effect that the activity of the AlkB alkane hydroxylase is enhanced and the product yields are increased.

AlkT rubredoxin-NAD(P)⁺ reductases of EC 1.18.1.1 or EC 1.18.1.4 catalyse the following reaction:

oxidized rubredoxin+NAD(P)H+H⁺=reduced rubredoxin+NAD(P)⁺ and are preferably encoded by a gene which is located in the immediate vicinity of a gene of an abovementioned AlkB alkane hydroxylase of EC 1.14.15.3 or of a rubredoxin AlkG described in the context of the present invention.

The expression “in the immediate vicinity” means that not more than three other structural genes are located between the genes in question.

Rubredoxins AlkG catalyse the following reactions:

alkane monoxygenase+reduced rubredoxin+alkanoic acid (ester)=alkane monoxygenase+oxidized rubredoxin+ω-hydroxyalkanoic acid (ester)+H₂O, alkane monoxygenase+2 reduced rubredoxins+alkanoic acid (ester)=alkane monoxygenase+2 oxidized rubredoxins+ω-oxoalkanoic acid (ester)+2H₂O oralkane monoxygenase+3 reduced rubredoxins+alkanoic acid (ester)=alkane monoxygenase+3 oxidized rubredoxins+ω-carboxyalkanoic acid (ester)+3H₂O andare preferably encoded by a gene which is located in the immediate vicinity of a gene of an abovementioned AlkB alkane hydroxylase of EC 1.14.15.3 or of an abovementioned AlkT rubredoxin-NAD(P)⁺ reductase of EC 1.18.1.1 or EC 1.18.1.4. The expression “in the immediate vicinity” means that not more than three other structural genes are located between the genes in question.

Preferred microorganisms have an activity of the AlkT rubredoxin-NAD(P)⁺ reductase and of rubredoxin AlkG which is reduced in comparison to their wild type.

Specific Embodiments of Preferred Microorganisms and Enzymes

According to the invention, microorganisms are especially preferably selected from among those which include

a first and a second genetic modification within the meaning of the invention,a first, a second and a fifth genetic modification within the meaning of the invention,a first, a second and a sixth genetic modification within the meaning of the invention,a first, a second and a seventh genetic modification within the meaning of the invention,a first, a second, a fifth and a sixth genetic modification within the meaning of the invention,a first, a second, a fifth and a seventh genetic modification within the meaning of the invention,a first, a second, a sixth and a seventh genetic modification within the meaning of the invention,a first, a second, a fifth, a sixth and a seventh genetic modification within the meaning of the invention,a first, a second and a third genetic modification within the meaning of the invention,a first, a second, a third and a fifth genetic modification within the meaning of the invention,a first, a second, a third and a sixth genetic modification within the meaning of the invention,a first, a second, a third and a seventh genetic modification within the meaning of the invention,a first, a second, a third, a fifth and a sixth genetic modification within the meaning of the invention,a first, a second, a third, a fifth and a seventh genetic modification within the meaning of the invention,a first, a second, a third, a sixth and a seventh genetic modification within the meaning of the invention,a first, a second, a third, a fifth, a sixth and a seventh genetic modification within the meaning of the invention,a first, a second and a fourth genetic modification within the meaning of the invention,a first, a second, a fourth and a fifth genetic modification within the meaning of the invention,a first, a second, a fourth and a sixth genetic modification within the meaning of the invention,a first, a second, a fourth and a seventh genetic modification within the meaning of the invention,a first, a second, a fourth, a fifth and a sixth genetic modification within the meaning of the invention,a first, a second, a fourth, a fifth and a seventh genetic modification within the meaning of the invention,a first, a second, a fourth, a sixth and a seventh genetic modification within the meaning of the invention ora first, a second, a fourth, a fifth, a sixth and a seventh genetic modification within the meaning of the invention.

Microorganisms which are especially preferred according to the invention are those which include a first genetic modification so that they are capable of forming more carboxylic acids and carboxylic acid derivatives from at least one simple carbon source in comparison with their wild type, where the first genetic modification represents an activity of at least one of the enzymes E_i or one of the enzymes with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% amino acid residues are modified by deletion, insertion, substitution or a combination thereof over the sequences specified by references in the table hereinbelow and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90% of the activity of the protein with the respective reference sequence, which activity is increased in comparison with the enzymatic activity of the wild type of the microorganism and where activity in this context and in the context of the determination of the activity of the enzyme E_i generally means in particular the hydrolysis of dodecanoyl-ACP thioester with the carbon chain length assigned to the individual enzymes E_i in the table hereinbelow

and the carboxylic acid and carboxylic acid derivatives have a carbon chain length of the carboxylic acid moiety as represented in the table hereinbelow:

Enzyme Ei selected from among    Carbon chain length
AAC49269.1, CAB60830.1, AAC49179.1, C8
AAC49784.1, ABB71579.1, CAC19934.1
and SEQ ID No.: 26, 29, 33, 38, 40, 97 and
99 of WO2011008565
AAC49269.1, CAB60830.1, AAC49179.1, C10
AAC49784.1, ABB71579.1, CAC19934.1
and SEQ ID No.: 73, 75, 87 and 89 of
WO2011008565.
Q41635.1, Q39473.1, AAC49180.1,  C12
CAC19934.1, AAC72881.1, AAC49783.1,
AAC49784.1 and SEQ ID No.: 49 and 51 of
WO2011008565.
Q41635.1, Q39473.1, AAC49180.1,  C14
CAC19934.1, AAC72881.1 AAC49783.1,
AAC49784.1 and SEQ ID No.: 49, 51, 53,
55, 61, 63, 67, 69, 77, 79, 83 and 85 of
WO2011008565.

The abovementioned deletions of amino acid residues over the sequences specified by references in the table hereinabove refer in particular to deletions at the N- and/or C-terminus, in particular the N-terminus. The abovementioned N-terminus is especially preferably that of a plant plastid targeting sequence. Such plant plastid targeting sequences can be predicted for example with the aid of the algorithms employed by the prediction tool TargetP 1.1 (www.cbs.dtu.dk/services/TargetP/) and described in the following publications, preferably without using cutoffs:

Predicting Subcellular Localization of Proteins Based on their N-Terminal Amino Acid Sequence.

Olof Emanuelsson, Henrik Nielsen, Søren Brunak and Gunnar von Heijne.

J. Mol. Biol., 300: 1005-1016, 2000 and Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Henrik Nielsen, Jacob Engelbrecht, Soren Brunak and Gunnar von Heijne. Protein Engineering, 10:1-6, 1997.

Microorganisms (abbreviated to MO) which are very especially preferred according to the invention are outstandingly suitable for the production of carboxylic acids and have increased or reduced enzymatic activities (abbreviated to E) which are described in the table hereinbelow, it being possible for these enzymatic activities additionally to be advantageously combined with an enzymatic activity described for the enzyme 3-ketoacyl-ACP (acyl carrier protein) synthase III (EC 2.3.1.41), which enzymatic activity is increased in comparison with the wild type of the microorganism, in particular the enzymatic activity of plants, preferably the enzymatic activity of plants whose seeds contain fatty acids with alkyl residues shorter than 14 C atoms and especially preferably the enzymatic activity of plants of the genera Cuphea, Elaeis, Cocos, Umbellularia and Cinnamomum and gene products selected from among AccA, AccB, AccC, AccD, AceE, AceF, Lpd, AcpP, FabA, FabB, FabD, FabF, FabG, FabH, FabI, FabZ, PanD, PanK, UdhA, PntA or PntB.

Any desired combinations of at least two of these enzymatic activities may advantageously be increased.

It may be additionally advantageous that the microorganism is equipped with an enzymatic activity which is described for the gene products selected from among TdcE, PflA, PflB, PflC, PfID, PoxB, YgfG, AckA, AckB, TdcD, Pta, LdhA, AdhE, MgsA, FdnG, FdnH, FdnI, FdhF, FdoG, FdoH, FdoI, PrpC, PrpD, PrpF, PrpB, TdcD, Pdc, PorA, PorB, PorC, PorD, AlsS, IlvB, IlvM, IlvN, IlvG, IlyI, IlvH, AlsD, ButB, Thl, ThlA, ThlB, PhaA, PhaB, Crt, BdhA, BdhB, Adc, Adh, CtfB, AtoA, AtoD, LdhL, GltA, FabR, FhuA, Dld, LldA or LldP, individually or in any desired combination, and which is reduced in comparison with the wild type of the microorganism.

MO	Increased E	Reduced E
1	AlkL
2	AlkLEi
3	AlkLEii
4	AlkLEiiEiib
5	AlkLEiii
6	AlkLEiv
7	AlkL	Ea
8	AlkLEi	Ea
9	AlkLEii	Ea
10	AlkLEiiEiib	Ea
11	AlkLEiii	Ea
12	AlkLEiv	Ea
13	AlkL	Eb
14	AlkLEi	Eb
15	AlkLEii	Eb
16	AlkLEiiEiib	Eb
17	AlkLEiii	Eb
18	AlkLEiv	Eb
19	AlkL	Ed
20	AlkLEi	Ed
21	AlkLEii	Ed
22	AlkLEiiEiib	Ed
23	AlkLEiii	Ed
24	AlkLEiv	Ed
25	AlkL	Ee
26	AlkLEi	Ee
27	AlkLEii	Ee
28	AlkLEiiEiib	Ee
29	AlkLEiii	Ee
30	AlkLEiv	Ee
31	AlkL	Ef
32	AlkLEi	Ef
33	AlkLEii	Ef
34	AlkLEiiEiib	Ef
35	AlkLEiii	Ef
36	AlkLEiv	Ef
37	AlkL		E1
38	AlkLEi		E1
39	AlkLEii		E1
40	AlkLEiiEiib		E1
41	AlkLEiii		E1
42	AlkLEiv		E1
43	AlkL	Ea	E1
44	AlkLEi	Ea	E1
45	AlkLEii	Ea	E1
46	AlkLEiiEiib	Ea	E1
47	AlkLEiii	Ea	E1
48	AlkLEiv	Ea	E1
49	AlkL	Eb	E1
50	AlkLEi	Eb	E1
51	AlkLEii	Eb	E1
52	AlkLEiiEiib	Eb	E1
53	AlkLEiii	Eb	E1
54	AlkLEiv	Eb	E1
55	AlkL	Ed	E1
56	AlkLEi	Ed	E1
57	AlkLEii	Ed	E1
58	AlkLEiiEiib	Ed	E1
59	AlkLEiii	Ed	E1
60	AlkLEiv	Ed	E1
61	AlkL	Ee	E1
62	AlkLEi	Ee	E1
63	AlkLEii	Ee	E1
64	AlkLEiiEiib	Ee	E1
65	AlkLEiii	Ee	E1
66	AlkLEiv	Ee	E1
67	AlkL	Ef	E1
68	AlkLEi	Ef	E1
69	AlkLEii	Ef	E1
70	AlkLEiiEiib	Ef	E1
71	AlkLEiii	Ef	E1
72	AlkLEiv	Ef	E1

Microorganisms (abbreviated to MO) which are very especially preferred according to the invention are outstandingly suitable for the production of carboxylic acid esters and have increased or reduced enzymatic activities (abbreviated to E) which are described in the table hereinbelow, it being possible for these enzymatic activities additionally to be advantageously combined with an enzymatic activity described for the enzyme 3-ketoacyl-ACP (acyl carrier protein) synthase III (EC 2.3.1.41), which enzymatic activity is increased in comparison with the wild type of the microorganism, in particular the enzymatic activity of plants, preferably the enzymatic activity of plants whose seeds contain fatty acids with alkyl residues shorter than 14 C atoms and especially preferably the enzymatic activity of plants of the genera Cuphea, Elaeis, Cocos, Umbellularia and Cinnamomum and gene products selected from among AccA, AccB, AccC, AccD, AceE, AceF, Lpd, AcpP, FabA, FabB, FabD, FabF, FabG, FabH, FabI, FabZ, PanD, PanK, UdhA, PntA or PntB.

Any desired combinations of at least two of these enzymatic activities may advantageously be increased.

It may be additionally advantageous that the microorganism is equipped with an enzymatic activity which is described for the gene products selected from among TdcE, PflA, PflB, PflC, PfID, PoxB, YgfG, AckA, AckB, TdcD, Pta, LdhA, AdhE, MgsA, FdnG, FdnH, FdnI, FdhF, FdoG, FdoH, FdoI, PrpC, PrpD, PrpF, PrpB, TdcD, Pdc, PorA, PorB, PorC, PorD, AlsS, IlvB, IlvM, IlvN, IlvG, IlyI, IlvH, AlsD, ButB, Thl, ThlA, ThlB, PhaA, PhaB, Crt, BdhA, BdhB, Adc, Adh, CtfB, AtoA, AtoD, LdhL, GltA, FabR, FhuA, Dld, LldA or LldP, individually or in any desired combination, and which is reduced in comparison with the wild type of the microorganism.

MO	Increased E	Reduced E
1	AlkL	Ev
2	AlkLEi	Ev
3	AlkLEii	Ev
4	AlkLEiiEiib	Ev
5	AlkLEiii	Ev
6	AlkLEiv	Ev
7	AlkL	Ev	Ea
8	AlkLEi	Ev	Ea
9	AlkLEii	Ev	Ea
10	AlkLEiiEiib	Ev	Ea
11	AlkLEiii	Ev	Ea
12	AlkLEiv	Ev	Ea
13	AlkL	Ev	Eb
14	AlkLEi	Ev	Eb
15	AlkLEii	Ev	Eb
16	AlkLEiiEiib	Ev	Eb
17	AlkLEiii	Ev	Eb
18	AlkLEiv	Ev	Eb
19	AlkL	Ev	Ed
20	AlkLEi	Ev	Ed
21	AlkLEii	Ev	Ed
22	AlkLEiiEiib	Ev	Ed
23	AlkLEiii	Ev	Ed
24	AlkLEiv	Ev	Ed
25	AlkL	Ev	Ee
26	AlkLEi	Ev	Ee
27	AlkLEii	Ev	Ee
28	AlkLEiiEiib	Ev	Ee
29	AlkLEiii	Ev	Ee
30	AlkLEiv	Ev	Ee
31	AlkL	Ev	Ef
32	AlkLEi	Ev	Ef
33	AlkLEii	Ev	Ef
34	AlkLEiiEiib	Ev	Ef
35	AlkLEiii	Ev	Ef
36	AlkLEiv	Ev	Ef
37	AlkL	EvEvi
38	AlkLEi	EvEvi
39	AlkLEii	EvEvi
40	AlkLEiiEiib	EvEvi
41	AlkLEiii	EvEvi
42	AlkLEiv	EvEvi
43	AlkL	EvEvi	Ea
44	AlkLEi	EvEvi	Ea
45	AlkLEii	EvEvi	Ea
46	AlkLEiiEiib	EvEvi	Ea
47	AlkLEiii	EvEvi	Ea
48	AlkLEiv	EvEvi	Ea
49	AlkL	EvEvi	Eb
50	AlkLEi	EvEvi	Eb
51	AlkLEii	EvEvi	Eb
52	AlkLEiiEiib	EvEvi	Eb
53	AlkLEiii	EvEvi	Eb
54	AlkLEiv	EvEvi	Eb
55	AlkL	EvEvi	Ed
56	AlkLEi	EvEvi	Ed
57	AlkLEii	EvEvi	Ed
58	AlkLEiiEiib	EvEvi	Ed
59	AlkLEiii	EvEvi	Ed
60	AlkLEiv	EvEvi	Ed
61	AlkL	EvEvi	Ee
62	AlkLEi	EvEvi	Ee
63	AlkLEii	EvEvi	Ee
64	AlkLEiiEiib	EvEvi	Ee
65	AlkLEiii	EvEvi	Ee
66	AlkLEiv	EvEvi	Ee
67	AlkL	EvEvi	Ef
68	AlkLEi	EvEvi	Ef
69	AlkLEii	EvEvi	Ef
70	AlkLEiiEiib	EvEvi	Ef
71	AlkLEiii	EvEvi	Ef
72	AlkLEiv	EvEvi	Ef
73	AlkL	Evii
74	AlkLEi	Evii
75	AlkLEii	Evii
76	AlkLEiiEiib	Evii
77	AlkLEiii	Evii
78	AlkLEiv	Evii
79	AlkL	Evii	Ea
80	AlkLEi	Evii	Ea
81	AlkLEii	Evii	Ea
82	AlkLEiiEiib	Evii	Ea
83	AlkLEiii	Evii	Ea
84	AlkLEiv	Evii	Ea
85	AlkL	Evii	Eb
86	AlkLEi	Evii	Eb
87	AlkLEii	Evii	Eb
88	AlkLEiiEiib	Evii	Eb
89	AlkLEiii	Evii	Eb
90	AlkLEiv	Evii	Eb
91	AlkL	Evii	Ed
92	AlkLEi	Evii	Ed
93	AlkLEii	Evii	Ed
94	AlkLEiiEiib	Evii	Ed
95	AlkLEiii	Evii	Ed
96	AlkLEiv	Evii	Ed
97	AlkL	Evii	Ee
98	AlkLEi	Evii	Ee
99	AlkLEii	Evii	Ee
100	AlkLEiiEiib	Evii	Ee
101	AlkLEiii	Evii	Ee
102	AlkLEiv	Evii	Ee
103	AlkL	Evii	Ef
104	AlkLEi	Evii	Ef
105	AlkLEii	Evii	Ef
106	AlkLEiiEiib	Evii	Ef
107	AlkLEiii	Evii	Ef
108	AlkLEiv	Evii	Ef
109	AlkL	EviEvii
110	AlkLEi	EviEvii
111	AlkLEii	EviEvii
112	AlkLEiiEiib	EviEvii
113	AlkLEiii	EviEvii
114	AlkLEiv	EviEvii
115	AlkL	EviEvii	Ea
116	AlkLEi	EviEvii	Ea
117	AlkLEii	EviEvii	Ea
118	AlkLEiiEiib	EviEvii	Ea
119	AlkLEiii	EviEvii	Ea
120	AlkLEiv	EviEvii	Ea
121	AlkL	EviEvii	Eb
122	AlkLEi	EviEvii	Eb
123	AlkLEii	EviEvii	Eb
124	AlkLEiiEiib	EviEvii	Eb
125	AlkLEiii	EviEvii	Eb
126	AlkLEiv	EviEvii	Eb
127	AlkL	EviEvii	Ed
128	AlkLEi	EviEvii	Ed
129	AlkLEii	EviEvii	Ed
130	AlkLEiiEiib	EviEvii	Ed
131	AlkLEiii	EviEvii	Ed
132	AlkLEiv	EviEvii	Ed
133	AlkL	EviEvii	Ee
134	AlkLEi	EviEvii	Ee
135	AlkLEii	EviEvii	Ee
136	AlkLEiiEiib	EviEvii	Ee
137	AlkLEiii	EviEvii	Ee
138	AlkLEiv	EviEvii	Ee
139	AlkL	EviEvii	Ef
140	AlkLEi	EviEvii	Ef
141	AlkLEii	EviEvii	Ef
142	AlkLEiiEiib	EviEvii	Ef
143	AlkLEiii	EviEvii	Ef
144	AlkLEiv	EviEvii	Ef
145	AlkL	EiibEviEvii
146	AlkLEi	EiibEviEvii
147	AlkLEii	EiibEviEvii
148	AlkLEiiEiib	EiibEviEvii
149	AlkLEiii	EiibEviEvii
150	AlkLEiv	EiibEviEvii
151	AlkL	EiibEviEvii	Ea
152	AlkLEi	EiibEviEvii	Ea
153	AlkLEii	EiibEviEvii	Ea
154	AlkLEiiEiib	EiibEviEvii	Ea
155	AlkLEiii	EiibEviEvii	Ea
156	AlkLEiv	EiibEviEvii	Ea
157	AlkL	EiibEviEvii	Eb
158	AlkLEi	EiibEviEvii	Eb
159	AlkLEii	EiibEviEvii	Eb
160	AlkLEiiEiib	EiibEviEvii	Eb
161	AlkLEiii	EiibEviEvii	Eb
162	AlkLEiv	EiibEviEvii	Eb
163	AlkL	EiibEviEvii	Ed
164	AlkLEi	EiibEviEvii	Ed
165	AlkLEii	EiibEviEvii	Ed
166	AlkLEiiEiib	EiibEviEvii	Ed
167	AlkLEiii	EiibEviEvii	Ed
168	AlkLEiv	EiibEviEvii	Ed
169	AlkL	EiibEviEvii	Ee
170	AlkLEi	EiibEviEvii	Ee
171	AlkLEii	EiibEviEvii	Ee
172	AlkLEiiEiib	EiibEviEvii	Ee
173	AlkLEiii	EiibEviEvii	Ee
174	AlkLEiv	EiibEviEvii	Ee
175	AlkL	EiibEviEvii	Ef
176	AlkLEi	EiibEviEvii	Ef
177	AlkLEii	EiibEviEvii	Ef
178	AlkLEiiEiib	EiibEviEvii	Ef
179	AlkLEiii	EiibEviEvii	Ef
180	AlkLEiv	EiibEviEvii	Ef
181	AlkL	Ev		E1
182	AlkLEi	Ev		E1
183	AlkLEii	Ev		E1
184	AlkLEiiEiib	Ev		E1
185	AlkLEiii	Ev		E1
186	AlkLEiv	Ev		E1
187	AlkL	Ev	Ea	E1
188	AlkLEi	Ev	Ea	E1
189	AlkLEii	Ev	Ea	E1
190	AlkLEiiEiib	Ev	Ea	E1
191	AlkLEiii	Ev	Ea	E1
192	AlkLEiv	Ev	Ea	E1
193	AlkL	Ev	Eb	E1
194	AlkLEi	Ev	Eb	E1
195	AlkLEii	Ev	Eb	E1
196	AlkLEiiEiib	Ev	Eb	E1
197	AlkLEiii	Ev	Eb	E1
198	AlkLEiv	Ev	Eb	E1
199	AlkL	Ev	Ed	E1
200	AlkLEi	Ev	Ed	E1
201	AlkLEii	Ev	Ed	E1
202	AlkLEiiEiib	Ev	Ed	E1
203	AlkLEiii	Ev	Ed	E1
204	AlkLEiv	Ev	Ed	E1
205	AlkL	Ev	Ee	E1
206	AlkLEi	Ev	Ee	E1
207	AlkLEii	Ev	Ee	E1
208	AlkLEiiEiib	Ev	Ee	E1
209	AlkLEiii	Ev	Ee	E1
210	AlkLEiv	Ev	Ee	E1
211	AlkL	Ev	Ef	E1
212	AlkLEi	Ev	Ef	E1
213	AlkLEii	Ev	Ef	E1
214	AlkLEiiEiib	Ev	Ef	E1
215	AlkLEiii	Ev	Ef	E1
216	AlkLEiv	Ev	Ef	E1
217	AlkL	EvEvi		E1
218	AlkLEi	EvEvi		E1
219	AlkLEii	EvEvi		E1
220	AlkLEiiEiib	EvEvi		E1
221	AlkLEiii	EvEvi		E1
222	AlkLEiv	EvEvi		E1
223	AlkL	EvEvi	Ea	E1
224	AlkLEi	EvEvi	Ea	E1
225	AlkLEii	EvEvi	Ea	E1
226	AlkLEiiEiib	EvEvi	Ea	E1
227	AlkLEiii	EvEvi	Ea	E1
228	AlkLEiv	EvEvi	Ea	E1
229	AlkL	EvEvi	Eb	E1
230	AlkLEi	EvEvi	Eb	E1
231	AlkLEii	EvEvi	Eb	E1
232	AlkLEiiEiib	EvEvi	Eb	E1
233	AlkLEiii	EvEvi	Eb	E1
234	AlkLEiv	EvEvi	Eb	E1
235	AlkL	EvEvi	Ed	E1
236	AlkLEi	EvEvi	Ed	E1
237	AlkLEii	EvEvi	Ed	E1
238	AlkLEiiEiib	EvEvi	Ed	E1
239	AlkLEiii	EvEvi	Ed	E1
240	AlkLEiv	EvEvi	Ed	E1
241	AlkL	EvEvi	Ee	E1
242	AlkLEi	EvEvi	Ee	E1
243	AlkLEii	EvEvi	Ee	E1
244	AlkLEiiEiib	EvEvi	Ee	E1
245	AlkLEiii	EvEvi	Ee	E1
246	AlkLEiv	EvEvi	Ee	E1
247	AlkL	EvEvi	Ef	E1
248	AlkLEi	EvEvi	Ef	E1
249	AlkLEii	EvEvi	Ef	E1
250	AlkLEiiEiib	EvEvi	Ef	E1
251	AlkLEiii	EvEvi	Ef	E1
252	AlkLEiv	EvEvi	Ef	E1
253	AlkL	Evii		E1
254	AlkLEi	Evii		E1
255	AlkLEii	Evii		E1
256	AlkLEiiEiib	Evii		E1
257	AlkLEiii	Evii		E1
258	AlkLEiv	Evii		E1
259	AlkL	Evii	Ea	E1
260	AlkLEi	Evii	Ea	E1
261	AlkLEii	Evii	Ea	E1
262	AlkLEiiEiib	Evii	Ea	E1
263	AlkLEiii	Evii	Ea	E1
264	AlkLEiv	Evii	Ea	E1
265	AlkL	Evii	Eb	E1
266	AlkLEi	Evii	Eb	E1
267	AlkLEii	Evii	Eb	E1
268	AlkLEiiEiib	Evii	Eb	E1
269	AlkLEiii	Evii	Eb	E1
270	AlkLEiv	Evii	Eb	E1
271	AlkL	Evii	Ed	E1
272	AlkLEi	Evii	Ed	E1
273	AlkLEii	Evii	Ed	E1
274	AlkLEiiEiib	Evii	Ed	E1
275	AlkLEiii	Evii	Ed	E1
276	AlkLEiv	Evii	Ed	E1
277	AlkL	Evii	Ee	E1
278	AlkLEi	Evii	Ee	E1
279	AlkLEii	Evii	Ee	E1
280	AlkLEiiEiib	Evii	Ee	E1
281	AlkLEiii	Evii	Ee	E1
282	AlkLEiv	Evii	Ee	E1
283	AlkL	Evii	Ef	E1
284	AlkLEi	Evii	Ef	E1
285	AlkLEii	Evii	Ef	E1
286	AlkLEiiEiib	Evii	Ef	E1
287	AlkLEiii	Evii	Ef	E1
288	AlkLEiv	Evii	Ef	E1
289	AlkL	EviEvii		E1
290	AlkLEi	EviEvii		E1
291	AlkLEii	EviEvii		E1
292	AlkLEiiEiib	EviEvii		E1
293	AlkLEiii	EviEvii		E1
294	AlkLEiv	EviEvii		E1
295	AlkL	EviEvii	Ea	E1
296	AlkLEi	EviEvii	Ea	E1
297	AlkLEii	EviEvii	Ea	E1
298	AlkLEiiEiib	EviEvii	Ea	E1
299	AlkLEiii	EviEvii	Ea	E1
300	AlkLEiv	EviEvii	Ea	E1
301	AlkL	EviEvii	Eb	E1
302	AlkLEi	EviEvii	Eb	E1
303	AlkLEii	EviEvii	Eb	E1
304	AlkLEiiEiib	EviEvii	Eb	E1
305	AlkLEiii	EviEvii	Eb	E1
306	AlkLEiv	EviEvii	Eb	E1
307	AlkL	EviEvii	Ed	E1
308	AlkLEi	EviEvii	Ed	E1
309	AlkLEii	EviEvii	Ed	E1
310	AlkLEiiEiib	EviEvii	Ed	E1
311	AlkLEiii	EviEvii	Ed	E1
312	AlkLEiv	EviEvii	Ed	E1
313	AlkL	EviEvii	Ee	E1
314	AlkLEi	EviEvii	Ee	E1
315	AlkLEii	EviEvii	Ee	E1
316	AlkLEiiEiib	EviEvii	Ee	E1
317	AlkLEiii	EviEvii	Ee	E1
318	AlkLEiv	EviEvii	Ee	E1
319	AlkL	EviEvii	Ef	E1
320	AlkLEi	EviEvii	Ef	E1
321	AlkLEii	EviEvii	Ef	E1
322	AlkLEiiEiib	EviEvii	Ef	E1
323	AlkLEiii	EviEvii	Ef	E1
324	AlkLEiv	EviEvii	Ef	E1
325	AlkL	EiibEviEvii		E1
326	AlkLEi	EiibEviEvii		E1
327	AlkLEii	EiibEviEvii		E1
328	AlkLEiiEiib	EiibEviEvii		E1
329	AlkLEiii	EiibEviEvii		E1
330	AlkLEiv	EiibEviEvii		E1
331	AlkL	EiibEviEvii	Ea	E1
332	AlkLEi	EiibEviEvii	Ea	E1
333	AlkLEii	EiibEviEvii	Ea	E1
334	AlkLEiiEiib	EiibEviEvii	Ea	E1
335	AlkLEiii	EiibEviEvii	Ea	E1
336	AlkLEiv	EiibEviEvii	Ea	E1
337	AlkL	EiibEviEvii	Eb	E1
338	AlkLEi	EiibEviEvii	Eb	E1
339	AlkLEii	EiibEviEvii	Eb	E1
340	AlkLEiiEiib	EiibEviEvii	Eb	E1
341	AlkLEiii	EiibEviEvii	Eb	E1
342	AlkLEiv	EiibEviEvii	Eb	E1
343	AlkL	EiibEviEvii	Ed	E1
344	AlkLEi	EiibEviEvii	Ed	E1
345	AlkLEii	EiibEviEvii	Ed	E1
346	AlkLEiiEiib	EiibEviEvii	Ed	E1
347	AlkLEiii	EiibEviEvii	Ed	E1
348	AlkLEiv	EiibEviEvii	Ed	E1
349	AlkL	EiibEviEvii	Ee	E1
350	AlkLEi	EiibEviEvii	Ee	E1
351	AlkLEii	EiibEviEvii	Ee	E1
352	AlkLEiiEiib	EiibEviEvii	Ee	E1
353	AlkLEiii	EiibEviEvii	Ee	E1
354	AlkLEiv	EiibEviEvii	Ee	E1
355	AlkL	EiibEviEvii	Ef	E1
356	AlkLEi	EiibEviEvii	Ef	E1
357	AlkLEii	EiibEviEvii	Ef	E1
358	AlkLEiiEiib	EiibEviEvii	Ef	E1
359	AlkLEiii	EiibEviEvii	Ef	E1
360	AlkLEiv	EiibEviEvii	Ef	E1

Microorganisms (abbreviated to MO) which are very especially preferred according to the invention are outstandingly suitable for the production of alkan-1-ols and alkan-1-als and have increased or reduced enzymatic activities (abbreviated to E) which are described in the table hereinbelow, it being possible for these enzymatic activities additionally to be advantageously combined with an enzymatic activity described for the 3-ketoacyl-ACP (acyl carrier protein) synthase III (EC 2.3.1.41), which enzymatic activity is increased in comparison with the wild type of the microorganism, in particular the enzymatic activity of plants, preferably the enzymatic activity of plants whose seeds contain fatty acids with alkyl residues shorter than 14 C atoms and especially preferably the enzymatic activity of plants of the genera Cuphea, Elaeis, Cocos, Umbellularia and Cinnamomum and gene products selected from among AccA, AccB, AccC, AccD, AceE, AceF, Lpd, AcpP, FabA, FabB, FabD, FabF, FabG, FabH, FabI, FabZ, PanD, PanK, UdhA, PntA or PntB.

Any desired combinations of at least two of these enzymatic activities may advantageously be increased.

It may be additionally advantageous that the microorganism is equipped with an enzymatic activity which is described for the gene products selected from among TdcE, PflA, PflB, PflC, PflD, PoxB, YgfG, AckA, AckB, TdcD, Pta, LdhA, AdhE, MgsA, FdnG, FdnH, FdnI, FdhF, FdoG, FdoH, FdoI, PrpC, PrpD, PrpF, PrpB, TdcD, Pdc, PorA, PorB, PorC, PorD, AlsS, IlvB, IlvM, IlvN, IlvG, IlyI, IlvH, AlsD, ButB, Thl, ThlA, ThlB, PhaA, PhaB, Crt, BdhA, BdhB, Adc, Adh, CtfB, AtoA, AtoD, LdhL, GltA, FabR, FhuA, Dld, LldA or LldP, individually or in any desired combination, and which is reduced in comparison with the wild type of the microorganism.

MO	Increased E	Reduced E
1	AlkL	Eviii
2	AlkLEi	Eviii
3	AlkLEii	Eviii
4	AlkLEiiEiib	Eviii
5	AlkLEiii	Eviii
6	AlkLEiv	Eviii
7	AlkL	Eviii	Ea
8	AlkLEi	Eviii	Ea
9	AlkLEii	Eviii	Ea
10	AlkLEiiEiib	Eviii	Ea
11	AlkLEiii	Eviii	Ea
12	AlkLEiv	Eviii	Ea
13	AlkL	Eviii	Eb
14	AlkLEi	Eviii	Eb
15	AlkLEii	Eviii	Eb
16	AlkLEiiEiib	Eviii	Eb
17	AlkLEiii	Eviii	Eb
18	AlkLEiv	Eviii	Eb
19	AlkL	Eviii	Ed
20	AlkLEi	Eviii	Ed
21	AlkLEii	Eviii	Ed
22	AlkLEiiEiib	Eviii	Ed
23	AlkLEiii	Eviii	Ed
24	AlkLEiv	Eviii	Ed
25	AlkL	Eviii	Ee
26	AlkLEi	Eviii	Ee
27	AlkLEii	Eviii	Ee
28	AlkLEiiEiib	Eviii	Ee
29	AlkLEiii	Eviii	Ee
30	AlkLEiv	Eviii	Ee
31	AlkL	Eviii	Ef
32	AlkLEi	Eviii	Ef
33	AlkLEii	Eviii	Ef
34	AlkLEiiEiib	Eviii	Ef
35	AlkLEiii	Eviii	Ef
36	AlkLEiv	Eviii	Ef
37	AlkL	Eix
38	AlkLEi	Eix
39	AlkLEii	Eix
40	AlkLEiiEiib	Eix
41	AlkLEiii	Eix
42	AlkLEiv	Eix
43	AlkL	Eix	Ea
44	AlkLEi	Eix	Ea
45	AlkLEii	Eix	Ea
46	AlkLEiiEiib	Eix	Ea
47	AlkLEiii	Eix	Ea
48	AlkLEiv	Eix	Ea
49	AlkL	Eix	Eb
50	AlkLEi	Eix	Eb
51	AlkLEii	Eix	Eb
52	AlkLEiiEiib	Eix	Eb
53	AlkLEiii	Eix	Eb
54	AlkLEiv	Eix	Eb
55	AlkL	Eix	Ed
56	AlkLEi	Eix	Ed
57	AlkLEii	Eix	Ed
58	AlkLEiiEiib	Eix	Ed
59	AlkLEiii	Eix	Ed
60	AlkLEiv	Eix	Ed
61	AlkL	Eix	Ee
62	AlkLEi	Eix	Ee
63	AlkLEii	Eix	Ee
64	AlkLEiiEiib	Eix	Ee
65	AlkLEiii	Eix	Ee
66	AlkLEiv	Eix	Ee
67	AlkL	Eix	Ef
68	AlkLEi	Eix	Ef
69	AlkLEii	Eix	Ef
70	AlkLEiiEiib	Eix	Ef
71	AlkLEiii	Eix	Ef
72	AlkLEiv	Eix	Ef
73	AlkL	Ex
74	AlkLEi	Ex
75	AlkLEii	Ex
76	AlkLEiiEiib	Ex
77	AlkLEiii	Ex
78	AlkLEiv	Ex
79	AlkL	Ex	Ea
80	AlkLEi	Ex	Ea
81	AlkLEii	Ex	Ea
82	AlkLEiiEiib	Ex	Ea
83	AlkLEiii	Ex	Ea
84	AlkLEiv	Ex	Ea
85	AlkL	Ex	Eb
86	AlkLEi	Ex	Eb
87	AlkLEii	Ex	Eb
88	AlkLEiiEiib	Ex	Eb
89	AlkLEiii	Ex	Eb
90	AlkLEiv	Ex	Eb
91	AlkL	Ex	Ed
92	AlkLEi	Ex	Ed
93	AlkLEii	Ex	Ed
94	AlkLEiiEiib	Ex	Ed
95	AlkLEiii	Ex	Ed
96	AlkLEiv	Ex	Ed
97	AlkL	Ex	Ee
98	AlkLEi	Ex	Ee
99	AlkLEii	Ex	Ee
100	AlkLEiiEiib	Ex	Ee
101	AlkLEiii	Ex	Ee
102	AlkLEiv	Ex	Ee
103	AlkL	Ex	Ef
104	AlkLEi	Ex	Ef
105	AlkLEii	Ex	Ef
106	AlkLEiiEiib	Ex	Ef
107	AlkLEiii	Ex	Ef
108	AlkLEiv	Ex	Ef
109	AlkL	EviEviii
110	AlkLEi	EviEviii
111	AlkLEii	EviEviii
112	AlkLEiiEiib	EviEviii
113	AlkLEiii	EviEviii
114	AlkLEiv	EviEviii
115	AlkL	EviEviii	Ea
116	AlkLEi	EviEviii	Ea
117	AlkLEii	EviEviii	Ea
118	AlkLEiiEiib	EviEviii	Ea
119	AlkLEiii	EviEviii	Ea
120	AlkLEiv	EviEviii	Ea
121	AlkL	EviEviii	Eb
122	AlkLEi	EviEviii	Eb
123	AlkLEii	EviEviii	Eb
124	AlkLEiiEiib	EviEviii	Eb
125	AlkLEiii	EviEviii	Eb
126	AlkLEiv	EviEviii	Eb
127	AlkL	EviEviii	Ed
128	AlkLEi	EviEviii	Ed
129	AlkLEii	EviEviii	Ed
130	AlkLEiiEiib	EviEviii	Ed
131	AlkLEiii	EviEviii	Ed
132	AlkLEiv	EviEviii	Ed
133	AlkL	EviEviii	Ee
134	AlkLEi	EviEviii	Ee
135	AlkLEii	EviEviii	Ee
136	AlkLEiiEiib	EviEviii	Ee
137	AlkLEiii	EviEviii	Ee
138	AlkLEiv	EviEviii	Ee
139	AlkL	EviEviii	Ef
140	AlkLEi	EviEviii	Ef
141	AlkLEii	EviEviii	Ef
142	AlkLEiiEiib	EviEviii	Ef
143	AlkLEiii	EviEviii	Ef
144	AlkLEiv	EviEviii	Ef
145	AlkL	EiibEviEx
146	AlkLEi	EiibEviEx
147	AlkLEii	EiibEviEx
148	AlkLEiiEiib	EiibEviEx
149	AlkLEiii	EiibEviEx
150	AlkLEiv	EiibEviEx
151	AlkL	EiibEviEx	Ea
152	AlkLEi	EiibEviEx	Ea
153	AlkLEii	EiibEviEx	Ea
154	AlkLEiiEiib	EiibEviEx	Ea
155	AlkLEiii	EiibEviEx	Ea
156	AlkLEiv	EiibEviEx	Ea
157	AlkL	EiibEviEx	Eb
158	AlkLEi	EiibEviEx	Eb
159	AlkLEii	EiibEviEx	Eb
160	AlkLEiiEiib	EiibEviEx	Eb
161	AlkLEiii	EiibEviEx	Eb
162	AlkLEiv	EiibEviEx	Eb
163	AlkL	EiibEviEx	Ed
164	AlkLEi	EiibEviEx	Ed
165	AlkLEii	EiibEviEx	Ed
166	AlkLEiiEiib	EiibEviEx	Ed
167	AlkLEiii	EiibEviEx	Ed
168	AlkLEiv	EiibEviEx	Ed
169	AlkL	EiibEviEx	Ee
170	AlkLEi	EiibEviEx	Ee
171	AlkLEii	EiibEviEx	Ee
172	AlkLEiiEiib	EiibEviEx	Ee
173	AlkLEiii	EiibEviEx	Ee
174	AlkLEiv	EiibEviEx	Ee
175	AlkL	EiibEviEx	Ef
176	AlkLEi	EiibEviEx	Ef
177	AlkLEii	EiibEviEx	Ef
178	AlkLEiiEiib	EiibEviEx	Ef
179	AlkLEiii	EiibEviEx	Ef
180	AlkLEiv	EiibEviEx	Ef
181	AlkL	Eviii		E1
182	AlkLEi	Eviii		E1
183	AlkLEii	Eviii		E1
184	AlkLEiiEiib	Eviii		E1
185	AlkLEiii	Eviii		E1
186	AlkLEiv	Eviii		E1
187	AlkL	Eviii	Ea	E1
188	AlkLEi	Eviii	Ea	E1
189	AlkLEii	Eviii	Ea	E1
190	AlkLEiiEiib	Eviii	Ea	E1
191	AlkLEiii	Eviii	Ea	E1
192	AlkLEiv	Eviii	Ea	E1
193	AlkL	Eviii	Eb	E1
194	AlkLEi	Eviii	Eb	E1
195	AlkLEii	Eviii	Eb	E1
196	AlkLEiiEiib	Eviii	Eb	E1
197	AlkLEiii	Eviii	Eb	E1
198	AlkLEiv	Eviii	Eb	E1
199	AlkL	Eviii	Ed	E1
200	AlkLEi	Eviii	Ed	E1
201	AlkLEii	Eviii	Ed	E1
202	AlkLEiiEiib	Eviii	Ed	E1
203	AlkLEiii	Eviii	Ed	E1
204	AlkLEiv	Eviii	Ed	E1
205	AlkL	Eviii	Ee	E1
206	AlkLEi	Eviii	Ee	E1
207	AlkLEii	Eviii	Ee	E1
208	AlkLEiiEiib	Eviii	Ee	E1
209	AlkLEiii	Eviii	Ee	E1
210	AlkLEiv	Eviii	Ee	E1
211	AlkL	Eviii	Ef	E1
212	AlkLEi	Eviii	Ef	E1
213	AlkLEii	Eviii	Ef	E1
214	AlkLEiiEiib	Eviii	Ef	E1
215	AlkLEiii	Eviii	Ef	E1
216	AlkLEiv	Eviii	Ef	E1
217	AlkL	Eix		E1
218	AlkLEi	Eix		E1
219	AlkLEii	Eix		E1
220	AlkLEiiEiib	Eix		E1
221	AlkLEiii	Eix		E1
222	AlkLEiv	Eix		E1
223	AlkL	Eix	Ea	E1
224	AlkLEi	Eix	Ea	E1
225	AlkLEii	Eix	Ea	E1
226	AlkLEiiEiib	Eix	Ea	E1
227	AlkLEiii	Eix	Ea	E1
228	AlkLEiv	Eix	Ea	E1
229	AlkL	Eix	Eb	E1
230	AlkLEi	Eix	Eb	E1
231	AlkLEii	Eix	Eb	E1
232	AlkLEiiEiib	Eix	Eb	E1
233	AlkLEiii	Eix	Eb	E1
234	AlkLEiv	Eix	Eb	E1
235	AlkL	Eix	Ed	E1
236	AlkLEi	Eix	Ed	E1
237	AlkLEii	Eix	Ed	E1
238	AlkLEiiEiib	Eix	Ed	E1
239	AlkLEiii	Eix	Ed	E1
240	AlkLEiv	Eix	Ed	E1
241	AlkL	Eix	Ee	E1
242	AlkLEi	Eix	Ee	E1
243	AlkLEii	Eix	Ee	E1
244	AlkLEiiEiib	Eix	Ee	E1
245	AlkLEiii	Eix	Ee	E1
246	AlkLEiv	Eix	Ee	E1
247	AlkL	Eix	Ef	E1
248	AlkLEi	Eix	Ef	E1
249	AlkLEii	Eix	Ef	E1
250	AlkLEiiEiib	Eix	Ef	E1
251	AlkLEiii	Eix	Ef	E1
252	AlkLEiv	Eix	Ef	E1
253	AlkL	Ex		E1
254	AlkLEi	Ex		E1
255	AlkLEii	Ex		E1
256	AlkLEiiEiib	Ex		E1
257	AlkLEiii	Ex		E1
258	AlkLEiv	Ex		E1
259	AlkL	Ex	Ea	E1
260	AlkLEi	Ex	Ea	E1
261	AlkLEii	Ex	Ea	E1
262	AlkLEiiEiib	Ex	Ea	E1
263	AlkLEiii	Ex	Ea	E1
264	AlkLEiv	Ex	Ea	E1
265	AlkL	Ex	Eb	E1
266	AlkLEi	Ex	Eb	E1
267	AlkLEii	Ex	Eb	E1
268	AlkLEiiEiib	Ex	Eb	E1
269	AlkLEiii	Ex	Eb	E1
270	AlkLEiv	Ex	Eb	E1
271	AlkL	Ex	Ed	E1
272	AlkLEi	Ex	Ed	E1
273	AlkLEii	Ex	Ed	E1
274	AlkLEiiEiib	Ex	Ed	E1
275	AlkLEiii	Ex	Ed	E1
276	AlkLEiv	Ex	Ed	E1
277	AlkL	Ex	Ee	E1
278	AlkLEi	Ex	Ee	E1
279	AlkLEii	Ex	Ee	E1
280	AlkLEiiEiib	Ex	Ee	E1
281	AlkLEiii	Ex	Ee	E1
282	AlkLEiv	Ex	Ee	E1
283	AlkL	Ex	Ef	E1
284	AlkLEi	Ex	Ef	E1
285	AlkLEii	Ex	Ef	E1
286	AlkLEiiEiib	Ex	Ef	E1
287	AlkLEiii	Ex	Ef	E1
288	AlkLEiv	Ex	Ef	E1
289	AlkL	EviEviii		E1
290	AlkLEi	EviEviii		E1
291	AlkLEii	EviEviii		E1
292	AlkLEiiEiib	EviEviii		E1
293	AlkLEiii	EviEviii		E1
294	AlkLEiv	EviEviii		E1
295	AlkL	EviEviii	Ea	E1
296	AlkLEi	EviEviii	Ea	E1
297	AlkLEii	EviEviii	Ea	E1
298	AlkLEiiEiib	EviEviii	Ea	E1
299	AlkLEiii	EviEviii	Ea	E1
300	AlkLEiv	EviEviii	Ea	E1
301	AlkL	EviEviii	Eb	E1
302	AlkLEi	EviEviii	Eb	E1
303	AlkLEii	EviEviii	Eb	E1
304	AlkLEiiEiib	EviEviii	Eb	E1
305	AlkLEiii	EviEviii	Eb	E1
306	AlkLEiv	EviEviii	Eb	E1
307	AlkL	EviEviii	Ed	E1
308	AlkLEi	EviEviii	Ed	E1
309	AlkLEii	EviEviii	Ed	E1
310	AlkLEiiEiib	EviEviii	Ed	E1
311	AlkLEiii	EviEviii	Ed	E1
312	AlkLEiv	EviEviii	Ed	E1
313	AlkL	EviEviii	Ee	E1
314	AlkLEi	EviEviii	Ee	E1
315	AlkLEii	EviEviii	Ee	E1
316	AlkLEiiEiib	EviEviii	Ee	E1
317	AlkLEiii	EviEviii	Ee	E1
318	AlkLEiv	EviEviii	Ee	E1
319	AlkL	EviEviii	Ef	E1
320	AlkLEi	EviEviii	Ef	E1
321	AlkLEii	EviEviii	Ef	E1
322	AlkLEiiEiib	EviEviii	Ef	E1
323	AlkLEiii	EviEviii	Ef	E1
324	AlkLEiv	EviEviii	Ef	E1
325	AlkL	EiibEviEx		E1
326	AlkLEi	EiibEviEx		E1
327	AlkLEii	EiibEviEx		E1
328	AlkLEiiEiib	EiibEviEx		E1
329	AlkLEiii	EiibEviEx		E1
330	AlkLEiv	EiibEviEx		E1
331	AlkL	EiibEviEx	Ea	E1
332	AlkLEi	EiibEviEx	Ea	E1
333	AlkLEii	EiibEviEx	Ea	E1
334	AlkLEiiEiib	EiibEviEx	Ea	E1
335	AlkLEiii	EiibEviEx	Ea	E1
336	AlkLEiv	EiibEviEx	Ea	E1
337	AlkL	EiibEviEx	Eb	E1
338	AlkLEi	EiibEviEx	Eb	E1
339	AlkLEii	EiibEviEx	Eb	E1
340	AlkLEiiEiib	EiibEviEx	Eb	E1
341	AlkLEiii	EiibEviEx	Eb	E1
342	AlkLEiv	EiibEviEx	Eb	E1
343	AlkL	EiibEviEx	Ed	E1
344	AlkLEi	EiibEviEx	Ed	E1
345	AlkLEii	EiibEviEx	Ed	E1
346	AlkLEiiEiib	EiibEviEx	Ed	E1
347	AlkLEiii	EiibEviEx	Ed	E1
348	AlkLEiv	EiibEviEx	Ed	E1
349	AlkL	EiibEviEx	Ee	E1
350	AlkLEi	EiibEviEx	Ee	E1
351	AlkLEii	EiibEviEx	Ee	E1
352	AlkLEiiEiib	EiibEviEx	Ee	E1
353	AlkLEiii	EiibEviEx	Ee	E1
354	AlkLEiv	EiibEviEx	Ee	E1
355	AlkL	EiibEviEx	Ef	E1
356	AlkLEi	EiibEviEx	Ef	E1
357	AlkLEii	EiibEviEx	Ef	E1
358	AlkLEiiEiib	EiibEviEx	Ef	E1
359	AlkLEiii	EiibEviEx	Ef	E1
360	AlkLEiv	EiibEviEx	Ef	E1

Microorganisms (abbreviated to MO) which are very especially preferred according to the invention are outstandingly suitable for the production of alkanes and have increased or reduced enzymatic activities (abbreviated to E) which are described in the table hereinbelow, it being possible for these enzymatic activities additionally to be advantageously combined with an enzymatic activity described for the enzyme 3-ketoacyl-ACP (acyl carrier protein) synthase III (EC 2.3.1.41), which enzymatic activity is increased in comparison with the wild type of the microorganism, in particular the enzymatic activity of plants, preferably the enzymatic activity of plants whose seeds contain fatty acids with alkyl residues shorter than 14 C atoms and especially preferably the enzymatic activity of plants of the genera Cuphea, Elaeis, Cocos, Umbellularia and Cinnamomum and gene products selected from among AccA, AccB, AccC, AccD, AceE, AceF, Lpd, AcpP, FabA, FabB, FabD, FabF, FabG, FabH, FabI, FabZ, PanD, PanK, UdhA, PntA or PntB.

Any desired combinations of at least two of these enzymatic activities may advantageously be increased.

It may be additionally advantageous that the microorganism is equipped with an enzymatic activity which is described for the gene products selected from among TdcE, PflA, PflB, PflC, PfID, PoxB, YgfG, AckA, AckB, TdcD, Pta, LdhA, AdhE, MgsA, FdnG, FdnH, FdnI, FdhF, FdoG, FdoH, FdoI, PrpC, PrpD, PrpF, PrpB, TdcD, Pdc, PorA, PorB, PorC, PorD, AlsS, IlvB, IlvM, IlvN, IlvG, IlvI, IlvH, AlsD, ButB, Thl, ThlA, ThlB, PhaA, PhaB, Crt, BdhA, BdhB, Adc, Adh, CtfB, AtoA, AtoD, LdhL, GltA, FabR, FhuA, Dld, LldA or LldP, individually or in any desired combination, and which is reduced in comparison with the wild type of the microorganism.

MO	Increased E	Reduced E
1	AlkLExii	Eviii
2	AlkLExiiEi	Eviii
3	AlkLExiiEii	Eviii
4	AlkLExiiEiiEiib	Eviii
5	AlkLExiiEiii	Eviii
6	AlkLExiiEiv	Eviii
7	AlkLExii	Eviii	Ea
8	AlkLExiiEi	Eviii	Ea
9	AlkLExiiEii	Eviii	Ea
10	AlkLExiiEiiEiib	Eviii	Ea
11	AlkLExiiEiii	Eviii	Ea
12	AlkLExiiEiv	Eviii	Ea
13	AlkLExii	Eviii	Eb
14	AlkLExiiEi	Eviii	Eb
15	AlkLExiiEii	Eviii	Eb
16	AlkLExiiEiiEiib	Eviii	Eb
17	AlkLExiiEiii	Eviii	Eb
18	AlkLExiiEiv	Eviii	Eb
19	AlkLExii	Eviii	Ed
20	AlkLExiiEi	Eviii	Ed
21	AlkLExiiEii	Eviii	Ed
22	AlkLExiiEiiEiib	Eviii	Ed
23	AlkLExiiEiii	Eviii	Ed
24	AlkLExiiEiv	Eviii	Ed
25	AlkLExii	Eviii	Ee
26	AlkLExiiEi	Eviii	Ee
27	AlkLExiiEii	Eviii	Ee
28	AlkLExiiEiiEiib	Eviii	Ee
29	AlkLExiiEiii	Eviii	Ee
30	AlkLExiiEiv	Eviii	Ee
31	AlkLExii	Eviii	Ef
32	AlkLExiiEi	Eviii	Ef
33	AlkLExiiEii	Eviii	Ef
34	AlkLExiiEiiEiib	Eviii	Ef
35	AlkLExiiEiii	Eviii	Ef
36	AlkLExiiEiv	Eviii	Ef
37	AlkLExii	Eix
38	AlkLExiiEi	Eix
39	AlkLExiiEii	Eix
40	AlkLExiiEiiEiib	Eix
41	AlkLExiiEiii	Eix
42	AlkLExiiEiv	Eix
43	AlkLExii	Eix	Ea
44	AlkLExiiEi	Eix	Ea
45	AlkLExiiEii	Eix	Ea
46	AlkLExiiEiiEiib	Eix	Ea
47	AlkLExiiEiii	Eix	Ea
48	AlkLExiiEiv	Eix	Ea
49	AlkLExii	Eix	Eb
50	AlkLExiiEi	Eix	Eb
51	AlkLExiiEii	Eix	Eb
52	AlkLExiiEiiEiib	Eix	Eb
53	AlkLExiiEiii	Eix	Eb
54	AlkLExiiEiv	Eix	Eb
55	AlkLExii	Eix	Ed
56	AlkLExiiEi	Eix	Ed
57	AlkLExiiEii	Eix	Ed
58	AlkLExiiEiiEiib	Eix	Ed
59	AlkLExiiEiii	Eix	Ed
60	AlkLExiiEiv	Eix	Ed
61	AlkLExii	Eix	Ee
62	AlkLExiiEi	Eix	Ee
63	AlkLExiiEii	Eix	Ee
64	AlkLExiiEiiEiib	Eix	Ee
65	AlkLExiiEiii	Eix	Ee
66	AlkLExiiEiv	Eix	Ee
67	AlkLExii	Eix	Ef
68	AlkLExiiEi	Eix	Ef
69	AlkLExiiEii	Eix	Ef
70	AlkLExiiEiiEiib	Eix	Ef
71	AlkLExiiEiii	Eix	Ef
72	AlkLExiiEiv	Eix	Ef
73	AlkLExii	Ex
74	AlkLExiiEi	Ex
75	AlkLExiiEii	Ex
76	AlkLExiiEiiEiib	Ex
77	AlkLExiiEiii	Ex
78	AlkLExiiEiv	Ex
79	AlkLExii	Ex	Ea
80	AlkLExiiEi	Ex	Ea
81	AlkLExiiEii	Ex	Ea
82	AlkLExiiEiiEiib	Ex	Ea
83	AlkLExiiEiii	Ex	Ea
84	AlkLExiiEiv	Ex	Ea
85	AlkLExii	Ex	Eb
86	AlkLExiiEi	Ex	Eb
87	AlkLExiiEii	Ex	Eb
88	AlkLExiiEiiEiib	Ex	Eb
89	AlkLExiiEiii	Ex	Eb
90	AlkLExiiEiv	Ex	Eb
91	AlkLExii	Ex	Ed
92	AlkLExiiEi	Ex	Ed
93	AlkLExiiEii	Ex	Ed
94	AlkLExiiEiiEiib	Ex	Ed
95	AlkLExiiEiii	Ex	Ed
96	AlkLExiiEiv	Ex	Ed
97	AlkLExii	Ex	Ee
98	AlkLExiiEi	Ex	Ee
99	AlkLExiiEii	Ex	Ee
100	AlkLExiiEiiEiib	Ex	Ee
101	AlkLExiiEiii	Ex	Ee
102	AlkLExiiEiv	Ex	Ee
103	AlkLExii	Ex	Ef
104	AlkLExiiEi	Ex	Ef
105	AlkLExiiEii	Ex	Ef
106	AlkLExiiEiiEiib	Ex	Ef
107	AlkLExiiEiii	Ex	Ef
108	AlkLExiiEiv	Ex	Ef
109	AlkLExii	EviEviii
110	AlkLExiiEi	EviEviii
111	AlkLExiiEii	EviEviii
112	AlkLExiiEiiEiib	EviEviii
113	AlkLExiiEiii	EviEviii
114	AlkLExiiEiv	EviEviii
115	AlkLExii	EviEviii	Ea
116	AlkLExiiEi	EviEviii	Ea
117	AlkLExiiEii	EviEviii	Ea
118	AlkLExiiEiiEiib	EviEviii	Ea
119	AlkLExiiEiii	EviEviii	Ea
120	AlkLExiiEiv	EviEviii	Ea
121	AlkLExii	EviEviii	Eb
122	AlkLExiiEi	EviEviii	Eb
123	AlkLExiiEii	EviEviii	Eb
124	AlkLExiiEiiEiib	EviEviii	Eb
125	AlkLExiiEiii	EviEviii	Eb
126	AlkLExiiEiv	EviEviii	Eb
127	AlkLExii	EviEviii	Ed
128	AlkLExiiEi	EviEviii	Ed
129	AlkLExiiEii	EviEviii	Ed
130	AlkLExiiEiiEiib	EviEviii	Ed
131	AlkLExiiEiii	EviEviii	Ed
132	AlkLExiiEiv	EviEviii	Ed
133	AlkLExii	EviEviii	Ee
134	AlkLExiiEi	EviEviii	Ee
135	AlkLExiiEii	EviEviii	Ee
136	AlkLExiiEiiEiib	EviEviii	Ee
137	AlkLExiiEiii	EviEviii	Ee
138	AlkLExiiEiv	EviEviii	Ee
139	AlkLExii	EviEviii	Ef
140	AlkLExiiEi	EviEviii	Ef
141	AlkLExiiEii	EviEviii	Ef
142	AlkLExiiEiiEiib	EviEviii	Ef
143	AlkLExiiEiii	EviEviii	Ef
144	AlkLExiiEiv	EviEviii	Ef
145	AlkLExii	EiibEviEx
146	AlkLExiiEi	EiibEviEx
147	AlkLExiiEii	EiibEviEx
148	AlkLExiiEiiEiib	EiibEviEx
149	AlkLExiiEiii	EiibEviEx
150	AlkLExiiEiv	EiibEviEx
151	AlkLExii	EiibEviEx	Ea
152	AlkLExiiEi	EiibEviEx	Ea
153	AlkLExiiEii	EiibEviEx	Ea
154	AlkLExiiEiiEiib	EiibEviEx	Ea
155	AlkLExiiEiii	EiibEviEx	Ea
156	AlkLExiiEiv	EiibEviEx	Ea
157	AlkLExii	EiibEviEx	Eb
158	AlkLExiiEi	EiibEviEx	Eb
159	AlkLExiiEii	EiibEviEx	Eb
160	AlkLExiiEiiEiib	EiibEviEx	Eb
161	AlkLExiiEiii	EiibEviEx	Eb
162	AlkLExiiEiv	EiibEviEx	Eb
163	AlkLExii	EiibEviEx	Ed
164	AlkLExiiEi	EiibEviEx	Ed
165	AlkLExiiEii	EiibEviEx	Ed
166	AlkLExiiEiiEiib	EiibEviEx	Ed
167	AlkLExiiEiii	EiibEviEx	Ed
168	AlkLExiiEiv	EiibEviEx	Ed
169	AlkLExii	EiibEviEx	Ee
170	AlkLExiiEi	EiibEviEx	Ee
171	AlkLExiiEii	EiibEviEx	Ee
172	AlkLExiiEiiEiib	EiibEviEx	Ee
173	AlkLExiiEiii	EiibEviEx	Ee
174	AlkLExiiEiv	EiibEviEx	Ee
175	AlkLExii	EiibEviEx	Ef
176	AlkLExiiEi	EiibEviEx	Ef
177	AlkLExiiEii	EiibEviEx	Ef
178	AlkLExiiEiiEiib	EiibEviEx	Ef
179	AlkLExiiEiii	EiibEviEx	Ef
180	AlkLExiiEiv	EiibEviEx	Ef
181	AlkLExii	Eviii		E1
182	AlkLExiiEi	Eviii		E1
183	AlkLExiiEii	Eviii		E1
184	AlkLExiiEiiEiib	Eviii		E1
185	AlkLExiiEiii	Eviii		E1
186	AlkLExiiEiv	Eviii		E1
187	AlkLExii	Eviii	Ea	E1
188	AlkLExiiEi	Eviii	Ea	E1
189	AlkLExiiEii	Eviii	Ea	E1
190	AlkLExiiEiiEiib	Eviii	Ea	E1
191	AlkLExiiEiii	Eviii	Ea	E1
192	AlkLExiiEiv	Eviii	Ea	E1
193	AlkLExii	Eviii	Eb	E1
194	AlkLExiiEi	Eviii	Eb	E1
195	AlkLExiiEii	Eviii	Eb	E1
196	AlkLExiiEiiEiib	Eviii	Eb	E1
197	AlkLExiiEiii	Eviii	Eb	E1
198	AlkLExiiEiv	Eviii	Eb	E1
199	AlkLExii	Eviii	Ed	E1
200	AlkLExiiEi	Eviii	Ed	E1
201	AlkLExiiEii	Eviii	Ed	E1
202	AlkLExiiEiiEiib	Eviii	Ed	E1
203	AlkLExiiEiii	Eviii	Ed	E1
204	AlkLExiiEiv	Eviii	Ed	E1
205	AlkLExii	Eviii	Ee	E1
206	AlkLExiiEi	Eviii	Ee	E1
207	AlkLExiiEii	Eviii	Ee	E1
208	AlkLExiiEiiEiib	Eviii	Ee	E1
209	AlkLExiiEiii	Eviii	Ee	E1
210	AlkLExiiEiv	Eviii	Ee	E1
211	AlkLExii	Eviii	Ef	E1
212	AlkLExiiEi	Eviii	Ef	E1
213	AlkLExiiEii	Eviii	Ef	E1
214	AlkLExiiEiiEiib	Eviii	Ef	E1
215	AlkLExiiEiii	Eviii	Ef	E1
216	AlkLExiiEiv	Eviii	Ef	E1
217	AlkLExii	Eix		E1
218	AlkLExiiEi	Eix		E1
219	AlkLExiiEii	Eix		E1
220	AlkLExiiEiiEiib	Eix		E1
221	AlkLExiiEiii	Eix		E1
222	AlkLExiiEiv	Eix		E1
223	AlkLExii	Eix	Ea	E1
224	AlkLExiiEi	Eix	Ea	E1
225	AlkLExiiEii	Eix	Ea	E1
226	AlkLExiiEiiEiib	Eix	Ea	E1
227	AlkLExiiEiii	Eix	Ea	E1
228	AlkLExiiEiv	Eix	Ea	E1
229	AlkLExii	Eix	Eb	E1
230	AlkLExiiEi	Eix	Eb	E1
231	AlkLExiiEii	Eix	Eb	E1
232	AlkLExiiEiiEiib	Eix	Eb	E1
233	AlkLExiiEiii	Eix	Eb	E1
234	AlkLExiiEiv	Eix	Eb	E1
235	AlkLExii	Eix	Ed	E1
236	AlkLExiiEi	Eix	Ed	E1
237	AlkLExiiEii	Eix	Ed	E1
238	AlkLExiiEiiEiib	Eix	Ed	E1
239	AlkLExiiEiii	Eix	Ed	E1
240	AlkLExiiEiv	Eix	Ed	E1
241	AlkLExii	Eix	Ee	E1
242	AlkLExiiEi	Eix	Ee	E1
243	AlkLExiiEii	Eix	Ee	E1
244	AlkLExiiEiiEiib	Eix	Ee	E1
245	AlkLExiiEiii	Eix	Ee	E1
246	AlkLExiiEiv	Eix	Ee	E1
247	AlkLExii	Eix	Ef	E1
248	AlkLExiiEi	Eix	Ef	E1
249	AlkLExiiEii	Eix	Ef	E1
250	AlkLExiiEiiEiib	Eix	Ef	E1
251	AlkLExiiEiii	Eix	Ef	E1
252	AlkLExiiEiv	Eix	Ef	E1
253	AlkLExii	Ex		E1
254	AlkLExiiEi	Ex		E1
255	AlkLExiiEii	Ex		E1
256	AlkLExiiEiiEiib	Ex		E1
257	AlkLExiiEiii	Ex		E1
258	AlkLExiiEiv	Ex		E1
259	AlkLExii	Ex	Ea	E1
260	AlkLExiiEi	Ex	Ea	E1
261	AlkLExiiEii	Ex	Ea	E1
262	AlkLExiiEiiEiib	Ex	Ea	E1
263	AlkLExiiEiii	Ex	Ea	E1
264	AlkLExiiEiv	Ex	Ea	E1
265	AlkLExii	Ex	Eb	E1
266	AlkLExiiEi	Ex	Eb	E1
267	AlkLExiiEii	Ex	Eb	E1
268	AlkLExiiEiiEiib	Ex	Eb	E1
269	AlkLExiiEiii	Ex	Eb	E1
270	AlkLExiiEiv	Ex	Eb	E1
271	AlkLExii	Ex	Ed	E1
272	AlkLExiiEi	Ex	Ed	E1
273	AlkLExiiEii	Ex	Ed	E1
274	AlkLExiiEiiEiib	Ex	Ed	E1
275	AlkLExiiEiii	Ex	Ed	E1
276	AlkLExiiEiv	Ex	Ed	E1
277	AlkLExii	Ex	Ee	E1
278	AlkLExiiEi	Ex	Ee	E1
279	AlkLExiiEii	Ex	Ee	E1
280	AlkLExiiEiiEiib	Ex	Ee	E1
281	AlkLExiiEiii	Ex	Ee	E1
282	AlkLExiiEiv	Ex	Ee	E1
283	AlkLExii	Ex	Ef	E1
284	AlkLExiiEi	Ex	Ef	E1
285	AlkLExiiEii	Ex	Ef	E1
286	AlkLExiiEiiEiib	Ex	Ef	E1
287	AlkLExiiEiii	Ex	Ef	E1
288	AlkLExiiEiv	Ex	Ef	E1
289	AlkLExii	EviEviii		E1
290	AlkLExiiEi	EviEviii		E1
291	AlkLExiiEii	EviEviii		E1
292	AlkLExiiEiiEiib	EviEviii		E1
293	AlkLExiiEiii	EviEviii		E1
294	AlkLExiiEiv	EviEviii		E1
295	AlkLExii	EviEviii	Ea	E1
296	AlkLExiiEi	EviEviii	Ea	E1
297	AlkLExiiEii	EviEviii	Ea	E1
298	AlkLExiiEiiEiib	EviEviii	Ea	E1
299	AlkLExiiEiii	EviEviii	Ea	E1
300	AlkLExiiEiv	EviEviii	Ea	E1
301	AlkLExii	EviEviii	Eb	E1
302	AlkLExiiEi	EviEviii	Eb	E1
303	AlkLExiiEii	EviEviii	Eb	E1
304	AlkLExiiEiiEiib	EviEviii	Eb	E1
305	AlkLExiiEiii	EviEviii	Eb	E1
306	AlkLExiiEiv	EviEviii	Eb	E1
307	AlkLExii	EviEviii	Ed	E1
308	AlkLExiiEi	EviEviii	Ed	E1
309	AlkLExiiEii	EviEviii	Ed	E1
310	AlkLExiiEiiEiib	EviEviii	Ed	E1
311	AlkLExiiEiii	EviEviii	Ed	E1
312	AlkLExiiEiv	EviEviii	Ed	E1
313	AlkLExii	EviEviii	Ee	E1
314	AlkLExiiEi	EviEviii	Ee	E1
315	AlkLExiiEii	EviEviii	Ee	E1
316	AlkLExiiEiiEiib	EviEviii	Ee	E1
317	AlkLExiiEiii	EviEviii	Ee	E1
318	AlkLExiiEiv	EviEviii	Ee	E1
319	AlkLExii	EviEviii	Ef	E1
320	AlkLExiiEi	EviEviii	Ef	E1
321	AlkLExiiEii	EviEviii	Ef	E1
322	AlkLExiiEiiEiib	EviEviii	Ef	E1
323	AlkLExiiEiii	EviEviii	Ef	E1
324	AlkLExiiEiv	EviEviii	Ef	E1
325	AlkLExii	EiibEviEx		E1
326	AlkLExiiEi	EiibEviEx		E1
327	AlkLExiiEii	EiibEviEx		E1
328	AlkLExiiEiiEiib	EiibEviEx		E1
329	AlkLExiiEiii	EiibEviEx		E1
330	AlkLExiiEiv	EiibEviEx		E1
331	AlkLExii	EiibEviEx	Ea	E1
332	AlkLExiiEi	EiibEviEx	Ea	E1
333	AlkLExiiEii	EiibEviEx	Ea	E1
334	AlkLExiiEiiEiib	EiibEviEx	Ea	E1
335	AlkLExiiEiii	EiibEviEx	Ea	E1
336	AlkLExiiEiv	EiibEviEx	Ea	E1
337	AlkLExii	EiibEviEx	Eb	E1
338	AlkLExiiEi	EiibEviEx	Eb	E1
339	AlkLExiiEii	EiibEviEx	Eb	E1
340	AlkLExiiEiiEiib	EiibEviEx	Eb	E1
341	AlkLExiiEiii	EiibEviEx	Eb	E1
342	AlkLExiiEiv	EiibEviEx	Eb	E1
343	AlkLExii	EiibEviEx	Ed	E1
344	AlkLExiiEi	EiibEviEx	Ed	E1
345	AlkLExiiEii	EiibEviEx	Ed	E1
346	AlkLExiiEiiEiib	EiibEviEx	Ed	E1
347	AlkLExiiEiii	EiibEviEx	Ed	E1
348	AlkLExiiEiv	EiibEviEx	Ed	E1
349	AlkLExii	EiibEviEx	Ee	E1
350	AlkLExiiEi	EiibEviEx	Ee	E1
351	AlkLExiiEii	EiibEviEx	Ee	E1
352	AlkLExiiEiiEiib	EiibEviEx	Ee	E1
353	AlkLExiiEiii	EiibEviEx	Ee	E1
354	AlkLExiiEiv	EiibEviEx	Ee	E1
355	AlkLExii	EiibEviEx	Ef	E1
356	AlkLExiiEi	EiibEviEx	Ef	E1
357	AlkLExiiEii	EiibEviEx	Ef	E1
358	AlkLExiiEiiEiib	EiibEviEx	Ef	E1
359	AlkLExiiEiii	EiibEviEx	Ef	E1
360	AlkLExiiEiv	EiibEviEx	Ef	E1

Microorganisms (abbreviated to MO) which are very especially preferred according to the invention are outstandingly suitable for the production of terminal olefins and have increased or reduced enzymatic activities (abbreviated to E) which are described in the table hereinbelow, it being possible for these enzymatic activities additionally to be advantageously combined with an enzymatic activity described for the enzyme 3-ketoacyl-ACP (acyl carrier protein) synthase III (EC 2.3.1.41), which enzymatic activity is increased in comparison with the wild type of the microorganism, in particular the enzymatic activity of plants, preferably the enzymatic activity of plants whose seeds contain fatty acids with alkyl residues shorter than 14 C atoms and especially preferably the enzymatic activity of plants of the genera Cuphea, Elaeis, Cocos, Umbellularia and Cinnamomum and gene products selected from among AccA, AccB, AccC, AccD, AceE, AceF, Lpd, AcpP, FabA, FabB, FabD, FabF, FabG, FabH, FabI, FabZ, PanD, PanK, UdhA, PntA or PntB.

Any desired combinations of at least two of these enzymatic activities may advantageously be increased.

It may be additionally advantageous that the microorganism is equipped with an enzymatic activity which is described for the gene products selected from among TdcE, PflA, PflB, PflC, PfID, PoxB, YgfG, AckA, AckB, TdcD, Pta, LdhA, AdhE, MgsA, FdnG, FdnH, FdnI, FdhF, FdoG, FdoH, FdoI, PrpC, PrpD, PrpF, PrpB, TdcD, Pdc, PorA, PorB, PorC, PorD, AlsS, IlvB, IlvM, IlvN, IlvG, IlyI, IlvH, AlsD, ButB, Thl, ThlA, ThlB, PhaA, PhaB, Crt, BdhA, BdhB, Adc, Adh, CtfB, AtoA, AtoD, LdhL, GltA, FabR, FhuA, Dld, LldA or LldP, individually or in any desired combination, and which is reduced in comparison with the wild type of the microorganism.

MO	Increased E	Reduced E
1	AlkL	Exi
2	AlkLEi	Exi
3	AlkLEii	Exi
4	AlkLEiiEiib	Exi
5	AlkLEiii	Exi
6	AlkLEiv	Exi
7	AlkL	Exi	Ea
8	AlkLEi	Exi	Ea
9	AlkLEii	Exi	Ea
10	AlkLEiiEiib	Exi	Ea
11	AlkLEiii	Exi	Ea
12	AlkLEiv	Exi	Ea
13	AlkL	Exi	Eb
14	AlkLEi	Exi	Eb
15	AlkLEii	Exi	Eb
16	AlkLEiiEiib	Exi	Eb
17	AlkLEiii	Exi	Eb
18	AlkLEiv	Exi	Eb
19	AlkL	Exi	Ed
20	AlkLEi	Exi	Ed
21	AlkLEii	Exi	Ed
22	AlkLEiiEiib	Exi	Ed
23	AlkLEiii	Exi	Ed
24	AlkLEiv	Exi	Ed
25	AlkL	Exi	Ee
26	AlkLEi	Exi	Ee
27	AlkLEii	Exi	Ee
28	AlkLEiiEiib	Exi	Ee
29	AlkLEiii	Exi	Ee
30	AlkLEiv	Exi	Ee
31	AlkL	Exi	Ef
32	AlkLEi	Exi	Ef
33	AlkLEii	Exi	Ef
34	AlkLEiiEiib	Exi	Ef
35	AlkLEiii	Exi	Ef
36	AlkLEiv	Exi	Ef
37	AlkL	Exi		E1
38	AlkLEi	Exi		E1
39	AlkLEii	Exi		E1
40	AlkLEiiEiib	Exi		E1
41	AlkLEiii	Exi		E1
42	AlkLEiv	Exi		E1
43	AlkL	Exi	Ea	E1
44	AlkLEi	Exi	Ea	E1
45	AlkLEii	Exi	Ea	E1
46	AlkLEiiEiib	Exi	Ea	E1
47	AlkLEiii	Exi	Ea	E1
48	AlkLEiv	Exi	Ea	E1
49	AlkL	Exi	Eb	E1
50	AlkLEi	Exi	Eb	E1
51	AlkLEii	Exi	Eb	E1
52	AlkLEiiEiib	Exi	Eb	E1
53	AlkLEiii	Exi	Eb	E1
54	AlkLEiv	Exi	Eb	E1
55	AlkL	Exi	Ed	E1
56	AlkLEi	Exi	Ed	E1
57	AlkLEii	Exi	Ed	E1
58	AlkLEiiEiib	Exi	Ed	E1
59	AlkLEiii	Exi	Ed	E1
60	AlkLEiv	Exi	Ed	E1
61	AlkL	Exi	Ee	E1
62	AlkLEi	Exi	Ee	E1
63	AlkLEii	Exi	Ee	E1
64	AlkLEiiEiib	Exi	Ee	E1
65	AlkLEiii	Exi	Ee	E1
66	AlkLEiv	Exi	Ee	E1
67	AlkL	Exi	Ef	E1
68	AlkLEi	Exi	Ef	E1
69	AlkLEii	Exi	Ef	E1
70	AlkLEiiEiib	Exi	Ef	E1
71	AlkLEiii	Exi	Ef	E1
72	AlkLEiv	Exi	Ef	E1

Microorganisms (abbreviated to MO) which are very especially preferred according to the invention are outstandingly suitable for the production of alkan-1-amines and have increased or reduced enzymatic activities (abbreviated to E) which are described in the table hereinbelow, it being possible for these enzymatic activities additionally to be advantageously combined with an enzymatic activity described for the enzyme 3-ketoacyl-ACP (acyl carrier protein) synthase III (EC 2.3.1.41), which enzymatic activity is increased in comparison with the wild type of the microorganism, in particular the enzymatic activity of plants, preferably the enzymatic activity of plants whose seeds contain fatty acids with alkyl residues shorter than 14 C atoms and especially preferably the enzymatic activity of plants of the genera Cuphea, Elaeis, Cocos, Umbellularia and Cinnamomum and gene products selected from among AccA, AccB, AccC, AccD, AceE, AceF, Lpd, AcpP, FabA, FabB, FabD, FabF, FabG, FabH, FabI, FabZ, PanD, PanK, UdhA, PntA or PntB.

Any desired combinations of at least two of these enzymatic activities may advantageously be increased.

It may be additionally advantageous that the microorganism is equipped with an enzymatic activity which is described for the gene products selected from among TdcE, PflA, PflB, PflC, PfID, PoxB, YgfG, AckA, AckB, TdcD, Pta, LdhA, AdhE, MgsA, FdnG, FdnH, FdnI, FdhF, FdoG, FdoH, FdoI, PrpC, PrpD, PrpF, PrpB, TdcD, Pdc, PorA, PorB, PorC, PorD, AlsS, IlvB, IlvM, IlvN, IlvG, IlyI, IlvH, AlsD, ButB, Thl, ThlA, ThlB, PhaA, PhaB, Crt, BdhA, BdhB, Adc, Adh, CtfB, AtoA, AtoD, LdhL, GRA, FabR, FhuA, Dld, LldA or LldP, individually or in any desired combination, and which is reduced in comparison with the wild type of the microorganism.

MO	Increased E	Reduced E
1	AlkLEvii	Eviii
2	AlkLEviiEi	Eviii
3	AlkLEviiEii	Eviii
4	AlkLEviiEiiEiib	Eviii
5	AlkLEviiEiii	Eviii
6	AlkLEviiEiv	Eviii
7	AlkLEvii	Eviii	Ea
8	AlkLEviiEi	Eviii	Ea
9	AlkLEviiEii	Eviii	Ea
10	AlkLEviiEiiEiib	Eviii	Ea
11	AlkLEviiEiii	Eviii	Ea
12	AlkLEviiEiv	Eviii	Ea
13	AlkLEvii	Eviii	Eb
14	AlkLEviiEi	Eviii	Eb
15	AlkLEviiEii	Eviii	Eb
16	AlkLEviiEiiEiib	Eviii	Eb
17	AlkLEviiEiii	Eviii	Eb
18	AlkLEviiEiv	Eviii	Eb
19	AlkLEvii	Eviii	Ed
20	AlkLEviiEi	Eviii	Ed
21	AlkLEviiEii	Eviii	Ed
22	AlkLEviiEiiEiib	Eviii	Ed
23	AlkLEviiEiii	Eviii	Ed
24	AlkLEviiEiv	Eviii	Ed
25	AlkLEvii	Eviii	Ee
26	AlkLEviiEi	Eviii	Ee
27	AlkLEviiEii	Eviii	Ee
28	AlkLEviiEiiEiib	Eviii	Ee
29	AlkLEviiEiii	Eviii	Ee
30	AlkLEviiEiv	Eviii	Ee
31	AlkLEvii	Eviii	Ef
32	AlkLEviiEi	Eviii	Ef
33	AlkLEviiEii	Eviii	Ef
34	AlkLEviiEiiEiib	Eviii	Ef
35	AlkLEviiEiii	Eviii	Ef
36	AlkLEviiEiv	Eviii	Ef
37	AlkLEvii	Eix
38	AlkLEviiEi	Eix
39	AlkLEviiEii	Eix
40	AlkLEviiEiiEiib	Eix
41	AlkLEviiEiii	Eix
42	AlkLEviiEiv	Eix
43	AlkLEvii	Eix	Ea
44	AlkLEviiEi	Eix	Ea
45	AlkLEviiEii	Eix	Ea
46	AlkLEviiEiiEiib	Eix	Ea
47	AlkLEviiEiii	Eix	Ea
48	AlkLEviiEiv	Eix	Ea
49	AlkLEvii	Eix	Eb
50	AlkLEviiEi	Eix	Eb
51	AlkLEviiEii	Eix	Eb
52	AlkLEviiEiiEiib	Eix	Eb
53	AlkLEviiEiii	Eix	Eb
54	AlkLEviiEiv	Eix	Eb
55	AlkLEvii	Eix	Ed
56	AlkLEviiEi	Eix	Ed
57	AlkLEviiEii	Eix	Ed
58	AlkLEviiEiiEiib	Eix	Ed
59	AlkLEviiEiii	Eix	Ed
60	AlkLEviiEiv	Eix	Ed
61	AlkLEvii	Eix	Ee
62	AlkLEviiEi	Eix	Ee
63	AlkLEviiEii	Eix	Ee
64	AlkLEviiEiiEiib	Eix	Ee
65	AlkLEviiEiii	Eix	Ee
66	AlkLEviiEiv	Eix	Ee
67	AlkLEvii	Eix	Ef
68	AlkLEviiEi	Eix	Ef
69	AlkLEviiEii	Eix	Ef
70	AlkLEviiEiiEiib	Eix	Ef
71	AlkLEviiEiii	Eix	Ef
72	AlkLEviiEiv	Eix	Ef
73	AlkLEvii	Ex
74	AlkLEviiEi	Ex
75	AlkLEviiEii	Ex
76	AlkLEviiEiiEiib	Ex
77	AlkLEviiEiii	Ex
78	AlkLEviiEiv	Ex
79	AlkLEvii	Ex	Ea
80	AlkLEviiEi	Ex	Ea
81	AlkLEviiEii	Ex	Ea
82	AlkLEviiEiiEiib	Ex	Ea
83	AlkLEviiEiii	Ex	Ea
84	AlkLEviiEiv	Ex	Ea
85	AlkLEvii	Ex	Eb
86	AlkLEviiEi	Ex	Eb
87	AlkLEviiEii	Ex	Eb
88	AlkLEviiEiiEiib	Ex	Eb
89	AlkLEviiEiii	Ex	Eb
90	AlkLEviiEiv	Ex	Eb
91	AlkLEvii	Ex	Ed
92	AlkLEviiEi	Ex	Ed
93	AlkLEviiEii	Ex	Ed
94	AlkLEviiEiiEiib	Ex	Ed
95	AlkLEviiEiii	Ex	Ed
96	AlkLEviiEiv	Ex	Ed
97	AlkLEvii	Ex	Ee
98	AlkLEviiEi	Ex	Ee
99	AlkLEviiEii	Ex	Ee
100	AlkLEviiEiiEiib	Ex	Ee
101	AlkLEviiEiii	Ex	Ee
102	AlkLEviiEiv	Ex	Ee
103	AlkLEvii	Ex	Ef
104	AlkLEviiEi	Ex	Ef
105	AlkLEviiEii	Ex	Ef
106	AlkLEviiEiiEiib	Ex	Ef
107	AlkLEviiEiii	Ex	Ef
108	AlkLEviiEiv	Ex	Ef
109	AlkLEvii	EviEviii
110	AlkLEviiEi	EviEviii
111	AlkLEviiEii	EviEviii
112	AlkLEviiEiiEiib	EviEviii
113	AlkLEviiEiii	EviEviii
114	AlkLEviiEiv	EviEviii
115	AlkLEvii	EviEviii	Ea
116	AlkLEviiEi	EviEviii	Ea
117	AlkLEviiEii	EviEviii	Ea
118	AlkLEviiEiiEiib	EviEviii	Ea
119	AlkLEviiEiii	EviEviii	Ea
120	AlkLEviiEiv	EviEviii	Ea
121	AlkLEvii	EviEviii	Eb
122	AlkLEviiEi	EviEviii	Eb
123	AlkLEviiEii	EviEviii	Eb
124	AlkLEviiEiiEiib	EviEviii	Eb
125	AlkLEviiEiii	EviEviii	Eb
126	AlkLEviiEiv	EviEviii	Eb
127	AlkLEvii	EviEviii	Ed
128	AlkLEviiEi	EviEviii	Ed
129	AlkLEviiEii	EviEviii	Ed
130	AlkLEviiEiiEiib	EviEviii	Ed
131	AlkLEviiEiii	EviEviii	Ed
132	AlkLEviiEiv	EviEviii	Ed
133	AlkLEvii	EviEviii	Ee
134	AlkLEviiEi	EviEviii	Ee
135	AlkLEviiEii	EviEviii	Ee
136	AlkLEviiEiiEiib	EviEviii	Ee
137	AlkLEviiEiii	EviEviii	Ee
138	AlkLEviiEiv	EviEviii	Ee
139	AlkLEvii	EviEviii	Ef
140	AlkLEviiEi	EviEviii	Ef
141	AlkLEviiEii	EviEviii	Ef
142	AlkLEviiEiiEiib	EviEviii	Ef
143	AlkLEviiEiii	EviEviii	Ef
144	AlkLEviiEiv	EviEviii	Ef
145	AlkLEvii	EiibEviEx
146	AlkLEviiEi	EiibEviEx
147	AlkLEviiEii	EiibEviEx
148	AlkLEviiEiiEiib	EiibEviEx
149	AlkLEviiEiii	EiibEviEx
150	AlkLEviiEiv	EiibEviEx
151	AlkLEvii	EiibEviEx
152	AlkLEviiEi	EiibEviEx
153	AlkLEviiEii	EiibEviEx
154	AlkLEviiEiiEiib	EiibEviEx
155	AlkLEviiEiii	EiibEviEx
156	AlkLEviiEiv	EiibEviEx
157	AlkLEvii	EiibEviEx	Ea
158	AlkLEviiEi	EiibEviEx	Ea
159	AlkLEviiEii	EiibEviEx	Ea
160	AlkLEviiEiiEiib	EiibEviEx	Ea
161	AlkLEviiEiii	EiibEviEx	Ea
162	AlkLEviiEiv	EiibEviEx	Ea
163	AlkLEvii	EiibEviEx	Eb
164	AlkLEviiEi	EiibEviEx	Eb
165	AlkLEviiEii	EiibEviEx	Eb
166	AlkLEviiEiiEiib	EiibEviEx	Eb
167	AlkLEviiEiii	EiibEviEx	Eb
168	AlkLEviiEiv	EiibEviEx	Eb
169	AlkLEvii	EiibEviEx	Ed
170	AlkLEviiEi	EiibEviEx	Ed
171	AlkLEviiEii	EiibEviEx	Ed
172	AlkLEviiEiiEiib	EiibEviEx	Ed
173	AlkLEviiEiii	EiibEviEx	Ed
174	AlkLEviiEiv	EiibEviEx	Ed
175	AlkLEvii	EiibEviEx	Ee
176	AlkLEviiEi	EiibEviEx	Ee
177	AlkLEviiEii	EiibEviEx	Ee
178	AlkLEviiEiiEiib	EiibEviEx	Ee
179	AlkLEviiEiii	EiibEviEx	Ee
180	AlkLEviiEiv	EiibEviEx	Ee
181	AlkLEvii	EiibEviEx	Ef
182	AlkLEviiEi	EiibEviEx	Ef
183	AlkLEviiEii	EiibEviEx	Ef
184	AlkLEviiEiiEiib	EiibEviEx	Ef
185	AlkLEviiEiii	EiibEviEx	Ef
186	AlkLEviiEiv	EiibEviEx	Ef
187	AlkLEvii	EiibEviEx
188	AlkLEviiEi	EiibEviEx
189	AlkLEviiEii	EiibEviEx
190	AlkLEviiEiiEiib	EiibEviEx
191	AlkLEviiEiii	EiibEviEx
192	AlkLEviiEiv	EiibEviEx
193	AlkLExiiiEvii	Eviii
194	AlkLExiiiEviiEi	Eviii
195	AlkLExiiiEviiEii	Eviii
196	AlkLExiiiEviiEiiEiib	Eviii
197	AlkLExiiiEviiEiii	Eviii
198	AlkLExiiiEviiEiv	Eviii
199	AlkLExiiiEvii	Eviii	Ea
200	AlkLExiiiEviiEi	Eviii	Ea
201	AlkLExiiiEviiEii	Eviii	Ea
202	AlkLExiiiEviiEiiEiib	Eviii	Ea
203	AlkLExiiiEviiEiii	Eviii	Ea
204	AlkLExiiiEviiEiv	Eviii	Ea
205	AlkLExiiiEvii	Eviii	Eb
206	AlkLExiiiEviiEi	Eviii	Eb
207	AlkLExiiiEviiEii	Eviii	Eb
208	AlkLExiiiEviiEiiEiib	Eviii	Eb
209	AlkLExiiiEviiEiii	Eviii	Eb
210	AlkLExiiiEviiEiv	Eviii	Eb
211	AlkLExiiiEvii	Eviii	Ed
212	AlkLExiiiEviiEi	Eviii	Ed
213	AlkLExiiiEviiEii	Eviii	Ed
214	AlkLExiiiEviiEiiEiib	Eviii	Ed
215	AlkLExiiiEviiEiii	Eviii	Ed
216	AlkLExiiiEviiEiv	Eviii	Ed
217	AlkLExiiiEvii	Eviii	Ee
218	AlkLExiiiEviiEi	Eviii	Ee
219	AlkLExiiiEviiEii	Eviii	Ee
220	AlkLExiiiEviiEiiEiib	Eviii	Ee
221	AlkLExiiiEviiEiii	Eviii	Ee
222	AlkLExiiiEviiEiv	Eviii	Ee
223	AlkLExiiiEvii	Eviii	Ef
224	AlkLExiiiEviiEi	Eviii	Ef
225	AlkLExiiiEviiEii	Eviii	Ef
226	AlkLExiiiEviiEiiEiib	Eviii	Ef
227	AlkLExiiiEviiEiii	Eviii	Ef
228	AlkLExiiiEviiEiv	Eviii	Ef
229	AlkLExiiiEvii	Eix
230	AlkLExiiiEviiEi	Eix
231	AlkLExiiiEviiEii	Eix
232	AlkLExiiiEviiEiiEiib	Eix
233	AlkLExiiiEviiEiii	Eix
234	AlkLExiiiEviiEiv	Eix
235	AlkLExiiiEvii	Eix	Ea
236	AlkLExiiiEviiEi	Eix	Ea
237	AlkLExiiiEviiEii	Eix	Ea
238	AlkLExiiiEviiEiiEiib	Eix	Ea
239	AlkLExiiiEviiEiii	Eix	Ea
240	AlkLExiiiEviiEiv	Eix	Ea
241	AlkLExiiiEvii	Eix	Eb
242	AlkLExiiiEviiEi	Eix	Eb
243	AlkLExiiiEviiEii	Eix	Eb
244	AlkLExiiiEviiEiiEiib	Eix	Eb
245	AlkLExiiiEviiEiii	Eix	Eb
246	AlkLExiiiEviiEiv	Eix	Eb
247	AlkLExiiiEvii	Eix	Ed
248	AlkLExiiiEviiEi	Eix	Ed
249	AlkLExiiiEviiEii	Eix	Ed
250	AlkLExiiiEviiEiiEiib	Eix	Ed
251	AlkLExiiiEviiEiii	Eix	Ed
252	AlkLExiiiEviiEiv	Eix	Ed
253	AlkLExiiiEvii	Eix	Ee
254	AlkLExiiiEviiEi	Eix	Ee
255	AlkLExiiiEviiEii	Eix	Ee
256	AlkLExiiiEviiEiiEiib	Eix	Ee
257	AlkLExiiiEviiEiii	Eix	Ee
258	AlkLExiiiEviiEiv	Eix	Ee
259	AlkLExiiiEvii	Eix	Ef
260	AlkLExiiiEviiEi	Eix	Ef
261	AlkLExiiiEviiEii	Eix	Ef
262	AlkLExiiiEviiEiiEiib	Eix	Ef
263	AlkLExiiiEviiEiii	Eix	Ef
264	AlkLExiiiEviiEiv	Eix	Ef
265	AlkLExiiiEvii	Ex
266	AlkLExiiiEviiEi	Ex
267	AlkLExiiiEviiEii	Ex
268	AlkLExiiiEviiEiiEiib	Ex
269	AlkLExiiiEviiEiii	Ex
270	AlkLExiiiEviiEiv	Ex
271	AlkLExiiiEvii	Ex	Ea
272	AlkLExiiiEviiEi	Ex	Ea
273	AlkLExiiiEviiEii	Ex	Ea
274	AlkLExiiiEviiEiiEiib	Ex	Ea
275	AlkLExiiiEviiEiii	Ex	Ea
276	AlkLExiiiEviiEiv	Ex	Ea
277	AlkLExiiiEvii	Ex	Eb
278	AlkLExiiiEviiEi	Ex	Eb
279	AlkLExiiiEviiEii	Ex	Eb
280	AlkLExiiiEviiEiiEiib	Ex	Eb
281	AlkLExiiiEviiEiii	Ex	Eb
282	AlkLExiiiEviiEiv	Ex	Eb
283	AlkLExiiiEvii	Ex	Ed
284	AlkLExiiiEviiEi	Ex	Ed
285	AlkLExiiiEviiEii	Ex	Ed
286	AlkLExiiiEviiEiiEiib	Ex	Ed
287	AlkLExiiiEviiEiii	Ex	Ed
288	AlkLExiiiEviiEiv	Ex	Ed
289	AlkLExiiiEvii	Ex	Ee
290	AlkLExiiiEviiEi	Ex	Ee
291	AlkLExiiiEviiEii	Ex	Ee
292	AlkLExiiiEviiEiiEiib	Ex	Ee
293	AlkLExiiiEviiEiii	Ex	Ee
294	AlkLExiiiEviiEiv	Ex	Ee
295	AlkLExiiiEvii	Ex	Ef
296	AlkLExiiiEviiEi	Ex	Ef
297	AlkLExiiiEviiEii	Ex	Ef
298	AlkLExiiiEviiEiiEiib	Ex	Ef
299	AlkLExiiiEviiEiii	Ex	Ef
300	AlkLExiiiEviiEiv	Ex	Ef
301	AlkLExiiiEvii	EviEviii
302	AlkLExiiiEviiEi	EviEviii
303	AlkLExiiiEviiEii	EviEviii
304	AlkLExiiiEviiEiiEiib	EviEviii
305	AlkLExiiiEviiEiii	EviEviii
306	AlkLExiiiEviiEiv	EviEviii
307	AlkLExiiiEvii	EviEviii	Ea
308	AlkLExiiiEviiEi	EviEviii	Ea
309	AlkLExiiiEviiEii	EviEviii	Ea
310	AlkLExiiiEviiEiiEiib	EviEviii	Ea
311	AlkLExiiiEviiEiii	EviEviii	Ea
312	AlkLExiiiEviiEiv	EviEviii	Ea
313	AlkLExiiiEvii	EviEviii	Eb
314	AlkLExiiiEviiEi	EviEviii	Eb
315	AlkLExiiiEviiEii	EviEviii	Eb
316	AlkLExiiiEviiEiiEiib	EviEviii	Eb
317	AlkLExiiiEviiEiii	EviEviii	Eb
318	AlkLExiiiEviiEiv	EviEviii	Eb
319	AlkLExiiiEvii	EviEviii	Ed
320	AlkLExiiiEviiEi	EviEviii	Ed
321	AlkLExiiiEviiEii	EviEviii	Ed
322	AlkLExiiiEviiEiiEiib	EviEviii	Ed
323	AlkLExiiiEviiEiii	EviEviii	Ed
324	AlkLExiiiEviiEiv	EviEviii	Ed
325	AlkLExiiiEvii	EviEviii	Ee
326	AlkLExiiiEviiEi	EviEviii	Ee
327	AlkLExiiiEviiEii	EviEviii	Ee
328	AlkLExiiiEviiEiiEiib	EviEviii	Ee
329	AlkLExiiiEviiEiii	EviEviii	Ee
330	AlkLExiiiEviiEiv	EviEviii	Ee
331	AlkLExiiiEvii	EviEviii	Ef
332	AlkLExiiiEviiEi	EviEviii	Ef
333	AlkLExiiiEviiEii	EviEviii	Ef
334	AlkLExiiiEviiEiiEiib	EviEviii	Ef
335	AlkLExiiiEviiEiii	EviEviii	Ef
336	AlkLExiiiEviiEiv	EviEviii	Ef
337	AlkLExiiiEvii	EiibEviEx
338	AlkLExiiiEviiEi	EiibEviEx
339	AlkLExiiiEviiEii	EiibEviEx
340	AlkLExiiiEviiEiiEiib	EiibEviEx
341	AlkLExiiiEviiEiii	EiibEviEx
342	AlkLExiiiEviiEiv	EiibEviEx
343	AlkLExiiiEvii	EiibEviEx	Ea
344	AlkLExiiiEviiEi	EiibEviEx	Ea
345	AlkLExiiiEviiEii	EiibEviEx	Ea
346	AlkLExiiiEviiEiiEiib	EiibEviEx	Ea
347	AlkLExiiiEviiEiii	EiibEviEx	Ea
348	AlkLExiiiEviiEiv	EiibEviEx	Ea
349	AlkLExiiiEvii	EiibEviEx	Eb
350	AlkLExiiiEviiEi	EiibEviEx	Eb
351	AlkLExiiiEviiEii	EiibEviEx	Eb
352	AlkLExiiiEviiEiiEiib	EiibEviEx	Eb
353	AlkLExiiiEviiEiii	EiibEviEx	Eb
354	AlkLExiiiEviiEiv	EiibEviEx	Eb
355	AlkLExiiiEvii	EiibEviEx	Ed
356	AlkLExiiiEviiEi	EiibEviEx	Ed
357	AlkLExiiiEviiEii	EiibEviEx	Ed
358	AlkLExiiiEviiEiiEiib	EiibEviEx	Ed
359	AlkLExiiiEviiEiii	EiibEviEx	Ed
360	AlkLExiiiEviiEiv	EiibEviEx	Ed
361	AlkLExiiiEvii	EiibEviEx	Ee
362	AlkLExiiiEviiEi	EiibEviEx	Ee
363	AlkLExiiiEviiEii	EiibEviEx	Ee
364	AlkLExiiiEviiEiiEiib	EiibEviEx	Ee
365	AlkLExiiiEviiEiii	EiibEviEx	Ee
366	AlkLExiiiEviiEiv	EiibEviEx	Ee
367	AlkLExiiiEvii	EiibEviEx	Ef
368	AlkLExiiiEviiEi	EiibEviEx	Ef
369	AlkLExiiiEviiEii	EiibEviEx	Ef
370	AlkLExiiiEviiEiiEiib	EiibEviEx	Ef
371	AlkLExiiiEviiEiii	EiibEviEx	Ef
372	AlkLExiiiEviiEiv	EiibEviEx	Ef
373	AlkLEvii	Eviii		E1
374	AlkLEviiEi	Eviii		E1
375	AlkLEviiEii	Eviii		E1
376	AlkLEviiEiiEiib	Eviii		E1
377	AlkLEviiEiii	Eviii		E1
378	AlkLEviiEiv	Eviii		E1
379	AlkLEvii	Eviii	Ea	E1
380	AlkLEviiEi	Eviii	Ea	E1
381	AlkLEviiEii	Eviii	Ea	E1
382	AlkLEviiEiiEiib	Eviii	Ea	E1
383	AlkLEviiEiii	Eviii	Ea	E1
384	AlkLEviiEiv	Eviii	Ea	E1
385	AlkLEvii	Eviii	Eb	E1
386	AlkLEviiEi	Eviii	Eb	E1
387	AlkLEviiEii	Eviii	Eb	E1
388	AlkLEviiEiiEiib	Eviii	Eb	E1
389	AlkLEviiEiii	Eviii	Eb	E1
390	AlkLEviiEiv	Eviii	Eb	E1
391	AlkLEvii	Eviii	Ed	E1
392	AlkLEviiEi	Eviii	Ed	E1
393	AlkLEviiEii	Eviii	Ed	E1
394	AlkLEviiEiiEiib	Eviii	Ed	E1
395	AlkLEviiEiii	Eviii	Ed	E1
396	AlkLEviiEiv	Eviii	Ed	E1
397	AlkLEvii	Eviii	Ee	E1
398	AlkLEviiEi	Eviii	Ee	E1
399	AlkLEviiEii	Eviii	Ee	E1
400	AlkLEviiEiiEiib	Eviii	Ee	E1
401	AlkLEviiEiii	Eviii	Ee	E1
402	AlkLEviiEiv	Eviii	Ee	E1
403	AlkLEvii	Eviii	Ef	E1
404	AlkLEviiEi	Eviii	Ef	E1
405	AlkLEviiEii	Eviii	Ef	E1
406	AlkLEviiEiiEiib	Eviii	Ef	E1
407	AlkLEviiEiii	Eviii	Ef	E1
408	AlkLEviiEiv	Eviii	Ef	E1
409	AlkLEvii	Eix		E1
410	AlkLEviiEi	Eix		E1
411	AlkLEviiEii	Eix		E1
412	AlkLEviiEiiEiib	Eix		E1
413	AlkLEviiEiii	Eix		E1
414	AlkLEviiEiv	Eix		E1
415	AlkLEvii	Eix	Ea	E1
416	AlkLEviiEi	Eix	Ea	E1
417	AlkLEviiEii	Eix	Ea	E1
418	AlkLEviiEiiEiib	Eix	Ea	E1
419	AlkLEviiEiii	Eix	Ea	E1
420	AlkLEviiEiv	Eix	Ea	E1
421	AlkLEvii	Eix	Eb	E1
422	AlkLEviiEi	Eix	Eb	E1
423	AlkLEviiEii	Eix	Eb	E1
424	AlkLEviiEiiEiib	Eix	Eb	E1
425	AlkLEviiEiii	Eix	Eb	E1
426	AlkLEviiEiv	Eix	Eb	E1
427	AlkLEvii	Eix	Ed	E1
428	AlkLEviiEi	Eix	Ed	E1
429	AlkLEviiEii	Eix	Ed	E1
430	AlkLEviiEiiEiib	Eix	Ed	E1
431	AlkLEviiEiii	Eix	Ed	E1
432	AlkLEviiEiv	Eix	Ed	E1
433	AlkLEvii	Eix	Ee	E1
434	AlkLEviiEi	Eix	Ee	E1
435	AlkLEviiEii	Eix	Ee	E1
436	AlkLEviiEiiEiib	Eix	Ee	E1
437	AlkLEviiEiii	Eix	Ee	E1
438	AlkLEviiEiv	Eix	Ee	E1
439	AlkLEvii	Eix	Ef	E1
440	AlkLEviiEi	Eix	Ef	E1
441	AlkLEviiEii	Eix	Ef	E1
442	AlkLEviiEiiEiib	Eix	Ef	E1
443	AlkLEviiEiii	Eix	Ef	E1
444	AlkLEviiEiv	Eix	Ef	E1
445	AlkLEvii	Ex		E1
446	AlkLEviiEi	Ex		E1
447	AlkLEviiEii	Ex		E1
448	AlkLEviiEiiEiib	Ex		E1
449	AlkLEviiEiii	Ex		E1
450	AlkLEviiEiv	Ex		E1
451	AlkLEvii	Ex	Ea	E1
452	AlkLEviiEi	Ex	Ea	E1
453	AlkLEviiEii	Ex	Ea	E1
454	AlkLEviiEiiEiib	Ex	Ea	E1
455	AlkLEviiEiii	Ex	Ea	E1
456	AlkLEviiEiv	Ex	Ea	E1
457	AlkLEvii	Ex	Eb	E1
458	AlkLEviiEi	Ex	Eb	E1
459	AlkLEviiEii	Ex	Eb	E1
460	AlkLEviiEiiEiib	Ex	Eb	E1
461	AlkLEviiEiii	Ex	Eb	E1
462	AlkLEviiEiv	Ex	Eb	E1
463	AlkLEvii	Ex	Ed	E1
464	AlkLEviiEi	Ex	Ed	E1
465	AlkLEviiEii	Ex	Ed	E1
466	AlkLEviiEiiEiib	Ex	Ed	E1
467	AlkLEviiEiii	Ex	Ed	E1
468	AlkLEviiEiv	Ex	Ed	E1
469	AlkLEvii	Ex	Ee	E1
470	AlkLEviiEi	Ex	Ee	E1
471	AlkLEviiEii	Ex	Ee	E1
472	AlkLEviiEiiEiib	Ex	Ee	E1
473	AlkLEviiEiii	Ex	Ee	E1
474	AlkLEviiEiv	Ex	Ee	E1
475	AlkLEvii	Ex	Ef	E1
476	AlkLEviiEi	Ex	Ef	E1
477	AlkLEviiEii	Ex	Ef	E1
478	AlkLEviiEiiEiib	Ex	Ef	E1
479	AlkLEviiEiii	Ex	Ef	E1
480	AlkLEviiEiv	Ex	Ef	E1
481	AlkLEvii	EviEviii		E1
482	AlkLEviiEi	EviEviii		E1
483	AlkLEviiEii	EviEviii		E1
484	AlkLEviiEiiEiib	EviEviii		E1
485	AlkLEviiEiii	EviEviii		E1
486	AlkLEviiEiv	EviEviii		E1
487	AlkLEvii	EviEviii	Ea	E1
488	AlkLEviiEi	EviEviii	Ea	E1
489	AlkLEviiEii	EviEviii	Ea	E1
490	AlkLEviiEiiEiib	EviEviii	Ea	E1
491	AlkLEviiEiii	EviEviii	Ea	E1
492	AlkLEviiEiv	EviEviii	Ea	E1
493	AlkLEvii	EviEviii	Eb	E1
494	AlkLEviiEi	EviEviii	Eb	E1
495	AlkLEviiEii	EviEviii	Eb	E1
496	AlkLEviiEiiEiib	EviEviii	Eb	E1
497	AlkLEviiEiii	EviEviii	Eb	E1
498	AlkLEviiEiv	EviEviii	Eb	E1
499	AlkLEvii	EviEviii	Ed	E1
500	AlkLEviiEi	EviEviii	Ed	E1
501	AlkLEviiEii	EviEviii	Ed	E1
502	AlkLEviiEiiEiib	EviEviii	Ed	E1
503	AlkLEviiEiii	EviEviii	Ed	E1
504	AlkLEviiEiv	EviEviii	Ed	E1
505	AlkLEvii	EviEviii	Ee	E1
506	AlkLEviiEi	EviEviii	Ee	E1
507	AlkLEviiEii	EviEviii	Ee	E1
508	AlkLEviiEiiEiib	EviEviii	Ee	E1
509	AlkLEviiEiii	EviEviii	Ee	E1
510	AlkLEviiEiv	EviEviii	Ee	E1
511	AlkLEvii	EviEviii	Ef	E1
512	AlkLEviiEi	EviEviii	Ef	E1
513	AlkLEviiEii	EviEviii	Ef	E1
514	AlkLEviiEiiEiib	EviEviii	Ef	E1
515	AlkLEviiEiii	EviEviii	Ef	E1
516	AlkLEviiEiv	EviEviii	Ef	E1
517	AlkLEvii	EiibEviEx		E1
518	AlkLEviiEi	EiibEviEx		E1
519	AlkLEviiEii	EiibEviEx		E1
520	AlkLEviiEiiEiib	EiibEviEx		E1
521	AlkLEviiEiii	EiibEviEx		E1
522	AlkLEviiEiv	EiibEviEx		E1
523	AlkLEvii	EiibEviEx		E1
524	AlkLEviiEi	EiibEviEx		E1
525	AlkLEviiEii	EiibEviEx		E1
526	AlkLEviiEiiEiib	EiibEviEx		E1
527	AlkLEviiEiii	EiibEviEx		E1
528	AlkLEviiEiv	EiibEviEx		E1
529	AlkLEvii	EiibEviEx	Ea	E1
530	AlkLEviiEi	EiibEviEx	Ea	E1
531	AlkLEviiEii	EiibEviEx	Ea	E1
532	AlkLEviiEiiEiib	EiibEviEx	Ea	E1
533	AlkLEviiEiii	EiibEviEx	Ea	E1
534	AlkLEviiEiv	EiibEviEx	Ea	E1
535	AlkLEvii	EiibEviEx	Eb	E1
536	AlkLEviiEi	EiibEviEx	Eb	E1
537	AlkLEviiEii	EiibEviEx	Eb	E1
538	AlkLEviiEiiEiib	EiibEviEx	Eb	E1
539	AlkLEviiEiii	EiibEviEx	Eb	E1
540	AlkLEviiEiv	EiibEviEx	Eb	E1
541	AlkLEvii	EiibEviEx	Ed	E1
542	AlkLEviiEi	EiibEviEx	Ed	E1
543	AlkLEviiEii	EiibEviEx	Ed	E1
544	AlkLEviiEiiEiib	EiibEviEx	Ed	E1
545	AlkLEviiEiii	EiibEviEx	Ed	E1
546	AlkLEviiEiv	EiibEviEx	Ed	E1
547	AlkLEvii	EiibEviEx	Ee	E1
548	AlkLEviiEi	EiibEviEx	Ee	E1
549	AlkLEviiEii	EiibEviEx	Ee	E1
550	AlkLEviiEiiEiib	EiibEviEx	Ee	E1
551	AlkLEviiEiii	EiibEviEx	Ee	E1
552	AlkLEviiEiv	EiibEviEx	Ee	E1
553	AlkLEvii	EiibEviEx	Ef	E1
554	AlkLEviiEi	EiibEviEx	Ef	E1
555	AlkLEviiEii	EiibEviEx	Ef	E1
556	AlkLEviiEiiEiib	EiibEviEx	Ef	E1
557	AlkLEviiEiii	EiibEviEx	Ef	E1
558	AlkLEviiEiv	EiibEviEx	Ef	E1
559	AlkLEvii	EiibEviEx		E1
560	AlkLEviiEi	EiibEviEx		E1
561	AlkLEviiEii	EiibEviEx		E1
562	AlkLEviiEiiEiib	EiibEviEx		E1
563	AlkLEviiEiii	EiibEviEx		E1
564	AlkLEviiEiv	EiibEviEx		E1
565	AlkLExiiiEvii	Eviii		E1
566	AlkLExiiiEviiEi	Eviii		E1
567	AlkLExiiiEviiEii	Eviii		E1
568	AlkLExiiiEviiEiiEiib	Eviii		E1
569	AlkLExiiiEviiEiii	Eviii		E1
570	AlkLExiiiEviiEiv	Eviii		E1
571	AlkLExiiiEvii	Eviii	Ea	E1
572	AlkLExiiiEviiEi	Eviii	Ea	E1
573	AlkLExiiiEviiEii	Eviii	Ea	E1
574	AlkLExiiiEviiEiiEiib	Eviii	Ea	E1
575	AlkLExiiiEviiEiii	Eviii	Ea	E1
576	AlkLExiiiEviiEiv	Eviii	Ea	E1
577	AlkLExiiiEvii	Eviii	Eb	E1
578	AlkLExiiiEviiEi	Eviii	Eb	E1
579	AlkLExiiiEviiEii	Eviii	Eb	E1
580	AlkLExiiiEviiEiiEiib	Eviii	Eb	E1
581	AlkLExiiiEviiEiii	Eviii	Eb	E1
582	AlkLExiiiEviiEiv	Eviii	Eb	E1
583	AlkLExiiiEvii	Eviii	Ed	E1
584	AlkLExiiiEviiEi	Eviii	Ed	E1
585	AlkLExiiiEviiEii	Eviii	Ed	E1
586	AlkLExiiiEviiEiiEiib	Eviii	Ed	E1
587	AlkLExiiiEviiEiii	Eviii	Ed	E1
588	AlkLExiiiEviiEiv	Eviii	Ed	E1
589	AlkLExiiiEvii	Eviii	Ee	E1
590	AlkLExiiiEviiEi	Eviii	Ee	E1
591	AlkLExiiiEviiEii	Eviii	Ee	E1
592	AlkLExiiiEviiEiiEiib	Eviii	Ee	E1
593	AlkLExiiiEviiEiii	Eviii	Ee	E1
594	AlkLExiiiEviiEiv	Eviii	Ee	E1
595	AlkLExiiiEvii	Eviii	Ef	E1
596	AlkLExiiiEviiEi	Eviii	Ef	E1
597	AlkLExiiiEviiEii	Eviii	Ef	E1
598	AlkLExiiiEviiEiiEiib	Eviii	Ef	E1
599	AlkLExiiiEviiEiii	Eviii	Ef	E1
600	AlkLExiiiEviiEiv	Eviii	Ef	E1
601	AlkLExiiiEvii	Eix		E1
602	AlkLExiiiEviiEi	Eix		E1
603	AlkLExiiiEviiEii	Eix		E1
604	AlkLExiiiEviiEiiEiib	Eix		E1
605	AlkLExiiiEviiEiii	Eix		E1
606	AlkLExiiiEviiEiv	Eix		E1
607	AlkLExiiiEvii	Eix	Ea	E1
608	AlkLExiiiEviiEi	Eix	Ea	E1
609	AlkLExiiiEviiEii	Eix	Ea	E1
610	AlkLExiiiEviiEiiEiib	Eix	Ea	E1
611	AlkLExiiiEviiEiii	Eix	Ea	E1
612	AlkLExiiiEviiEiv	Eix	Ea	E1
613	AlkLExiiiEvii	Eix	Eb	E1
614	AlkLExiiiEviiEi	Eix	Eb	E1
615	AlkLExiiiEviiEii	Eix	Eb	E1
616	AlkLExiiiEviiEiiEiib	Eix	Eb	E1
617	AlkLExiiiEviiEiii	Eix	Eb	E1
618	AlkLExiiiEviiEiv	Eix	Eb	E1
619	AlkLExiiiEvii	Eix	Ed	E1
620	AlkLExiiiEviiEi	Eix	Ed	E1
621	AlkLExiiiEviiEii	Eix	Ed	E1
622	AlkLExiiiEviiEiiEiib	Eix	Ed	E1
623	AlkLExiiiEviiEiii	Eix	Ed	E1
624	AlkLExiiiEviiEiv	Eix	Ed	E1
625	AlkLExiiiEvii	Eix	Ee	E1
626	AlkLExiiiEviiEi	Eix	Ee	E1
627	AlkLExiiiEviiEii	Eix	Ee	E1
628	AlkLExiiiEviiEiiEiib	Eix	Ee	E1
629	AlkLExiiiEviiEiii	Eix	Ee	E1
630	AlkLExiiiEviiEiv	Eix	Ee	E1
631	AlkLExiiiEvii	Eix	Ef	E1
632	AlkLExiiiEviiEi	Eix	Ef	E1
633	AlkLExiiiEviiEii	Eix	Ef	E1
634	AlkLExiiiEviiEiiEiib	Eix	Ef	E1
635	AlkLExiiiEviiEiii	Eix	Ef	E1
636	AlkLExiiiEviiEiv	Eix	Ef	E1
637	AlkLExiiiEvii	Ex		E1
638	AlkLExiiiEviiEi	Ex		E1
639	AlkLExiiiEviiEii	Ex		E1
640	AlkLExiiiEviiEiiEiib	Ex		E1
641	AlkLExiiiEviiEiii	Ex		E1
642	AlkLExiiiEviiEiv	Ex		E1
643	AlkLExiiiEvii	Ex	Ea	E1
644	AlkLExiiiEviiEi	Ex	Ea	E1
645	AlkLExiiiEviiEii	Ex	Ea	E1
646	AlkLExiiiEviiEiiEiib	Ex	Ea	E1
647	AlkLExiiiEviiEiii	Ex	Ea	E1
648	AlkLExiiiEviiEiv	Ex	Ea	E1
649	AlkLExiiiEvii	Ex	Eb	E1
650	AlkLExiiiEviiEi	Ex	Eb	E1
651	AlkLExiiiEviiEii	Ex	Eb	E1
652	AlkLExiiiEviiEiiEiib	Ex	Eb	E1
653	AlkLExiiiEviiEiii	Ex	Eb	E1
654	AlkLExiiiEviiEiv	Ex	Eb	E1
655	AlkLExiiiEvii	Ex	Ed	E1
656	AlkLExiiiEviiEi	Ex	Ed	E1
657	AlkLExiiiEviiEii	Ex	Ed	E1
658	AlkLExiiiEviiEiiEiib	Ex	Ed	E1
659	AlkLExiiiEviiEiii	Ex	Ed	E1
660	AlkLExiiiEviiEiv	Ex	Ed	E1
661	AlkLExiiiEvii	Ex	Ee	E1
662	AlkLExiiiEviiEi	Ex	Ee	E1
663	AlkLExiiiEviiEii	Ex	Ee	E1
664	AlkLExiiiEviiEiiEiib	Ex	Ee	E1
665	AlkLExiiiEviiEiii	Ex	Ee	E1
666	AlkLExiiiEviiEiv	Ex	Ee	E1
667	AlkLExiiiEvii	Ex	Ef	E1
668	AlkLExiiiEviiEi	Ex	Ef	E1
669	AlkLExiiiEviiEii	Ex	Ef	E1
670	AlkLExiiiEviiEiiEiib	Ex	Ef	E1
671	AlkLExiiiEviiEiii	Ex	Ef	E1
672	AlkLExiiiEviiEiv	Ex	Ef	E1
673	AlkLExiiiEvii	EviEviii		E1
674	AlkLExiiiEviiEi	EviEviii		E1
675	AlkLExiiiEviiEii	EviEviii		E1
676	AlkLExiiiEviiEiiEiib	EviEviii		E1
677	AlkLExiiiEviiEiii	EviEviii		E1
678	AlkLExiiiEviiEiv	EviEviii		E1
679	AlkLExiiiEvii	EviEviii	Ea	E1
680	AlkLExiiiEviiEi	EviEviii	Ea	E1
681	AlkLExiiiEviiEii	EviEviii	Ea	E1
682	AlkLExiiiEviiEiiEiib	EviEviii	Ea	E1
683	AlkLExiiiEviiEiii	EviEviii	Ea	E1
684	AlkLExiiiEviiEiv	EviEviii	Ea	E1
685	AlkLExiiiEvii	EviEviii	Eb	E1
686	AlkLExiiiEviiEi	EviEviii	Eb	E1
687	AlkLExiiiEviiEii	EviEviii	Eb	E1
688	AlkLExiiiEviiEiiEiib	EviEviii	Eb	E1
689	AlkLExiiiEviiEiii	EviEviii	Eb	E1
690	AlkLExiiiEviiEiv	EviEviii	Eb	E1
691	AlkLExiiiEvii	EviEviii	Ed	E1
692	AlkLExiiiEviiEi	EviEviii	Ed	E1
693	AlkLExiiiEviiEii	EviEviii	Ed	E1
694	AlkLExiiiEviiEiiEiib	EviEviii	Ed	E1
695	AlkLExiiiEviiEiii	EviEviii	Ed	E1
696	AlkLExiiiEviiEiv	EviEviii	Ed	E1
697	AlkLExiiiEvii	EviEviii	Ee	E1
698	AlkLExiiiEviiEi	EviEviii	Ee	E1
699	AlkLExiiiEviiEii	EviEviii	Ee	E1
700	AlkLExiiiEviiEiiEiib	EviEviii	Ee	E1
701	AlkLExiiiEviiEiii	EviEviii	Ee	E1
702	AlkLExiiiEviiEiv	EviEviii	Ee	E1
703	AlkLExiiiEvii	EviEviii	Ef	E1
704	AlkLExiiiEviiEi	EviEviii	Ef	E1
705	AlkLExiiiEviiEii	EviEviii	Ef	E1
706	AlkLExiiiEviiEiiEiib	EviEviii	Ef	E1
707	AlkLExiiiEviiEiii	EviEviii	Ef	E1
708	AlkLExiiiEviiEiv	EviEviii	Ef	E1
709	AlkLExiiiEvii	EiibEviEx		E1
710	AlkLExiiiEviiEi	EiibEviEx		E1
711	AlkLExiiiEviiEii	EiibEviEx		E1
712	AlkLExiiiEviiEiiEiib	EiibEviEx		E1
713	AlkLExiiiEviiEiii	EiibEviEx		E1
714	AlkLExiiiEviiEiv	EiibEviEx		E1
715	AlkLExiiiEvii	EiibEviEx	Ea	E1
716	AlkLExiiiEviiEi	EiibEviEx	Ea	E1
717	AlkLExiiiEviiEii	EiibEviEx	Ea	E1
718	AlkLExiiiEviiEiiEiib	EiibEviEx	Ea	E1
719	AlkLExiiiEviiEiii	EiibEviEx	Ea	E1
720	AlkLExiiiEviiEiv	EiibEviEx	Ea	E1
721	AlkLExiiiEvii	EiibEviEx	Eb	E1
722	AlkLExiiiEviiEi	EiibEviEx	Eb	E1
723	AlkLExiiiEviiEii	EiibEviEx	Eb	E1
724	AlkLExiiiEviiEiiEiib	EiibEviEx	Eb	E1
725	AlkLExiiiEviiEiii	EiibEviEx	Eb	E1
726	AlkLExiiiEviiEiv	EiibEviEx	Eb	E1
727	AlkLExiiiEvii	EiibEviEx	Ed	E1
728	AlkLExiiiEviiEi	EiibEviEx	Ed	E1
729	AlkLExiiiEviiEii	EiibEviEx	Ed	E1
730	AlkLExiiiEviiEiiEiib	EiibEviEx	Ed	E1
731	AlkLExiiiEviiEiii	EiibEviEx	Ed	E1
732	AlkLExiiiEviiEiv	EiibEviEx	Ed	E1
733	AlkLExiiiEvii	EiibEviEx	Ee	E1
734	AlkLExiiiEviiEi	EiibEviEx	Ee	E1
735	AlkLExiiiEviiEii	EiibEviEx	Ee	E1
736	AlkLExiiiEviiEiiEiib	EiibEviEx	Ee	E1
737	AlkLExiiiEviiEiii	EiibEviEx	Ee	E1
738	AlkLExiiiEviiEiv	EiibEviEx	Ee	E1
739	AlkLExiiiEvii	EiibEviEx	Ef	E1
740	AlkLExiiiEviiEi	EiibEviEx	Ef	E1
741	AlkLExiiiEviiEii	EiibEviEx	Ef	E1
742	AlkLExiiiEviiEiiEiib	EiibEviEx	Ef	E1
743	AlkLExiiiEviiEiii	EiibEviEx	Ef	E1
744	AlkLExiiiEviiEiv	EiibEviEx	Ef	E1

Especially preferred alternative embodiments of microorganisms according to the invention are explained hereinafter:

For preparing carboxylic acids with 6 to 18 carbon atoms, in particular fatty acids, microorganisms according to the invention which are particularly preferably suitable are characterized in that the first genetic modification is an activity which is increased in comparison with the enzymatic activity of the wild type of the microorganism of at least one of the enzymes E_i which comprises sequences selected from among: AAC49180.1 (encoded by SEQ ID No.: 10), AAC49269.1 (encoded by SEQ ID No.: 8), Q39513.1 (encoded by SEQ ID No.: 9), AAC49001.1 (encoded by SEQ ID No.: 37), AEM72521.1 (encoded by SEQ ID No.: 35)

andproteins having a polypeptide sequence in which up to 60%, preferably up to 25%, particularly preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_i is generally understood in particular as meaning the hydrolysis of dodecanoyl-ACP thioester,and the alkL gene product is selected from among those that are encoded by the alkL gene of Pseudomonas putida GPo1, which is rendered by SEQ ID No. 1, and proteins with polypeptide sequence SEQ ID No. 2, SEQ ID No. 31, SEQ ID No. 32 or SEQ ID No. 33 or with a polypeptide sequence in which up to 60%, preferably up to 25%, particularly preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with SEQ ID No. 2, SEQ ID No. 31, SEQ ID No. 32 or SEQ ID No. 33 by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, particularly preferably 80%, in particular more than 90%, of the activity of the protein with the respective reference sequence SEQ ID No. 2, SEQ ID No. 31, SEQ ID No. 32 or SEQ ID No. 33, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, more particularly in a system as is described in the exemplary embodiments, in which glucose is reacted to form palmitoleic acid in an E. coli cell.

In this context it can be advantageous when the microorganism contains a fifth genetic modification which has an activity which is reduced compared with the enzymatic activity of the wild type of the microorganism of at least one of the enzymes E_b, where E_b is selected from among enzymes which comprise sequences selected from YP_—488518.1 (encoded by SEQ ID No. 14, formerly AP_—000876.1) and

proteins having a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% of the activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_b is generally understood in particular as meaning the oxidation of dodecanoyl-CoA thioester to 2-dodecenoyl-CoA thioester.

For producing esters of carboxylic acids having 6 to 18 carbon atoms in the carboxylic acid portion in which the alcohol component is derived from methanol or ethanol, especially preferably, microorganisms according to the invention are suitable which are characterized in that the first genetic modification is an activity which is increased in comparison with the enzymatic activity of the wild type of the microorganism of at least one of the enzymes E_i, which comprises sequences selected from among: AAC49180.1 (encoded by SEQ ID No.: 10), AAC49269.1 (encoded by SEQ ID No.: 8), Q39513.1 (encoded by SEQ ID No.: 9), AAC49001.1 (encoded by SEQ ID No.: 37), AEM72521.1 (encoded by SEQ ID No.: 35)

andproteins having a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_i is generally understood in particular as meaning the hydrolysis of dodecanoyl-ACP thioester,andthe alkL gene product is selected from those which are encoded by the alkL gene of Pseudomonas putida GPo1, which is rendered by SEQ ID No. 1, and proteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with SEQ ID No. 2 by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90% of the activity of the protein with the reference sequence SEQ ID No. 2, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, namely in a system as described in the exemplary embodiments in which glucose is reacted to form palmitoleic acid in an E. coli cell,andin that it has a third genetic modification which has an activity of the enzymes E_v and E_vi, which is increased in comparison with the enzymatic activity of the wild type of the microorganism,where E_v is selected from among YP_—694462.1 (encoded by SEQ ID No. 67) and YP_—045555.1 (encoded by SEQ ID No. 19), andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequence by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_v is generally understood in particular as meaning the conversion of dodecanoyl-CoA thioester with methanol to form dodecanoyl methyl ester,and E_vi is selected from among YP_—001724804.1 (encoded by SEQ ID No.: 18), and proteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequence by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_vi is generally understood in particular as meaning the synthesis of dodecanoyl-CoA thioester.

In this context, it can also be advantageous if the microorganism contains a fifth genetic modification which has an activity which is reduced compared with the enzymatic activity of the wild type of the microorganism of at least one of the enzymes E_b, where E_b is selected from enzymes which comprises sequences that are selected from among YP_—488518.1 (encoded by SEQ ID No. 14, formerly AP_—000876.1), and

proteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_b is generally understood in particular as meaning the oxidation of dodecanoyl-CoA thioester to form 2-dodecenoyl-CoA thioester.

In an alternative embodiment for producing esters of carboxylic acid with 6 to 18 carbon atoms in the carboxylic acid portion, in which the alcohol component is derived from methanol or ethanol, microorganisms according to the invention suitable which are particularly preferably are characterized in that the first genetic modification is an activity which is increased in comparison with the enzymatic activity of the wild type of at least one of the enzymes E_i which comprises sequences that are selected from among: AAC49269.1 (encoded by SEQ ID No.: 8), Q39513.1 (encoded by SEQ ID No.: 9), AAC49001.1 (encoded by SEQ ID No.: 37), AEM72521.1 (encoded by SEQ ID No.: 35)

andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_i is generally understood in particular as meaning the hydrolysis of dodecanoyl-ACP thioester,andthe alkL gene product is selected from those which are encoded by the alkL gene of Pseudomonas putida GPo1, which is shown by SEQ ID No. 1, and proteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with SEQ ID No. 2 by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the reference sequence SEQ ID No. 2, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, more precisely in a system as described in the exemplary embodiments in which glucose is reacted to form palmitoleic acid in an E. coli cell,andin that it has a third genetic modification which has an activity which is increased in comparison with the enzymatic activity of the wild type of the microorganism of the enzyme E_va,where E_va is selected from among YP_—888622.1 (encoded by SEQ ID No. 114) and proteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequence by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_va is generally understood in particular as meaning the conversion of lauric acid and S-adenosylmethionine to form lauric acid methyl ester and S-adenosylhomocysteine.

In this context it can also be advantageous if the microorganism contains a fifth genetic modification which has an activity which is reduced compared with the enzymatic activity of the wild type of the microorganism of at least one of the enzymes E_b, where E_b is selected from enzymes which have sequences that are selected from among YP_—488518.1 (encoded by SEQ ID No. 14, formerly AP_—000876.1), and

proteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_b is generally understood in particular as meaning the oxidation of dodecanoyl-CoA thioester to give 2-dodecenoyl-CoA thioester.

For production of monohydric alcohols with 6 to 18 carbon atoms, microorganisms according to the invention which are especially preferably suitable are characterized in that the first genetic modification is an activity that is increased in comparison with the enzymatic activity of the wild type of the microorganism of at least one of the enzymes E_i which comprises sequences selected from among: AAC49269.1 (encoded by SEQ ID No: 8), AEM72521.1 (encoded by SEQ ID No: 35)

andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_i is generally understood in particular as meaning the hydrolysis of dodecanoyl-ACP thioester,andthe alkL gene product is selected from among those encoded by the alkL gene of Pseudomonas putida GPo1, which is shown by SEQ ID No. 1, and proteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with SEQ ID No. 2 by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the reference sequence SEQ ID No. 2, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, namely in a system as described in the exemplary embodiments in which glucose is reacted to form palmitoleic acid in an E. coli cell, and in that it has a third genetic modification which has an activity which is increased in comparison with the enzymatic activity of the wild type of the microorganism of the enzyme E_vi,where E_vi is selected from among YP_—001724804.1 (encoded by SEQ ID No: 18)andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequence by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_vi is generally understood in particular as meaning the synthesis of dodecanoyl-CoA thioester, andin that it has a fourth genetic modification which has an activity which is increased in comparison with the enzymatic activity of the wild type of the microorganism of the enzyme E_x, where E_x is selected from among BAB85476.1 (encoded by SEQ ID No. 77), YP_—047869.1 (encoded by SEQ ID No. 79 or 81), YP_—959486.1 (encoded by SEQ ID No. 83), YP_—959769.1 (encoded by SEQ ID No. 139), B9TSP7.1 (encoded by SEQ ID No. 141), andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), in comparison with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_x is generally understood in particular as meaning the synthesis of lauryl alcohol and NAD(P)⁺ from lauryl-ACP, NAD(P)H and H⁺. In this context it can also be advantageous if the microorganism contains a fifth genetic modification which has an activity which is reduced compared with the enzymatic activity of the wild type of the microorganism of at least one of the enzymes E_b, wherein E_b is selected from enzymes that have sequences which are selected from among YP_—488518.1 (encoded by SEQ ID No. 14, formerly AP_—000876.1), andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution, or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_b is generally understood in particular as meaning the oxidation of dodecanoyl-CoA thioester to form 2-dodecenoyl-CoA thioester.

For producing monohydric alcohols and aldehydes with 6 to 18 carbon atoms, microorganisms according to the invention which are especially preferably suitable are characterized in that the first genetic modification is an activity that is increased in comparison with the enzymatic activity of the wild type of the microorganism of at least one of the enzymes E_i which comprises sequences selected from among: AAC49269.1 (encoded by SEQ ID No: 8), Q39513.1 (encoded by SEQ ID No: 9), AAC49001.1 (encoded by SEQ ID No: 37), AEM72521.1 (encoded by SEQ ID No: 35)

andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_i is generally understood in particular as meaning the hydrolysis of dodecanoyl-ACP thioester,andthe alkL gene product is selected from those encoded by the alkL gene of Pseudomonas putida GPo1, which is shown by SEQ ID No. 1, and proteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with SEQ ID No. 2 by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the reference sequence SEQ ID No. 2, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, namely in a system as described in the exemplary embodiments, in which glucose is reacted to form palmitoleic acid in an E. coli cell,andin that it has a fourth genetic modification which has an activity which is increased in comparison with the enzymatic activity of the wild type of the microorganism of the enzyme E_ix, where E_ix is selected from among YP_—887275.1 (encoded by SEQ ID No. 117), ABI83656.1 (encoded by SEQ ID No. 122), andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_ix is generally understood in particular as meaning the synthesis of lauryl aldehyde, NADP, AMP and 2 P_i from lauric acid, ATP, NADPH and H⁺.

In this context it can also be advantageous if the microorganism contains a fifth genetic modification which has an activity which is reduced in comparison with the enzymatic activity of the wild type of the microorganism of at least one of the enzymes E_b, where E_b is selected from enzymes which comprise sequences selected from among YP_—488518.1 (encoded by SEQ ID No. 14, formerly AP_—000876.1), and

proteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_b is generally understood in particular as meaning the oxidation of dodecanoyl-CoA thioester to form 2-dodecenoyl-CoA thioester.

For production of alkylamines with 8 to 16 carbon atoms, microorganisms according to the invention which are especially preferably suitable are characterized in that the first genetic modification is an activity that is increased in comparison with the enzymatic activity of the wild type of the microorganism of at least one of the enzymes E_i, which comprises sequences that are selected from among: AAC49269.1 (encoded by SEQ ID No: 8), Q39513.1 (encoded by SEQ ID No: 9), AAC49001.1 (encoded by SEQ ID No: 37),

andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), in comparison with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_i is generally understood in particular as meaning the hydrolysis of dodecanoyl-ACP thioester,andthe alkL gene product is selected from those encoded by the alkL gene of Pseudomonas putida GPo1, which is shown by SEQ ID No. 1, and proteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with SEQ ID No. 2 by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the reference sequence SEQ ID No. 2, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, more precisely in a system as described in the exemplary embodiments in which glucose is reacted to form palmitoleic acid in an E. coli cell,andit has a fourth genetic modification which has an activity which is increased in comparison with the enzymatic activity of the wild type of the microorganism of at least one enzyme E_xiii, where this is selected from among NP_—901695.1 (encoded by SEQ ID No. 132) andproteins having a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequence by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_xiii is generally understood in particular as meaning the reaction of ω-oxolauric acid and/or ω-oxolauric acid methyl ester to form ω-aminolauric acid and/or ω-aminolauric acid methyl ester.

It can also be advantageous in this context if the microorganism contains a fifth genetic modification which has an activity which is reduced in comparison with the enzymatic activity of the wild type of the microorganism of at least one of the enzymes E_b, where E_b is selected from enzymes which have sequences selected from among YP_—488518.1 (encoded by SEQ ID No. 14, formerly AP_—000876.1), and

proteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_b is generally understood in particular as meaning the oxidation of dodecanoyl-CoA thioester to form 2-dodecenoyl-CoA thioester.

For production of alkenes with 6 to 18 carbon atoms, microorganisms according to the invention which are particularly preferably suitable are characterized in that the first genetic modification is an activity which is increased in comparison with the enzymatic activity of the wild type of the microorganism of at least one of the enzymes E_i, which comprises sequences selected from among: AAC49269.1 (encoded by SEQ ID No: 8), Q39513.1 (encoded by SEQ ID No: 9), AAC49001.1 (encoded by SEQ ID No: 37), AEM72521.1 (encoded by SEQ ID No: 35)

andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_i is generally understood in particular as meaning the hydrolysis of dodecanoyl-ACP thioester,andthe alkL gene product is selected from among those encoded by the alkL gene of Pseudomonas putida GPo1, which is shown by SEQ ID No. 1, and proteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with SEQ ID No. 2, by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the reference sequence SEQ ID No. 2, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, namely in a system as is described in the exemplary embodiments, in which glucose is reacted to form palmitoleic acid in an E. coli cell,andit has a fourth genetic modification which has an activity which is increased in comparison with the enzymatic activity of the wild type of the microorganism of at least one enzyme E_xi, where this is selected from among ADW41779.1 (encoded by SEQ ID No. 168) andproteins with a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequence by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_xiii is generally understood in particular as meaning the reaction of sodium palmitate with hydrogen peroxide to form pentadecene, CO₂ and water.

In this context it can also be advantageous if the microorganism contains a fifth genetic modification which has an activity which is reduced in comparison with the enzymatic activity of the wild type of the microorganism of at least one of the enzymes E_b, where E_b is selected from among enzymes which comprise sequences selected from among YP_—488518.1 (encoded by SEQ ID No. 14),

andproteins having a polypeptide sequence in which up to 60%, preferably up to 25%, especially preferably up to 15%, in particular up to 10, 9, 8, 7, 6, 5, 4, 3, 2, 1% of the amino acid residues are modified in comparison with the abovementioned reference sequences by deletion, insertion, substitution or a combination thereof and which still have at least 50%, preferably 65%, especially preferably 80%, in particular more than 90%, of the activity of the protein with the corresponding abovementioned reference sequence, where 100% activity of the reference protein is understood as meaning the increase of the activity of the cells used as biocatalyst, that is to say the amount of substance reacted per unit time, based on the cell weight used (units per gram of cell dry weight [U/g CDW]), compared with the activity of the biocatalyst without the presence of the reference protein, where activity in this context and in the context of the determination of the activity of the enzyme E_b is generally understood in particular as meaning the oxidation of dodecanoyl-CoA thioester to 2-dodecenoyl-CoA thioester.

Use of the Microorganisms According to the Invention

A further subject matter of the present invention relates to the use of the abovementioned microorganisms for the production of organic substances, in particular of fatty acids, fatty acid esters, alkan-1-als, alkan-1-ols and alkan-1-amines, alken-1-als, alken-1-ols, alken-1-amines, alkanes and alkenes, in particular 1-alkenes, which may optionally include a further double bond.

Organic substances and microorganisms which have been emphasized as being preferred in the context of the microorganisms according to the invention are also preferred in the context of the use according to the invention.

The organisms according to the invention which are preferably used for specific organic substances have already been emphasized in the context of the microorganisms according to the invention.

Process for the Production of an Organic Substance from a Simple Carbon Source

A further subject matter of the present invention relates to a process for the production of an organic substance, in particular of fatty acids, fatty acid esters, alkan-1-als, alkan-1-ols and alkan-1-amines, alken-1-als, alken-1-ols, alken-1-amines, alkanes and alkenes, in particular 1-alkenes, which may optionally include a further double bond, from a simple carbon source comprising the process steps

I) bringing a microorganism according to the invention into contact with a medium comprising the simple carbon source,II) culturing the microorganism under conditions which make it possible for the microorganism to form the organic substance from the simple carbon source, andIII) if appropriate, isolation of the organic substance formed.

In the process according to the invention, the microorganisms according to the invention may, for the purpose of producing the organic substance, be brought into contact with the nutrient medium and thus cultured continuously or discontinuously in the batch method or in the fed-batch method or in the repeated fed-batch method. Also feasible is a semicontinuous process as described in GB-A-1009370. A summary of known culture methods is described in the textbook by Chmiel (“Bioprozesstechnik 1. Einfuhrung in die Bioverfahrenstechnik”, Gustav Fischer Verlag, Stuttgart, 1991) or in the textbook by Storhas (“Bioreaktoren and periphere Einrichtungen”, Vieweg Verlag, Braunschweig/Wiesbaden, 1994).

The culture medium to be used must suitably satisfy the requirements of the respective strains. Descriptions of culture media of various microorganisms are contained in the handbook “Manual of Methods for General Bacteriology” of the American Society for Bacteriology (Washington D.C., USA, 1981).

In the process according to the invention, it is preferred to employ preferred microorganisms according to the invention.

The simple carbon source which is employed in the process according to the invention are those mentioned above as being preferred.

Nitrogen sources which can be employed are organic nitrogenous compounds such as peptones, yeast extract, meat extract, malt extract, cornsteep liquor, soyabean meal and urea or inorganic compounds such as ammonium sulphate, ammonium chloride, ammonium phosphate, ammonium carbonate and ammonium nitrate, ammonia, ammonium hydroxide or ammonia water. The nitrogen sources may be employed individually or as a mixture. Phosphorus sources which can be used are phosphoric acid, potassium dihydrogen phosphate or dipotassium hydrogen phosphate or the corresponding sodium-containing salts. The culture medium must furthermore contain salts of metals such as, for example, magnesium sulphate or iron sulphate, which are necessary for growth. Finally, essential growth factors such as amino acids and vitamins may be employed in addition to the abovementioned substances. Moreover, suitable precursors may be added to the culture medium. The feed substances mentioned may be added to the culture as a single batch or may be fed in a suitable manner during culturing. The pH of the culture is controlled by employing basic compounds such as sodium hydroxide, potassium hydroxide, ammonia or ammonia water, or acidic compounds such as phosphoric acid or sulphuric acid in a suitable manner. Foaming may be controlled by using antifoams such as, for example, fatty acid polyglycol esters. To maintain stability of plasmids, suitable selective substances such as antibiotics, for example, may be added to the medium. Oxygen or oxygen-containing gas mixtures such as, for example, air are introduced into the culture so as to maintain aerobic conditions.

According to one embodiment of the process according to the invention, said process is carried out in a two-phase system comprising

A) an aqueous phase andB) an organic phase,where the organic substance is formed by the microorganism in process step II) in the aqueous phase and the organic substance formed accumulates in the organic phase. In this manner, it is possible for the organic substance formed to be extracted in situ.

Preferred organic substances which are produced by the process according to the invention are the substances mentioned hereinabove as being preferred, in particular the fatty acids and fatty acid derivatives.

In the examples mentioned hereinbelow, the present invention will be described with the aid of examples without it being intended to limit the invention, whose scope of use is revealed in the entire description and the claims, to the embodiments mentioned in the examples.

The organisms according to the invention which are preferably employed for specific organic substances in preferred processes according to the invention have already been emphasized in the context of the microorganisms according to the invention.

EXAMPLES

Example 1

Preparation of an E. coli Expression Vector for the Overexpression of the alkL Gene from P. putida GPo1

To prepare an E. coli expression vector for the overexpression of the Pseudomonas putida alkL gene (SEQ ID No.: 01), this gene was prepared synthetically and then amplified like the P_lacuv5 promoter (SEQ ID No.: 34) from a pJ294 derivative, with the introduction of homologous regions for recombination cloning. At the same time, a cleavage site was introduced upstream of the promoter and a cleavage site was introduced downstream of the alkL stop codon via the oligonucleotides used.

The following oligonucleotides were employed for the amplification of the alkL gene and the P_lacuv5 promoter from the respective pJ294 derivatives as the template:

Promoter region:
(SEQ ID No.: 03)
fw-Prom + H1: 5′-ACC ACA GCC AGG ATC CTT CAA TAT
              TAT TGA AGC-3′
(SEQ ID No.: 04)
rv-Prom:      5′-ATG CCA CTC TCC TTG-3′
(SEQ ID No.: 05)
fw-alkL + H2: 5′-CAA GGA GAG TGG CAT GTG AGT TTT
              TCT AAT TAT -3′
(SEQ ID No.: 06)
rv-alkL + H3: 5′-TTA CCA GAC TCG AGG GTA CCT TAG
              AAA ACA TAT GAC-3′

The following parameters were employed for the PCR: 1×: initial denaturation, 98° C., 0:30 min; 35×: denaturation, 98° C., 0:30 min, annealing, 50.5° C., 0:45 min; elongation, 72° C., 0:15 min; 1×: terminal elongation, 72° C., 5 min. The Phusion™ High-Fidelity Master Mix from New England Biolabs (Frankfurt) was used for the amplification, following the manufacturer's recommendations. Thereafter, in each case 100 μl of the PCR reactions were separated on a 2% agarose gel. The procedure of the PCR, the agarose gel electrophoresis, the ethidium bromide staining of the DNA and the determination of the PCR fragment sizes were carried out in a manner known to the skilled worker.

In both cases, PCR fragments of the expected size were successfully amplified. The size was 654 base pairs for the promoter region and 728 base pairs for the alkL construct.

To isolate the DNA from an agarose gel, the target DNA was excised from the gel using a surgical blade and purified using the “Quick Gel Extraction Kit” from Qiagen (Hilden). This was done following the manufacturer's instructions. In the next step, the PCR products together with the BamHI-KpnI-cut pCDFDuet-1 (71340-3, Merck, Darmstadt) underwent recombination by means of in vitro cloning using the “In-Fusion Advantage PCR Cloning Kit” from Clontech (Saint-Germain-en-Laye), giving rise to the resulting vector. The use corresponded to the manufacturer's instructions.

pCDFDuet-1 is an E. coli vector which confers spectinomycin/streptomycin resistance to the organism and which contains a CoIDF13 replication origin. The transformation of chemically competent E. coli DH5α cells (New England Biolabs, Frankfurt) was performed in the manner known to the skilled worker.

The correctness of the plasmid was checked by restriction analysis with XbaI. The authenticity of the inserted fragments was verified by DNA sequencing. The finished E. coli expression vector was named pCDF[alkL] (SEQ ID No.:07).

Example 2

Preparation of Expression Vectors for the fatB2 and fatB1 Genes from Cuphea hookeriana and fatB2 from Cuphea palustris

To prepare expression vectors for the fatB2 and fatB1 genes from Cuphea hookeriana (SEQ ID No. 08 and SEQ ID No. 09, respectively) and fatB2 from Cuphea palustris (SEQ ID No. 10), these genes were codon-optimized for the expression in Escherichia coli. The genes were synthesized together with a tac promoter (SEQ ID No. 39) and, simultaneously, a cleavage site was introduced upstream of the promoter and a cleavage site was introduced downstream of the terminator. The synthesized DNA fragments P_tac-ChFatB2, P_tac-ChFatB1 and P_tac-CpFatB2 were digested with the restriction endonucleases BamHI and NotI and ligated into the correspondingly cut vector pJ294 (DNA 2.0 Inc.; Menlo Park, Calif., USA). The finished E. coli expression vectors were named pJ294[Ptac-ChFATB2_optEc] (SEQ ID No. 11), pJ294[Ptac-CpFATB2_optEc] (SEQ ID No. 13) and pJ294[Ptac-ChFATB1_optEc] (SEQ ID No. 12), respectively.

Example 3

Chromatographic Quantification of Products

Fatty acids were quantified following derivatization as fatty acid methyl esters, using gas chromatography. After the addition of 1 ml of acetone and 2 ml of water, 50 μl of heptadecanoic acid (10 g/l dissolved in ethanol) were added as internal reference substance to the samples, consisting of 2 ml of culture broth. The samples were acidified with 200 μl of acetic acid and treated with 10 ml of a 1:1 (v/v) chloroform/methanol mixture. The samples were mixed thoroughly for at least 1 min. Thereafter, the chloroform phase was removed and evaporated. The dry residue was taken up in 1 ml of 1.25 M methanolic hydrochloric acid and incubated at 50° C. overnight to esterify the fatty acids present. The reaction was stopped by addition of 5 ml of saturated sodium carbonate solution (all substances from Sigma-Aldrich, Steinheim). The fatty acid methyl esters were extracted by addition of 1 ml of n-heptane and mixing vigorously for 15 seconds. The heptane phase was measured by means of gas chromatography. To separate fatty acid methyl esters, the capillary column SP™-2560 of dimensions 100 m×0.25 mm and a film thickness of 0.2 μm (Supelco, Sigma-Aldrich, Steinheim) was employed as the stationary phase. The carrier gas employed was helium. The separation was carried out within 45 min at an injector temperature of 260° C., a detector temperature of 260° C. and a column temperature of 140° C. at the beginning, held for 5 min, and increased to 240° C. at a rate of 4° C./min and held for 15 min. The injection volume was 1 μl, the split rate was 1:20 and the flow rate of the carrier gas 1 ml/min. Detection was by means of a flame ionization detector (GC Perkin Elmer Clarus 500, Perkin Elmer, Rodgau). Heptadecanoic acid (Sigma-Aldrich, Steinheim) was used as the internal reference substance for quantifying the fatty acid methyl esters. The reference substances C8:0-Me caprylic acid methyl ester, C10:0-Me capric acid methyl ester, C12:0-Me lauric acid methyl ester, C14:0-Me myristic acid methyl ester, C16:0-Me palmitic acid methyl ester, C16:1-Me palmitoleic acid methyl ester, C18:0-Me stearic acid methyl ester, C18:1-Me oleic acid methyl ester (GLC Standard Mix GLC-20 1892-1AMP, GLC-30 1893-1AMP, GLC-50 1894-1AMP, Sigma-Aldrich, Steinheim) were used for the calibration. The lower detection limits were a concentration of 10 mg/l for all fatty acid methyl esters.

Example 4

Production of Fatty Acids by E. coli Strains with Deletion in the fadE Gene, which Overexpress the alkL Genes from Pseudomonas putida GPo1 in Various Modifications and fatB2 from Cuphea hookeriana

The first step was to construct an E. coli strain with deletion in the fadE gene (SEQ ID No. 14). To make the gene deletion, a plasmid which carries the DNA sequence ΔfadE (SEQ ID No. 15) was constructed. This sequence was synthesized and is composed of homologous regions 500 base pairs upstream and downstream of the fadE gene and the recognition sequence for the restriction endonuclease NotI at the 5′ and the 3′ end. The sequence ΔfadE was digested with the restriction endonuclease NotI and ligated into the analogously cut vector pKO3. The strain E. coli W3110 ΔfadE was constructed using the pKO3-ΔfadE construct (SEQ ID No. 16) using methods known to the skilled worker (see Link A J, Phillips D, Church G M. J. Bacteriol. 1997. 179(20).). The DNA sequence after the deletion is shown in SEQ ID No. 17.

To generate E. coli strains with the expression vector for the alkL gene from Pseudomonas putida GPo1 in combination with the expression vector for the fatB2 gene from Cuphea hookeriana, electrocompetent cells of E. coli W3110 ΔfadE were prepared. This was done in a manner known to the skilled worker. The cells were transformed with the plasmids pCDFDuet-1 or pCDF[alkL] in combination with pJ294[Ptac-ChFATB2_optEc] and plated onto LB plates supplemented with spectinomycin (100 μg/ml) and ampicillin (100 μg/ml). Transformants were checked for the presence of the correct plasmids by plasmid preparation and analytical restriction analysis.

The following E. coli strains were generated in this manner:

• • E. coli W3110 ΔfadE pCDFDuet-1/pJ294[Ptac-ChFATB2_optEc]
  • E. coli W3110 ΔfadE pCDF[alkL]/pJ294[Ptac-ChFATB2_optEc]

These strains were used to study their ability to produce fatty acids. The following procedure was employed:

The strains were subjected to a multi-stage aerobic culturing process. The strains to be studied were first grown from in each case one single colony in Luria-Bertani broth as described by Miller (Merck, Darmstadt) as a 5 ml preculture. The next culturing step was performed in M9 medium. The medium, composed of 38 mM disodium hydrogenphosphate dihydrate, 22 mM potassium dihydrogenphosphate, 8.6 mM sodium chloride, 37 mM ammonium chloride, 2% (w/v) glucose, 2 mM magnesium sulphate heptahydrate (all chemicals from Merck, Darmstadt) and 0.1% (v/v) trace element solution, was brought to pH 7.4 using 25% strength ammonium hydroxide solution. The added trace element solution, composed of 9.7 mM manganese(II) chloride tetrahydrate, 6.5 mM zinc sulphate heptahydrate, 2.5 mM sodium EDTA (Titriplex III), 4.9 mM boric acid, 1 mM sodium molybdate dihydrate, 32 mM calcium chloride dihydrate, 64 mM iron(II) sulphate heptahydrate and 0.9 mM copper(II) chloride dihydrate, dissolved in 37% hydrochloric acid solution (all chemicals from Merck, Darmstadt), was filter-sterilized before being added to the M9 medium. 10 ml of M9 medium together with 100 μg/ml of spectinomycin and 100 μg/ml of ampicillin were introduced into 100 ml baffled Erlenmeyer flasks and inoculated with 0.5 ml of the preculture. Culturing was done at 37° C. and 200 rpm in a shaker-incubator. After a culturing time of 8 hours, 50 ml of M9 medium supplemented with 100 μg/ml of spectinomycin and 100 μg/ml of ampicillin were introduced into a 250 ml baffled Erlenmeyer flask and inoculated with the 10 ml culture so that an optical density (600 nm) of 0.2 was obtained. Culturing was done at 30° C. and 200 rpm in a shaker-incubator. When an optical density (600 nm) of from 0.4 to 0.5 had been reached, the gene expression was induced by adding 1 mM of IPTG (time t₀). The strains were cultured for at least another 24 hours under identical conditions. During the culture period, 2 ml samples were taken, and the concentration of fatty acids with different carbon chain length was quantified analogously to Example 3. The results are shown in the table which follows.

TABLE 1
Production of fatty acids using E. coli W3110 ΔfadE, which overexpresses fatB2 from
C. hookeriana and alkL from P. putida GPo1. The data shown are the concentrations of fatty
acids with different carbon chain lengths after incubation for 29 hours.
	CCaprylic acid	CCapric acid	CMyristic acid	CPalmitic acid	CPalmitoleic acid	CStearic acid	COleic acid
Strain	[mg/l * OD]	[mg/l * OD]	[mg/l * OD]	[mg/l * OD]	[mg/l * OD]	[mg/l * OD]	[mg/l * OD]
E. coli W3110 ΔfadE pCDFDuet-	30.1	2.4	1.9	13.6	17.3	3.6	1.9
1/pJ294[Ptac-ChFATB2_optEc]
E. coli W3110 ΔfadE	82.6	10.6	4.1	23.7	74.0	9.1	4.1
pCDF[alkL]/pJ294[Ptac-
ChFATB2_optEc]

This demonstrated that the strains with alkL form considerably more caprylic acid, capric acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid and oleic acid than the strains without alkL. This demonstrates that enhancing alkL promotes the production of fatty acids of different chain lengths and degrees of saturation from nonrelated carbon sources.

Example 5

Preparation of an E. coli Expression Vector for the Genes fadD from Escherichia coli and atfA from Acinetobacter sp. ADP1

To prepare the E. coli expression vector for the genes fadD (SEQ ID No.: 18) from Escherichia coli and atfA with terminator (SEQ ID No.: 19) from Acinetobacter sp. ADP1 under the control of a tac promoter, these genes were amplified by PCR from chromosomal DNA of E. coli W3110 and Acinetobacter calcoaceticus ADP1, respectively, with the introduction of homologous regions for recombination cloning. The synthetic tac promoter (SEQ ID No.: 20) was amplified with ribosome binding site from a pJ294 derivative, with introduction of homologous regions. Chromosomal DNA was prepared from E. coli W3110 and Acinetobacter calcoaceticus ADP1, respectively, by means of the DNeasy Blood & Tissue Kit (Qiagen, Hilden) following the manufacturer's instructions. The following oligonucleotides were employed in the amplification of the genes fadD from E. coli and atfA from Acinetobacter sp. ADP1 with chromosomal DNA of E. coli W3110 and Acinetobacter calcoaceticus ADP1, respectively, as the template and in the amplification of the synthetic P_tac promoter from a pJ294 derivative:

Ptac:
(SEQ ID No.: 21)
11-001_fw: 5′-TTATGCGACTCCTGCGTTTAGGGAAAGAGCATTT
           G-3′
(SEQ ID No.: 22)
Ptac-rv:   5′-GTTAACATATGTTTTACCTCCTGTTAAACAAA-3′
fadD [E. coli]:
(SEQ ID No.: 23)
fadD-fw:   5′-TAAAACATATGTTAACGGCATGTATATCATTT-3′
(SEQ ID No.: 24)
fadD-rv:   5′-TCTCCTCAGACTTAACGCTCAGGCTTTATTGT-3′
atfA [Acinetobacter sp. ADP1]:
(SEQ ID No.: 25)
atfA-fw:   5′-GTTAAGTCTGAGGAGATCCACGCTATGCGCCC-3′
(SEQ ID No.: 26)
11-00_rv:  5′-CAATTGAGATCTGCCACGACTGCAATGGTTCATC-3′

The following parameters were employed for the PCR: 1×: initial denaturation, 103° C., 3:00 min; 35×: denaturation, 98° C., 0:10 min, annealing, 65° C., 0:15 min; elongation, 72° C., 0:45 min; 1×: terminal elongation, 72° C., 10 min. The Phusion™ High-Fidelity Master Mix from New England Biolabs (Frankfurt) was used for the amplification, following the manufacturer's recommendations. Thereafter, in each case 50 μl of the PCR reactions were separated on a 1% TAE agarose gel. The procedure of the PCR, the agarose gel electrophoresis, the ethidium bromide staining of the DNA and the determination of the PCR fragment sizes were carried out in a manner known to the skilled worker.

In all cases, PCR fragments of the expected size were successfully amplified. The size was 607 bp for the P_tac promoter region, 1778 by for fadD and 1540 by for atfA.

To isolate the DNA from an agarose gel, the target DNA was isolated from the gel using a surgical blade and purified using the “Quick Gel Extraction Kit” from Qiagen (Hilden) following the manufacturer's instructions. The purified PCR products underwent recombination with the EcoNI/NdeI-cut vector pCDFDuet™-1 (71340-3, Merck, Darmstadt) by means of in-vitro cloning using the Geneart Seamless Cloning and Assembly Kit from Invitrogen (Darmstadt). The use corresponded to the manufacturer's instructions. pCDFDuet-1 is an E. coli vector which confers spectinomycin/streptomycin resistance to the organism and which contains a CoIDF13 replication origin. The transformation of chemically competent E. coli DH5α cells (New England Biolabs, Frankfurt) was performed in the manner known to the skilled worker. The correctness of the plasmid was checked by restriction analysis with XbaI. The authenticity of the inserted fragments was verified by DNA sequencing. The finished E. coli expression vector was named pCDF[fadD-atfA] (SEQ ID No.:27).

Example 6

Preparation of an E. coli Expression Vector for the Genes fadD from Escherichia coli atfA from Acinetobacter sp. ADP1 and alkL from Pseudomonas putida GPo1

To prepare an E. coli expression vector for the genes fadD from Escherichia coli, atfA from Acinetobacter sp. ADP1 and alkL from Pseudomonas putida GPo1, the plasmid pCDF[alkL] (SEQ ID No.: 07) is digested with FseI and XhoI, and the fragment which carries the alkL gene from Pseudomonas putida GPo1 under the control of the P_lacuv5 promoter (see Example 1) is subsequently isolated.

To this end, the digested plasmid is separated on a 1% TAE agarose gel. The procedure of the restriction digestion, the agarose gel electrophoresis, the ethidium bromide staining of the DNA and the determination of the restriction fragment sizes are performed in a manner known to the skilled worker. To isolate the DNA from an agarose gel, the target DNA is isolated from the gel using a surgical blade and purified using the Quick Gel Extraktion Kit from Qiagen (Hilden) following the manufacturer's instructions.

Thereafter, the purified restriction fragment is ligated with the likewise FseI- and XhoI-cut vector fragment (7290 bp) of pCDF[fadD-atfA] (SEQ ID No.: 27). Ligation of the DNA fragment and transformation of chemically competent E. coli DH5α cells (New England Biolabs, Frankfurt) are performed in the manner known to the skilled worker.

The correctness of the plasmids produced is checked by restriction analysis with FseI and XhoI. The authenticity of the inserted fragments is verified by DNA sequencing. The finished E. coli/expression vector is named pCDF[fadD-atfA]-[alkL] (SEQ ID No.:28).

Example 7

Chromatographic Quantification of Products

The quantification of fatty acid esters is performed using gas chromatography. 100 μl of methyl heptadecanoate solution (5 g/l dissolved in acetone) are added to the samples, consisting of 1 ml of culture broth, and then 1.1 ml of n-heptane are added and the samples are vortexed vigorously for 15 seconds. The heptane phase is measured by means of gas chromatography. To separate fatty acid esters, the capillary column SP™-2560 of dimensions 100 m×0.25 mm and a film thickness of 0.2 μm (Supelco, Sigma-Aldrich, Steinheim) is employed as the stationary phase. The carrier gas employed is helium. The separation is carried out within 45 min at an injector temperature of 260° C., a detector temperature of 260° C. and a column temperature of 140° C. at the beginning, held for 5 min, and increased to 240° C. at a rate of 4° C./min and held for 15 min. The injection volume is 1 μl, the split rate is 1:20 and the flow rate of the carrier gas 1 ml/min. Detection is by means of a flame ionization detector (GC Perkin Elmer Glarus 500, Perkin Elmer, Rodgau). Methyl heptanoate (Sigma-Aldrich, Steinheim) is used as the internal reference substance for quantifying the fatty acid esters. The reference substances C8:0-Me caprylic acid methyl ester, C10:0-Me capric acid methyl ester, C12:0-Me lauric acid methyl ester, C14:0-Me myristic acid methyl ester, C16:0-Me palmitic acid methyl ester, C16:1-Me palmitoleic acid methyl ester, C18:0-Me stearic acid methyl ester, C18:1-Me oleic acid methyl ester (GLC Standard Mix GLC-20 1892-1AMP, GLC-30 1893-1AMP, GLC-50 1894-1AMP, Sigma-Aldrich, Steinheim), C8:0-Et caprylic acid ethyl ester, C10:0-Et capric acid ethyl ester, C12:0-Et lauric acid ethyl ester, C14:0-Et myristic acid ethyl ester, C16:0-Et palmitic acid ethyl ester, C18:0-Et stearic acid ethyl ester, C18:1-Et oleic acid ethyl ester (all from Sigma-Aldrich, Steinheim) and C16:1-Et palmitoleic acid ethyl ester (Biomol, Hamburg) are used for the calibration. The lower detection limits are a concentration of 10 mg/l for all fatty acid esters.

Example 8

Production of Fatty Acid Esters by E. coli Strains which have a Deletion in the fadE Gene and which Overexpress the alkL Genes from Pseudomonas putida GPo1, ChfatB1 and ChfatB2 from Cuphea hookeriana, and Cpfat2″ from Cuphea palustris, fadD from E. coli and atfA from Acinetobacter sp. ADP1

To generate E. coli strains with the expression vector for the alkL genes from Pseudomonas putida GPo1, fadD from Escherichia coli and atfA from Acinetobacter sp. ADP1 from Pseudomonas putida GPo1 in combination with the expression vector for the fatB2 gene from Cuphea hookeriana, electrocompetent cells of E. coli W3110 ΔfadE (see Example 4) are prepared. This was done in a manner known to the skilled worker. They are transformed with the plasmids pCDF[fadD-atfA] (SEQ ID No.: 27) and pCDF[fadD-atfA]-[alkL] (SEQ ID No.: 28), respectively, in combination with pJ294[Ptac-ChFATB2_optEc] (SEQ ID No. 11), pJ294[Ptac-CpFATB2_optEc] (SEQ ID No.: 13) and pJ294[Ptac-ChFATB1_optEc] (SEQ ID No.: 12), respectively, in and plated onto LB plates supplemented with spectinomycin (100 μg/ml) and ampicillin (100 μg/ml). Transformants are checked for the presence of the correct plasmids by plasmid preparation and analytical restriction analysis.

The following E. coli strains are generated in this manner:

• • E. coli W3110 ΔfadE pCDF[fadD-atfA]pJ294[Ptac-ChFATB2_optEc]
  • E. coli W3110 ΔfadE pCDF[fadD-atfA]alkl-4-pJ294[Ptac-ChFATB2_optEc]
  • E. coli W3110 ΔfadE pCDF[fadD-atfA]/pJ294[Ptac-CpFATB2_optEc]
  • E. coli W3110 ΔfadE pCDF[fadD-atfA]alkLypJ294[Ptac-CpFATB2_optEc]
  • E. coli W3110 ΔfadE pCDF[fadD-atfA]/pJ294[Ptac-ChFATB1_optEc]
  • E. coli W3110 ΔfadE pCDF[fadD-atfA]alkl-4-pJ294[Ptac-ChFATB1_optEc]

These strains are used to study their ability to produce fatty acid esters. The following procedure is employed:

The strains are subjected to a multi-stage aerobic culturing process. The strains to be studied are first grown from in each case one single colony in Luria-Bertani broth as described by Miller (Merck, Darmstadt) as a 5 ml preculture. The next culturing step is performed in M9 medium. The medium, composed of 38 mM disodium hydrogenphosphate dihydrate, 22 mM potassium dihydrogenphosphate, 8.6 mM sodium chloride, 37 mM ammonium chloride, 2% (w/v) glucose, 2 mM magnesium sulphate heptahydrate (all chemicals from Merck, Darmstadt) and 0.1% (v/v) trace element solution, is brought to pH 7.4 using 25% strength ammonium hydroxide solution. The added trace element solution, composed of 9.7 mM manganese(II) chloride tetrahydrate, 6.5 mM zinc sulphate heptahydrate, 2.5 mM sodium EDTA (Titriplex III), 4.9 mM boric acid, 1 mM sodium molybdate dihydrate, 32 mM calcium chloride dihydrate, 64 mM iron(II) sulphate heptahydrate and 0.9 mM copper(II) chloride dihydrate, dissolved in 37% hydrochloric acid solution (all chemicals from Merck, Darmstadt), is filter-sterilized before being added to the M9 medium. 10 ml of M9 medium together with 100 μg/ml of spectinomycin and 100 μg/ml of ampicillin are introduced into 100 ml baffled Erlenmeyer flasks and inoculated with 0.5 ml of the preculture. Culturing is done at 37° C. and 200 rpm in a shaker-incubator. After a culturing time of 8 hours, 50 ml of M9 medium supplemented with 100 μg/ml of spectinomycin and 100 μg/ml of ampicillin are introduced into a 250 ml baffled Erlenmeyer flask and inoculated with the 10 ml culture so that an optical density (600 nm) of 0.2 is obtained. Culturing is done at 30° C. and 200 rpm in a shaker-incubator. When an optical density (600 nm) of from 0.4 to 0.5 has been reached, the gene expression is induced by adding 1 mM of IPTG (time t₀). The strains are cultured for at least another 24 hours under identical conditions. During the culture period, 2 ml samples are taken, and the concentration of fatty acid methyl esters or fatty acid ethyl esters with different carbon chain lengths is quantified analogously to Example 7. This demonstrates that the strains E. coli W3110 ΔfadE pCDF[fadD-atfA]-/pJ294[Ptac-ChFATB2_optEc] and E. coli W3110 ΔfadE pCDF[fadD-atfA]-[alkL]/pJ294[Ptac-ChFATB2_optEc] are predominantly capable of forming C8:0-Me caprylic acid methyl ester, C10:0-Me capric acid methyl ester, C16:0-Me palmitic acid methyl ester, C16:1-Me palmitoleic acid methyl ester and C18:1-Me oleic acid methyl ester (when methanol is added) and C8:0-Et caprylic acid ethyl ester, C10:0-Et capric acid ethyl ester, C16:0-Et palmitic acid ethyl ester, C16:1-Et palmitoleic acid ethyl ester and C18:1-Et oleic acid ethyl ester (when ethanol is added), respectively.

Furthermore, it is demonstrated that the strains E. coli W3110 ΔfadE pCDF[fadD-atfA]-/pJ294[Ptac-CpFATB2_optEc] and E. coli W3110 ΔfadE pCDF[fadD-atfA]-[alkL]/pJ294[Ptac-CpFATB2_optEc] are capable of predominantly forming C12:0-Me lauric acid methy ester, C14:0-Me myristic acid methyl ester, C16:0-Me palmitic acid methyl ester, C16:1-Me palmitoleic acid methyl ester, C18:0-Me stearic acid methyl ester and C18:1-Me oleic acid methyl ester (when methanol is added) and C12:0-Et lauric acid ethyl ester, C14:0-Et myristic acid ethyl ester, C16:0-Et palmitic acid ethyl ester, C16:1-Et palmitoleic acid ethyl ester and C18:1-Et oleic acid ethyl ester (when ethanol is added), respectively.

Furthermore, it is demonstrated that the strains E. coli W3110 ΔfadE pCDF[fadD-atfA]-/pJ294[Ptac-ChFATB1_optEc] and E. coli W3110 ΔfadE pCDF[fadD-atfA]-[alkL]/pJ294[Ptac-ChFATB1_optEc] are capable of predominantly forming C14:0-Me methyl myristate, C16:0-Me methyl palmitate, C16:1-Me methyl palmitoleate, C18:0-Me methyl stearate and C18:1-Me methyl oleate (when methanol is added) and C14:0-Et ethyl myristate, C16:0-Et ethyl palmitate, C16:1-Et ethyl palmitoleate and C18:1-Et ethyl oleate (when ethanol is added), respectively. Finally, it is demonstrated that the strains E. coli W3110 ΔfadE pCDF[fadD-atfA]-[alkL]/pJ294[Ptac-ChFATB2_optEc], E. coli W3110 ΔfadE pCDF[fadD-atfA]-[alkL]/pJ294[Ptac-CpFATB2_optEc] and E. coli W3110 ΔfadE pCDF[fadD-atfA]-[alkL]/pJ294[Ptac-ChFATB1_optEc]_t, which are named in this example, form substantially more of the respective fatty acid methyl esters (when methanol is added) and fatty acid ethyl esters (when ethanol is added), respectively, than the strains E. coli W3110 ΔfadE pCDF[fadD-atfA]/pJ294[Ptac-ChFATB2_optEc], E. coli W3110 ΔfadE pCDF[fadD-atfA]/pJ294[Ptac-CpFATB2_optEc] and E. coli W3110 ΔfadE pCDF[fadD-atfA]/pJ294[Ptac-ChFATB1_optEc]. This demonstrates that the enhancement of the alkL gene product promotes the production of fatty acid esters with various chain lengths of the alkyl chain both of the fatty acid residue and the alcohol residue of the fatty acid esters and with a different degree of saturation of the alkyl chain of the fatty acid, respectively, from unrelated carbon sources.

Example 9

Preparation of Expression Vectors for the Genes CnfatB3 from Cocos nucifera and synUcTE from Umbellularia californica

To prepare expression vectors for the genes fatB3 (SEQ ID No. 35) from Cocos nucifera and synUcTE (SEQ ID No. 37) from Umbellularia californica (each encoding one enzyme E_i), these genes were codon-optimized for expression in Escherichia coli. The genes were synthesized in each case together with a tac promoter (SEQ ID No. 39) and at the same time a cleavage site was introduced upstream of the promoter and a cleavage site was introduced downstream of the terminator. The synthesized DNA fragments P_tac-CnFATB3 and P_tac synUcTE were digested with the restriction endonucleases BamHI and NotI and ligated into the correspondingly cut vector pJ294 (DNA2.0 Inc., Menlo Park, Calif., USA). The completed E. coli expression vectors were termed pJ294{Ptac}[CnFATB3(co_Ec)] (SEQ ID No. 40), pJ294[Ptac-synUcTE] (SEQ ID No. 41). The vector pJ294 is an E. coli vector which imparts ampicillin resistance and also carries a p15A replication origin and therefore has a low copy number (10-15 copies per cell).

Example 10

Preparation of Expression Vectors for the Genes alkL_Oa from Oceanocaulis alexandrii, alkL_Ma from Marinobacter aquaeolei, alkL_CspK31 from Caulobacter sp. K31

To prepare expression vectors for the genes alkL_Oa (SEQ ID No. 42) from Oceanocaulis alexandrii HTCC2633, alkL_Ma (SEQ ID No. 44) from Marinobacter aquaeolei VT8, alkL_CspK31 (SEQ ID No. 46) from Caulobacter sp. K31 (in each case encoding one AlkL gene product), these genes were synthesized together with a lacuv5 promoter (SEQ ID No. 34). The synthesized DNA fragments P_lacuv5 alkL_Oa, P_lacuv5 alkL_Ma and P_lacuv5 alkL_CspK31 were amplified with introduction of homologous regions for recombination cloning.

The following oligonucleotides were used for amplification of the target genes.

(SEQ ID No. 48)
alkL_H1_fw: 5′-GCTTACTGAATTTGCCTGAACCATGGGGCAGTGA
            G-3′
(SEQ ID No. 49)
alkL_H2_rv: 5′-TTCTGAAGTGGGGGCGGCCGCCCTTTTGACGGGTAC
            C-3′

The following parameters were used for the PCR: 1×: initial denaturation, 98° C., 1 min; 35×: denaturation, 98° C., 0:15 min, annealing, 60° C., 0:45 min; elongation, 72° C., 1:30 min; 1×: terminal elongation, 72° C., 10 min. For the amplification, the Phusion™ High-Fidelity Master Mix from New England Biolabs (Frankfurt) was used in accordance with the manufacturer's recommendations. In each case 50 μl of the PCR reactions were then separated on a 1% strength TAE agarose gel. The PCR, agarose gel electrophoresis, ethidium bromide staining of the DNA and determination of the PCR fragment sizes were carried out in a manner known to those skilled in the art. In all cases PCR fragments of the expected size were able to be amplified. These were 906 base pairs for P_lacuv5 alkL_Oa, 960 base pairs for P_lacuv5 alkL_Ma and 903 base pairs for P_lacuv5 alkL_CspK31. To isolate the DNA from the TAE agarose gel, the target DNA was cut out of the gel with a scalpel and purified using the QiaQuick Gel extraction kit according to the manufacturer's instructions (Qiagen, Hilden). The purified PCR products were cloned together with the NotI-cut vector pJ294[Ptac-ChFATB2_optEc] (SEQ ID No. 11) by recombination, using the Geneart® Seamless Cloning and Assembly Kit according to the manufacturer's instructions (Life Technologies, Carlsbad, Calif., USA). From the resultant pJ294 derivatives pJ294{Ptac}[ChFATB2(co_Ec){Placuv5}[alkL_Oa] (SEQ ID No. 50), pJ294{Ptac}[ChFATB2(co_Ec){Placuv5}[alkL_Ma] (SEQ ID No. 51) and pJ294{Ptac}[ChFATB2(co_Ec){Placuv5}[alkL_CspK31] (SEQ ID No. 52) the fragments P_lacuv5 alkL_Oa, P_lacuv5 alkL_Ma and P_lacuv5 alkL_CspK31 were cut out using a restriction digest with the restriction endonucleases NcoI and NotI and ligated into the corresponding cut vector pCDFDuet-1 (71340-3, Merck, Darmstadt; SEQ ID No. 53). Chemically competent E. coli DH5α (New England Biolabs, Frankfurt) was transformed in a manner known to those skilled in the art. Correct insertion of the target genes was examined by restriction analysis, and authenticity of the introduced genes was validated by DNA sequencing. The resultant expression vectors were named pCDF[alkL_Oa] (SEQ ID No. 54), pCDF[alkL_Ma] (SEQ ID No. 55) and pCDF[alkL_CspK31] (SEQ ID No. 56).

Example 11

HPLC/ESI-Based Quantification of Fatty Acids

Octanoic acid, 3-hydroxydecanoic acid, decanoic acid, lauric acid, 3-hydroxymyristic acid, myristic acid, palmitoleic acid, palmitic acid, oleic acid and stearic acid in fermentation samples were quantified by means of HPLC-ESI/MS on the basis of internal calibration for all analytes and using the internal standards D3-lauric acid (methyl-D3, 99%) for octanoic acid, 3-hydroxydecanoic acid, decanoic acid, lauric acid, 3-hydroxymyristic acid, myristic acid, palmitoleic acid and D3-stearic acid (methyl-D3, 98%) for palmitic acid, oleic acid, stearic acid.

The following apparatuses were used:

• • HPLC system: Surveyor (Thermo Fisher Scientific, Waltham, Mass., USA), consisting of Surveyor MS Pump, Surveyor Autosampler plus and Surveyor PDA Surveyor
  • Mass spectrometer: TSQ Vantage with HESI II—source (Thermo Fisher Scientific, Waltham, Mass., USA)
  • HPLC columns: XBridge BEH C8, 100×2.1 mm, particle size: 2.5 μm, pore size 130 Å (Waters, Milford Mass., USA)

The samples were prepared in that 1200 μl of acetone and 300 μl of sample were mixed for approximately 10 seconds and then centrifuged at approximately 13 000 rpm for 5 min. The clear supernatant was taken off and analysed after appropriate dilution with acetone. To each 900 μl of the diluted sample were added 100 μl of ISTD by pipette.

HPLC separation proceeded using the abovementioned HPLC column. The injection volume was 2 μl, the column temperature was 25° C., and the flow rate was 0.3 ml/min. The mobile phase consisted of eluent A (water+10 mmol of ammonium acetate adjusted with ammonia to pH=9) and eluent B (acetonitrile/eluent A 95/5). The following gradient profile was used

Time [min]	Eluent A [%]	Eluent B [%]
0	95	5
1	95	5
1.1	70	30
7	5	95
8	5	95

The ESI-MS analysis proceeded with negative ionization using the following parameters of the ESI source:

• • Spray voltage: 3000 V
  • Vaporizer temperature: 380° C.
  • Sheath gas pressure: 40
  • Aux gas pressure: 15
  • Capillary temperature: 380° C.

The individual compounds were detected and quantified using “single ion monitoring” (SIM) using the following parameters:

	Ion	Scan	Scan	Peak
	[M − H]−	width	time	width
Analyte	[m/z]	[m/z]	[ms]	Q3
Octanoic acid	143.13	0.002	100	0.7
3-Hydroxydecanoic acid	187.13	0.002	50	0.7
Decanoic acid	171.13	0.002	100	0.7
Lauric acid	199.16	0.002	50	0.7
3-Hydroxymyristic acid	243.18	0.002	50	0.7
Myristic acid	227.19	0.002	50	0.7
Palmitoleic acid	253.18	0.002	50	0.7
Palmitic acid	255.22	0.002	30	0.7
Oleic acid	281.23	0.002	30	0.7
Stearic acid	283.25	0.002	30	0.7
D3-lauric acid	202.16	0.002	50	0.7
D3-stearic acid	286.25	0.002	30	0.7

Example 12

Production of Fatty Acids by E. coli Strains with a Deletion in the fadE Gene, which Overexpresses the Genes alkL from Pseudomonas putida GPo1, alkL from Oceanocaulis alexandrii HTCC2633 or alkL from Caulobacter sp. K31 and fatB1 from Cuphea hookeriana, fatB2 from Cuphea hookeriana, synUcTE from Umbellularia californica or fatB3 from Cocos nucifera

To generate E. coli strains having the expression vector for the gene alkL from Pseudomonas putida GPo1, alkL from Oceanocaulis alexandrii HTCC2633 or alkL from Caulobacter sp. K31 in combination with the expression vector for the fatB1 gene from Cuphea hookeriana, fatB2 from Cuphea hookeriana, synUcTE from Umbellularia californica or fatB3 from Cocos nucifera electrocompetent cells of E. coli W3110 ΔfadE and E. coli JW5020-1 Kan^S were prepared. This was carried out in a manner known to those skilled in the art. E. coli JW5020-1 Kan^S is a derivative of E. coli JW5020-1 (CGSC, The coli genetic stock center, Yale University, New Haven, USA), and this in turn is an E. coli BW25113 derivative, which carries a deletion of the fadE gene. The fadE gene was replaced by a kanamycin cassette. This was removed before equipping the strain with the expression vectors using a helper plasmid which encodes flp recombinase, in a manner known to those skilled in the art (see Datsenko K. A. and Wanner B. L. (2000) PNAS 97(12):6640-6645) resulting in strain E. coli JW5020-1 Kan^S. E. coli JW5020-1 Kan^S was transformed with the plasmids pJ294[Ptac-ChFATB1_optEc] (SEQ ID No. 12), pJ294[Ptac-ChFATB2_optEc] (SEQ ID No. 11) or pJ294{Ptac}[CnFATB3(co_Ec)] (SEQ ID No. 40) in combination with pCDFDuet-1, pCDF[alkL] (SEQ ID No. 7) or pCDF[alkL_Oa] (SEQ ID No. 54) or pCDF[alkL_CspK31] (SEQ ID No. 56), and E. coli W3110 ΔfadE was transformed with the plasmids pJ294[Ptac-synUcTE] (SEQ ID No. 41) in combination with pCDFDuet-1 (SEQ ID No. 53) or pCDF[alkL] (SEQ ID No. 7) and plated onto LB-agar plates with spectinomycin (100 μg/ml) and ampicillin (100 μg/ml). Transformants were checked for presence of the correct plasmids by plasmid preparation and analytical restriction analysis.

The following E. coli strains were generated in this manner:

• • E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB1_optEc]/pCDFDuet-1
  • E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB1_optEc]/pCDF[alkL]
  • E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB2_optEc]/pCDFDuet-1
  • E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB2_optEc]/pCDF[alkL_Oa]
  • E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB2_optEc]/pCDF[alkL_CspK31]
  • E. coli JW5020-1 Kan^S pJ294{Ptac}[CnFATB3(co_Ec)]/pCDFDuet-1
  • E. coli JW5020-1 Kan^S pJ294{Ptac}[CnFATB3(co_Ec)]/pCDF[alkL]
  • E. coli W3110 ΔfadE pJ294[Ptac-synUcTE]/pCDFDuet-1
  • E. coli W3110 ΔfadE pJ294[Ptac-synUcTE]/pCDF[alkL]

These strains were employed to investigate their ability to produce fatty acids. The following procedure was used:

The strains were subjected to a multistage aerobic culturing process. The strains under investigation were first initially grown in Luria-Bertani Bouillon according to Miller (Merck, Darmstadt) with 100 μg/ml ampicillin and 100 μg/ml spectinomycin as 5 ml preliminary culture from one single colony each. The next culturing step proceeded in M9 medium. The medium, consisting of 38 mM disodium hydrogenphosphate dihydrate, 22 mM potassium dihydrogenphosphate, 8.6 mM sodium chloride, 37 mM ammonium chloride, 2% (w/v) glucose, 2 mM magnesium sulphate heptahydrate (all substances from Merck, Darmstadt) and 0.1% (v/v) trace element solution, was adjusted to a pH of 7.4 using 25% strength ammonium hydroxide solution. The added trace element solution consisting of 9.7 mM manganese(II) chloride tetrahydrate, 6.5 mM zinc sulphate heptahydrate, 2.5 mM sodium EDTA (Titriplex III), 4.9 mM boric acid, 1 mM sodium molybdate dihydrate, 32 mM calcium chloride dihydrate, 64 mM iron(II) sulphate heptahydrate and 0.9 mM copper(II) chloride dihydrate dissolved in 1 M hydrochloric acid (all substances from Merck, Darmstadt) was sterile-filtered before addition to the M9 medium. 10 ml of M9 medium were charged with 100 μg/ml spectinomycin and 100 μg/ml ampicillin into 100 ml conical flasks with chicane and inoculated with 0.5 ml from the preliminary culture. The culturing proceeded at 37° C. and 200 rpm in an incubating shaker. After a cultivating time of 8 hours, 50 ml of M9 medium containing 100 μg/ml of spectinomycin and 100 μg/ml of ampicillin are charged into a 250 ml conical flask with chicane and inoculated with the 10 ml culture, in such a manner that an optical density (600 nm) of 0.2 is achieved. The cuturing proceeded at 37° C. and 200 rpm in an incubating shaker. When an optical density (600 nm) of 0.6 to 0.8 is achieved, gene expression is induced by adding 1 mM IPTG. The strains were cultured for a further 24 hours at 30° C. and 200 rpm. During the culturing, samples of 300 μl are taken off and the concentration of fatty acids of differing carbon chain lengths is quantified as described in Example 10. The results are shown in the tables hereinafter.

Production of fatty acids using E. coli JW5020-1 Kan^S, which overexpresses fatB2 from C. hookeriana and alkL from Oceanocaulis alexandrii HTCC2633 and alkL from Caulobacter sp.

K31. The concentrations of fatty acids of differing carbon chain length are reported after culturing for 24 hours (n.d.=not detectable):

	cCaprylic acid	cCapric acid	cPalmitoleic acid	CVaccenic acid
Strain	[mg/l/OD]	[mg/l/OD]	[mg/l/OD]	[mg/l/OD]
E. coli JW5020-1 KanS pJ294[Ptac-	21.0	1.8	0.1	1.3
ChFATB2_optEc]/pCDFDuet-1
E. coli JW5020-1 KanS pJ294[Ptac-	27.5	6.3	5.9	2.3
ChFATB2_optEc]/pCDF[alkL_Oa]
E. coli JW5020-1 KanS pJ294[Ptac-	38.6	4.7
ChFATB2_optEc]/pCDF[alkL_CspK31]

Production of fatty acids with E. coli JW5020-1 Kan^S, which overexpresses fatB3 from C. nucifera and alkL from Pseudomonas putida GPo1. The concentrations of fatty acids of differing carbon chain length are reported after 48 hours of culturing (n.d.=not detectable):

	CCaprylic acid	CLauric acid	CMyristic acid	CPalmitoleic acid	CPalmitic acid	CVaccenic acid
Strain	[mg/l/OD]	[mg/l/OD]	[mg/l/OD]	[mg/l/OD]	[mg/l/OD]	[mg/l/OD]
E. coli JW5020-1 KanS	0.1	3.2	4.5	13.4	1.7	4.0
pJ294{Ptac}[CnFATB3(co_Ec)]/pCDFDuet-1
E. coli JW5020-1 KanS	0.5	6.8	9.9	21.2	3.1	5.6
pJ294{Ptac}[CnFATB3(co_Ec)]/pCDF[alkL]

Production of fatty acids with E. coli JW5020-1 Kan^S, which overexpresses fatB1 from C. hookeriana and alkL from Pseudomonas putida GPo1. The concentrations of fatty acids of differing carbon chain lengths are reported after 24 hours of culturing (n.d.=not detectable):

	cMyristic acid	cPalmitoleic acid
Strain	[mg/l/OD]	[mg/l/OD]
E. coli JW5020-1 KanS pJ294[Ptac-	38.2	0.1
ChFATB1_optEc]/pCDFDuet-1
E. coli JW5020-1 KanS pJ294[Ptac-	42.8	62.0
ChFATB1_optEc]/pCDF[alkL]

Production of fatty acids using E. coli JW5020-1 Kan^S, which overexpresses synUcTE from U. californica and alkL from Pseudomonas putida GPo1. The concentrations of fatty acids of differing carbon chain lengths are reported after 24 hours of culturing (n.d.=not detectable):

		cLauric acid	cMyristic acid
	Strain	[mg/l/OD]	[mg/l/OD]
	E. coli W3110 ΔfadE pJ294[Ptac-	0.1	0.1
	synUcTE]/pCDFDuet-1
	E. coli W3110 ΔfadE pJ294[Ptac-	20.1	1.9
	synUcTE]/pCDF[alkL]

Therefore it was found that strains which overexpress alkL from P. putida, O. alexandrii or Caulobacter sp. are able to form more caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, palmitoleic acid or vaccenic acid, depending on the specificity of the overexpressed acyl-ACP thioesterase. This shows that reinforcement of alkL is required for the preparation of fatty acids of differing chain lengths and degrees of saturation from unrelated carbon sources.

Example 13

Preparation of Vectors for the Coexpression of the Genes fatB2 from Cuphea hookeriana, fatB3 from Cocos nucifera, synUcTE from Umbellularia californica with alkL from Pseudomonas putida

For preparation of vectors for the coexpression of the gene fatB2 (SEQ ID No. 8) from Cuphea hookeriana, fatB3 (SEQ ID No. 35) from Cocos nucifera, synUcTE (SEQ ID No. 37) from Umbellularia californica with an alkL gene from Pseudomonas putida, the gene alkL (SEQ ID No. 1) was amplified together with the lacuv5 promotor and terminator from the vector pCDF[alkL] (SEQ ID No. 7).

For amplification of the fragment P-alkL-T (SEQ ID No. 58) for coexpression with fatB2 and synUcTE, the following oligonucleotides were used.

(SEQ ID No. 59)
NP-FA-P19: 5′-ATCCGCTCACAATTGCAAATGCCTGAGGTTTCAG
           C-3′
(SEQ ID No. 60)
NP-FA-P20: 5′-CTTCCCTTCATTTTGGTCTCGGTCGATCATTCAG
           C-3′

For amplification of the fragment P-alkL-T (SEQ ID No. 58) for coexpression with fatB3, the following oligonucleotides were used.

(SEQ ID No. 59)
NP-FA-P19: 5′-ATCCGCTCACAATTGCAAATGCCTGAGGTTTCAG
           C-3′
(SEQ ID No. 61)
NP-FA-P21: 5′-ACTTAGTCGCTGAAGGTCTCGGTCGATCATTCAG
           C-3′

The following parameters were used for the PCR: 1×: initial denaturation, 98° C., 1 min; 35×: denaturation, 98° C., 0:15 min, annealing, 65° C., 0:45 min; elongation, 72° C., 1:30 min; 1×: terminal elongation, 72° C., 10 min. For the amplification, the Phusion™ High-Fidelity Master Mix from New England Biolabs (Frankfurt) was used in accordance with the recommendations of the manufacturer. In each case 50 μl of the PCR reactions were then separated on a 1% strength TAE agarose gel. The PCR, agarose gel electrophoresis, ethidium bromide staining of the DNA and determination of the PCR fragment sizes were carried out in a manner known to those skilled in the art. The PCR fragments with an expected size of 1095 base pairs were able to be amplified. To isolate the DNA from the TAE agarose gel, the target DNA was cut out from the gel with a scalpel and purified by the QiaQuick Gel extraction Kit according to the manufacturer's instructions (Qiagen, Hilden). The purified PCR products were cloned together with the above-described vectors pJ294[Ptac-ChFATB2_optEc] (SEQ ID No. 11), pJ294{Ptac}[CnFATB3(co_Ec)] (SEQ ID No. 40), pJ294[Ptac-synUcTE] (SEQ ID No. 41), which were linearized with BamHI, by means of recombination, using the Geneart® Seamless Cloning and Assembly Kit according to the manufacturer's instructions (Life Technologies, Carlsbad, Calif., USA). The resultant expression vectors were named pJ294{Placuv5}[alkL]{Ptac}[ChFATB2(co_Ec)] (SEQ ID No. 62), pJ294{Placuv5}[alkL]{Ptac}[CnFATB3(co_Ec)] (SEQ ID No. 63) and pJ294{Placuv5}[alkL]{Ptac}[synUcTE(co_Ec)] (SEQ ID No. 64). The transformation of chemically competent E. coli DH5α proceeded in a manner known to those skilled in the art. Correct insertion of the target genes was checked by restriction analysis and the authenticity of the insert was verified by DNA sequencing.

Example 14

Preparation of Expression Vectors for the Genes fadD from Escherichia coli and Wax-dgaT (atfA) from Acinetobacter Sp. ADP1 and atfA1 from Alcanivorax borkumensis

To produce expression vectors for the genes fadD (SEQ ID No. 57) from Escherichia coli (encoding an enzyme E_vi) and wax-dgaT (atfA in Example 5) (SEQ ID No. 65) from Acinetobacter sp. ADP1 and atfA1 (SEQ ID No. 67) from Alcanivorax borkumensis SK2 (in each case encoding an enzyme E_v), the genes wax-dgaT and atfA1 were codon-optimized for expression in Escherichia coli and synthesized in combination with the gene fadD from E. coli. The synthesized DNA fragments wax-dgaT_AsADP1-fadD_Ec (SEQ ID No. 69) and atfA1_Ab-fadD_Ec (SEQ ID No. 70) were amplified with introduction of homologous regions for recombination cloning.

To amplify the fragment wax-dgaT_AsADP1-fadD_Ec, the following oligonucleotides were used:

(SEQ ID No. 71)
wax-dgaT_H1_fw: 5′-ACAGGAGGTAAAACATATGCGTCCTCTGCACC
                CG-3′
(SEQ ID No. 72)
fadD_H2_rv:     5′-GTTTCTTTACCAGACTCGAGATTGTTTTCTCT
                TTAGTGGGCGTC-3′

To amplify the fragment atfA1_Ab-fadD_Ec, the following oligonucleotides were used:

(SEQ ID No. 73)
atfA_Ab_fw_kurz: 5′-ACAGGAGGTAAAACATATGAAAGCGCT
                 GTCCC-3′
(SEQ ID No. 74)
fadD_H2_rv_N:    5′-GTTTCTTTACCAGACTCGAGATTGTTT
                 TCTCTTTAGTGGGC-3′

The following parameters were used for the PCR: 1×: initial denaturation, 98° C., 0:30 min; 35×: denaturation, 98° C., 0:10 min, annealing, 70° C., 0:20 min; elongation, 72° C., 1 min; 1×: terminal elongation, 72° C., 10 min. For the amplification, the Phusion™ High-Fidelity Master Mix from New England Biolabs (Frankfurt) was used in accordance with the manufacturer's recommendations. Each 50 μl of the PCR reactions was then separated on a 1% strength TAE agarose gel. The PCR, agarose gel electrophoresis, ethidium bromide staining of the DNA and determination of the PCR fragment sizes was carried out in a manner known to those skilled in the art. In both cases, PCR fragments of the expected size were able to be amplified. These were for wax-dgaT_AsADP1-fadD_Ec 3192 base pairs and atfA1_Ab-fadD_Ec 3189 base pairs. To isolate the DNA from the agarose gel, the target DNA was cut out of the gel using a scalpel and purified with the QiaQuick Gel extraction kit according to the manufacturer's instructions (Qiagen, Hilden). The purified PCR products were cloned into a NdeI- and XhoI-cut pCDF derivative which already contains a synthetic tac promotor (SEQ ID No. 39), by recombination, using the Geneart® Seamless Cloning and Assembly Kit according to the manufacturer's instructions (Life Technologies, Carlsbad, Calif., USA). Chemically competent E. coli DH5α (New England Biolabs, Frankfurt) was transformed in a manner known to those skilled in the art. Correct insertion of the target genes was checked by restriction analysis and the authenticity of the introduced genes was verified by DNA sequencing. The resultant expression vectors were named pCDF[wax-dgaT_AsAPD1(co_Ec)-fadD_Ec] (SEQ ID No. 75) and pCDF[atfA1_Ab(co_Ec)-fadD_Ec] (SEQ ID No. 76).

Example 15

Gas-Chromatographic Quantification of Fatty Acid Methyl Esters

Fatty acid methyl esters were quantified in the culture broth by means of gas chromatography. 500 mg/l of heptadecanoic acid methyl ester were added to the culture broth as internal reference substance. The culture broth was shaken in an equivalent volume of n-heptane for 15 min at 12 Hz to extract the fatty acid methyl esters. For phase separation, the sample was centrifuged for 10 min at 16 000×g and the organic phase was measured by gas chromatography. To separate fatty acid methyl esters, the capillary column SP™-2560 with the dimensions 100 m×0.25 mm and a film thickness of 0.2 μm (Supelco, Sigma-Aldrich, Steinheim) was used as stationary phase. The carrier gas used was helium. The separation proceeded in the course of 45 min with an injector temperature of 260° C., detector temperature of 260° C. and column temperature of 140° C. at the start, held for 5 min and increased to 240° C. at a rate of 4° C./min and held for 15 min. The injection volume was 1 μl, the split rate 1:20 and the flow rate of the carrier gas 1 ml/min. The detection was carried out by means of a flame-ionization detector (GC Perkin Elmer Clarus 500, Perkin Elmer, Rodgau). Heptadecanoic acid methyl ester (Sigma-Aldrich, Steinheim) was used as internal reference substance for quantifying the fatty acid methyl esters. The reference substances C8:0-Me caprylic acid methyl ester, C10:0-Me capric acid methyl ester, C12:0-Me lauric acid methyl ester, C14:0-Me myristic acid methyl ester, C16:0-Me palmitic acid methyl ester, C16:1-Me palmitoleic acid methyl ester, C18:0-Me stearic acid methyl ester, C18:1-Me oleic acid methyl ester (GLC Standard Mix GLC-20 1892-1AMP, GLC-30 1893-1AMP, GLC-50 1894-1AMP, Sigma-Aldrich, Steinheim) were used for calibration. The determination limits for all fatty acid methyl esters were at a concentration of 10 mg/l.

Example 16

Production of Fatty Acid Methyl Esters by E. coli Strains with Deletion in the fadE Gene which Overexpresses the Genes alkL from Pseudomonas putida GPo1 and a Plant Acyl-ACP Thioesterase and an Acyl-CoA Synthetase and a Wax-Ester Synthase

To generate E. coli strains having the expression vector for the genes alkL from Pseudomonas putida GPo1 and fatB2 from Cuphea hookeriana, fatB3 from Cocos nucifera and synUcTE from Umbellularia californica in combination with the expression vector for the genes fadD from Escherichia coli and wax-dgaT from Acinetobacter sp. ADP1 and atfA1 from Alcanivorax borkumensis SK2, electrocompetent cells of E. coli W3110 ΔfadE and E. coli JW5020-1 Kan^S were produced. This took place in a manner known to those skilled in the art. E. coli JW5020-1 Kan^S was transformed with the vectors pJ294{Placuv5}[alkL]{Ptac}[ChFATB2(co_Ec)] (SEQ ID No. 62) or pJ294[Placuv5}[alkL]{Ptac}[CnFATB3(co_Ec)] (SEQ ID No. 63) and pJ294[Ptac-ChFATB2_optEc] (SEQ ID No. 11) or pJ294{Ptac}[CnFATB3(co_Ec)] (SEQ ID No. 40) in combination with pCDF[atfA1_Ab(co_Ec)-fadD_Ec] (SEQ ID No. 76) and E. coli W3110 ΔfadE with the vectors pJ294{Placuv5}[alkL]{Ptac}[synUcTE] (SEQ ID No. 62) and pJ294[Ptac-synUcTE] (SEQ ID No. 41) in combination with pCDF[wax-dgaT_AsAPD1(co_Ec)-fadD_Ec] (SEQ ID No. 75) and were plated onto LB-agar plates containing spectinomycin (100 μg/ml) and ampicillin (100 μg/ml). Transformants were checked for the presence of the correct plasmids by plasmid preparation and analytical restriction analysis.

In this manner the E. coli strains hereinafter were generated:

• • E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB2_optEc]/pCDF[atfA1_Ab(co_Ec)-fadD_Ec]
  • E. coli JW5020-1 Kan^S pJ294{Placuv5}[alkL]{Ptac}[ChFATB2(co_Ec)]/pCDF[atfA1_Ab(co_Ec)-fadD_Ec]
  • E. coli JW5020-1 Kan^S pJ294{Ptac}[CnFATB3(co_Ec)]/pCDF[atfA1_Ab(co_Ec)-fadD_Ec]
  • E. coli JW5020-1 Kan^S pJ294{Placuv5}[alkL]{Ptac}[CnFATB3(co_Ec)]/pCDF[atfA1_Ab(co_Ec)-fadD_Ec]
  • E. coli W3110 ΔfadE pJ294[Ptac-synUcTE]/pCDF[wax-dgaT_AsAPD1(co_Ec)-fadD_Ec]
  • E. coli W3110 ΔfadE pJ294{Placuv5}[alkL]{Ptac}[synUcTE]/pCDF[wax-dgaT_AsAPD1(co_Ec)-fadD_Ec]

These strains were employed to investigate their ability to produce fatty acid methyl esters. In this process the following procedure was used:

The strains are subjected to a multistage aerobic culturing process. The strains under test were initially grown in Luria-Bertani Bouillon according to Miller (Merck, Darmstadt) containing 100 μg/ml of ampicillin and 100 μg/ml of spectinomycin as 5 ml preliminary culture from a single colony each time. The next culture step proceeded in M9 medium. The medium, consisting of 38 mM disodium hydrogenphosphate dihydrate, 22 mM potassium dihydrogenphosphate, 8.6 mM sodium chloride, 37 mM ammonium chloride, 2% (w/v) glucose, 2 mM magnesium sulphate heptahydrate (all substances from Merck, Darmstadt) and 0.1% (v/v) trace element solution was adjusted to pH 7.4 using 25% strength ammonium hydroxide solution. The added trace element solution consisting of 9.7 mM manganese(II) chloride tetrahydrate, 6.5 mM zinc sulphate heptahydrate, 2.5 mM sodium EDTA (Titriplex III), 4.9 mM boric acid, 1 mM sodium molybdate dihydrate, 32 mM calcium chloride dihydrate, 64 mM iron(II) sulphate heptahydrate and 0.9 mM copper(II) chloride dihydrate dissolved in 1 M hydrochloric acid (all substances from Merck, Darmstadt) was sterile-filtered before addition to the M9 medium. 10 ml of M9 medium were charged with 100 μg/ml of spectinomycin and 100 μg/ml of ampicillin into 100 ml conical flasks with chicane and inoculated with 0.5 ml from the preliminary culture. The culturing proceeded at 37° C. and 200 rpm in an incubating shaker. After a culturing time of 8 hours, 50 ml of M9 medium containing 100 μg/ml of spectinomycin and 100 μg/ml of ampicillin were charged in a 250 ml conical flask with chicane and inoculated with the 10 ml culture, in such a manner that an optical density (600 nm) of 0.2 was achieved. The culturing proceeded at 37° C. and 200 rpm in an incubating shaker. When an optical density (600 nm) of 0.6 to 0.8 is achieved, the gene expression is induced by adding 1 mM IPTG. The strains were cultured for a further 24 hours at 30° C. and 200 rpm. One hour after induction of gene expression, 1% (v/v) methanol is added to the culture broth. During the culturing, samples are withdrawn and the concentration of fatty acid methyl ester of different carbon chain lengths are quantified as described in Example 15. The results are shown in the tables hereinafter.

Production of fatty acid methyl esters with E. coli JW5020-1 Kan^S and E. coli W3110 ΔfadE, which overexpress one acyl-ACP thioesterase, fadD from E. coli and a wax-ester synthase. Strains with and without overexpression of alkL from P. putida GPo1 are shown. The concentrations of fatty acid methyl ester of differing carbon chain length are reported after 24 hours of culturing (n.d.=not detectable):

	cCaprylic acid	cCapric acid	cLauric acid	cMyristic acid
	methyl ester	methyl ester	methyl ester	methyl ester
Strain	[mg/L/OD]	[mg/L/OD]	[mg/L/OD]	[mg/L/OD]
E. coli W3110 ΔfadE pJ294[Ptac-synUcTE]/pCDF[wax-	n.d.	n.d.	0.1	1.5
dgaT_AsADP1(co_Ec)-fadD_Ec]
E. coli W3110 ΔfadE pJ294[alkL][Ptac-synUcTE]/	n.d.	n.d.	11.1	3.7
pCDF[wax-dgaT_AsADP1(co_Ec)-fadD_Ec]
E. coli JW5020-1 KanS pJ294[Ptac-ChFATB2_optEc]/	8.0	4.0
pCDF[atfA1_Ab(co_Ec)-fadD_Ec]
E. coli JW5020-1 KanS	9.5	4.8
pJ294{Placuv5}[alkL]{Ptac}[ChFATB2(co_Ec)]/
pCDF[atfA1_Ab(co_Ec)-fadD_Ec]
E. coli JW5020-1 KanS pJ294{Ptac}[CnFATB3(co_Ec)]/	n.d.	n.d.	3.1	6.3
pCDF[atfA1_Ab(co_Ec)-fadD_Ec]
E. coli JW5020-1 KanS	n.d.	n.d.	4.3	8.5
pJ294{Placuv5}[alkL]{Ptac}[CnFATB3(co_Ec)]/
pCDF[atfA1_Ab(co_Ec)-fadD_Ec]

It was thus shown that strains which overexpress alkL from P. putida are able to form more caprylic acid methyl ester, capric acid methyl ester, lauric acid methyl ester and myristic acid methyl ester, depending on the specificity of the overexpressed acyl-ACP thioesterase. This shows that a reinforcement of alkL is necessary for the preparation of fatty acid methyl esters of differing carbon chain length from unrelated carbon sources.

Example 17

Preparation of Expression Vectors for the Coexpression of Acyl-ACP Reductase Genes with the Acyl-CoA Synthetase Gene fadD from Escherichia coli and alkL from Pseudomonas putida

To produce expression vectors for the coexpression of fadD (SEQ ID No. 57) from Escherichia coli (encoding an enzyme E_vi) and acrM (SEQ ID No. 77) from Acinetobacter sp. M-1, acr1b (SEQ ID No 79) from Acinetobacter sp. ADP1, acr1a (SEQ ID No. 81) from Acinetobacter sp. ADP1 and Maqu_—2220 (SEQ ID No. 83) from Marinobacter aquaeolei VT8 (encoding an enzyme E_x) and alkL from Pseudomonas putida (SEQ ID No. 1, encoding an AlkL gene product), the genes acr1a from Acinetobacter sp. ADP1 and Maqu_—2220 were codon-optimized for expression in Escherichia coli and these genes and the gene acrM from Acinetobacter sp. M-1 were synthesized (DNA2.0 Inc., Menlo Park, Calif., USA). These genes were amplified by PCR proceeding from the synthetic DNA and also the gene acr1b from Acinetobacter sp. ADP1 proceeding from chromosomal DNA as a matrix. Via the oligonucleotides used, the amplified DNA fragments were provided with homologous regions to the respective neighbouring fragment and to the PspXl-linearized target vector pCDF[alkL] (SEQ ID No. 7) for recombination cloning. At the same time, the gene fadD from Escherichia coli was amplified by PCR together with a synthetic tac promotor (SEQ ID No. 39) proceeding from a pCDF derivative as a matrix and likewise provided with homologous regions via the oligonucleotides used.

To produce the expression vector for the genes luxC, luxD and luxE from the lux operon of Photorhabdus luminescens and alkL from Pseudomonas putida GPo1, the luxCDE operon (SEQ ID No. 85) was codon-optimized for expression in Escherichia coli and synthesized (DNA2.0 Inc., Menlo Park, Calif., USA). The operon was amplified by PCR proceeding from the synthesized DNA as matrix, and the tac promotor, proceeding from a pCDF derivative which contains this promotor (SEQ ID No. 39). Both DNA fragments were provided via the oligonucleotides used with homologous regions for the target vector to the respective neighbouring fragment and to the linearized target vector for the recombination cloning.

The following oligonucleotides were employed in amplification of the tac promotor, the acyl-CoA synthetase gene and the acyl-ACP reductase genes for the coexpression with alkL:

Ptac and fadD for the coexpression with acr1a
[Acinetobacter sp. ADP1]:
(SEQ ID No. 86)
NP-FA-P1:  5′-TTTTCTAAGGTACCCGATAACAATTACGAGCTT
           CATG-3′
(SEQ ID No. 87)
NP-FA-P2:  5′-CTCCTTCAGCTCAGGCTTTATTGTCCAC-3′
Ptac and fadD for the coexpression with acrM
[Acinetobacter sp. M-1]:
(SEQ ID No. 86)
NP-FA-P1:  5′-TTTTCTAAGGTACCCGATAACAATTACGAGCTT
           CATG-3′
(SEQ ID No. 88)
NP-FA-P5:  5′-CTCCTTCAGCTCAGGCTTTATTGTC-3′
Ptac and fadD for the coexpression with Maqu_2220
[Marinobacterium aquaeolei VT8]:
(SEQ ID No. 86)
NP-FA-P1:  5′-TTTTCTAAGGTACCCGATAACAATTACGAGCTT
           CATG-3′
(SEQ ID No. 89)
NP-FA-P8:  5′-TCCTTCTCGCTCAGGCTTTATTGTCC-3′
Ptac and fadD for the coexpression with acr1b
[Acinetobacter sp. ADP1]:
(SEQ ID No. 86)
NP-FA-P1:  5′-TTTTCTAAGGTACCCGATAACAATTACGAGCTT
           CATG-3′
(SEQ ID No. 90)
NP-FA-P14: 5′-CCTGATTGGCTCAGGCTTTATTGTC-3′
Ptac for the expression of luxCDE
[Photorhabdus luminescens]:
(SEQ ID No. 86)
NP-FA-P1:  5′-TTTTCTAAGGTACCCGATAACAATTACGAGCTT
           CATG-3′
(SEQ ID No. 91)
NP-FA-P11: 5′-ACCTCCTAGTTTTACCTCCTGTTAAACAA-3′
acr1a [Acinetobacter sp. ADP1]:
(SEQ ID No. 92)
NP-FA-P3:  5′-CCTGAGCTGAAGGAGTTACAGTTTGATC-3′
(SEQ ID No. 93)
NP-FA-P4:  5′-GTTTCTTTACCAGACTTATCACCAGTGCTCACC
           -3′
acrM [Acinetobacter sp. M1]:
(SEQ ID No. 94)
NP-FA-P6:  5′-CCTGAGCTGAAGGAGTTACAGTATGAATG-3′
(SEQ ID No. 95)
NP-FA-P7:  5′-GTTTCTTTACCAGACTTATTACCAGTGTTCG-
           3′
Maqu_2220 [Marinobacterium aquaeolei VT8]:
(SEQ ID No. 96)
NP-FA-P9:  5′-CCTGAGCGAGAAGGAGTTCTATCATGG-3′
(SEQ ID No. 97)
NP-FA-P10: 5′-GTTTCTTTACCAGACTCATTACGCGGCCTTTT
           TGC-3′
acr1b [Acinetobacter sp. ADP1]:
(SEQ ID No. 98)
NP-FA-P15: 5′-CCTGAGCCAATCAGGGAAAAACGCGTG-3′
(SEQ ID No. 99)
NP-FA-P16: 5′-GTTTCTTTACCAGACCTCTCGGTATGAGAGGC
           TTC-3′
luxCDE [Photorhabdus luminescens]:
(SEQ ID No. 100)
NP-FA-P12: 5′-GTAAAACTAGGAGGTAAAAAAAATGACG-3′
(SEQ ID No. 101)
NP-FA-P13: 5′-GTTTCTTTACCAGACTTAGCTATCGAACGAACG
           CCTCG-3′

The following parameters were used for the PCR: 1×: initial denaturation, 98° C., 0:30 min; 35×: denaturation, 98° C., 0:10 min, annealing, 60° C., 0:45 min; elongation, 72° C., 1:30 min; 1×: terminal elongation, 72° C., 10 min. For the amplification, the Phusion™ High-Fidelity Master Mix from New England Biolabs (Frankfurt) was used in accordance with the manufacturer's recommendations. In each case 50 μl of the PCR reactions were then separated on a 1% strength TAE-agarose gel. The PCR, the agarose-gel electrophoresis, ethidium bromide staining of the DNA and determination of the PCR fragment sizes were carried out in a manner known to those skilled in the art.

In all cases, PCR fragments of the expected size were able to be amplified. These were, for the tac promotor 171 base pairs, for the tac promotor and fadD for coexpression with acr1a [A.sp. ADP1] and Maqu2220 1927 base pairs, for coexpression with acrM 1919 base pairs and for coexpression with acr1b [A.sp. ADP1] 1933 base pairs. The PCR fragments for acr1a [A.sp. ADP1] were 952 base pairs, for acrM 906 base pairs, for Maqu2220 1561 base pairs, for acr1b [A.sp.ADP1] 903 base pairs, and for luxCDE 3621 base pairs. For isolation of the DNA from the agarose gel, the target DNA was cut out from the gel using a scalpel and purified using the QiaQuick Gel extraction kit according to the manufacturer's instructions (Qiagen, Hilden). The purified PCR products were cloned by recombination, using the Geneart® Seamless Cloning and Assembly Kit according to the manufacturer's instructions (Life Technologies, Carlsbad, Calif., USA) into the PspX/-linearized vector pCDF[alkL] (SEQ ID No. 7). Chemically competent E. coli DH5α (New England Biolabs, Frankfurt) was transformed in a manner known to those skilled in the art. The correct insertion of the target genes was checked by restriction analysis and the authenticity of the introduced genes was validated by DNA sequencing.

In this manner the following expression vectors resulted:

(SEQ ID No. 102)
• pCDF{Placuv5}[alkL]{Ptac}[fadD_Ec-acr1b_AsADP1]
(SEQ ID No. 103)
• pCDF{Placuv5}[alkL]{Ptac}
[fadD_Ec-acr1a_AsADP1(co_Ec)]
(SEQ ID No. 104)
• pCDF{Placuv5}[alkL]{Ptac}[fadD_Ec-acrM_AsM1]
(SEQ ID No. 105)
• pCDF{Placuv5}[alkL]{Ptac}
[fadD_Ec-Maqu2220(co_Ec)]
(SEQ ID No. 106)
• pCDF{Placuv5}[alkL]{Ptac}[luxCDE_Pl(co_Ec)]

For preparation of vectors for the coexpression of fadD from Escherichia coli and acrM from Acinetobacter sp. M-1, acr1b from Acinetobacter sp. ADP1, acr1a from Acinetobacter sp. ADP1 (codon-optimized) and Maqu_—2220 from Marinobacter aquaeolei VT8 (codon-optimized) and the expression of luxC, luxD and luxE from Photorhabdus luminescens (codon-optimized) without the coexpression of alkL, these genes were amplified by PCR starting from the previously generated expression vectors pCDF{Placuv5}[alkL]{Ptac}[fadD_Ec-acr1b_AsADP1], pCDF{Placuv5}[alkL]{Ptac}[fadD_Ec-acr1a_AsADP1(co_Ec)], pCDF{Placuv5}[alkL]{Ptac}[fadD_Ec-acrM_AsM1], pCDF{Placuv5}[alkL]{Ptac}[fadD_Ec-Maqu2220(co_Ec)] and pCDF{Placuv5}[alkL]{Ptac}[luxCDE_Pl(co_Ec)] with introduction of homologous regions to PspXI/NcoI-cut target vector pCDF[alkL] (SEQ ID No. 7).

The following oligonucleotides were employed here:

(SEQ ID No. 107)
NP-FA-P17: 5′-AATAAGGAGATATACGATAACAATTACGAGCTTCAT
           G-3′
(SEQ ID No. 108)
NP-FA-P18: 5′-GTTTCTTTACCAGACGCGTTCAAATTTCGCAGCA
           G-3′

The following parameters were employed for the PCR: 1×: initial denaturation, 98° C., 0:30 min; 35×: denaturation, 98° C., 0:15 min, annealing, 60° C., 0:45 min; elongation, 72° C., 1:30 min; 1×: terminal elongation, 72° C., 10 min. The Phusion™ High-Fidelity Master Mix from New England Biolabs (Frankfurt) was used for the amplification, following the manufacturer's recommendations. 50 μl of the PCR reactions in each case were then separated on a 1% strength TAE-agarose gel. The PCR, the agarose gel electrophoresis, ethidium bromide staining of the DNA and determination of the PCR fragment sizes were carried out in a manner known to those skilled in the art.

In all cases, PCR fragments of the expected size were able to be amplified. These were 2901 base pairs for P_tac-fadD_Ec-acr1a_AsADP1, 2877 base pairs for P_tac-fadD_Ec-acrM_AsM1, 3532 base pairs for P_tac-fadD_Ec-Maqu_—2220, 2907 base pairs for P_tac-fadD_Ec-acr1b_AsADP1, and 3810 base pairs for P_tac-luxCDE.

To isolate the DNA from the agarose gel, the target gel was cut out of the gel using a scalpel and purified using the QiaQuick Gel extraction kit according to the manufacturer's instructions (Qiagen, Hilden). The purified PCR products were cloned into the vector pCDF[alkL] (SEQ ID No. 7) digested with PspXI and NcoI by means of recombination, using the Geneart® Seamless Cloning and Assembly Kit according to the manufacturer's instructions (Life Technologies, Carlsbad, Calif., USA). Owing to the restriction of the vector, the alkL gene is removed therefrom. The transformation of chemically competent E. coli DH5α (New England Biolabs, Frankfurt) was performed in a manner known to those skilled in the art. The correct insertion of the target genes was checked by restriction analysis and the authenticity of the introduced genes was verified by DNA sequencing.

The expression vectors hereinafter resulted in this manner:

(SEQ ID No. 109)
• pCDF{Ptac}[fadD_Ec-acr1b_AsADP1]
(SEQ ID No. 110)
• pCDF{Ptac}[fadD_Ec-acr1a_AsADP1(co_Ec)]
(SEQ ID No. 111)
• pCDF{Ptac}[fadD_Ec-acrM_AsM1]
(SEQ ID No. 112)
• pCDF{Ptac}[fadD_Ec-Maqu2220(co_Ec)]
(SEQ ID No. 113)
• pCDF{Ptac}[luxCDE_Pl(co_Ec)]

Example 18

Chromatographic Quantification of Fatty Alcohols and Fatty Aldehydes

Fatty alcohols and fatty aldehydes are quantified by gas chromatography with mass-spectrometric coupling (GC/MS).

To extract the samples consisting of 1 ml of culture broth they are admixed with 500 μl of ethyl acetate (Chromasolv®Plus 99.9%, Sigma No. 650528-1L), shaken for 10 min at 12 Hz and sedimented for 5 min at 13 200 rpm in a bench centrifuge (Eppendorf, Hamburg). The organic phase (ethyl acetate) is transferred to HPLC vials with an insert and analysed for fatty alcohols and fatty aldehydes of differing chain length (C8-C18) by GC/MS coupling.

To separate fatty alcohols and fatty aldehydes, the ZB-50 capillary column having the dimensions 30 m×320 μm and a film thickness of 0.5 μm (Phenomenex, Aschaffenburg) is used as stationary phase. The carrier gas used is helium at a constant flow rate of 1.5 ml/min. The separation proceeds in the course of 45 min at an injection temperature of 250° C. and a detector temperature of 250° C. The column temperature at the start is 40° C. and is held for 2 min. Thereafter the column temperature is increased at 7° C./min to 150° C., then at 15° C./min to 320° C. and held for 10 min. The injection volume is 1 μl splitless. Detection is performed by means of MS (DSQ II) detector (Thermo Fisher Scientific) with a mass range of 12-800 m/z. The reference substance employed is a standard mixture consisting of in each case 10 μg/ml 1-octanal (99%, Sigma-Aldrich), 1-octanol (Sigma-Aldrich), 1-decanal (>98%, Sigma-Aldrich), 1-decanol (>99%, Sigma-Aldrich), 1-dodecanal (>92%, Sigma-Aldrich), 1-dodecanol (>98%, Sigma-Aldrich), 1-tetradecanal, 1-tetradecanol (>99%, Fluka), 1-hexadecanal and 1-hexadecanol (99%, Sigma-Aldrich) for calibration. Relative quantification of the samples is performed via the peak areas.

Example 19

Production of Fatty Alcohols by E. coli Strains Having a Deletion in the fadE Gene which Overexpresses the alkL Genes from Pseudomonas putida GPo1 and fatB2 from Cuphea hookeriana or fatB3 from Cocos nucifera and the fadD Gene from Escherichia coli and an Acyl-ACP Reductase Gene

To generate E. coli strains having the expression vector for the alkL gene from Pseudomonas putida GPo1 and the fadD gene from E. coli, and the genes acr1a from Acinetobacter sp. ADP1 or acr1b from Acinetobacter sp. ADP1 or acrM from Acinetobacter sp. M-1 or Maqu2220 from Marinobacterium aquaeolei VT8 or luxCDE from Photorhabdus luminescens in combination with the expression vector for the fatB2 gene from Cuphea hookeriana and/or fatB3 from Cocos nucifera, electrocompetent cells of E. coli W3110 ΔfadE and E. coli JW5020-1 Kan^S were prepared. This took place in a manner known to those skilled in the art. E. coli JW5020-1 Kan^S is a derivative of E. coli JW5020-1 (CGSC, The coli genetic stock center, Yale University, New Haven, USA), this in turn is a E. coli BW25113 derivative which bears a deletion of the fadE gene. The fadE gene was replaced by a kanamycin cassette. This was removed in a manner known to those skilled in the art before the strain was equipped with the expression vectors using a helper plasmid which encodes fip recombinase (see Datsenko K. A. and Wanner B. L. (2000) PNAS 97(12):6640-6645) resulting in strain E. coli JW5020-1 Kan^S. E. coli JW5020-1

Kan^S was transformed with the plasmids pJ294[Ptac-ChFATB2_optEc] (SEQ ID No. 10) in combination with pCDF{Ptac}[fadD_Ec-acr1a_AsADP1(co_Ec)] (SEQ ID No. 110), pCDF{Placuv5}[alkL]{Ptac}[fadD_Ec-acr1a_AsADP1(co_Ec)] (SEQ ID No. 103), pCDF{Ptac}[fadD_Ec-Maqu2220(co_Ec)] (SEQ ID No. 112) or pCDF{Placuv5}[alkL]{Ptac}[fadD_Ec-Maqu2220(co_Ec)] (SEQ ID No. 105) and E. coli W3110 ΔfadE with the plasmids pJ294{Ptac}[CnFATB3(co_Ec)] (SEQ ID No. 40) in combination with pCDF{Ptac}[fadD_Ec-acr1b_AsADP1] (SEQ ID No. 109), pCDF{Placuv5}[alkL]{Ptac}[fadD_Ec-acr1b_AsADP1] (SEQ ID No. 102), pCDF{Ptac}[fadD_Ec-acrM_AsM1] (SEQ ID No. 111), pCDF{Placuv5}[alkL]{Ptac}[fadD_Ec-acrM_AsM1] (SEQ ID No. 104), pCDF{Ptac}[luxCDE_Pl(co_Ec)] (SEQ ID No. 113) or pCDF{Placuv5}[alkL]{Ptac}[luxCDE_Pl(co_Ec)] (SEQ ID No. 106) and plated out on LB-agar plates containing spectinomycin (100 μg/ml) and ampicillin (100 μg/ml). Transformants were checked for the presence of the correct plasmids by plasmid preparation and analytical restriction analysis.

In this manner the E. coli strains hereinafter were generated:

• • E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB2_optEc]/pCDF{Ptac}[fadD_Ec-acr1a_AsADP1(co_Ec)]
  • E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB2_optEc]/pCDF{Placuv5}[alkL]{Ptac}[fadD_Ec-acr1a_AsADP1(co_Ec)]
  • E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB2_optEc]/pCDF{Ptac}[fadD_Ec-Maqu2220(co_Ec)]
  • E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB2_optEc]/pCDF{Placuv5}[alkL]{Ptac}[fadD_Ec-Maqu2220(co_Ec)]
  • E. coli W3110 ΔfadE pJ294{Ptac}[CnFATB3(co_Ec)]/pCDF{Ptac}[fadD_Ec-acrM_AsM1]
  • E. coli W3110 ΔfadE pJ294{Ptac}[CnFATB3(co_Ec)]/pCDF{Ptac}[alkL][fadD_Ec-acrM_AsM1]
  • E. coli W3110 ΔfadE pJ294{Ptac}[CnFATB3(co_Ec)]/pCDF{Ptac}[fadD_Ec-acr1b_AsADP1]
  • E. coli W3110 ΔfadE pJ294{Ptac}[CnFATB3(co_Ec)]/pCDF{Placuv5}[alkL]{Ptac}[fadD_Ec-acr1b_AsADP1]
  • E. coli W3110 ΔfadE pJ294{Ptac}[CnFATB3(co_Ec)]/pCDF{Ptac}[luxCDE_Pl(co_Ec)]
  • E. coli W3110 ΔfadE pJ294{Ptac}[CnFATB3(co_Ec)]/pCDF{Placuv5}[alkL]{Ptac}[luxCDE_Pl(co_Ec)]

These strains were used to study their ability to produce fatty alcohols. The following procedure was adopted here:

The strains are subjected to a multistage aerobic culturing process. The strains under investigation were first initially grown in Luria-Bertani Bouillon according to Miller (Merck, Darmstadt) containing 100 μg/ml of ampicillin and 100 μg/ml of spectinomycin as a 5 ml preliminary culture in each case from a single colony. The next culturing step proceeded in M9 medium. The medium consisting of 38 mM disodium hydrogenphosphate dihydrate, 22 mM potassium dihydrogenphosphate, 8.6 mM sodium chloride, 37 mM ammonium chloride, 2% (w/v) glucose, 2 mM magnesium sulphate heptahydrate (all substances from Merck, Darmstadt) and 0.1% (v/v) trace element solution were adjusted to a pH of 7.4 with 25% strength ammonium hydroxide solution. The added trace element solution consisting of 9.7 mM manganese(II) chloride tetrahydrate, 6.5 mM zinc sulphate heptahydrate, 2.5 mM sodium EDTA (Titriplex III), 4.9 mM boric acid, 1 mM sodium molybdate dihydrate, 32 mM calcium chloride dihydrate, 64 mM iron(II) sulphate heptahydrate and 0.9 mM copper(II) chloride dihydrate dissolved in 1 M hydrochloric acid (all substances from Merck, Darmstadt) was sterile-filtered before addition to the M9 medium. 10 ml of M9 medium were charged into a 100 ml conical flask with chicane with 100 μg/ml of spectinomycin and 100 μg/ml of ampicillin and inoculated with 0.5 ml from the preliminary culture. The culturing proceeded at 37° C. and 200 rpm in an incubating shaker. After a culturing time of 8 hours, 50 ml of M9 medium containing 100 μg/ml of spectinomycin and 100 μg/ml of ampicillin were charged into a 250 ml conical flask with chicane and inoculated with the 10 ml culture, in such a manner that an optical density (600 nm) of 0.2 is achieved. Culturing proceeded at 37° C. and 200 rpm in an incubating shaker. When an optical density (600 nm) of 0.6 to 0.8 is achieved, the gene expression is induced by adding 1 mM IPTG. The strains were cultured for a further 24 hours at 30° C. and 200 rpm. During culturing, samples are withdrawn and the concentration of fatty alcohols of differing carbon chain lengths is quantified as described in Example 18. The results are shown in the table hereinafter.

Production of fatty alcohols using E. coli JW5020-1 Kan^S and E. coli W3110 ΔfadE which overexpress a plant acyl-ACP thioesterase, fadD from E. coli and also a fatty acyl-CoA reductase. Strains with and without overexpression of alkL from P. putida GPo1 are shown. The concentrations of fatty alcohols of differing carbon chain length are reported after culturing for 24 hours (n.d.=not detectable):

	Decanol	Dodecanol	Tetradecanol	Hexadecanol
	[Peak area/OD]	[Peak area/OD]	[Peak area/OD]	[Peak area/OD]
E. coli W3110 ΔfadE pJ294{Ptac}[CnFATB3(co_Ec)]/	n.d.	2.53E+06	9.74E+06	1.39E+07
pCDF{Ptac}[fadD_Ec-acrM_AsM1(co_Ec)]
E. coli W3110 ΔfadE pJ294{Ptac}[CnFATB3(co_Ec)]/	n.d.	1.15E+07	2.90E+07	3.01E+07
pCDF{Placuv5}[alkL]{Ptac}[fadD_Ec-
acrM_AsM1(co_Ec)]
E. coli W3110 ΔfadE pJ294{Ptac}[CnFATB3(co_Ec)]/	n.d.	1.42E+06	6.91E+06	n.d.
pCDF{Ptac}[luxCDE_PI(co_Ec)]
E. coli W3110 ΔfadE pJ294{Ptac}[CnFATB3(co_Ec)]/	n.d.	3.78E+06	1.77E+07	n.d.
pCDF{Placuv5}[alkL]{Ptac}[luxCDE_PI(co_Ec)]
E. coli W3110 ΔfadE pJ294{Ptac}[CnFATB3(co_Ec)]/	n.d.	2.43E+04	1.59E+06	n.d.
pCDF{Ptac}[fadD_Ec-acr1b_AsADP1)]
E. coli W3110 ΔfadE pJ294{Ptac}[CnFATB3(co_Ec)]/	n.d.	8.65E+05	2.44E+06	n.d.
pCDF{Placuv5}[alkL]{Ptac}[fadD_Ec-acr1b_AsADP1)]
E. coli JW5020-1 KanS pJ294{Ptac}[Ptac-	4.65E+06	n.d.	3.49E+06	5.63E+06
ChFATB2_optEc]/pCDF{Ptac}[fadD_Ec-
acr1a_AsADP1(co_Ec)]
E. coli JW5020-1 KanS pJ294[Ptac-ChFATB2_optEc]/	1.61E+07	n.d.	4.23E+07	3.45E+07
pCDF{Placuv5}[alkL]{Ptac}[fadD_Ec-
acr1a_AsADP1(co_Ec)]
E. coli JW5020-1 KanS pJ294[Ptac-ChFATB2_optEc]/	n.d.	n.d.	5.66E+04.	7.12E+04
pCDF{Ptac}[fadD_Ec-Maqu2220_Ma(co_Ec)]
E. coli JW5020-1 KanS pJ294[Ptac-ChFATB2_optEc]/	n.d.	n.d.	6.74E+07	2.48E+08
pCDF{Placuv5}[alkL]{Ptac}[fadD_Ec-
Maqu2220_Ma(co_Ec)]

It was thus shown that strains which overexpress alkL from P. putida are able to form more decanol, dodecanol, tetradecanol and hexadecanol than strains without alkL. This shows that reinforcement of alkL is necessary for producing fatty alcohols of various chain lengths from unrelated carbon sources.

Example 20

Preparation of an Expression Vector for the Mmar_—3356 Gene from Mycobacterium marinum

To produce an expression vector for the Mmar_—3356 gene (SEQ ID No. 114) from Mycobacterium marinum, the gene was codon-optimized for expression in E. coli. The synthesized gene for the SAM-dependent methyltransferase (E_va) was amplified with introduction of an NdeI cleavage site upstream and an XbaI cleavage site downstream. The restriction cleavage sites were introduced via the oligonucleotides used.

(SEQ ID No.119)
mt_fw_Ndel: 5′-TATATACATATGCCAAGAGAGATTAGATTACC-3′
(SEQ ID No. 120)
mt_rv_Xbal: 5′-TATATATCTAGACTGAGTTAGGCACGTTTCG-3′

The following parameters were used for the PCR: 1×: initial denaturation, 98° C., 0:30 min; 35×: denaturation, 98° C., 0:10 min, annealing, 62° C., 0:20 min; elongation, 72° C., 0:30 min; 1×: terminal elongation, 72° C., 10 min. The Phusion™ High-Fidelity Master Mix from New England Biolabs (Frankfurt) was used for the amplification in accordance with the manufacturer's recommendations. 50 μl of the PCR reactions were then separated in each case on a 1.5% strength TAE-agarose gel. The PCR, the agarose gel electrophoresis, ethidium bromide staining of the DNA and determination of the PCR fragment sizes were carried out in a manner known to those skilled in the art.

The PCR fragment having the expected size of 1133 base pairs was able to be amplified. To isolate the DNA from the agarose gel, the target DNA was cut out of the gel using a scalpel and purified using the QiaQuick Gel extraction kit in accordance with the manufacturer's instructions (Qiagen, Hilden). The purified PCR product was digested using the restriction endonucleases NdeI and XbaI and was ligated into an appropriately cut pJ281 derivative (SEQ ID No. 121) which contains a lacuv5 promotor. The transformation of chemically competent E. coli DH5α (New England Biolabs, Frankfurt) proceeded according to a manner known to those skilled in the art. Correct insertion of the target genes was checked by restriction analysis and the authenticity of the introduced genes was validated by DNA sequencing. The completed E. coli expression vector was termed pJ281{Placuv5}[Mmar_—3356(co_Ec)] (SEQ ID No. 116).

Example 21

Production of Fatty Acid Esters by E. coli Strains with a Deletion in the fadE Gene which Overexpress a Plant Acyl-ACP Thioesterase Gene, the alkL Genes from Pseudomonas putida GPo1 and Mmar_—3356 from Mycobacterium marinum

To generate an E. coli strain having expression vectors for the genes fatB1 from Cuphea hookeriana, fatB2 from Cuphea hookeriana, fatB3 from Cocos nucifera or synUcTE from Umbellularia californica in combination with an expression vector for the Mmar_—3356 gene from Mycobacterium marinum and an expression vector for the alkL gene from Pseudomonas putida GPo1, electrocompetent cells of E. coli JW5020-1 Kan^S and E. coli W3110 ΔfadE are produced. This proceeded in a manner are known to those skilled in the art. The strains are transformed sequentially with the vectors pJ294[Ptac-ChFATB1_optEc] (SEQ ID No. 12), pJ294[Ptac-ChFATB2_optEc] (SEQ ID No. 10), pJ294{Ptac}[CnFATB3(co_Ec)] (SEQ ID No. 40) and/or pJ294[Ptac-synUcTE] (SEQ ID No. 41) and pJ281{Placuv5}[Mmar_—3356(co_Ec)] (SEQ ID No. 116) and pCDF[alkL] (SEQ ID No. 7) and/or pCDFDuet-1 (71340-3, Merck, Darmstadt) and plated onto LB-agar plates containing ampicillin (100 μg/ml), kanamycin (50 μg/ml) and spectinomycin (100 μg/ml). Transformants are checked by plasmid preparation and analytical restriction analysis with respect to the presence of the correct plasmids. In this manner the strains hereinafter were constructed:

• • E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB1_optEc]/pJ281{Placuv5}[Mmar_—3356(co_Ec)]/pCDF[alkL]
  • E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB1_optEc]/pJ281{Placuv5}[Mmar_—3356(co_Ec)]/pCDFDuet-1
  • E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB2_optEc]/pJ281{Placuv5}[Mmar_—3356(co_Ec)]/pCDF[alkL]
  • E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB2_optEc]/pJ281{Placuv5}[Mmar_—3356(co_Ec)]/pCDFDuet-1
  • E. coli JW5020-1 Kan^S pJ294{Ptac}[CnFATB3(co_Ec)]/pJ281{Placuv5}[Mmar_—3356(co_Ec)]/pCDF[alkL]
  • E. coli JW5020-1 Kan^S pJ294{Ptac}[CnFATB3(co_Ec)]/pJ281{Placuv5}[Mmar_—3356(co_Ec)]/pCDFDuet-1
  • E. coli W3110 ΔfadE pJ294[Ptac-synUcTE]/pJ281{Placuv5}[Mmar_—3356(co_Ec)]/pCDF[alkL]
  • E. coli W3110 ΔfadE pJ294[Ptac-synUcTE]/pJ281{Placuv5}[Mmar_—3356(co_Ec)]/pCDFDuet-1

These strains are used to study their ability to produce fatty acid methyl esters from glucose. The following procedure is adopted here:

The strains are subjected to a multistage aerobic culturing process. The strains under investigation are first initially grown in Luria-Bertani Bouillon according to Miller (Merck, Darmstadt) containing 50 μg/ml of kanamycin, 100 μg/ml of spectinomycin and 100 μg/ml of ampicillin as 5 ml preliminary culture from a single colony in each case. The next culture step proceeds in M9 medium. The medium, consisting of 38 mM disodium hydrogenphosphate dihydrate, 22 mM potassium dihydrogenphosphate, 8.6 mM sodium chloride, 37 mM ammonium chloride, 2% (w/v) glucose, 2 mM magnesium sulphate heptahydrate (all substances from Merck, Darmstadt) and 0.1% (v/v) trace element solution, is adjusted to a pH of 7.4 using 25% strength ammonium hydroxide solution. The added trace element solution consisting of 9.7 mM manganese(II) chloride tetrahydrate, 6.5 mM zinc sulphate heptahydrate, 2.5 mM sodium EDTA (Titriplex III), 4.9 mM boric acid, 1 mM sodium molybdate dihydrate, 32 mM calcium chloride dihydrate, 64 mM iron(II) sulphate heptahydrate and 0.9 mM copper(II) chloride dihydrate dissolved in 1 M hydrochloric acid (all substances from Merck, Darmstadt) is sterile-filtered before addition to the M9 medium. 10 ml of M9 medium are charged together with 50 μg/ml kanamycin, 100 μg/ml spectinomycin and 100 μg/ml ampicillin into a 100 ml conical flask with chicane and inoculated with 0.5 ml of the preliminary culture. The culturing proceeds at 37° C. and 200 rpm in an incubating shaker. After a culturing time of 8 hours, 50 ml of M9 medium containing 50 μg/ml of kanamycin, 100 μg/ml of spectinomycin and 100 μg/ml of ampicillin are charged in a 250 ml conical flask with chicane and inoculated with the 10 ml culture in such a manner that an optical density (600 nm) of 0.2 is achieved. The culturing proceeds at 37° C. and 200 rpm in an incubating shaker. When an optical density (600 nm) of 0.6 to 0.8 is reached, the gene expression is induced by adding 1 mM IPTG. The strains are cultured for at least a further 24 hours at 30° C. and 200 rpm. During the culturing, samples are withdrawn and the concentration of fatty acid methyl esters of differing carbon chain lengths is quantified as described in Example 15. It is shown that the strains E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB1_optEc]/pJ281{Placuv5}[Mmar_—3356(co_Ec)]/pCDF[alkL], E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB2_optEc]/pJ281{Placuv5}[Mmar_—3356(co_Ec)]/pCDF[alkL], E. coli JW5020-1 Kan^S pJ294{Ptac}[CnFATB3(co_Ec)]/pJ281{Placuv5}[Mmar_—3356(co_Ec)]/pCDF[alkL] and E. coli W3110 ΔfadE pJ294[Ptac-synUcTE]/pJ281{Placuv5}[Mmar_—3356(co_Ec)]/pCDF[alkL] are able, depending on the specificity of the overexpressed acyl-CoA thioesterase gene, to form fatty acid methyl esters of different carbon chain length and degree of saturation compared with the corresponding strains which do not overexpress the alkL gene. In particular, E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB1_optEc]/pJ281{Placuv5}[Mmar_—3356(co_Ec)]/pCDF[alkL] can produce more fatty acid methyl esters of chain length C14:0, C16:0 and C16:1, E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB2_optEc]/pJ281{Placuv5}[Mmar_—3356(co_Ec)]/pCDF[alkL] can produce more fatty acid methyl esters of chain length C8:0 and C10:0, E. coli JW5020-1 Kan^S pJ294{Ptac}[CnFATB3(co_Ec)]/pJ281{Placuv5}[Mmar_—3356(co_Ec)]/pCDF[alkL] can produce more fatty acid methyl esters of chain length C12:0, C14:0 and C16:1 and E. coli W3110 ΔfadE pJ294[Ptac-synUcTE]/pJ281{Placuv5}[Mmar_—3356(co_Ec)]/pCDF[alkL] can produce more fatty acid methyl esters of chain length C12:0 and C14:0 from glucose than the corresponding strains which lack the alkL gene from Pseudomonas putida GPo1.

Example 22

Preparation of an Expression Vector for the Coexpression of the Genes MSMEG_—2956 from Mycobacterium smegmatis, npt from Nocardia sp. with alkL from Pseudomonas putida

To prepare a E. coli expression vector for the genes MSMEG_—2956 (SEQ ID No. 117) from Mycobacterium smegmatis, npt (SEQ ID No: 122) from Nocardia sp. and alkL (SEQ ID No. 1) from Pseudomonas putida GPo1, the genes MSMEG_—2956 and npt are codon-optimized for expression in Escherichia coli and synthesized. The synthesized genes are cloned as an operon following a lacuv5 promoter using recombination cloning. MSMEG 2956 and npt are derivative with introduction of homologous regions for recombination cloning. The oligonucleotides hereinafter are used here:

Promoter region Placuv5:
(SEQ ID No. 126)
NP-FA-P22: 5′-CCGGTAGTCAATAAAATCGCACCTGGTGTTTAAAC
           G-3′
(SEQ ID No. 127)
NP-FA-P23: 5′-TGTCATATGCCACTCTCCTTGGTTCC-3′
MSMEG_2956(co_Ec) and npt_Noc(co_Ec):
(SEQ ID No. 128)
NP-FA-P24: 5′-GAGTGGCATATGACAATTGAAACGCGCGAAG-3′
(SEQ ID No. 129)
NP-FA-P25: 5′-TCTATTGCTGGTTTACCTAGGTTATCATTATCATG
           C-3′

The following parameters are used for the PCR: 1×: initial denaturation, 98° C., 0:30 min; 35×: denaturation, 98° C., 0:15 min, annealing, 60° C., 0:30 min; elongation, 72° C., 0:20 min; 1×: terminal elongation, 72° C., 10 min. The Phusion™ High-Fidelity Master Mix from New England Biolabs (Frankfurt) is used for the amplification in accordance with the manufacturer's recommendations. 50 μl of the PCR reactions in each case are then separated on a 1% strength TAE agarose gel and cut out from the agarose gel and purified. The PCR, agarose gel electrophoresis, ethidium bromide staining of the DNA and determination of the PCR fragment sizes and purification of the DNA fragments are carried out in a manner known to those skilled in the art. PCR fragments of 210 base pairs for the lacuv5 promoter region and 4241 base pairs for the DNA fragment MSMEG_—2956(co_Ec)-npt_Noc(co_Ec) are expected. The purified PCR fragments are cloned into the restriction endonuclease-Age/-digested vector pCDF[alkL] (SEQ ID No. 7) and pCDFDuet-1 (71340-3, Merck, Darmstadt) by means of recombination and using the Geneart® Seamless Cloning and Assembly Kit in accordance with the manufacturer's instructions (life Technologies, Carlsbad, Calif., USA). This generates the vectors pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)] (SEQ ID No. 124) and pCDF[MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)] (SEQ ID No. 125). Chemically competent E. coli DH10β is transformed in a manner known to those skilled in the art. Correct insertion of the target genes is checked by restriction analysis and the authenticity of the insert is validated by DNA sequencing.

Example 23

Production of Fatty Aldehydes and Fatty Alcohols by E. coli Strains with a Deletion in the fadE Gene which Overexpress a Plant Acyl-ACP Thioesterase Gene, the Genes alkL from Pseudomonas putida GPo1 and MSMEG_—2956 from Mycobacterium smegmatis and npt from Nocardia sp

To generate E. coli strains having expression vectors for the genes fatB1 from Cuphea hookeriana, fatB2 from Cuphea hookeriana, fatB3 from Cocos nucifera or synUcTE from Umbellularia californica in combination with an expression vector for the genes MSMEG_—2956 from Mycobacterium smegmatis, npt from Nocardia sp. and alkL from Pseudomonas putida GPo1 electrocompetent cells of E. coli JW5020-1 Kan^S and E. coli W3110 ΔfadE are prepared. This is performed in a manner known to those skilled in the art. The strains are transformed with the vectors pJ294[Ptac-ChFATB1_optEc] (SEQ ID No. 12), pJ294[Ptac-ChFATB2_optEc] (SEQ ID No. 11), pJ294{Ptac}[CnFATB3(co_Ec)] (SEQ ID No. 40) and/or pJ294[Ptac-synUcTE] (SEQ ID No. 41) and pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)] (SEQ ID No. 124) and/or pCDF[MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)] (SEQ ID No. 128) and plated onto LB-agar plates containing ampicillin (100 μg/ml) and spectinomycin (100 μg/ml). Transformants are checked with respect to the presence of the correct plasmids by plasmid preparation and analytical restriction analysis. The strains hereinafter are constructed in this manner:

• • E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB1_optEc]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)]
  • E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB1_optEc]/pCDF[MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)]
  • E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB2_optEc]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)]
  • E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB2_optEc]/pCDF[MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)]
  • E. coli JW5020-1 Kan^S pJ294{Ptac}[CnFATB3(co_Ec)]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)]
  • E. coli JW5020-1 Kan^S pJ294{Ptac}[CnFATB3(co_Ec)]/pCDF[MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)]
  • E. coli W3110 ΔfadE pJ294{Ptac}[CnFATB3(co_Ec)]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)]
  • E. coli W3110 ΔfadE pJ294{Ptac}[CnFATB3(co_Ec)]/pCDF[MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)]
  • E. coli W3110 ΔfadE pJ294[Ptac-synUcTE]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)]
  • E. coli W3110 ΔfadE pJ294[Ptac-synUcTE]/pCDF[MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)]

These strains are employed to study their ability to produce fatty alcohols and fatty aldehydes from glucose. The following procedure is adopted here:

The strains are subjected to a multistage aerobic culturing process. The strains under investigation are initially grown in Luria-Bertani Bouillon according to Miller (Merck, Darmstadt) containing 100 μg/ml of ampicillin and 100 μg/ml of spectinomycin as a 5 ml preliminary culture from a single colony in each case. The next culturing step proceeds in M9 medium. The medium, consisting of 38 mM disodium hydrogenphosphate dihydrate, 22 mM potassium dihydrogenphosphate, 8.6 mM sodium chloride, 37 mM ammonium chloride, 2% (w/v) glucose, 2 mM magnesium sulphate heptahydrate (all substances from Merck, Darmstadt) and 0.1% (v/v) trace element solution, is adjusted to a pH of 7.4 using 25% strength ammonium hydroxide solution. The added trace element solution consisting of 9.7 mM manganese(II) chloride tetrahydrate, 6.5 mM zinc sulphate heptahydrate, 2.5 mM sodium EDTA (Titriplex III), 4.9 mM boric acid, 1 mM sodium molybdate dihydrate, 32 mM calcium chloride dihydrate, 64 mM iron(II) sulphate heptahydrate and 0.9 mM copper(II) chloride dihydrate dissolved in 1 M hydrochloric acid (all substances from Merck, Darmstadt) is sterile-filtered before addition to the M9 medium. 10 ml of M9 medium are charged with 100 μg/ml spectinomycin and 100 μg/ml ampicillin into 100 ml conical flasks with chicane and inoculated with 0.5 ml of the preliminary culture. The culturing proceeds at 37° C. and 200 rpm in an incubating shaker. After a culturing time of 8 hours, 50 ml of M9 medium are charged with 100 μg/ml of spectinomycin and 100 μg/ml of ampicillin in a 250 ml conical flask with chicane and inoculated with the 10 ml culture in such a manner that an optical density (600 nm) of 0.2 is achieved. The culturing proceeds at 37° C. and 200 rpm in an incubating shaker. When an optical density (600 nm) of 0.6 to 0.8 is achieved, the gene expression is induced by adding 1 mM IPTG. The strains are cultured for at least a further 24 hours at 30° C. and 200 rpm. During the culturing, samples are withdrawn and the concentration of fatty alcohols and fatty aldehydes of different carbon chain lengths is quantified as described in Example 18. It is shown that the strains E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB1_optEc]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)], E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB2_optEc]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)], E. coli JW5020-1 Kan^S pJ294{Ptac}[CnFATB3(co_Ec)]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)], E. coli W3110 ΔfadE pJ294{Ptac}[CnFATB3(co_Ec)]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)] and E. coli W3110 ΔfadE pJ294[Ptac-synUcTE]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)] are able, depending on the specificity of the overexpressed acyl-CoA thioesterase gene, to form fatty alcohols and fatty aldehydes of differing carbon chain length and differing degree of saturation compared to the corresponding strains which do not overexpress the gene alkL. In particular, E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB1_optEc]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)] can produce from glucose more fatty alcohols and fatty aldehydes of chain length C14:0, C16:0 and C16:1, E. coli JW5020-1 Kan^S pJ294[Ptac-ChFATB2_optEc]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)] can produce from glucose more fatty alcohols and fatty aldehydes of chain length C8:0 and C10:0, E. coli JW5020-1 Kan^S pJ294{Ptac}[CnFATB3(co_Ec)]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)] can produce from glucose more fatty alcohols and fatty aldehydes of chain length C12:0, C14:0 and C16:1, E. coli W3110 ΔfadE pJ294{Ptac}[CnFATB3(co_Ec)]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)] can produce from glucose more fatty alcohols and fatty aldehydes of chain length C12:0, C14:0 and C16:1 and E. coli W3110 ΔfadE pJ294[Ptac-synUcTE]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)] can produce from glucose more fatty alcohols and fatty aldehydes of chain length C12:0 and C14:0, than the corresponding strains which lack the gene alkL from Pseudomonas putida GPo1.

Example 24

Preparation of Expression Vectors for the Coexpression of an Acyl-ACP Thioesterase Gene, Ald from Bacillus subtilis and Cv 2025 from Chromobacterium violaceum

To produce E. coli expression vectors for the genes fatB1 (SEQ ID No. 9) from Cuphea hookeriana, fatB2 (SEQ ID No. 8) from Cuphea hookeriana and synUcTE (SEQ ID No. 37) from Umbellularia californica (in each case encoding an enzyme E_i) and ald (SEQ ID No. 130) from Bacillus subtilis (encoding an enzyme E_xiv) and Cv_—2025 (SEQ ID No. 132) from Chromobacterium violaceum (encoding an enzyme E_xiii), the genes fatB1, fatB2 and synUcTE are codon-optimized for expression in Escherichia coli and synthesized together with a tac promotor (SEQ ID No. 39). During the synthesis, a cleavage site is introduced upstream of the promoter and a cleavage site is introduced downstream of the terminator. The synthesized DNA fragments are digested with the restriction endonucleases BamHI and NotI and ligated into the correspondingly cut vector pJ294_alaDH_B.s._TA_C.v.(Ct) (SEQ ID No. 121). The expression vector used here has already been described in German patent application DE102011110946 and recorded there under SEQ ID No. 17. The completed vectors are named pJ294[alaDH_B.s._TA_C.v.(Ct)_Ptac-ChFATB1_optEc] (SEQ ID No. 134), pJ294[alaDH_B.s._TA_C.v.(Ct)_Ptac-ChFATB2_optEc] (SEQ ID No. 135) and pJ294[alaDH_B.s._TA_C.v.(Ct)_Ptac-synUcTE] (SEQ ID No. 136).

Example 25

Production of Alkylamines by E. coli Strains Having a Deletion in the fadE Gene which Overexpress an Acyl-CoA Thioesterase Gene, the Genes Cv_—2025 from Chromobacterium violaceum and ald from Bacillus subtilis, alkL from Pseudomonas putida GPo1, carA from Mycobacterium smegmatis and npt from Nocardia sp

To generate E. coli strains having expression vectors for the genes ald from Bacillus subtilis, Cv_—2025 from Chromobacterium violaceum and fatB1 from Cuphea hookeriana, fatB2 from Cuphea hookeriana, synUcTE from Umbellularia californica in combination with an expression vector for the genes MSMEG_—2956 from Mycobacterium smegmatis, npt from Nocardia sp. and alkL from Pseudomonas putida GPo1, electrocompetent cells of E. coli JW5020-1 Kan^S and E. coli W3110 ΔfadE are prepared. This takes place in a manner known to those skilled in the art. The strains are transformed with the vectors pJ294[alaDH_B.s._TA_C.v.(Ct)_Ptac-ChFATB1_optEc] (SEQ ID No. 134), pJ294[alaDH_B.s._TA_C.v.(Ct)_Ptac-ChFATB2_optEc](SEQ ID No. 135) and/or pJ294[alaDH_B.s._TA_C.v.(Ct)_Ptac-synUcTE] (SEQ ID No. 136) in combination with pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)] (SEQ ID No. 124) and/or pCDF[MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)] (SEQ ID No. 125) and plated onto LB-agar plates containing ampicillin (100 μg/ml) and spectinomycin (100 μg/ml). Transformants are checked with regard to the presence of the correct plasmids via plasmid preparation and analytical restriction analysis. The strains hereinafter are constructed in this manner:

• • E. coli JW5020-1 Kan^S pJ294[alaDH_B.s._TA_C.v.(Ct)_Ptac-ChFATB1_optEc]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)]
  • E. coli JW5020-1 Kan^S pJ294[alaDH_B.s._TA_C.v.(Ct)_Ptac-ChFATB1_optEc]/pCDF[MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)]
  • E. coli JW5020-1 Kan^S pJ294[alaDH_B.s._TA_C.v.(Ct)_Ptac-ChFATB2_optEc]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)]
  • E. coli JW5020-1 Kan^S pJ294[alaDH_B.s._TA_C.v.(Ct)_Ptac-ChFATB2_optEc]/pCDF[MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)]
  • E. coli W3110 ΔfadE pJ294[alaDH_B.s._TA_C.v.(Ct)_Ptac-synUcTE]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)]
  • E. coli W3110 ΔfadE pJ294[alaDH_B.s._TA_C.v.(Ct)_Ptac-synUcTE]/pCDF[MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)]

These strains are employed to study their ability to produce alkylamines and glucose. The following procedure is adopted here:

The strains are subjected to a multistage aerobic culturing process. The strains under investigation are initially grown in Luria-Bertani Bouillon according to Miller (Merck, Darmstadt) containing 100 μg/ml of ampicillin and 100 μg/ml of spectinomycin as 5 ml preliminary culture each from an individual colony. The next culturing step proceeds in M9 medium. The medium consisting of 38 mM disodium hydrogenphosphate dihydrate, 22 mM potassium dihydrogenphosphate, 8.6 mM sodium chloride, 37 mM ammonium chloride, 2% (w/v) glucose, 2 mM magnesium sulphate heptahydrate (all substances from Merck, Darmstadt) and 0.1% (v/v) trace element solution is adjusted to a pH of 7.4 using 25% strength ammonium hydroxide solution. The added trace element solution consisting of 9.7 mM manganese(II) chloride tetrahydrate, 6.5 mM zinc sulphate heptahydrate, 2.5 mM sodium EDTA (Titriplex III), 4.9 mM boric acid, 1 mM sodium molybdate dihydrate, 32 mM calcium chloride dihydrate, 64 mM iron(II) sulphate heptahydrate and 0.9 mM copper(II) chloride dihydrate dissolved in 1 M hydrochloric acid (all substances from Merck, Darmstadt) is sterile-filtered before addition to the M9 medium. 10 ml of M9 medium are charged with 100 μg/ml of spectinomycin and 100 μg/ml of ampicillin in 100 ml conical flask with chicane and inoculated with 0.5 ml of the preliminary culture. Culturing proceeds at 37° C. and 200 rpm in an incubating shaker. After a culturing time of 8 hours, 50 ml of M9 medium containing 100 μg/ml of spectinomycin and 100 μg/ml of ampicillin are charged in a 250 ml conical flask with chicane and inoculated with the 10 ml culture, in such a manner that an optical density (600 nm) of 0.2 is achieved. The culturing proceeds at 37° C. and 200 rpm in an incubating shaker. When an optical density (600 nm) of 0.6 to 0.8 is achieved, the gene expression is induced by addition of 1 mM IPTG. The strains are cultured for at least a further 24 hours at 30° C. and 200 rpm. During the culturing, samples are withdrawn and the concentration of fatty aldehydes of differing carbon chain lengths is quantified. It is shown that the strains E. coli JW5020-1 Kan^S pJ294[alaDH_B.s._TA_C.v.(Ct)_Ptac-ChFATB1_optEc]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)], E. coli JW5020-1 Kan^S pJ294[alaDH_B.s._TA_C.v.(Ct)_Ptac-ChFATB2_optEc]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)] and E. coli W3110 ΔfadE pJ294[alaDH_B.s._TA_C.v.(Ct)_Ptac-synUcTE]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)] are able, depending on the specificity of the overexpressed alkyl-CoA thioesterase gene, to form alkylamines of differing carbon chain length and differing degree of saturation in comparison with the corresponding strains which do not overexpress the alkL gene. In particular, E. coli JW5020-1 Kan^S pJ294[alaDH_B.s._TA_C.v.(Ct)_Ptac-ChFATB1_optEc]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)] can produce from glucose more alkylamines of chain length C14:0, C16:0 and C16:1, E. coli JW5020-1 Kan^S pJ294[alaDH_B.s._TA_C.v.(Ct)_Ptac-ChFATB2_optEc]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)] can produce from glucose more alkylamines of chain length C8:0 and C10:0 and E. coli W3110 ΔfadE pJ294[alaDH_B.s._TA_C.v.(Ct)_Ptac-synUcTE]/pCDF[alkL][MSMEG_—2956(co_Ec)-npt_Noc(co_Ec)] can produce from glucose more alkylamines of chain length C12:0 and C14:0 than the corresponding strains which lack the gene alkL from Pseudomonas putida GPo1.

Example 26

Preparation of E. coli Expression Vectors for the Expression of Various Acyl-CoA Reductases for Preparation of Fatty Alcohols and Fatty Aldehydes

The gene Maqu_—2220 (SEQ ID No. 137) from Marinobacter aquaeolei VT8 or Maqu_—2507 (SEQ ID No. 139) from Marinobacter aquaeolei VT8 or AtFAR6 (SEQ ID No. 141) from Arabidopsis thaliana or AcrM (SEQ ID No. 143) from Acinetobacter sp. M-1 or Acr1a (SEQ ID No. 145) from Acinetobacter sp. ADP1 or Acr1b (SEQ ID No. 147) from Acinetobacter sp. ADP1 (in each case encoding an enzyme E_x) was cloned into a pJ294 derivative (DNA2.0 Inc., Menlo Park, Calif., USA) following the P_lac promotor (SEQ ID No. 149) via the cleavage sites NdeI and NotI. The genes Maqu_—2220, Maqu_—2507, AtFAR6, AcrM and Acr1a are codon-optimized sequences for E-coli. The Acr1b gene is the wild type sequence. All codon-optimizations were carried out by DNA2.0 (DNA2.0 Inc., Menlo Park, Calif., USA). The DNA sequences were held in a vector specific to DNA2.0.

The genes Maqu_—2220, Maqu_—2507, AtFAR6 and AcrM were amplified using the polymerase chain reaction (PCR), while introducing the restriction cleavage sites NdeI (at the 5′ end of the respective gene) and NotI (at the 3′ end of the respective gene) as described hereinafter. The matrices used were the vectors from DNA2.0 (DNA2.0 Inc., Menlo Park, Calif., USA) pJ221[Maqu_—2220(co_ec)], pJ207[Maqu_—2507(co_Ec)], pJ201[AtFAR6(co_Ec)] and pJ221[AcrM(AsM1)].

The oliaonucleotides hereinafter were used in the PCR solutions:

			Seq
			ID
Gene	Primer	Sequence (5′ => 3′)	NO.
Maqu_2220	Pr-DesFA-	TATATACATATGGCAATTCAGCAGGT	150
	1-FW	ACATCACG
	Pr-DesFA-	TATATAGCGGCCGCTCATTACGCGGC	151
	1-RV	CTTTTTGC
Maqu_2507	Pr-DesFA-	TATATACATATGAACTATTTTCTTAC	152
	2-FW	AGGCGGTACAGG
	Pr-DesFA-	TATATAGCGGCCGCTTATTACCAGTA	153
	2-RV	AATACCACGCATAATTGC
AtFAR6	Pr-DesFA-	TATATACATATGGCGACGACGAATGT	154
	3-FW	ACTGGC
	Pr-DesFA-	TATATAGCGGCCGCTTATTACTCGGT	155
	3-RV	TTTCTTCTTGCTCAGG
AcrM	Pr-DesFA-	TATATACATATGAATGCAAAACTCAA	156
	5-FW	AAAACTTTTTCAGC
	Pr-DesFA-	TATATAGCGGCCGCTTATTACCAGTG	157
	5-RV	TTCGCCTGGG

The following parameters were used for the PCRs: 1×: initial denaturation, 98° C., 0:30 min; 35 x: denaturation, 98° C., 0:30 min, annealing, 50° C. (Maqu_—2220) 160° C. (Maqu_—2507, AcrM, AtFAR6), 0:20 min; elongation, 72° C., 0:35 min; 1×: terminal elongation, 72° C., 5 min. The Phusion™ High-Fidelity Master Mix from New England Biolabs (Frankfurt) was used for the amplification in accordance with the manufacturer's recommendations. 50 μl of the PCR reactions in each case were then separated on a 1% strength agarose gel. The PCR, the agarose gel electrophoresis, ethidium bromide staining of the DNA and determination of the PCR fragment sizes was carried out in the manner known to those skilled in the art. The genes Acr1a and Acr1b from Acinetobacter sp. ADP1 were cloned via in-vitro cloning using the “GeneArt® Seamless Cloning and Assembly Kit” (Cat. No. A13288, Life Technologies GmbH, Darmstadt) in accordance with the manufacturer's instructions. For this purpose, both genes were amplified by PCR, while introducing homologous regions for recombination cloning. The matrices used were the DNA2.0 vector pJ221[Acr1a_AsADP1(co_Ec)] and the vector pCDF{Ptac}[fadD_Ec-acr1b_AsADP1] (SEQ ID No. 109).

The oligonucleotides hereinafter were used in the PCR solutions:

Gene	Primer	Sequence (5′ => 3′)	Seq
			ID NO.
Acr1a	Pr-FA_4.1-	AACAGGAGGTAAAACATTGATCTC	158
	FW	GATCCGTGAAAAACGT
	Pr-FA_4.1-	TGAAGTGGGGGCGGCCTTATCACC	159
	RV	AGTGCTCACCCGGGAA
Acr1b	Pr-	AACAGGAGGTAAAACAGTGAACAA	160
	DesFA_4.2-	AAAACTTGAAGCTCTC
	FW
	Pr-	TGAAGTGGGGGCGGCCTTATTACC	161
	DesFA_4.2-	AGTGTTCGCCTGGGAA
	RV

The following parameters were used for the PCRs: 1×: initial denaturation, 98° C., 0:30 min; 35×: denaturation, 98° C., 0:30 min, annealing, 64° C., 0:20 min; elongation, 72° C., 0:15 min; 1×: terminal elongation, 72° C., 5 min. The Phusion™ High-Fidelity Master Mix from New England Biolabs (Frankfurt) was used for the amplification in accordance with the manufacturer's recommendations. 50 μl of the PCR reactions in each case were then separated on a 1% strength agarose gel. The PCR, the agarose gel electrophoresis, ethidium bromide staining of the DNA and determination of the PCR fragment sizes were carried out in the manner known to those skilled in the art.

In all cases, PCR fragments of the expected size were able to be amplified. These were 1568 base pairs (bp) for Maqu_—2220, 2012 by for Maqu_—2507, 1673 by for AtFAR6, 914 by for AcrM, 947 by for Acr1a and 923 base pairs for Acr1b 923.

To isolate the DNA from an agarose gel, the target DNA was cut out of the gel using a scalpel and purified using the “Quick Gel Extraction Kit” from Qiagen (Hilden). The procedure was carried out according to the manufacturer's instructions.

In the next step, the PCR products of Maqu_—2220, Maqu_—2507, AtFAR6 and AcrM, just like the pJ294 derivate (DNA2.0 Inc., Menlo Park, Calif., USA), were cut using the restriction enzymes NdeI and NotI (New England Biolabs, Frankfurt) in accordance with the manufacturer's instructions. The cut vector was then applied to a 1% strength agarose gel. The agarose gel electrophoresis, ethidium bromide staining of the DNA and determination of the fragment sizes were carried out in the manner known to those skilled in the art. To isolate the DNA from an agarose gel, the target DNA was cut out from the gel using a scalpel and purified with the “Quick Gel Extraction Kit” from Qiagen (Hilden). The procedure was carried out according to the manufacturer's instructions. The NdeI-NotI-cut PCR amplificates Maqu_—2220, Maqu_—2507, AtFAR6 and AcrM were then ligated in each case with the NdeI-NotI-cut vector via the T4 DNA ligase (New England Biolabs, Frankfurt) in accordance with the manufacturer's instructions, obtaining the resultant vectors.

The PCR products of Acr1a and Acr1b from Acinetobacter sp. ADP1 were recombined together with the NdeII-NotI-cut pJ294 derivative using in-vitro cloning, using the “GeneArt® Seamless Cloning and Assembly Kit” (Cat. No. A13288, Life Technologies GmbH, Darmstadt), obtaining the resulting vectors. The use corresponded to the manufacturer's recommendations. The vector pJ294 is a E. coli expression vector which imparts an ampicillin resistance to the organism, and bears a p15A replication origin. Upstream of the cleavage site NdeI there is a P_lac promotor. The transformation of chemically competent E. coli DH5α cells (New England Biolabs, Frankfurt) proceeded in the manner known to those skilled in the art.

The correctness of the respective plasmid was controlled by restriction analysis using NruI. The authenticity of the inserted fragments was checked by DNA sequencing.

The completed E. coli expression vectors were named as follows:

	Vector name	Vector	Gene	SEQ ID No.
	pHg-12-58	pJ294	Maqu_2220	162
	pHg-12-59	pJ294	Maqu_2507	163
	pHg-12-60	pJ294	AtFAR6	164
	pHg-12-61	pJ294	AcrM	165
	pHg-12-62	pJ294	Acr1a	166
	pHg-12-63	pJ294	Acr1b	167

Example 27

Production of Fatty Alcohols and Fatty Aldehydes by E. coli Strains Having a Deletion in the fadE Gene and Expression Vectors for the Genes Maqu_—2220 from Marinobacter aquaeolei VT8, Maqu_—2507 from Marinobacter aquaeolei VT8, AtFAR6 from Arabidopsis thaliana, AcrM from Acinetobacter sp. M-1, Acr1 from Acinetobacter sp. ADP1 or Acr1 from Acinetobacter calcoaceticus in Combination with an Expression Vector for the alkL Gene from Pseudomonas putida

First, a E. coli W3110 strain having a deletion in the fadE gene is produced as described in Example 4.

To generate E. coli strains having the expression vector for the alkL gene from Pseudomonas putida GPo1 in combination with the expression vector for the Maqu_—2220 gene from Marinobacter aquaeolei VT8 or Maqu_—2507 from Marinobacter aquaeolei VT8 or AtFAR6 from Arabidopsis thaliana or AcrM from Acinetobacter sp. M-1 or Acr1 from Acinetobacter sp. ADP1 or Acr1 from Acinetobacter calcoaceticus, electrocompetent cells of E. coli W3110 ΔfadE and E. coli JW5020-1 Kan^S were prepared. This proceeds in a manner known to those skilled in the art. The host strain E. coli JW5020-1 Kan^S is a descendant of the E. coli JW5020-1 (CSGC, The coli genetic stock center, Yale University, New Haven, USA) and is a E. coli BW25113 derivative which carries a deletion of the fadE gene. The fadE gene was replaced by a kanamycin cassette. It was removed in a manner known to those skilled in the art (see Datsenko K. A. and Wanner B. L. (2000) PNAS 97(12):6640-6645) before the strain is equipped with the expression vectors using a helper plasmid which encodes the Hp recombinase, resulting in strain E. coli JW5020-1 Kan^S.

The competent cells were transformed with the plasmids pCDFDuet-1 or pCDF[alkL] in combination with pHg-12-58 or pHg-12-59 or pHg-12-60 or pHg-12-61 or pHg-12-62 or pHg-12-63 and plated out on LB plates containing spectinomycin (100 μg/ml) and ampicillin (100 μg/ml). Transformants were examined with respect to the presence of the correct plasmids via plasmid preparation and analytical restriction analysis.

In this manner the E. coli strains hereinafter were generated:

• • E. coli W3110 ΔfadE pCDF[alkL]/pHg-12-58
  • E. coli W3110 ΔfadE pCDF[alkL]/pHg-12-59
  • E. coli W3110 ΔfadE pCDF[alkL]/pHg-12-60
  • E. coli W3110 ΔfadE pCDF[alkL]/pHg-12-61
  • E. coli W3110 ΔfadE pCDF[alkL]/pHg-12-62
  • E. coli W3110 ΔfadE pCDF[alkL]/pHg-12-63
  • E. coli W3110 ΔfadE pCDFDuet-1/pHg-12-58
  • E. coli W3110 ΔfadE pCDFDuet-1/pHg-12-59
  • E. coli W3110 ΔfadE pCDFDuet-1/pHg-12-60
  • E. coli W3110 ΔfadE pCDFDuet-1/pHg-12-61
  • E. coli W3110 ΔfadE pCDFDuet-1/pHg-12-62
  • E. coli W3110 ΔfadE pCDFDuet-1/pHg-12-63
  • E. coli JW5020-1 Kan^s ΔfadE pCDF[alkL]/pHg-12-58
  • E. coli JW5020-1 Kan^s ΔfadE pCDF[alkL]/pHg-12-59
  • E. coli JW5020-1 Kan^s ΔfadE pCDF[alkL]/pHg-12-60
  • E. coli JW5020-1 Kan^s ΔfadE pCDF[alkL]/pHg-12-61
  • E. coli JW5020-1 Kan^s ΔfadE pCDF[alkL]/pHg-12-62
  • E. coli JW5020-1 Kan^s ΔfadE pCDF[alkL]/pHg-12-63
  • E. coli JW5020-1 Kan^s ΔfadE pCDFDuet-1/pHg-12-58
  • E. coli JW5020-1 Kan^s ΔfadE pCDFDuet-1/pHg-12-59
  • E. coli JW5020-1 Kan^s ΔfadE pCDFDuet-1/pHg-12-60
  • E. coli JW5020-1 Kan^s ΔfadE pCDFDuet-1/pHg-12-61
  • E. coli JW5020-1 Kan^s ΔfadE pCDFDuet-1/pHg-12-62
  • E. coil JW5020-1 Kan^s ΔfadE pCDFDuet-1/pHg-12-63

These strains are employed to investigate their ability to produce fatty alcohols and fatty aldehydes from glucose. The following procedure is followed here:

The strains are subjected to a multistage aerobic culturing process. The strains under examination are initially grown in Luria-Bertani Bouillon according to Miller (Merck, Darmstadt) as a 5 ml preliminary culture from an individual colony in each case. The next culturing step proceeds in M9 medium. The medium consisting of 38 mM disodium hydrogenphosphate dihydrate, 22 mM potassium dihydrogenphosphate, 8.6 mM sodium chloride, 37 mM ammonium chloride, 2% (w/v) glucose, 2 mM magnesium sulphate heptahydrate (all substances from Merck, Darmstadt) and 0.1% (v/v) trace element solution is adjusted to a pH of 7.4 using 25% strength ammonium hydroxide solution. The added trace element solution consisting of 9.7 mM manganese(II) chloride tetrahydrate, 6.5 mM zinc sulphate heptahydrate, 2.5 mM sodium EDTA (Titriplex III), 4.9 mM boric acid, 1 mM sodium molybdate dihydrate, 32 mM calcium chloride dihydrate, 64 mM iron(II) sulphate heptahydrate and 0.9 mM copper(II) chloride dihydrate dissolved in 1 M hydrochloric acid (all substances from Merck, Darmstadt) is sterile-filtered before addition to the M9 medium. 10 ml of M9 medium are charged with 100 μg/ml of spectinomycin and 100 μg/ml of ampicillin into 100 ml conical flasks with chicane and inoculated with 0.5 ml of the preliminary culture. The culturing proceeds at 37° C. and 200 rpm in an incubating shaker. After a culturing time of 8 hours, 50 ml of M9 medium containing 100 μg/ml of spectinomycin and 100 μg/ml of ampicillin are charged in a 250 ml conical flask with chicane and inoculated with the 10 ml culture in such a manner that an optical density (600 nm) of 0.2 is achieved. The culturing proceeds at 37° C. and 200 rpm in an incubating shaker. When an optical density (600 nm) of 0.6 to 0.8 is achieved, the gene expression is induced by adding 1 mM of IPTG. The strains are cultured for a further 48 hours at 30° C. and 200 rpm in an incubating shaker. During the culturing, samples of 1 ml are withdrawn and the concentration of fatty alcohols and fatty aldehydes of differing carbon chain lengths is quantified using the method described in Example 18. It is shown that the strains E. coli W3110 ΔfadE pCDF[alkL]/pHg-12-58, E. coli W3110 ΔfadE pCDF[alkL]/pHg-12-59, E. coli W3110 ΔfadE pCDF[alkL]/pHg-12-60, E. coli W3110 ΔfadE pCDF[alkL]/pHg-12-61, E. coli W3110 ΔfadE pCDF[alkL]/pHg-12-62, E. coli W3110 ΔfadE pCDF[alkL]/pHg-12-63 and the strains E. coli JW5020-1 Kan^s ΔfadE pCDF[alkL]/pHg-12-58, E. coli JW5020-1 Kan^s ΔfadE pCDF[alkL]/pHg-12-59, E. coli JW5020-1 Kan^s ΔfadE pCDF[alkL]/pHg-12-60, E. coli JW5020-1 Kan^s ΔfadE pCDF[alkL]/pHg-12-61, E. coli JW5020-1 Kan^s ΔfadE pCDF[alkL]/pHg-12-62 and E. coli JW5020-1 Kan^s ΔfadE pCDF[alkL]/pHg-12-63 can produce a higher titre of fatty alcohols and fatty aldehydes of differing chain length from glucose than the strains which lack the gene alkL from Pseudomonas putida GPo1. In particular, E. coli W3110 ΔfadE pCDF[alkL]/pHg-12-58 can produce more fatty alcohols and fatty aldehydes of chain length C14:0, C16:0 and C16:1, E. coli W3110 ΔfadE pCDF[alkL]/pHg-12-59 can produce more fatty alcohols and fatty aldehydes of chain length C14:0, C16:0 and C16:1, E. coli W3110 ΔfadE pCDF[alkL]/pHg-12-60 can produce more fatty alcohols and fatty aldehydes of chain length C16:0 and C16:1, E. coli W3110 ΔfadE pCDF[alkL]/pHg-12-61 can produce more fatty alcohols and fatty aldehydes of chain length C8:0 and 010:0, E. coli W3110 ΔfadE pCDF[alkL]/pHg-12-62 can produce more fatty alcohols and fatty aldehydes of chain length C12:0 and C14:0, E. coli W3110 ΔfadE pCDF[alkL]/pHg-12-63 can produce more fatty alcohols and fatty aldehydes of chain length C12:0 and C14:0, E. coli JW5020-1 Kan^s ΔfadE pCDF[alkL]/pHg-12-58 can produce more fatty alcohols and fatty aldehydes of chain length C14:0, C16:0 and C16:1, E. coli JW5020-1 Kan^s ΔfadE pCDF[alkL]/pHg-12-59 can produce more fatty alcohols and fatty aldehydes of chain length C14:0, C16:0 and C16:1, E. coli JW5020-1 Kan^s ΔfadE pCDF[alkL]/pHg-12-60 can produce more fatty alcohols and fatty aldehydes of chain length C16:0 and C16:1, E. coli JW5020-1 Kan^s ΔfadE pCDF[alkL]/pHg-12-61 can produce more fatty alcohols and fatty aldehydes of chain length C8:0 and C10:0, E. coli JW5020-1 Kan^s ΔfadE pCDF[alkL]/pHg-12-62 can produce more fatty alcohols and fatty aldehydes of chain length C12:0 and C14:0 and E. coli JW5020-1 Kan^{s ΔfadE pCDF[alkL]/pHg-}12-63 can produce more fatty alcohols and fatty aldehydes of chain length C12:0 and C14:0 from glucose than the corresponding strains which lack the gene alkL from Pseudomonas putida GPo1.

Example 28

Preparation of E. coli Expression Vectors for the Gene oleT_JE from Jeotgalicoccus sp. ATCC 8456 for Preparation of Alkenes

For the preparation of expression vectors, the sequence of the gene oleT_JE (SEQ ID No. 168) from Jeotgalicoccus sp. ATCC 8456 (encoding an enzyme E_xi) was codon-optimized for expression in E. coli with DNA2.0 (DNA2.0 Inc., Menlo Park, Calif., USA) and synthesized in combination with the P_lac promotor (SEQ ID No. 149) or the P_lac promotor and the alkL gene (SEQ ID No. 1). The cloning of the constructs P_lac-oleT_JE (SEQ ID No. 170) and P_lac-oleT_JE-alkL (SEQ ID No. 171) proceeded in vectors specific to DNA2.0. Both constructs are terminated by a terminator sequence (SEQ ID No. 172). In addition, a cleavage site (EcoNI or NotI) was introduced upstream of the P_lac promotor and downstream of the terminator in each case. The synthesized DNA fragments P_lac-oleT_JE and P_lac-oleT_JE-alkL and the vector pCDFDuet-1 (Merck, Darmstadt) (SEQ ID No 53) were cut with the restriction endonucleases EcoNI and NotI (New England Biolabs, Frankfurt) in accordance with the manufacturer's instructions. The NdeI-NotI-cut constructs and the cut vector were then applied to a 1% strength agarose gel. The agarose gel electrophoresis, ethidium bromide staining of the DNA and determination of the fragment sizes was carried out in the manner known to those skilled in the art. For isolation of the DNA from an agarose gel, the target DNA was cut out from the gel with a scalpel and purified using the “Quick Gel Extraction Kit” from Qiagen (Hilden). The procedure was in accordance with the manufacturer's instructions.

Subsequently, the fragment P_lac-oleT_JE or P_lac-oleT_JE-alkL carried out was ligated into the vector pCDFDuet-1 vector via the T4 DNA ligase (New England Biolabs, Frankfurt) in accordance with the manufacturer's instructions, obtaining the resultant vectors.

The vector pCDFDuet-1 is an E. coli vector which imparts a spectinomycin/streptomycin resistance to the organism, and also carries a CoIDF13 replication origin. The transformations of chemically competent E. coli DH5α cells (New England Biolabs, Frankfurt) proceeded in the manner known to those skilled in the art.

The correctness of the respective plasmid was controlled by restriction analysis with EcoRV.

The authenticity of the inserted fragments was checked by DNA sequencing.

The completed E. coli expression vectors were named pHg-12-66 (pCDF[P_lac-oleT_JE]; SEQ ID No 173) and pHg-12-67 (pCDF[P_lac-oleT_JE-alkL]; SEQ ID No 174).

Example 29

Production of Alkenes by E. coli Strains Having a Deletion in the fadE Gene and Expression Vectors for the Genes fatB1 from Cuphea Hookeriana, fatB2 from Cuphea hookeriana, fatB3 from Cocos nucifera, synUcTE from Umbellularia californica in Combination with Expression Vectors for the Gene oleT_JE from Jeotgalicoccus Sp. ATCC 8456 and alkL from Pseudomonas putida

First, an E. coli W3110 strain having a deletion in the fadE gene is prepared as described in Example 4.

To generate E. coli strains having the expression vectors for the genes fatB1 from Cuphea palustris or fatB2 from Cuphea palustris or fatB3 from Cocos nucifera or synUcTE from Umbellularia californica in combination with the expression vectors for the gene oleT_JE from Jeotgalicoccus sp. ATCC 8456 or the genes oleT_JE from Jeotgalicoccus sp. ATCC 8456 and alkL from Pseudomonas putida, electrocompetent cells of E. coli W3110 ΔfadE and E. coli JW5020-1 Kan^S are prepared. This proceeds in a manner known to those skilled in the art. The host strain E. coli JW5020-1 Kan^s is a descendant of E. coli JW5020-1 (CSGC, The coli genetic stock center, Yale University, New Haven, USA) and is an E. coli BW25113 derivative which carries a deletion of the fadE gene. The fadE gene was replaced by a kanamycin cassette. This was removed in a manner known to those skilled in the art (see Datsenko K. A. and Wanner B. L. (2000) PNAS 97(12):6640-6645) before equipping the strain with the expression vectors using a helper plasmid which encodes the Flp recombinase, resulting in strain E. coli JW5020-1 Kan^S. The competent cells were transformed using the plasmids pJ294[Ptac-ChFATB1_optEc] or pJ294[Ptac-ChFATB2_optEc] or pJ294{Ptac}[CnFATB3(co_Ec)] or pJ294[Ptac-synUcTE] in combination with pHg-12-66 or pHg-12-67 and plated onto LB plates containing ampicillin (100 μg/ml) and spectinomycin (100 μg/ml). Transformants were checked with respect to the presence of the correct plasmids by plasmid preparation and analytical restriction analysis.

In this manner the E. coli strains hereinafter were generated:

• • E. coli W3110 ΔfadE pJ294[Ptac-ChFATB1_optEc]/pHg-12-66
  • E. coli W3110 ΔfadE pJ294[Ptac-ChFATB1_optEc]/pHg-12-67
  • E. coli JW5020-1 Kan^s pJ294[Ptac-ChFATB1_optEc]/pHg-12-66
  • E. coli JW5020-1 Kan^s pJ294[Ptac-ChFATB1_optEc]/pHg-12-67
  • E. coli JW5020-1 Kan^s pJ294[Ptac-ChFATB2_optEc]/pHg-12-66
  • E. coli JW5020-1 Kan^s pJ294[Ptac-ChFATB2_optEc]/pHg-12-67
  • E. coli JW5020-1 Kan^s pJ294[Ptac-CnFATB3_optEc]/pHg-12-66
  • E. coli JW5020-1 Kan^s pJ294[Ptac-CnFATB3_optEc]/pHg-12-67
  • E. coli W3110 ΔfadE pJ294[Ptac-synUcTE]/pHg-12-66
  • E. coli W3110 ΔfadE pJ294[Ptac-synUcTE]/pHg-12-67

These strains are employed in order to investigate their ability to produce alkenes via the production of fatty acids from glucose. The following procedure is used:

The strains are subjected to a multistage aerobic culturing process. The strains under examination are initially grown in Luria-Bertani Bouillon according to Miller (Merck, Darmstadt) as a 5 ml preliminary culture each from a single colony. The next culturing step proceeds in M9 medium. The medium consisting of 38 mM disodium hydrogenphosphate dihydrate, 22 mM potassium dihydrogenphosphate, 8.6 mM sodium chloride, 37 mM ammonium chloride, 2% (w/v) glucose, 2 mM magnesium sulphate heptahydrate (all substances from Merck, Darmstadt) and 0.1% (v/v) trace element solution is adjusted to a pH of 7.4 using 25% strength ammonium hydroxide solution. The added trace element solution consisting of 9.7 mM manganese(II) chloride tetrahydrate, 6.5 mM zinc sulphate heptahydrate, 2.5 mM sodium EDTA (Titriplex III), 4.9 mM boric acid, 1 mM sodium molybdate dihydrate, 32 mM calcium chloride dihydrate, 64 mM iron(II) sulphate heptahydrate and 0.9 mM copper(II) chloride dihydrate dissolved in 1M hydrochloric acid (all substances from Merck, Darmstadt) is sterile-filtered before addition to the M9 medium. 10 ml of M9 medium are charged with 100 μg/ml of spectinomycin and 100 μg/ml of ampicillin into 100 ml conical flasks having chicane and inoculated with 0.5 ml from the preliminary culture. The culturing proceeds at 37° C. and 200 rpm in an incubating shaker. After a culturing time of 8 hours, 50 ml of M9 medium containing 100 μg/ml of spectinomycin and 100 μg/ml of ampicillin are charged in a 250 ml conical flask with chicane and inoculated with the 10 ml culture in such a manner that an optical density (600 nm) of 0.2 is achieved. The culturing proceeds at 37° C. and 200 rpm in an incubating shaker. On reaching an optical density (600 nm) of 0.6 to 0.8, the gene expression is induced by addition of 1 mM IPTG. The strains are cultured for a further 48 hours at 30° C. and 200 rpm in an incubating shaker. During the culturing, samples of 1 ml are withdrawn and the concentration of free fatty acids and alkenes of differing carbon chain lengths are quantified using the method described in Example 30. It is shown that the strains E. coli W3110 ΔfadE pJ294[Ptac-ChFATB1_optEc]/pHg-12-67, E. coli JW5020-1 Kan^s pJ294[Ptac-ChFATB1_optEc]/pHg-12-67, E. coli JW5020-1 Kan^s pJ294[Ptac-ChFATB2_optEc]/pHg-12-67, E. coli JW5020-1 Kan^s pJ294[Ptac-CnFATB3_optEc]/pHg-12-67 and E. coil W3110 ΔfadE pJ294[Ptac-synUcTE]/pHg-12-67 can produce higher titres of alkenes of different chain length from glucose than the strains which lack the gene alkL from Pseudomonas putida GPo1. In particular E. coli W3110 ΔfadE pJ294[Ptac-ChFATB1_optEc]/pHg-12-67 can produce more 1-alkenes of chain length C13 and C15 and also 1,8-dienes of chain length C15, E. coli JW5020-1 Kan^s pJ294[Ptac-ChFATB1_optEc]/pHg-12-67 can produce more 1-alkenes of chain length C13 and C15 and also 1,8-dienes of chain length C15, E. coli JW5020-1 Kan^s pJ294[Ptac-ChFATB2_optEc]/pHg-12-67 can produce more 1-alkenes of chain length C7 and C9, E. coil JW5020-1 Kan^s pJ294[Ptac-CnFATB3_optEc]/pHg-12-67 can produce more 1-alkenes of chain length C11 and C13 and also 1,8-dienes of chain length C15 and E. coli W3110 ΔfadE pJ294[Ptac-synUcTE]/pHg-12-67 can produce more 1-alkenes of chain length C11 and C13 from glucose than the corresponding strains which lack the gene alkL from Pseudomonas putida GPo1.

Example 30

Chromatographic Quantification of Alkenes

Alkenes are quantified by means of gas chromatography with coupled mass spectrometry (GC/MS).

To extract the samples, consisting of 1 ml of culture broth, they are admixed with 500 μl of ethyl acetate (Chromasolv®Plus 99.9%, Sigma No. 650528-1L), shaken for 10 min at 12 Hz and sedimented for 5 min at 13 200 rpm in a bench centrifuge (Eppendorf, Hamburg). The organic phase (ethyl acetate) is transferred to HPLC vials with an insert and analysed by means of coupled GC/MS for alkenes of differing chain length (C8-C18).

For separation of alkenes, the capillary column ZB-50 having the dimensions 30 m×320 μm and a film thickness of 0.5 μm (Phenomenex, Aschaffenburg) is used as stationary phase. The carrier gas used is helium at a constant flow rate of 1.5 ml/min. The separation proceeds in the course of 45 min at an injector temperature of 250° C. and a detector temperature of 250° C. The column temperature at the start is 40° C. and is held for 2 min. Subsequently, the column temperature is raised at 7° C./min to 150° C., then raised at 15° C./min to 320° C. and held for 10 min. The injection volume is 1 μl splitless. The detection proceeds by means of an MS (DSQ II) detector (Thermo Fisher Scientific) with a mass range of 12-800 m/z (0-8 min SIM at m/z 55.97). The reference substance employed for the alkenes is a standard mixture consisting of in each case 10 μg/ml 1-octene (Sigma-Aldrich), 1-decene (94%, Sigma-Aldrich), 1-dodecene (>99%, Sigma-Aldrich), 1-tetradecene (>97%, Sigma-Aldrich), 1-hexadecene (99.9%, Sigma-Aldrich), 1-octadecene (Sigma-Aldrich), for calibration. Relative quantification of the samples is performed via the peak areas.

Claims

1. A microorganism comprising: a first genetic modification so that the microorganism is capable of forming more of an organic substance from at least one simple carbon source in comparison to a wild type version of the microorganism, anda second genetic modification so that the microorganism forms more of an alkL gene product in comparison to a wild type version of the microorganism.

2. The microorganism of claim 1, wherein the organic substance is selected from the group consisting of: an optionally substituted carboxylic acid,an optionally substituted carboxylic acid ester,an optionally substituted alkane having 3 to 34 carbon atoms,an optionally substituted alkene having 3 to 34 carbon atoms,an optionally substituted monohydric alcohol having 3 to 34 carbon atoms,an optionally substituted aldehydes having 3 to 34 carbon atoms, andan optionally substituted monovalent amine having 3 to 34 carbon atoms.

3. The microorganism of claim 1, wherein the organic substance is selected from the group consisting of a fatty acid, a fatty acid ester, an alkan-1-al, and alkan-1-ol, an alkan-1-amine, and alkane and an alkene.

4. The microorganism of claim 1, wherein the alkL gene product is encoded by an alkL gene from a Gram-negative bacterium.

5. The microorganism of claim 1, wherein the alkL gene product is selected from the group consisting of: a protein encoded by SEQ ID NO: 1;a protein encoded by SEQ ID NO: 3;a protein comprising a polypeptide sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 32, and SEQ ID NO: 33; anda protein comprising a polypeptide sequence in which up to 60% of the amino acid residues are modified compared to SEQ ID NO: 2, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 32, or SEQ ID NO: 33 by deletion, insertion, substitution or a combination thereof, wherein the protein has at least 50% of an activity compared to SEQ ID NO: 2, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 32, or SEQ ID NO: 33, respectively.

6. The microorganism of claim 1, which is a Gram-negative bacterium.

7. The microorganism of claim 1, wherein the first genetic modification affects an activity of at least one enzyme selected from the group consisting of: Ei acyl-ACP thioesterase,Eii acyl-CoA thioesterase,Eiib acyl-CoA:ACP transacylase,Eiii polyketide synthase that catalyzes a reaction involved in the synthesis of carboxylic acids and carboxylic acid esters, andEiv hexanoic acid synthase,wherein the activity is increased in comparison to an enzymatic activity of the wild type version of the microorganism.

8. The microorganism of claim 1, further comprising a third genetic modification that affects an activity of at least one enzyme selected from the group consisting of: Eiib acyl-CoA:ACP transacylase,Ev wax ester synthase or alcohol O-acyl transferase,Eva fatty acid-O-methyltransferase that catalyzes the synthesis of a fatty acid methyl ester from a fatty acid and S-adenosylmethionine,Evi acyl-CoA synthetase, andEvii acyl thioesterase,wherein the activity is increased in comparison to an enzymatic activity of the wild type version of the microorganism.

9. The microorganism of claim 1, further comprising a fourth genetic modification that affects an activity of at least one enzyme selected from the group consisting of: Eiib acyl-CoA:ACP transacylase,Evi acyl-CoA synthetase,Eviii acyl-CoA reductase,Eix fatty acid reductase,Ex acyl-ACP reductase,Exi cytochrome P450 fatty acid decarboxylase that catalyzes the conversion of an alkanoic acid with n carbon atoms into a corresponding terminal olefin with n−1 carbon atoms,Exii alkan-1-al decarbonylase that catalyzes the conversion of an alkan-1-al (n carbon atoms) into a corresponding alkane (n−1 carbon atoms) or terminal olefin (n−1 carbon atoms), andExiii alkan-1-al transaminase that catalyzes the conversion of an alkan-1-al into a corresponding alkan-1-amine,wherein the activity is increased in comparison to an enzymatic activity of the wild type version of the microorganism.

10. The microorganism of claim 1, further comprising a fifth genetic modification that affects an activity of at least one enzyme selected from the group consisting of: Ea acyl-CoA synthetase (EC 6.2.1.3) that catalyzes the synthesis of an acyl-coenzyme A thioester,Eb acyl-CoA dehydrogenase (EC 1.3.99.-, EC 1.3.99.3 or EC 1.3.99.13) that catalyzes the oxidation of an acyl-coenzyme A thioester to give a corresponding enoyl-coenzyme A thioester,Ec acyl-CoA oxidase (EC 1.3.3.6) that catalyzes the oxidation of an acyl-coenzyme A thioester to give a corresponding enoyl-coenzyme A thioester,Ed enoyl-CoA hydratase (EC 4.2.1.17 or EC 4.2.1.74) that catalyzes the hydratization of an enoyl-coenzyme A thioester to give a corresponding 3-hydroxyacyl-coenzyme A thioester,Ef 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35 or EC 1.1.1.211) that catalyzes the oxidation of a 3-hydroxyacyl-coenzyme A thioester to give a corresponding 3-oxoacyl-coenzyme A thioester, andEg acetyl-CoA acyltransferase (EC 2.3.1.16) that catalyzes the transfer of an acetyl residue from a 3-oxoacyl-coenzyme A thioester to coenzymes A and thus generates an acyl-coenzyme A thioester that is shortened by two carbon atoms,wherein the activity is reduced in comparison to an enzymatic activity of the wild type version of the microorganism.

11. The microorganism of claim 1, further comprising a seventh genetic modification that affects an activity of at least one enzyme selected from the group consisting of: E1 P450 alkane hydroxylases,E1b AlkB alkane hydroxylases of EC 1.14.15.3,E1c fatty alcohol oxidases of EC 1.1.3.20,E1d AlkJ alcohol dehydrogenases of EC 1.1.99,E1e alcohol dehydrogenase of EC 1.1.1.1 or EC 1.1.1.2 andE1f aldehyde dehydrogenases of EC 1.2.1.3, EC 1.2.1.4 or EC 1.2.1.5wherein the activity is reduced in comparison to the wild type version of the microorganism.

12. (canceled)

13. A process for producing an organic substance from a simple carbon source, the process comprising I) contacting the microorganism of claim 1 with a medium comprising the simple carbon source,II) culturing the microorganism under conditions which make it possible for the microorganism to form the organic substance from the simple carbon source, andIII) optionally isolating the organic substance formed.